{
  "3201": {
    "title": "NHP2  Dyskeratosis Congenita",
    "label": "Dyskeratosis Congenita",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:14377": {
        "ontology": "HGNC",
        "curie": "HGNC:14377",
        "uri": "HGNC14377"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015780"
      },
      "OMIM613987": {
        "ontology": "OMIM",
        "curie": "OMIM:613987",
        "uri": "OMIM613987",
        "iri": "http://purl.obolibrary.org/obo/OMIM_613987"
      },
      "ORPHA1775": {
        "ontology": "ORPHA",
        "curie": "ORPHA:1775",
        "uri": "ORPHA1775",
        "iri": "http://www.orpha.net/ORDO/Orphanet_1775"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"NHP2\",\"Hgnc\":\"14377\",\"OrphaNet\":\"ORPHA1775\",\"Disease\":\"Dyskeratosis Congenita\",\"Omim\":\"613987\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"1.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.\",\"author\":\"Vulliamy T\",\"pubdate\":\"2008 Jun 10\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18523010\"}],\"notes\":{\"note\":\"Variant points were downgraded because later papers suggest that the null variant may still result in functional protein product.\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"1.0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Effects of dyskeratosis congenita mutations in dyskerin, NHP2 and NOP10 on assembly of H/ACA pre-RNPs.\",\"author\":\"Trahan C\",\"pubdate\":\"2010 Mar 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"20008900\"},{\"title\":\"Proteostatic control of telomerase function through TRiC-mediated folding of TCAB1.\",\"author\":\"Freund A\",\"pubdate\":\"2014 Dec 4\",\"source\":\"Cell\",\"uid\":\"25467444\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.5\",\"tally\":\"2.5\",\"pmid\":{\"publications\":[{\"title\":\"Stable expression in yeast of the mature form of human telomerase RNA depends on its association with the box H/ACA small nucleolar RNP proteins Cbf5p, Nhp2p and Nop10p.\",\"author\":\"Dez C\",\"pubdate\":\"2001 Feb 1\",\"source\":\"Nucleic Acids Res\",\"uid\":\"11160879\"},{\"title\":\"Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.\",\"author\":\"Vulliamy T\",\"pubdate\":\"2008 Jun 10\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18523010\"},{\"title\":\"Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.\",\"author\":\"Vulliamy T\",\"pubdate\":\"2008 Jun 10\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18523010\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"2\",\"GeneticEvidencePointsTotal\":\"2\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"6\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"08/04/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"01/25/2017\",\"FinalClassificationNotes\":\"During expert review, the expert added more experimental evidence; however, the clinical validity classification remained limited.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1485331200,
    "dateISO8601": "2017-01-25T00:00:00",
    "dateFormated": "Jan 25, 2017"
  },
  "3202": {
    "title": "RAD51C  Fanconi anemia",
    "label": "Fanconi anemia",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:9820": {
        "ontology": "HGNC",
        "curie": "HGNC:9820",
        "uri": "HGNC9820"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019391"
      },
      "OMIM613390": {
        "ontology": "OMIM",
        "curie": "OMIM:613390",
        "uri": "OMIM613390",
        "iri": "http://purl.obolibrary.org/obo/OMIM_613390"
      },
      "ORPHA84": {
        "ontology": "ORPHA",
        "curie": "ORPHA:84",
        "uri": "ORPHA84",
        "iri": "http://www.orpha.net/ORDO/Orphanet_84"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RAD51C\",\"Hgnc\":\"9820\",\"OrphaNet\":\"ORPHA84\",\"Disease\":\"Fanconi anemia\",\"Omim\":\"613390\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of the RAD51C gene in a Fanconi anemia-like disorder.\",\"author\":\"Vaz F\",\"pubdate\":\"2010 May\",\"source\":\"Nat Genet\",\"uid\":\"20400963\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of the RAD51C gene in a Fanconi anemia-like disorder.\",\"author\":\"Vaz F\",\"pubdate\":\"2010 May\",\"source\":\"Nat Genet\",\"uid\":\"20400963\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.\",\"author\":\"Somyajit K\",\"pubdate\":\"2012 Jan 27\",\"source\":\"J Biol Chem\",\"uid\":\"22167183\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"3.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of the RAD51C gene in a Fanconi anemia-like disorder.\",\"author\":\"Vaz F\",\"pubdate\":\"2010 May\",\"source\":\"Nat Genet\",\"uid\":\"20400963\"},{\"title\":\"Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.\",\"author\":\"Somyajit K\",\"pubdate\":\"2012 Jan 27\",\"source\":\"J Biol Chem\",\"uid\":\"22167183\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of the RAD51C gene in a Fanconi anemia-like disorder.\",\"author\":\"Vaz F\",\"pubdate\":\"2010 May\",\"source\":\"Nat Genet\",\"uid\":\"20400963\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5.5\",\"GeneticEvidenceTotal\":\"2\",\"GeneticEvidencePointsTotal\":\"2\",\"ExperimentalEvidencePointsTotal\":\"5.5\",\"EvidencePointsTotal\":\"7.5\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"06/01/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"01/05/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1483603200,
    "dateISO8601": "2017-01-05T00:00:00",
    "dateFormated": "Jan 05, 2017"
  },
  "3205": {
    "title": "RPS10  Diamond-Blackfan anemia",
    "label": "Diamond-Blackfan anemia",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:10383": {
        "ontology": "HGNC",
        "curie": "HGNC:10383",
        "uri": "HGNC10383"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015253"
      },
      "OMIM613308": {
        "ontology": "OMIM",
        "curie": "OMIM:613308",
        "uri": "OMIM613308",
        "iri": "http://purl.obolibrary.org/obo/OMIM_613308"
      },
      "ORPHA124": {
        "ontology": "ORPHA",
        "curie": "ORPHA:124",
        "uri": "ORPHA124",
        "iri": "http://www.orpha.net/ORDO/Orphanet_124"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RPS10\",\"Hgnc\":\"10383\",\"OrphaNet\":\"ORPHA124\",\"Disease\":\"Diamond-Blackfan anemia\",\"Omim\":\"613308\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia.\",\"author\":\"Doherty L\",\"pubdate\":\"2010 Feb 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"20116044\"},{\"title\":\"Clinical and genomic heterogeneity of Diamond Blackfan anemia in the Russian Federation.\",\"author\":\"Smetanina NS\",\"pubdate\":\"2015 Sep\",\"source\":\"Pediatr Blood Cancer\",\"uid\":\"25946618\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"10.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia.\",\"author\":\"Doherty L\",\"pubdate\":\"2010 Feb 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"20116044\"},{\"title\":\"Clinical and genomic heterogeneity of Diamond Blackfan anemia in the Russian Federation.\",\"author\":\"Smetanina NS\",\"pubdate\":\"2015 Sep\",\"source\":\"Pediatr Blood Cancer\",\"uid\":\"25946618\"},{\"title\":\"A novel mutation of ribosomal protein S10 gene in a Japanese patient with diamond-Blackfan anemia.\",\"author\":\"Yazaki M\",\"pubdate\":\"2012 May\",\"source\":\"J Pediatr Hematol Oncol\",\"uid\":\"22510774\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"A census of human soluble protein complexes.\",\"author\":\"Havugimana PC\",\"pubdate\":\"2012 Aug 31\",\"source\":\"Cell\",\"uid\":\"22939629\"},{\"title\":\"A high-throughput approach for measuring temporal changes in the interactome.\",\"author\":\"Kristensen AR\",\"pubdate\":\"2012 Sep\",\"source\":\"Nat Methods\",\"uid\":\"22863883\"},{\"title\":\"Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia.\",\"author\":\"Doherty L\",\"pubdate\":\"2010 Feb 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"20116044\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"13.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"07/04/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01/19/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1484812800,
    "dateISO8601": "2017-01-19T00:00:00",
    "dateFormated": "Jan 19, 2017"
  },
  "3206": {
    "title": "RPS24  Diamond-Blackfan anemia",
    "label": "Diamond-Blackfan anemia",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:10411": {
        "ontology": "HGNC",
        "curie": "HGNC:10411",
        "uri": "HGNC10411"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015253"
      },
      "OMIM610629": {
        "ontology": "OMIM",
        "curie": "OMIM:610629",
        "uri": "OMIM610629",
        "iri": "http://purl.obolibrary.org/obo/OMIM_610629"
      },
      "ORPHA124": {
        "ontology": "ORPHA",
        "curie": "ORPHA:124",
        "uri": "ORPHA124",
        "iri": "http://www.orpha.net/ORDO/Orphanet_124"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RPS24\",\"Hgnc\":\"10411\",\"OrphaNet\":\"ORPHA124\",\"Disease\":\"Diamond-Blackfan anemia\",\"Omim\":\"610629\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations.\",\"author\":\"Quarello P\",\"pubdate\":\"2010 Feb\",\"source\":\"Haematologica\",\"uid\":\"19773262\"},{\"title\":\"Novel deletion of RPL15 identified by array-comparative genomic hybridization in Diamond-Blackfan anemia.\",\"author\":\"Landowski M\",\"pubdate\":\"2013 Nov\",\"source\":\"Hum Genet\",\"uid\":\"23812780\"},{\"title\":\"Clinical and genomic heterogeneity of Diamond Blackfan anemia in the Russian Federation.\",\"author\":\"Smetanina NS\",\"pubdate\":\"2015 Sep\",\"source\":\"Pediatr Blood Cancer\",\"uid\":\"25946618\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia.\",\"author\":\"Gazda HT\",\"pubdate\":\"2006 Dec\",\"source\":\"Am J Hum Genet\",\"uid\":\"17186470\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder.\",\"author\":\"Choesmel V\",\"pubdate\":\"2008 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"18230666\"},{\"title\":\"A census of human soluble protein complexes.\",\"author\":\"Havugimana PC\",\"pubdate\":\"2012 Aug 31\",\"source\":\"Cell\",\"uid\":\"22939629\"},{\"title\":\"Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia.\",\"author\":\"Gazda HT\",\"pubdate\":\"2006 Dec\",\"source\":\"Am J Hum Genet\",\"uid\":\"17186470\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder.\",\"author\":\"Choesmel V\",\"pubdate\":\"2008 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"18230666\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3.5\",\"GeneticEvidenceTotal\":\"10.5\",\"GeneticEvidencePointsTotal\":\"10.5\",\"ExperimentalEvidencePointsTotal\":\"3.5\",\"EvidencePointsTotal\":\"14\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"07/04/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01/17/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1484812800,
    "dateISO8601": "2017-01-19T00:00:00",
    "dateFormated": "Jan 19, 2017"
  },
  "3207": {
    "title": "WRAP53  Dyskeratosis Congenita",
    "label": "Dyskeratosis Congenita",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:25522": {
        "ontology": "HGNC",
        "curie": "HGNC:25522",
        "uri": "HGNC25522"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015780"
      },
      "OMIM613988": {
        "ontology": "OMIM",
        "curie": "OMIM:613988",
        "uri": "OMIM613988",
        "iri": "http://purl.obolibrary.org/obo/OMIM_613988"
      },
      "ORPHA1775": {
        "ontology": "ORPHA",
        "curie": "ORPHA:1775",
        "uri": "ORPHA1775",
        "iri": "http://www.orpha.net/ORDO/Orphanet_1775"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"WRAP53\",\"Hgnc\":\"25522\",\"OrphaNet\":\"ORPHA1775\",\"Disease\":\"Dyskeratosis Congenita\",\"Omim\":\"613988\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"3.5\",\"tally\":\"3.5\",\"pmid\":{\"publications\":[{\"title\":\"Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.\",\"author\":\"Zhong F\",\"pubdate\":\"2011 Jan 1\",\"source\":\"Genes Dev\",\"uid\":\"21205863\"}],\"notes\":{\"note\":\"The expert chose to upgrade the variant points because of the specificity of the phenotype.\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.5\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Proteostatic control of telomerase function through TRiC-mediated folding of TCAB1.\",\"author\":\"Freund A\",\"pubdate\":\"2014 Dec 4\",\"source\":\"Cell\",\"uid\":\"25467444\"},{\"title\":\"Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.\",\"author\":\"Zhong F\",\"pubdate\":\"2011 Jan 1\",\"source\":\"Genes Dev\",\"uid\":\"21205863\"},{\"title\":\"WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies.\",\"author\":\"Mahmoudi S\",\"pubdate\":\"2010 Nov 2\",\"source\":\"PLoS Biol\",\"uid\":\"21072240\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"3.5\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.\",\"author\":\"Zhong F\",\"pubdate\":\"2011 Jan 1\",\"source\":\"Genes Dev\",\"uid\":\"21205863\"},{\"title\":\"Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.\",\"author\":\"Batista LF\",\"pubdate\":\"2011 May 22\",\"source\":\"Nature\",\"uid\":\"21602826\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.\",\"author\":\"Zhong F\",\"pubdate\":\"2011 Jan 1\",\"source\":\"Genes Dev\",\"uid\":\"21205863\"},{\"title\":\"WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies.\",\"author\":\"Mahmoudi S\",\"pubdate\":\"2010 Nov 2\",\"source\":\"PLoS Biol\",\"uid\":\"21072240\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"CuratorModifyCalculation\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"3.5\",\"GeneticEvidencePointsTotal\":\"3.5\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"9.5\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"08/04/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"01/25/2017\",\"FinalClassificationNotes\":\"This gene/disease relationship was initially classified as limited by the curator. During expert review, the expert added more experimental evidence and it was increased to moderate.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1485331200,
    "dateISO8601": "2017-01-25T00:00:00",
    "dateFormated": "Jan 25, 2017"
  },
  "3208": {
    "title": "AKAP9  Long QT syndrome",
    "label": "Long QT syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:379": {
        "ontology": "HGNC",
        "curie": "HGNC:379",
        "uri": "HGNC379"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0002442"
      },
      "OMIM611820": {
        "ontology": "OMIM",
        "curie": "OMIM:611820",
        "uri": "OMIM611820",
        "iri": "http://purl.obolibrary.org/obo/OMIM_611820"
      },
      "ORPHA101016": {
        "ontology": "ORPHA",
        "curie": "ORPHA:101016",
        "uri": "ORPHA101016",
        "iri": "http://www.orpha.net/ORDO/Orphanet_101016"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"AKAP9\",\"Hgnc\":\"379\",\"OrphaNet\":\"101016\",\"Disease\":\"Long Qt Syndrome \",\"Omim\":\"611820\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of an A-kinase-anchoring protein causes long-QT syndrome.\",\"author\":\"Chen L\",\"pubdate\":\"2007 Dec 26\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18093912\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel.\",\"author\":\"Marx SO\",\"pubdate\":\"2002 Jan 18\",\"source\":\"Science\",\"uid\":\"11799244\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of an A-kinase-anchoring protein causes long-QT syndrome.\",\"author\":\"Chen L\",\"pubdate\":\"2007 Dec 26\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18093912\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"0.5\",\"GeneticEvidencePointsTotal\":\"0.5\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"2\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"04/05/16\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/15/16\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1481788800,
    "dateISO8601": "2016-12-15T00:00:00",
    "dateFormated": "Dec 15, 2016"
  },
  "3209": {
    "title": "SCN4B  Long QT Syndrome",
    "label": "Long QT Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:10592": {
        "ontology": "HGNC",
        "curie": "HGNC:10592",
        "uri": "HGNC10592"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0002442"
      },
      "OMIM611819": {
        "ontology": "OMIM",
        "curie": "OMIM:611819",
        "uri": "OMIM611819",
        "iri": "http://purl.obolibrary.org/obo/OMIM_611819"
      },
      "ORPHA768": {
        "ontology": "ORPHA",
        "curie": "ORPHA:768",
        "uri": "ORPHA768",
        "iri": "http://www.orpha.net/ORDO/Orphanet_768"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SCN4B\",\"Hgnc\":\"10592\",\"OrphaNet\":\"ORPHA768\",\"Disease\":\"Long QT Syndrome\",\"Omim\":\"611819\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome.\",\"author\":\"Medeiros-Domingo A\",\"pubdate\":\"2007 Jul 10\",\"source\":\"Circulation\",\"uid\":\"17592081\"}],\"notes\":{\"note\":\"Only unrelated probands considered.\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome.\",\"author\":\"Medeiros-Domingo A\",\"pubdate\":\"2007 Jul 10\",\"source\":\"Circulation\",\"uid\":\"17592081\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome.\",\"author\":\"Medeiros-Domingo A\",\"pubdate\":\"2007 Jul 10\",\"source\":\"Circulation\",\"uid\":\"17592081\"}],\"notes\":{\"note\":\"8x increase in late sodium current by mutant form\"}}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"3\",\"GeneticEvidencePointsTotal\":\"2\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"3\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"06/14/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/15/16\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1481788800,
    "dateISO8601": "2016-12-15T00:00:00",
    "dateFormated": "Dec 15, 2016"
  },
  "3210": {
    "title": "SMAD3  Aneurysm-osteoarthritis syndrome",
    "label": "Aneurysm-osteoarthritis syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:6769": {
        "ontology": "HGNC",
        "curie": "HGNC:6769",
        "uri": "HGNC6769"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0013426"
      },
      "OMIM613795": {
        "ontology": "OMIM",
        "curie": "OMIM:613795",
        "uri": "OMIM613795",
        "iri": "http://purl.obolibrary.org/obo/OMIM_613795"
      },
      "ORPHA284984": {
        "ontology": "ORPHA",
        "curie": "ORPHA:284984",
        "uri": "ORPHA284984",
        "iri": "http://www.orpha.net/ORDO/Orphanet_284984"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SMAD3\",\"Hgnc\":\"6769\",\"OrphaNet\":\"ORPHA284984\",\"Disease\":\"Aneurysm-osteoarthritis syndrome\",\"Omim\":\"613795\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"},{\"title\":\"Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.\",\"author\":\"Regalado ES\",\"pubdate\":\"2011 Sep 2\",\"source\":\"Circ Res\",\"uid\":\"21778426\"},{\"title\":\"Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2012 Jan\",\"source\":\"J Med Genet\",\"uid\":\"22167769\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"},{\"title\":\"Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.\",\"author\":\"Regalado ES\",\"pubdate\":\"2011 Sep 2\",\"source\":\"Circ Res\",\"uid\":\"21778426\"},{\"title\":\"Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2012 Jan\",\"source\":\"J Med Genet\",\"uid\":\"22167769\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"},{\"title\":\"Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.\",\"author\":\"Regalado ES\",\"pubdate\":\"2011 Sep 2\",\"source\":\"Circ Res\",\"uid\":\"21778426\"}],\"notes\":{\"note\":\"\"}}}}},\"TotalGeneticEvidencePoints\":{\"notes\":\"Additional genetic evidence is available, but not curated due to achievement of maximum genetic evidence score.\"}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Transforming growth factor-beta and fibrosis.\",\"author\":\"Verrecchia F\",\"pubdate\":\"2007 Jun 14\",\"source\":\"World J Gastroenterol\",\"uid\":\"17589920\"},{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.5\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage.\",\"author\":\"Yang X\",\"pubdate\":\"2001 Apr 2\",\"source\":\"J Cell Biol\",\"uid\":\"11285272\"},{\"title\":\"SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS.\",\"author\":\"Tan CK\",\"pubdate\":\"2013 Jun 19\",\"source\":\"J Am Heart Assoc\",\"uid\":\"23782924\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"17\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"03/30/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/01/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1480579200,
    "dateISO8601": "2016-12-01T00:00:00",
    "dateFormated": "Dec 01, 2016"
  },
  "3211": {
    "title": "TMPO  Familial or idiopathic dilated cardiomyopathy",
    "label": "Familial or idiopathic dilated cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:11875": {
        "ontology": "HGNC",
        "curie": "HGNC:11875",
        "uri": "HGNC11875"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015470"
      },
      "OMIM613740": {
        "ontology": "OMIM",
        "curie": "OMIM:613740",
        "uri": "OMIM613740",
        "iri": "http://purl.obolibrary.org/obo/OMIM_613740"
      },
      "ORPHA154": {
        "ontology": "ORPHA",
        "curie": "ORPHA:154",
        "uri": "ORPHA154",
        "iri": "http://www.orpha.net/ORDO/Orphanet_154"
      }
    },
    "scores": {
      "3973": {
        "label": "Contradictory (refuted)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"TMPO\",\"Hgnc\":\"11875\",\"OrphaNet\":\"\",\"Disease\":\"Dilated Cardiomyopathy\",\"Omim\":\"115200\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"publications\":[{\"title\":\"Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.\",\"author\":\"Taylor MR\",\"pubdate\":\"2005 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"16247757\"}],\"notes\":{\"note\":\"c.2068C>T is classified as Benign/Likely Benign by ClinVar submitters.\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.\",\"author\":\"Taylor MR\",\"pubdate\":\"2005 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"16247757\"}],\"notes\":{\"note\":\"Interaction of mutated protein product with A-type Lamins\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"ValidContradictoryEvidence\":{\"YesNo\":\"YES\",\"pmid\":{\"publications\":{\"1484319977422\":{\"title\":\"Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.\",\"author\":\"Taylor MR\",\"pubdate\":\"2005 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"16247757\"}},\"notes\":{\"note\":\"The only variant that has been reported in association with human disease has been found at high publication frequency in ExAC.\"}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"0.5\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0.5\",\"EvidencePointsTotal\":\"0.5\",\"CalculatedClassification\":\"CONFLICTING EVIDENCE REPORTED\",\"CalculatedClassificationDate\":\"10/07/16\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"REFUTED\",\"FinalClassificationDate\":\"11/30/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1480492800,
    "dateISO8601": "2016-11-30T00:00:00",
    "dateFormated": "Nov 30, 2016"
  },
  "3212": {
    "title": "DICER1  Pleuropulmonary blastoma",
    "label": "Pleuropulmonary blastoma",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:17098": {
        "ontology": "HGNC",
        "curie": "HGNC:17098",
        "uri": "HGNC17098"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011014"
      },
      "OMIM601200": {
        "ontology": "OMIM",
        "curie": "OMIM:601200",
        "uri": "OMIM601200",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601200"
      },
      "ORPHA64742": {
        "ontology": "ORPHA",
        "curie": "ORPHA:64742",
        "uri": "ORPHA64742",
        "iri": "http://www.orpha.net/ORDO/Orphanet_64742"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"DICER1\",\"Hgnc\":\"17098\",\"OrphaNet\":\"ORPHA64742\",\"Disease\":\"Pleuropulmonary Blastoma\",\"Omim\":\"601200\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"12.0\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"DICER1 mutations in familial pleuropulmonary blastoma.\",\"author\":\"Hill DA\",\"pubdate\":\"2009 Aug 21\",\"source\":\"Science\",\"uid\":\"19556464\"},{\"title\":\"DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome.\",\"author\":\"Doros L\",\"pubdate\":\"2012 Sep\",\"source\":\"Pediatr Blood Cancer\",\"uid\":\"22180160\"},{\"title\":\"Nasal chondromesenchymal hamartomas arise secondary to germline and somatic mutations of DICER1 in the pleuropulmonary blastoma tumor predisposition disorder.\",\"author\":\"Stewart DR\",\"pubdate\":\"2014 Nov\",\"source\":\"Hum Genet\",\"uid\":\"25118636\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"DICER1 mutations in familial pleuropulmonary blastoma.\",\"author\":\"Hill DA\",\"pubdate\":\"2009 Aug 21\",\"source\":\"Science\",\"uid\":\"19556464\"},{\"title\":\"Dicer function is essential for lung epithelium morphogenesis.\",\"author\":\"Harris KS\",\"pubdate\":\"2006 Feb 14\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"16452165\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Dicer function is essential for lung epithelium morphogenesis.\",\"author\":\"Harris KS\",\"pubdate\":\"2006 Feb 14\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"16452165\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"05/06/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1483862400,
    "dateISO8601": "2017-01-08T00:00:00",
    "dateFormated": "Jan 08, 2017"
  },
  "3213": {
    "title": "PALB2  Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:26144": {
        "ontology": "HGNC",
        "curie": "HGNC:26144",
        "uri": "HGNC26144"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM114480": {
        "ontology": "OMIM",
        "curie": "OMIM:114480",
        "uri": "OMIM114480",
        "iri": "http://purl.obolibrary.org/obo/OMIM_114480"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PALB2\",\"Hgnc\":\"26144\",\"OrphaNet\":\"ORPHA227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"114480\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"7.5\",\"tally\":\"7.5\",\"pmid\":{\"publications\":[{\"title\":\"A recurrent mutation in PALB2 in Finnish cancer families.\",\"author\":\"Erkko H\",\"pubdate\":\"2007 Mar 15\",\"source\":\"Nature\",\"uid\":\"17287723\"},{\"title\":\"The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.\",\"author\":\"Heikkinen T\",\"pubdate\":\"2009 May 1\",\"source\":\"Clin Cancer Res\",\"uid\":\"19383810\"},{\"title\":\"Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.\",\"author\":\"Casadei S\",\"pubdate\":\"2011 Mar 15\",\"source\":\"Cancer Res\",\"uid\":\"21285249\"},{\"title\":\"Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada.\",\"author\":\"Hartley T\",\"pubdate\":\"2014\",\"source\":\"Hered Cancer Clin Pract\",\"uid\":\"25225577\"},{\"title\":\"The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.\",\"author\":\"Janatova M\",\"pubdate\":\"2013 Dec\",\"source\":\"Cancer Epidemiol Biomarkers Prev\",\"uid\":\"24136930\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada.\",\"author\":\"Hartley T\",\"pubdate\":\"2014\",\"source\":\"Hered Cancer Clin Pract\",\"uid\":\"25225577\"},{\"title\":\"The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.\",\"author\":\"Janatova M\",\"pubdate\":\"2013 Dec\",\"source\":\"Cancer Epidemiol Biomarkers Prev\",\"uid\":\"24136930\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"A recurrent mutation in PALB2 in Finnish cancer families.\",\"author\":\"Erkko H\",\"pubdate\":\"2007 Mar 15\",\"source\":\"Nature\",\"uid\":\"17287723\"},{\"title\":\"The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.\",\"author\":\"Heikkinen T\",\"pubdate\":\"2009 May 1\",\"source\":\"Clin Cancer Res\",\"uid\":\"19383810\"}],\"notes\":{\"note\":\"\"}}},\"AggregateVariantAnalysis\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis.\",\"author\":\"Cybulski C\",\"pubdate\":\"2015 Jun\",\"source\":\"Lancet Oncol\",\"uid\":\"25959805\"}]}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.\",\"author\":\"Xia B\",\"pubdate\":\"2006 Jun 23\",\"source\":\"Mol Cell\",\"uid\":\"16793542\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A recurrent mutation in PALB2 in Finnish cancer families.\",\"author\":\"Erkko H\",\"pubdate\":\"2007 Mar 15\",\"source\":\"Nature\",\"uid\":\"17287723\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.\",\"author\":\"Bowman-Colin C\",\"pubdate\":\"2013 May 21\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"23657012\"},{\"title\":\"Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.\",\"author\":\"Foo TK\",\"pubdate\":\"2017 Jul 20\",\"source\":\"Oncogene\",\"uid\":\"28319063\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"06/02/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/01/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1480579200,
    "dateISO8601": "2016-12-01T00:00:00",
    "dateFormated": "Dec 01, 2016"
  },
  "3215": {
    "title": "RAD51D  Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:9823": {
        "ontology": "HGNC",
        "curie": "HGNC:9823",
        "uri": "HGNC9823"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RAD51D\",\"Hgnc\":\"9823\",\"OrphaNet\":\"ORPHA227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.\",\"author\":\"Couch FJ\",\"pubdate\":\"2017 Sep 1\",\"source\":\"JAMA Oncol\",\"uid\":\"28418444\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Evidence for simultaneous protein interactions between human Rad51 paralogs.\",\"author\":\"Schild D\",\"pubdate\":\"2000 Jun 2\",\"source\":\"J Biol Chem\",\"uid\":\"10749867\"},{\"title\":\"RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors.\",\"author\":\"Martin RW\",\"pubdate\":\"2007 Oct 15\",\"source\":\"Cancer Res\",\"uid\":\"17942895\"},{\"title\":\"Identification and purification of two distinct complexes containing the five RAD51 paralogs.\",\"author\":\"Masson JY\",\"pubdate\":\"2001 Dec 15\",\"source\":\"Genes Dev\",\"uid\":\"11751635\"},{\"title\":\"Proteomics. Tissue-based map of the human proteome.\",\"author\":\"Uhl\\u00e9n M\",\"pubdate\":\"2015 Jan 23\",\"source\":\"Science\",\"uid\":\"25613900\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations in RAD51D confer susceptibility to ovarian cancer.\",\"author\":\"Loveday C\",\"pubdate\":\"2011 Aug 7\",\"source\":\"Nat Genet\",\"uid\":\"21822267\"},{\"title\":\"Extensive chromosomal instability in Rad51d-deficient mouse cells.\",\"author\":\"Smiraldo PG\",\"pubdate\":\"2005 Mar 15\",\"source\":\"Cancer Res\",\"uid\":\"15781618\"},{\"title\":\"The homologous recombination protein RAD51D protects the genome from large deletions.\",\"author\":\"Reh WA\",\"pubdate\":\"2017 Feb 28\",\"source\":\"Nucleic Acids Res\",\"uid\":\"27924006\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"4\",\"GeneticEvidencePointsTotal\":\"4\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"6\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"11/08/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1510128000,
    "dateISO8601": "2017-11-08T00:00:00",
    "dateFormated": "Nov 08, 2017"
  },
  "3216": {
    "title": "C1QB  Immunodeficiency due to an early component of complement deficiency",
    "label": "Immunodeficiency due to an early component of complement deficiency",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:1242": {
        "ontology": "HGNC",
        "curie": "HGNC:1242",
        "uri": "HGNC1242"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0013343"
      },
      "OMIM613652": {
        "ontology": "OMIM",
        "curie": "OMIM:613652",
        "uri": "OMIM613652",
        "iri": "http://purl.obolibrary.org/obo/OMIM_613652"
      },
      "ORPHA169147": {
        "ontology": "ORPHA",
        "curie": "ORPHA:169147",
        "uri": "ORPHA169147",
        "iri": "http://www.orpha.net/ORDO/Orphanet_169147"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"C1QB\",\"Hgnc\":\"1242\",\"OrphaNet\":\"ORPHA169147\",\"Disease\":\"Immunodeficiency due to an early component of complement deficiency\",\"Omim\":\"613652\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"2.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Molecular basis of a new type of C1q-deficiency associated with a non-functional low molecular weight (LMW) C1q: parallels and differences to other known genetic C1q-defects.\",\"author\":\"Petry F\",\"pubdate\":\"1997 Dec\",\"source\":\"Immunopharmacology\",\"uid\":\"9476130\"},{\"title\":\"C1q deficiency in an Inuit family: identification of a new class of C1q disease-causing mutations.\",\"author\":\"Marquart HV\",\"pubdate\":\"2007 Jul\",\"source\":\"Clin Immunol\",\"uid\":\"17513176\"},{\"title\":\"A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual.\",\"author\":\"McAdam RA\",\"pubdate\":\"1988\",\"source\":\"Immunogenetics\",\"uid\":\"2894352\"},{\"title\":\"Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy.\",\"author\":\"Troedson C\",\"pubdate\":\"2013 May\",\"source\":\"Lupus\",\"uid\":\"23651859\"},{\"title\":\"The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: a case report.\",\"author\":\"Higuchi Y\",\"pubdate\":\"2013 Oct 28\",\"source\":\"Pediatr Rheumatol Online J\",\"uid\":\"24160257\"},{\"title\":\"Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections.\",\"author\":\"van Schaarenburg RA\",\"pubdate\":\"2015 Mar\",\"source\":\"Immunobiology\",\"uid\":\"25454803\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.5\",\"tally\":\"3.5\",\"pmid\":{\"publications\":[{\"title\":\"C1q deficiency in an Inuit family: identification of a new class of C1q disease-causing mutations.\",\"author\":\"Marquart HV\",\"pubdate\":\"2007 Jul\",\"source\":\"Clin Immunol\",\"uid\":\"17513176\"},{\"title\":\"The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: a case report.\",\"author\":\"Higuchi Y\",\"pubdate\":\"2013 Oct 28\",\"source\":\"Pediatr Rheumatol Online J\",\"uid\":\"24160257\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections.\",\"author\":\"van Schaarenburg RA\",\"pubdate\":\"2015 Mar\",\"source\":\"Immunobiology\",\"uid\":\"25454803\"},{\"title\":\"The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: a case report.\",\"author\":\"Higuchi Y\",\"pubdate\":\"2013 Oct 28\",\"source\":\"Pediatr Rheumatol Online J\",\"uid\":\"24160257\"},{\"title\":\"A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual.\",\"author\":\"McAdam RA\",\"pubdate\":\"1988\",\"source\":\"Immunogenetics\",\"uid\":\"2894352\"},{\"title\":\"Molecular basis of a new type of C1q-deficiency associated with a non-functional low molecular weight (LMW) C1q: parallels and differences to other known genetic C1q-defects.\",\"author\":\"Petry F\",\"pubdate\":\"1997 Dec\",\"source\":\"Immunopharmacology\",\"uid\":\"9476130\"},{\"title\":\"C1q deficiency in an Inuit family: identification of a new class of C1q disease-causing mutations.\",\"author\":\"Marquart HV\",\"pubdate\":\"2007 Jul\",\"source\":\"Clin Immunol\",\"uid\":\"17513176\"},{\"title\":\"Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections.\",\"author\":\"van Schaarenburg RA\",\"pubdate\":\"2015 Mar\",\"source\":\"Immunobiology\",\"uid\":\"25454803\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual.\",\"author\":\"McAdam RA\",\"pubdate\":\"1988\",\"source\":\"Immunogenetics\",\"uid\":\"2894352\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"C1q regulatory region polymorphism down-regulating murine c1q protein levels with linkage to lupus nephritis.\",\"author\":\"Miura-Shimura Y\",\"pubdate\":\"2002 Aug 1\",\"source\":\"J Immunol\",\"uid\":\"12133956\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"17\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"06/13/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01/09/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1483948800,
    "dateISO8601": "2017-01-09T00:00:00",
    "dateFormated": "Jan 09, 2017"
  },
  "3217": {
    "title": "CD3E  Severe combined immunodeficiency",
    "label": "Severe combined immunodeficiency",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:1674": {
        "ontology": "HGNC",
        "curie": "HGNC:1674",
        "uri": "HGNC1674"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015974"
      },
      "OMIM615615": {
        "ontology": "OMIM",
        "curie": "OMIM:615615",
        "uri": "OMIM615615",
        "iri": "http://purl.obolibrary.org/obo/OMIM_615615"
      },
      "ORPHA183660": {
        "ontology": "ORPHA",
        "curie": "ORPHA:183660",
        "uri": "ORPHA183660",
        "iri": "http://www.orpha.net/ORDO/Orphanet_183660"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CD3E\",\"Hgnc\":\"1674\",\"OrphaNet\":\"ORPHA183660\",\"Disease\":\"Severe combined immunodeficiency\",\"Omim\":\"615615\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency.\",\"author\":\"Soudais C\",\"pubdate\":\"1993 Jan\",\"source\":\"Nat Genet\",\"uid\":\"8490660\"},{\"title\":\"Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3.\",\"author\":\"de Saint Basile G\",\"pubdate\":\"2004 Nov\",\"source\":\"J Clin Invest\",\"uid\":\"15546002\"},{\"title\":\"Successful haploidentical hematopoietic stem cell transplantation in a patient with SCID due to CD3\\u03b5 deficiency: need for IgG-substitution 6 years later.\",\"author\":\"Fuehrer M\",\"pubdate\":\"2014 May\",\"source\":\"Klin Padiatr\",\"uid\":\"24515816\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"6.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\"}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Pairwise, cooperative and inhibitory interactions describe the assembly and probable structure of the T-cell antigen receptor.\",\"author\":\"Manolios N\",\"pubdate\":\"1991 Jul\",\"source\":\"EMBO J\",\"uid\":\"1828760\"},{\"title\":\"Structural analysis of low TCR-CD3 complex expression in T cells of an immunodeficient patient.\",\"author\":\"Thoenes G\",\"pubdate\":\"1992 Jan 5\",\"source\":\"J Biol Chem\",\"uid\":\"1370449\"},{\"title\":\"Successful haploidentical hematopoietic stem cell transplantation in a patient with SCID due to CD3\\u03b5 deficiency: need for IgG-substitution 6 years later.\",\"author\":\"Fuehrer M\",\"pubdate\":\"2014 May\",\"source\":\"Klin Padiatr\",\"uid\":\"24515816\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3.\",\"author\":\"de Saint Basile G\",\"pubdate\":\"2004 Nov\",\"source\":\"J Clin Invest\",\"uid\":\"15546002\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene.\",\"author\":\"Wang B\",\"pubdate\":\"1994 Sep 27\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"7937778\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5.5\",\"GeneticEvidenceTotal\":\"6\",\"GeneticEvidencePointsTotal\":\"6\",\"ExperimentalEvidencePointsTotal\":\"5.5\",\"EvidencePointsTotal\":\"11.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"05/26/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01/09/2017\",\"FinalClassificationNotes\":\"Expert agrees with decision to round up to \\\"Definitive,\\\" and is aware of additional unpublished genetic evidence to corroborate this claim.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1483948800,
    "dateISO8601": "2017-01-09T00:00:00",
    "dateFormated": "Jan 09, 2017"
  },
  "3220": {
    "title": "CHD1L  Renal or urinary tract malformation (CAKUT)",
    "label": "Renal or urinary tract malformation (CAKUT)",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:1916": {
        "ontology": "HGNC",
        "curie": "HGNC:1916",
        "uri": "HGNC1916"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019719"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA93545": {
        "ontology": "ORPHA",
        "curie": "ORPHA:93545",
        "uri": "ORPHA93545",
        "iri": "http://www.orpha.net/ORDO/Orphanet_93545"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CHD1L\",\"Hgnc\":\"1916\",\"OrphaNet\":\"ORPHA93545\",\"Disease\":\"Renal or urinary tract malformation (CAKUT)\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.5\",\"tally\":\"2.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract.\",\"author\":\"Hwang DY\",\"pubdate\":\"2014 Jun\",\"source\":\"Kidney Int\",\"uid\":\"24429398\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"CHD1L: a new candidate gene for congenital anomalies of the kidneys and urinary tract (CAKUT).\",\"author\":\"Brockschmidt A\",\"pubdate\":\"2012 Jun\",\"source\":\"Nephrol Dial Transplant\",\"uid\":\"22146311\"}],\"notes\":{\"note\":\"\"}}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"3.5\",\"GeneticEvidencePointsTotal\":\"2.5\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"3.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"05/25/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/18/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1479456000,
    "dateISO8601": "2016-11-18T00:00:00",
    "dateFormated": "Nov 18, 2016"
  },
  "3221": {
    "title": "FGFR3  Achondroplasia",
    "label": "Achondroplasia",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:3690": {
        "ontology": "HGNC",
        "curie": "HGNC:3690",
        "uri": "HGNC3690"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0007037"
      },
      "OMIM100800": {
        "ontology": "OMIM",
        "curie": "OMIM:100800",
        "uri": "OMIM100800",
        "iri": "http://purl.obolibrary.org/obo/OMIM_100800"
      },
      "ORPHA15": {
        "ontology": "ORPHA",
        "curie": "ORPHA:15",
        "uri": "ORPHA15",
        "iri": "http://www.orpha.net/ORDO/Orphanet_15"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"FGFR3\",\"Hgnc\":\"3690\",\"OrphaNet\":\"ORPHA15\",\"Disease\":\"Achondroplasia\",\"Omim\":\"100800\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.\",\"author\":\"Rousseau F\",\"pubdate\":\"1994 Sep 15\",\"source\":\"Nature\",\"uid\":\"8078586\"}],\"notes\":{\"note\":\"Additional cases are available beyond those in this reference.\"}}},\"ProbandWithLOF\":{\"value\":\"10.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.\",\"author\":\"Rousseau F\",\"pubdate\":\"1994 Sep 15\",\"source\":\"Nature\",\"uid\":\"8078586\"},{\"title\":\"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.\",\"author\":\"Shiang R\",\"pubdate\":\"1994 Jul 29\",\"source\":\"Cell\",\"uid\":\"7913883\"}],\"notes\":{\"note\":\"Additional cases are available beyond those in these references.\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.\",\"author\":\"Rousseau F\",\"pubdate\":\"1994 Sep 15\",\"source\":\"Nature\",\"uid\":\"8078586\"}],\"notes\":{\"note\":\"\"}}}}},\"TotalGeneticEvidencePoints\":{\"notes\":\"Additional genetic evidence is available beyond this maximum score.\"}},\"ExperimentalEvidence\":{\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3.\",\"author\":\"Naski MC\",\"pubdate\":\"1998 Dec\",\"source\":\"Development\",\"uid\":\"9811582\"},{\"title\":\"Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.\",\"author\":\"Cho JY\",\"pubdate\":\"2004 Jan 13\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"14699054\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.\",\"author\":\"Wang Y\",\"pubdate\":\"1999 Apr 13\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"10200283\"}],\"notes\":{\"note\":\"\"}}},\"TotalExperimentalEvidencePoints\":{\"notes\":\"Additional experimental data may be available.\"}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"15\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"04/05/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/01/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1480579200,
    "dateISO8601": "2016-12-01T00:00:00",
    "dateFormated": "Dec 01, 2016"
  },
  "4841": {
    "title": "SKI Shprintzen-Goldberg syndrome",
    "label": "Shprintzen-Goldberg syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:10896": {
        "ontology": "HGNC",
        "curie": "HGNC:10896",
        "uri": "HGNC10896"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0008426"
      },
      "OMIM182212": {
        "ontology": "OMIM",
        "curie": "OMIM:182212",
        "uri": "OMIM182212",
        "iri": "http://purl.obolibrary.org/obo/OMIM_182212"
      },
      "ORPHA2462": {
        "ontology": "ORPHA",
        "curie": "ORPHA:2462",
        "uri": "ORPHA2462",
        "iri": "http://www.orpha.net/ORDO/Orphanet_2462"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SKI\",\"Hgnc\":\"10896\",\"OrphaNet\":\"ORPHA2462\",\"Disease\":\"Shprintzen-Goldberg syndrome\",\"Omim\":\"182212\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the TGF-\\u03b2 repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm.\",\"author\":\"Doyle AJ\",\"pubdate\":\"2012 Nov\",\"source\":\"Nat Genet\",\"uid\":\"23023332\"},{\"title\":\"In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome.\",\"author\":\"Carmignac V\",\"pubdate\":\"2012 Nov 2\",\"source\":\"Am J Hum Genet\",\"uid\":\"23103230\"}],\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"12.0\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome.\",\"author\":\"Carmignac V\",\"pubdate\":\"2012 Nov 2\",\"source\":\"Am J Hum Genet\",\"uid\":\"23103230\"},{\"title\":\"Mutations in the TGF-\\u03b2 repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm.\",\"author\":\"Doyle AJ\",\"pubdate\":\"2012 Nov\",\"source\":\"Nat Genet\",\"uid\":\"23023332\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome.\",\"author\":\"Carmignac V\",\"pubdate\":\"2012 Nov 2\",\"source\":\"Am J Hum Genet\",\"uid\":\"23103230\"}],\"notes\":{\"note\":\"\"}}}}},\"TotalGeneticEvidencePoints\":{\"notes\":\"Additional genetic evidence available beyond 12 point maximum score.\"}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the TGF-\\u03b2 repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm.\",\"author\":\"Doyle AJ\",\"pubdate\":\"2012 Nov\",\"source\":\"Nat Genet\",\"uid\":\"23023332\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the TGF-\\u03b2 repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm.\",\"author\":\"Doyle AJ\",\"pubdate\":\"2012 Nov\",\"source\":\"Nat Genet\",\"uid\":\"23023332\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the TGF-\\u03b2 repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm.\",\"author\":\"Doyle AJ\",\"pubdate\":\"2012 Nov\",\"source\":\"Nat Genet\",\"uid\":\"23023332\"}],\"notes\":{\"note\":\"\"}}},\"TotalExperimentalEvidencePoints\":{\"notes\":\"Additional experimental data may be available.\"}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4.5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4.5\",\"EvidencePointsTotal\":\"16.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"06/02/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/01/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1480579200,
    "dateISO8601": "2016-12-01T00:00:00",
    "dateFormated": "Dec 01, 2016"
  },
  "4842": {
    "title": "ATF6 Achromatopsia",
    "label": "Achromatopsia",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:791": {
        "ontology": "HGNC",
        "curie": "HGNC:791",
        "uri": "HGNC791"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018852"
      },
      "OMIM616517": {
        "ontology": "OMIM",
        "curie": "OMIM:616517",
        "uri": "OMIM616517",
        "iri": "http://purl.obolibrary.org/obo/OMIM_616517"
      },
      "ORPHA49382": {
        "ontology": "ORPHA",
        "curie": "ORPHA:49382",
        "uri": "ORPHA49382",
        "iri": "http://www.orpha.net/ORDO/Orphanet_49382"
      }
    },
    "scores": {
      "3978": {
        "label": "Strong"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"ATF6\",\"Hgnc\":\"791\",\"OrphaNet\":\"ORPHA49382\",\"Disease\":\"Achromatopsia\",\"Omim\":\"616517\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"3.5\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ATF6 causes autosomal recessive achromatopsia.\",\"author\":\"Ansar M\",\"pubdate\":\"2015 Sep\",\"source\":\"Hum Genet\",\"uid\":\"26063662\"},{\"title\":\"Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia.\",\"author\":\"Kohl S\",\"pubdate\":\"2015 Jul\",\"source\":\"Nat Genet\",\"uid\":\"26029869\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"9.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ATF6 causes autosomal recessive achromatopsia.\",\"author\":\"Ansar M\",\"pubdate\":\"2015 Sep\",\"source\":\"Hum Genet\",\"uid\":\"26063662\"},{\"title\":\"Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia.\",\"author\":\"Kohl S\",\"pubdate\":\"2015 Jul\",\"source\":\"Nat Genet\",\"uid\":\"26029869\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ATF6 causes autosomal recessive achromatopsia.\",\"author\":\"Ansar M\",\"pubdate\":\"2015 Sep\",\"source\":\"Hum Genet\",\"uid\":\"26063662\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of ATF6 causes autosomal recessive achromatopsia.\",\"author\":\"Ansar M\",\"pubdate\":\"2015 Sep\",\"source\":\"Hum Genet\",\"uid\":\"26063662\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia.\",\"author\":\"Kohl S\",\"pubdate\":\"2015 Jul\",\"source\":\"Nat Genet\",\"uid\":\"26029869\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"14\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"14\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"06/01/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"11/16/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1479283200,
    "dateISO8601": "2016-11-16T00:00:00",
    "dateFormated": "Nov 16, 2016"
  },
  "4843": {
    "title": "COL2A1 Spondyloepiphyseal dysplasia Stanescu type",
    "label": "Spondyloepiphyseal dysplasia (Stanescu type)",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:2200": {
        "ontology": "HGNC",
        "curie": "HGNC:2200",
        "uri": "HGNC2200"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0014701"
      },
      "OMIM616583": {
        "ontology": "OMIM",
        "curie": "OMIM:616583",
        "uri": "OMIM616583",
        "iri": "http://purl.obolibrary.org/obo/OMIM_616583"
      },
      "ORPHA": {
        "ontology": "ORPHA",
        "curie": "ORPHA:",
        "uri": "ORPHA",
        "iri": "http://www.orpha.net/ORDO/Orphanet_"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"COL2A1\",\"Hgnc\":\"2200\",\"OrphaNet\":\"N/A\",\"Disease\":\"Spondyloepiphyseal dysplasia (Stanescu type)\",\"Omim\":\"616583\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Novel COL2A1 variant (c.619G>A, p.Gly207Arg) manifesting as a phenotype similar to progressive pseudorheumatoid dysplasia and spondyloepiphyseal dysplasia, Stanescu type.\",\"author\":\"Jurgens J\",\"pubdate\":\"2015 Oct\",\"source\":\"Hum Mutat\",\"uid\":\"26183434\"},{\"title\":\"Pathogenenic variant in the COL2A1 gene is associated with Spondyloepiphyseal dysplasia type Stanescu.\",\"author\":\"Hammarsj\\u00f6 A\",\"pubdate\":\"2016 Jan\",\"source\":\"Am J Med Genet A\",\"uid\":\"26420734\"}],\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Novel COL2A1 variant (c.619G>A, p.Gly207Arg) manifesting as a phenotype similar to progressive pseudorheumatoid dysplasia and spondyloepiphyseal dysplasia, Stanescu type.\",\"author\":\"Jurgens J\",\"pubdate\":\"2015 Oct\",\"source\":\"Hum Mutat\",\"uid\":\"26183434\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Characterization of an arginine 789 to cysteine substitution in alpha 1 (II) collagen chains of a patient with spondyloepiphyseal dysplasia.\",\"author\":\"Chan D\",\"pubdate\":\"1993 Jul 15\",\"source\":\"J Biol Chem\",\"uid\":\"8325895\"},{\"title\":\"Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia.\",\"author\":\"Vandenberg P\",\"pubdate\":\"1991 Sep 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"1881905\"},{\"title\":\"Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene.\",\"author\":\"Garofalo S\",\"pubdate\":\"1991 Nov 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"1946380\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia.\",\"author\":\"Vandenberg P\",\"pubdate\":\"1991 Sep 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"1881905\"},{\"title\":\"Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene.\",\"author\":\"Garofalo S\",\"pubdate\":\"1991 Nov 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"1946380\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"3\",\"GeneticEvidencePointsTotal\":\"3\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"9\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"05/25/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"12/01/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1480579200,
    "dateISO8601": "2016-12-01T00:00:00",
    "dateFormated": "Dec 01, 2016"
  },
  "4845": {
    "title": "PSD3 Antecubital Pterygium Syndrome",
    "label": "Antecubital pterygium syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:19093": {
        "ontology": "HGNC",
        "curie": "HGNC:19093",
        "uri": "HGNC19093"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0008339"
      },
      "OMIM178200": {
        "ontology": "OMIM",
        "curie": "OMIM:178200",
        "uri": "OMIM178200",
        "iri": "http://purl.obolibrary.org/obo/OMIM_178200"
      },
      "ORPHA2987": {
        "ontology": "ORPHA",
        "curie": "ORPHA:2987",
        "uri": "ORPHA2987",
        "iri": "http://www.orpha.net/ORDO/Orphanet_2987"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PSD3\",\"Hgnc\":\"19093\",\"OrphaNet\":\"N/A\",\"Disease\":\"Antecubital pterygium syndrome\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin.\",\"author\":\"Bayram Y\",\"pubdate\":\"2016 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"26752647\"}],\"notes\":{\"note\":\"Only unrelated probands considered.\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin.\",\"author\":\"Bayram Y\",\"pubdate\":\"2016 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"26752647\"}],\"notes\":{\"note\":\"LOD score 1.8\"}}}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"4.5\",\"GeneticEvidencePointsTotal\":\"4.5\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"4.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"06/03/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/24/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1479974400,
    "dateISO8601": "2016-11-24T00:00:00",
    "dateFormated": "Nov 24, 2016"
  },
  "5456": {
    "title": "HNRNPK Au-Kline Syndrome",
    "label": "Au-Kline Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "5044": {
        "ontology": "HGNC",
        "curie": "HGNC:5044",
        "uri": "HGNC5044"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018681"
      },
      "OMIM616580": {
        "ontology": "OMIM",
        "curie": "OMIM:616580",
        "uri": "OMIM616580",
        "iri": "http://purl.obolibrary.org/obo/OMIM_616580"
      },
      "ORPHA453499": {
        "ontology": "ORPHA",
        "curie": "ORPHA:453499",
        "uri": "ORPHA453499",
        "iri": "http://www.orpha.net/ORDO/Orphanet_453499"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"HNRNPK\",\"Hgnc\":\"5044\",\"OrphaNet\":\"453499\",\"Disease\":\"Au-Kline Syndrome; AUKS\",\"Omim\":\"616580\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"GeneMatcher aids in the identification of a new malformation syndrome with intellectual disability, unique facial dysmorphisms, and skeletal and connective tissue abnormalities caused by de novo variants in HNRNPK.\",\"author\":\"Au PY\",\"pubdate\":\"2015 Oct\",\"source\":\"Hum Mutat\",\"uid\":\"26173930\"},{\"title\":\"A de novo frameshift in HNRNPK causing a Kabuki-like syndrome with nodular heterotopia.\",\"author\":\"Lange L\",\"pubdate\":\"2016 Sep\",\"source\":\"Clin Genet\",\"uid\":\"26954065\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Cytoplasmic hnRNPK interacts with GSK3\\u03b2 and is essential for the osteoclast differentiation.\",\"author\":\"Fan X\",\"pubdate\":\"2015 Dec 7\",\"source\":\"Sci Rep\",\"uid\":\"26638989\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0.5\",\"GeneticEvidenceTotal\":\"6.5\",\"GeneticEvidencePointsTotal\":\"6\",\"ExperimentalEvidencePointsTotal\":\"0.5\",\"EvidencePointsTotal\":\"6.5\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"11/15/2016\",\"FinalClassificationNotes\":\"Evidence is rapidly emerging supporting the association between HNRNPK and Au-Kline syndrome.  Gallardo et al. published a paper in 2015 describing an Hnrnpk +/- haploinsufficient mouse, which they developed to study its role in tumorigenesis.  Personal communication with the senior author of that paper, Sean Post, in August 2016, revealed that the haploinsufficient mice appeared to have \\\"significant reduction in overall size and had numerous structural/bone abnormalities,\\\" remniscient of the human phenotype, though he clarified that his group is not able to formally assess them for these types of phenotypes.  Additionally, we are aware of at least one additional unpublished case - this evidence is not being formally considered, as it is not part of the public domain.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1479196800,
    "dateISO8601": "2016-11-15T00:00:00",
    "dateFormated": "Nov 15, 2016"
  },
  "5461": {
    "title": "LAMB1 Lissencephaly",
    "label": "Lissencephaly",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:6486": {
        "ontology": "HGNC",
        "curie": "HGNC:6486",
        "uri": "HGNC6486"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0014077"
      },
      "OMIM615191": {
        "ontology": "OMIM",
        "curie": "OMIM:615191",
        "uri": "OMIM615191",
        "iri": "http://purl.obolibrary.org/obo/OMIM_615191"
      },
      "ORPHA352682": {
        "ontology": "ORPHA",
        "curie": "ORPHA:352682",
        "uri": "ORPHA352682",
        "iri": "http://www.orpha.net/ORDO/Orphanet_352682"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"LAMB1\",\"Hgnc\":\"6486\",\"OrphaNet\":\"352682\",\"Disease\":\"Lissencephaly 5\",\"Omim\":\"615191\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.\",\"author\":\"Radmanesh F\",\"pubdate\":\"2013 Mar 7\",\"source\":\"Am J Hum Genet\",\"uid\":\"23472759\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"4.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.\",\"author\":\"Radmanesh F\",\"pubdate\":\"2013 Mar 7\",\"source\":\"Am J Hum Genet\",\"uid\":\"23472759\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Laminin beta1 and gamma1 containing laminins are essential for basement membrane integrity in the zebrafish eye.\",\"author\":\"Lee J\",\"pubdate\":\"2007 Jun\",\"source\":\"Invest Ophthalmol Vis Sci\",\"uid\":\"17525174\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"8\",\"GeneticEvidencePointsTotal\":\"8\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"9\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"11/03/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"11/15/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1479196800,
    "dateISO8601": "2016-11-15T00:00:00",
    "dateFormated": "Nov 15, 2016"
  },
  "5462": {
    "title": "LBR Anadysplasia-like, spontaneously remitting spondylometaphyseal dysplasia",
    "label": "Anadysplasia-like, spontaneously remitting spondylometaphyseal dysplasia",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:6518": {
        "ontology": "HGNC",
        "curie": "HGNC:6518",
        "uri": "HGNC6518"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018663"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA448267": {
        "ontology": "ORPHA",
        "curie": "ORPHA:448267",
        "uri": "ORPHA448267",
        "iri": "http://www.orpha.net/ORDO/Orphanet_448267"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"LBR\",\"Hgnc\":\"HGNC:6518\",\"OrphaNet\":\"ORPHA448267\",\"Disease\":\"Anadysplasia-like, spontaneously remitting spondylometaphyseal dysplasia\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"An anadysplasia-like, spontaneously remitting spondylometaphyseal dysplasia secondary to lamin B receptor (LBR) gene mutations: further definition of the phenotypic heterogeneity of LBR-bone dysplasias.\",\"author\":\"Sobreira N\",\"pubdate\":\"2015 Jan\",\"source\":\"Am J Med Genet A\",\"uid\":\"25348816\"},{\"title\":\"Pelger-huet anomaly and a mild skeletal phenotype secondary to mutations in LBR.\",\"author\":\"Borovik L\",\"pubdate\":\"2013 Aug\",\"source\":\"Am J Med Genet A\",\"uid\":\"23824842\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"4.0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Lamin B receptor: multi-tasking at the nuclear envelope.\",\"author\":\"Olins AL\",\"pubdate\":\"2010 Jan-Feb\",\"source\":\"Nucleus\",\"uid\":\"21327105\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Induction of a massive endoplasmic reticulum and perinuclear space expansion by expression of lamin B receptor mutants and the related sterol reductases TM7SF2 and DHCR7.\",\"author\":\"Zwerger M\",\"pubdate\":\"2010 Jan 15\",\"source\":\"Mol Biol Cell\",\"uid\":\"19940018\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutations at the mouse ichthyosis locus are within the lamin B receptor gene: a single gene model for human Pelger-Hu\\u00ebt anomaly.\",\"author\":\"Shultz LD\",\"pubdate\":\"2003 Jan 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"12490533\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2.5\",\"GeneticEvidenceTotal\":\"4\",\"GeneticEvidencePointsTotal\":\"4\",\"ExperimentalEvidencePointsTotal\":\"2.5\",\"EvidencePointsTotal\":\"6.5\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"12/01/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1480579200,
    "dateISO8601": "2016-12-01T00:00:00",
    "dateFormated": "Dec 01, 2016"
  },
  "5463": {
    "title": "VPS8 Arthrogryposis",
    "label": "Arthrogryposis",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:29122": {
        "ontology": "HGNC",
        "curie": "HGNC:29122",
        "uri": "HGNC29122"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015168"
      },
      "OMIM108120": {
        "ontology": "OMIM",
        "curie": "OMIM:108120",
        "uri": "OMIM108120",
        "iri": "http://purl.obolibrary.org/obo/OMIM_108120"
      },
      "ORPHA1037": {
        "ontology": "ORPHA",
        "curie": "ORPHA:1037",
        "uri": "ORPHA1037",
        "iri": "http://www.orpha.net/ORDO/Orphanet_1037"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"VPS8\",\"Hgnc\":\"HGNC:29122\",\"OrphaNet\":\"ORPHA1037\",\"Disease\":\"Arthrogryposis\",\"Omim\":\"108120\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin.\",\"author\":\"Bayram Y\",\"pubdate\":\"2016 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"26752647\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"A novel RING finger protein, Vps8p, functionally interacts with the small GTPase, Vps21p, to facilitate soluble vacuolar protein localization.\",\"author\":\"Horazdovsky BF\",\"pubdate\":\"1996 Dec 27\",\"source\":\"J Biol Chem\",\"uid\":\"8969229\"},{\"title\":\"The N-terminal domains of Vps3 and Vps8 are critical for localization and function of the CORVET tethering complex on endosomes.\",\"author\":\"Epp N\",\"pubdate\":\"2013\",\"source\":\"PLoS One\",\"uid\":\"23840658\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"0\"},\"ModelsRescue\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"0.5\",\"GeneticEvidencePointsTotal\":\"0.5\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"2\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"08/18/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/24/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1479974400,
    "dateISO8601": "2016-11-24T00:00:00",
    "dateFormated": "Nov 24, 2016"
  },
  "5465": {
    "title": "MYO9A Arthrogryposis",
    "label": "Arthrogryposis",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "7608": {
        "ontology": "HGNC",
        "curie": "HGNC:7608",
        "uri": "HGNC7608"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015225"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA109007": {
        "ontology": "ORPHA",
        "curie": "ORPHA:109007",
        "uri": "ORPHA109007",
        "iri": "http://www.orpha.net/ORDO/Orphanet_109007"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MYO9A\",\"Hgnc\":\"7608\",\"OrphaNet\":\"ORPHA109007\",\"Disease\":\"Arthrogryposis\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin.\",\"author\":\"Bayram Y\",\"pubdate\":\"2016 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"26752647\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"2.0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Myr 7 is a novel myosin IX-RhoGAP expressed in rat brain.\",\"author\":\"Chieregatti E\",\"pubdate\":\"1998 Dec 18\",\"source\":\"J Cell Sci\",\"uid\":\"9819351\"},{\"title\":\"The cloning and developmental expression of unconventional myosin IXA (MYO9A) a gene in the Bardet-Biedl syndrome (BBS4) region at chromosome 15q22-q23.\",\"author\":\"Gorman SW\",\"pubdate\":\"1999 Jul 15\",\"source\":\"Genomics\",\"uid\":\"10409426\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Myosin-IXA regulates collective epithelial cell migration by targeting RhoGAP activity to cell-cell junctions.\",\"author\":\"Omelchenko T\",\"pubdate\":\"2012 Feb 21\",\"source\":\"Curr Biol\",\"uid\":\"22305756\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"2\",\"GeneticEvidencePointsTotal\":\"2\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"3.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"09/08/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/24/2016\",\"FinalClassificationNotes\":\"The expert scored this at 3 points, which corresponded to a solid Limited classification.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1479974400,
    "dateISO8601": "2016-11-24T00:00:00",
    "dateFormated": "Nov 24, 2016"
  },
  "5466": {
    "title": "BAG3 Myofibrillar Myopathy",
    "label": "Myofibrillar Myopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:939": {
        "ontology": "HGNC",
        "curie": "HGNC:939",
        "uri": "HGNC939"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018943"
      },
      "OMIM612954": {
        "ontology": "OMIM",
        "curie": "OMIM:612954",
        "uri": "OMIM612954",
        "iri": "http://purl.obolibrary.org/obo/OMIM_612954"
      },
      "ORPHA593": {
        "ontology": "ORPHA",
        "curie": "ORPHA:593",
        "uri": "ORPHA593",
        "iri": "http://www.orpha.net/ORDO/Orphanet_593"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"BAG3\",\"Hgnc\":\"HGNC:939\",\"OrphaNet\":\"ORPHA593\",\"Disease\":\"myofibrillar myopathy 6\",\"Omim\":\"612954\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutation in BAG3 causes severe dominant childhood muscular dystrophy.\",\"author\":\"Selcen D\",\"pubdate\":\"2009 Jan\",\"source\":\"Ann Neurol\",\"uid\":\"19085932\"},{\"title\":\"Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation.\",\"author\":\"Odgerel Z\",\"pubdate\":\"2010 Jul\",\"source\":\"Neuromuscul Disord\",\"uid\":\"20605452\"},{\"title\":\"Unusual multisystemic involvement and a novel BAG3 mutation revealed by NGS screening in a large cohort of myofibrillar myopathies.\",\"author\":\"Semmler AL\",\"pubdate\":\"2014 Aug 1\",\"source\":\"Orphanet J Rare Dis\",\"uid\":\"25208129\"},{\"title\":\"BAG3 myofibrillar myopathy presenting with cardiomyopathy.\",\"author\":\"Konersman CG\",\"pubdate\":\"2015 May\",\"source\":\"Neuromuscul Disord\",\"uid\":\"25728519\"},{\"title\":\"BAG3-related myopathy, polyneuropathy and cardiomyopathy with long QT syndrome.\",\"author\":\"Kostera-Pruszczyk A\",\"pubdate\":\"2015 Dec\",\"source\":\"J Muscle Res Cell Motil\",\"uid\":\"26545904\"},{\"title\":\"Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy.\",\"author\":\"D\",\"pubdate\":\"2016 Jun\",\"source\":\"J Muscle Res Cell Motil\",\"uid\":\"27443559\"},{\"title\":\"BAG3 mutations: another cause of giant axonal neuropathy.\",\"author\":\"Jaffer F\",\"pubdate\":\"2012 Jun\",\"source\":\"J Peripher Nerv Syst\",\"uid\":\"22734908\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"BAG3 deficiency results in fulminant myopathy and early lethality.\",\"author\":\"Homma S\",\"pubdate\":\"2006 Sep\",\"source\":\"Am J Pathol\",\"uid\":\"16936253\"},{\"title\":\"Mutation in BAG3 causes severe dominant childhood muscular dystrophy.\",\"author\":\"Selcen D\",\"pubdate\":\"2009 Jan\",\"source\":\"Ann Neurol\",\"uid\":\"19085932\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"6.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"BAG3 deficiency results in fulminant myopathy and early lethality.\",\"author\":\"Homma S\",\"pubdate\":\"2006 Sep\",\"source\":\"Am J Pathol\",\"uid\":\"16936253\"},{\"title\":\"BAG3 and Hsc70 interact with actin capping protein CapZ to maintain myofibrillar integrity under mechanical stress.\",\"author\":\"Hishiya A\",\"pubdate\":\"2010 Nov 12\",\"source\":\"Circ Res\",\"uid\":\"20884878\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"7\",\"GeneticEvidencePointsTotal\":\"7\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"12\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/18/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1482048000,
    "dateISO8601": "2016-12-18T00:00:00",
    "dateFormated": "Dec 18, 2016"
  },
  "5479": {
    "title": "SMARCA1 Coffin-Siris syndrome",
    "label": "Coffin-Siris syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "HGNC:11097": {
        "ontology": "HGNC",
        "curie": "HGNC:11097",
        "uri": "HGNC11097"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015452"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA1465": {
        "ontology": "ORPHA",
        "curie": "ORPHA:1465",
        "uri": "ORPHA1465",
        "iri": "http://www.orpha.net/ORDO/Orphanet_1465"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SMARCA1\",\"Hgnc\":\"HGNC:11097\",\"OrphaNet\":\"ORPHA:1465\",\"Disease\":\"Coffin-Siris Syndrome\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease.\",\"author\":\"Karaca E\",\"pubdate\":\"2015 Nov 4\",\"source\":\"Neuron\",\"uid\":\"26539891\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Identification of novel genetic causes of Rett syndrome-like phenotypes.\",\"author\":\"Lopes F\",\"pubdate\":\"2016 Mar\",\"source\":\"J Med Genet\",\"uid\":\"26740508\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Identification of novel genetic causes of Rett syndrome-like phenotypes.\",\"author\":\"Lopes F\",\"pubdate\":\"2016 Mar\",\"source\":\"J Med Genet\",\"uid\":\"26740508\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"1.5\",\"GeneticEvidencePointsTotal\":\"1.5\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"4.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"06/14/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"06/14/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"11/15/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1479196800,
    "dateISO8601": "2016-11-15T00:00:00",
    "dateFormated": "Nov 15, 2016"
  },
  "5610": {
    "title": "CDH23 Usher Syndrome Type 1",
    "label": "Usher syndrome type 1",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "13733": {
        "ontology": "HGNC",
        "curie": "HGNC:13733",
        "uri": "HGNC13733"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010168"
      },
      "OMIM276900": {
        "ontology": "OMIM",
        "curie": "OMIM:276900",
        "uri": "OMIM276900",
        "iri": "http://purl.obolibrary.org/obo/OMIM_276900"
      },
      "ORPHA231169": {
        "ontology": "ORPHA",
        "curie": "ORPHA:231169",
        "uri": "ORPHA231169",
        "iri": "http://www.orpha.net/ORDO/Orphanet_231169"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CDH23\",\"Hgnc\":\"13733\",\"OrphaNet\":\"231169\",\"Disease\":\"Usher Syndrome, Type 1\",\"Omim\":\"276900\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"1.5\",\"tally\":\"10.5\",\"pmid\":{\"publications\":[{\"title\":\"Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23.\",\"author\":\"Bork JM\",\"pubdate\":\"2001 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"11090341\"},{\"title\":\"CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness.\",\"author\":\"Astuto LM\",\"pubdate\":\"2002 Aug\",\"source\":\"Am J Hum Genet\",\"uid\":\"12075507\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"9.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23.\",\"author\":\"Bork JM\",\"pubdate\":\"2001 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"11090341\"}],\"notes\":{\"note\":\"\"}}}}},\"TotalGeneticEvidencePoints\":{\"notes\":\"More genetic evidence is available but the curator stopped at the max score.\"}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"The Usher syndrome proteins cadherin 23 and harmonin form a complex by means of PDZ-domain interactions.\",\"author\":\"Siemens J\",\"pubdate\":\"2002 Nov 12\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"12407180\"}],\"notes\":{\"note\":\"Protein Interaction, Expression\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Nasal epithelial cells are a reliable source to study splicing variants in Usher syndrome.\",\"author\":\"Vach\\u00e9 C\",\"pubdate\":\"2010 Jun\",\"source\":\"Hum Mutat\",\"uid\":\"20513143\"}],\"notes\":{\"note\":\"Patient Cells\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Genomic structure, alternative splice forms and normal and mutant alleles of cadherin 23 (Cdh23).\",\"author\":\"Di Palma F\",\"pubdate\":\"2001 Dec 27\",\"source\":\"Gene\",\"uid\":\"11750125\"},{\"title\":\"An ENU-induced mutation of Cdh23 causes congenital hearing loss, but no vestibular dysfunction, in mice.\",\"author\":\"Manji SS\",\"pubdate\":\"2011 Aug\",\"source\":\"Am J Pathol\",\"uid\":\"21689626\"}],\"notes\":{\"note\":\"Animal model. The retinitis pigmentosa phenotype is not found in the mouse models.\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09/15/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01/30/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1485763200,
    "dateISO8601": "2017-01-30T00:00:00",
    "dateFormated": "Jan 30, 2017"
  },
  "5613": {
    "title": "OTOF: Nonsyndromic sensorineural Hearing Loss (Auditory Neuropathy)",
    "label": "Nonsyndromic sensorineural hearing loss (auditory neuropathy)",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "8515": {
        "ontology": "HGNC",
        "curie": "HGNC:8515",
        "uri": "HGNC8515"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010986"
      },
      "OMIM601071": {
        "ontology": "OMIM",
        "curie": "OMIM:601071",
        "uri": "OMIM601071",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601071"
      },
      "ORPHA90636": {
        "ontology": "ORPHA",
        "curie": "ORPHA:90636",
        "uri": "ORPHA90636",
        "iri": "http://www.orpha.net/ORDO/Orphanet_90636"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"OTOF\",\"Hgnc\":\"8515\",\"OrphaNet\":\"90636\",\"Disease\":\"Sensorineural Hearing Loss (Auditory Neuropathy)\",\"Omim\":\"601071\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"1.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness.\",\"author\":\"Yasunaga S\",\"pubdate\":\"1999 Apr\",\"source\":\"Nat Genet\",\"uid\":\"10192385\"},{\"title\":\"A novel mutation in a family with non-syndromic sensorineural hearing loss that disrupts the newly characterised OTOF long isoforms.\",\"author\":\"Houseman MJ\",\"pubdate\":\"2001 Aug\",\"source\":\"J Med Genet\",\"uid\":\"11483641\"},{\"title\":\"Substitutions in the conserved C2C domain of otoferlin cause DFNB9, a form of nonsyndromic autosomal recessive deafness.\",\"author\":\"Mirghomizadeh F\",\"pubdate\":\"2002 Jul\",\"source\":\"Neurobiol Dis\",\"uid\":\"12127154\"},{\"title\":\"A novel otoferlin splice-site mutation in siblings with auditory neuropathy spectrum disorder.\",\"author\":\"Runge CL\",\"pubdate\":\"2013\",\"source\":\"Audiol Neurootol\",\"uid\":\"24135434\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"6.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"11.5\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness.\",\"author\":\"Yasunaga S\",\"pubdate\":\"1999 Apr\",\"source\":\"Nat Genet\",\"uid\":\"10192385\"},{\"title\":\"A novel mutation in a family with non-syndromic sensorineural hearing loss that disrupts the newly characterised OTOF long isoforms.\",\"author\":\"Houseman MJ\",\"pubdate\":\"2001 Aug\",\"source\":\"J Med Genet\",\"uid\":\"11483641\"},{\"title\":\"Substitutions in the conserved C2C domain of otoferlin cause DFNB9, a form of nonsyndromic autosomal recessive deafness.\",\"author\":\"Mirghomizadeh F\",\"pubdate\":\"2002 Jul\",\"source\":\"Neurobiol Dis\",\"uid\":\"12127154\"},{\"title\":\"A novel otoferlin splice-site mutation in siblings with auditory neuropathy spectrum disorder.\",\"author\":\"Runge CL\",\"pubdate\":\"2013\",\"source\":\"Audiol Neurootol\",\"uid\":\"24135434\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"0\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"TotalGeneticEvidencePoints\":{\"notes\":\"More genetic evidence is available, but the curator stopped at the max score.\"}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness.\",\"author\":\"Yasunaga S\",\"pubdate\":\"1999 Apr\",\"source\":\"Nat Genet\",\"uid\":\"10192385\"},{\"title\":\"Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse.\",\"author\":\"Roux I\",\"pubdate\":\"2006 Oct 20\",\"source\":\"Cell\",\"uid\":\"17055430\"},{\"title\":\"Otoferlin interacts with myosin VI: implications for maintenance of the basolateral synaptic structure of the inner hair cell.\",\"author\":\"Heidrych P\",\"pubdate\":\"2009 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"19417007\"}],\"notes\":{\"note\":\"Expression, Protein Interaction\"}}},\"ModelsRescue\":{\"value\":\"4.5\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse.\",\"author\":\"Roux I\",\"pubdate\":\"2006 Oct 20\",\"source\":\"Cell\",\"uid\":\"17055430\"}],\"notes\":{\"note\":\"Animal Model\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5.5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"5.5\",\"EvidencePointsTotal\":\"17.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08/25/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01/30/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1485763200,
    "dateISO8601": "2017-01-30T00:00:00",
    "dateFormated": "Jan 30, 2017"
  },
  "5619": {
    "title": "NGLY1 Alacrimia-choreoathetosis-liver dysfunction syndrome",
    "label": "Alacrimia-choreoathetosis-liver dysfunction syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10026",
      "name": "General Gene Curation"
    },
    "genes": {
      "17646": {
        "ontology": "HGNC",
        "curie": "HGNC:17646",
        "uri": "HGNC17646"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0014109"
      },
      "OMIM615273": {
        "ontology": "OMIM",
        "curie": "OMIM:615273",
        "uri": "OMIM615273",
        "iri": "http://purl.obolibrary.org/obo/OMIM_615273"
      },
      "ORPHA404454": {
        "ontology": "ORPHA",
        "curie": "ORPHA:404454",
        "uri": "ORPHA404454",
        "iri": "http://www.orpha.net/ORDO/Orphanet_404454"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"NGLY1\",\"Hgnc\":\"17646\",\"OrphaNet\":\"ORPHA404454\",\"Disease\":\"Alacrimia-choreoathetosis-liver dysfunction syndrome\",\"Omim\":\"615273\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Clinical application of exome sequencing in undiagnosed genetic conditions.\",\"author\":\"Need AC\",\"pubdate\":\"2012 Jun\",\"source\":\"J Med Genet\",\"uid\":\"22581936\"},{\"title\":\"NGLY1 mutation causes neuromotor impairment, intellectual disability, and neuropathy.\",\"author\":\"Caglayan AO\",\"pubdate\":\"2015 Jan\",\"source\":\"Eur J Med Genet\",\"uid\":\"25220016\"},{\"title\":\"Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum-associated degradation pathway.\",\"author\":\"Enns GM\",\"pubdate\":\"2014 Oct\",\"source\":\"Genet Med\",\"uid\":\"24651605\"},{\"title\":\"Novel genetic causes for cerebral visual impairment.\",\"author\":\"Bosch DG\",\"pubdate\":\"2016 May\",\"source\":\"Eur J Hum Genet\",\"uid\":\"26350515\"},{\"title\":\"Multi-systemic involvement in NGLY1-related disorder caused by two novel mutations.\",\"author\":\"Heeley J\",\"pubdate\":\"2015 Apr\",\"source\":\"Am J Med Genet A\",\"uid\":\"25707956\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"10.0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Clinical application of exome sequencing in undiagnosed genetic conditions.\",\"author\":\"Need AC\",\"pubdate\":\"2012 Jun\",\"source\":\"J Med Genet\",\"uid\":\"22581936\"},{\"title\":\"A congenital disorder of deglycosylation: Biochemical characterization of N-glycanase 1 deficiency in patient fibroblasts.\",\"author\":\"He P\",\"pubdate\":\"2015 Aug\",\"source\":\"Glycobiology\",\"uid\":\"25900930\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Clinical application of exome sequencing in undiagnosed genetic conditions.\",\"author\":\"Need AC\",\"pubdate\":\"2012 Jun\",\"source\":\"J Med Genet\",\"uid\":\"22581936\"},{\"title\":\"Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum-associated degradation pathway.\",\"author\":\"Enns GM\",\"pubdate\":\"2014 Oct\",\"source\":\"Genet Med\",\"uid\":\"24651605\"},{\"title\":\"Multi-systemic involvement in NGLY1-related disorder caused by two novel mutations.\",\"author\":\"Heeley J\",\"pubdate\":\"2015 Apr\",\"source\":\"Am J Med Genet A\",\"uid\":\"25707956\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Endo-\\u03b2-N-acetylglucosaminidase forms N-GlcNAc protein aggregates during ER-associated degradation in Ngly1-defective cells.\",\"author\":\"Huang C\",\"pubdate\":\"2015 Feb 3\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"25605922\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"10\",\"GeneticEvidencePointsTotal\":\"10\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/01/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1480579200,
    "dateISO8601": "2016-12-01T00:00:00",
    "dateFormated": "Dec 01, 2016"
  },
  "5657": {
    "title": "PCDH15 Usher syndrome type 1",
    "label": "Usher syndrome type 1",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "14674": {
        "ontology": "HGNC",
        "curie": "HGNC:14674",
        "uri": "HGNC14674"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010168"
      },
      "OMIM602083": {
        "ontology": "OMIM",
        "curie": "OMIM:602083",
        "uri": "OMIM602083",
        "iri": "http://purl.obolibrary.org/obo/OMIM_602083"
      },
      "ORPHA231169": {
        "ontology": "ORPHA",
        "curie": "ORPHA:231169",
        "uri": "ORPHA231169",
        "iri": "http://www.orpha.net/ORDO/Orphanet_231169"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PCDH15\",\"Hgnc\":\"14674\",\"OrphaNet\":\"ORPHA231169\",\"Disease\":\"Usher syndrome type 1F\",\"Omim\":\"602083\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2001 Jul\",\"source\":\"Am J Hum Genet\",\"uid\":\"11398101\"},{\"title\":\"Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F.\",\"author\":\"Alagramam KN\",\"pubdate\":\"2001 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"11487575\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"16.5\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2001 Jul\",\"source\":\"Am J Hum Genet\",\"uid\":\"11398101\"},{\"title\":\"Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F.\",\"author\":\"Alagramam KN\",\"pubdate\":\"2001 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"11487575\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2001 Jul\",\"source\":\"Am J Hum Genet\",\"uid\":\"11398101\"},{\"title\":\"Photoreceptor expression of the Usher syndrome type 1 protein protocadherin 15 (USH1F) and its interaction with the scaffold protein harmonin (USH1C).\",\"author\":\"Reiners J\",\"pubdate\":\"2005 May 12\",\"source\":\"Mol Vis\",\"uid\":\"15928608\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"The mouse Ames waltzer hearing-loss mutant is caused by mutation of Pcdh15, a novel protocadherin gene.\",\"author\":\"Alagramam KN\",\"pubdate\":\"2001 Jan\",\"source\":\"Nat Genet\",\"uid\":\"11138007\"},{\"title\":\"A new spontaneous mutation in the mouse Ames waltzer gene, Pcdh15.\",\"author\":\"Hampton LL\",\"pubdate\":\"2003 Jun\",\"source\":\"Hear Res\",\"uid\":\"12782354\"},{\"title\":\"Drosophila melanogaster Cad99C, the orthologue of human Usher cadherin PCDH15, regulates the length of microvilli.\",\"author\":\"D\",\"pubdate\":\"2005 Nov 7\",\"source\":\"J Cell Biol\",\"uid\":\"16260500\"},{\"title\":\"Duplicated genes with split functions: independent roles of protocadherin15 orthologues in zebrafish hearing and vision.\",\"author\":\"Seiler C\",\"pubdate\":\"2005 Feb\",\"source\":\"Development\",\"uid\":\"15634702\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08/16/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/15/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1487145600,
    "dateISO8601": "2017-02-15T00:00:00",
    "dateFormated": "Feb 15, 2017"
  },
  "5658": {
    "title": "TMC1: Nonsyndromic sensorineural Hearing Loss",
    "label": "Nonsyndromic sensorineural hearing loss",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "16513": {
        "ontology": "HGNC",
        "curie": "HGNC:16513",
        "uri": "HGNC16513"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010967"
      },
      "OMIM600974": {
        "ontology": "OMIM",
        "curie": "OMIM:600974",
        "uri": "OMIM600974",
        "iri": "http://purl.obolibrary.org/obo/OMIM_600974"
      },
      "ORPHA90636": {
        "ontology": "ORPHA",
        "curie": "ORPHA:90636",
        "uri": "ORPHA90636",
        "iri": "http://www.orpha.net/ORDO/Orphanet_90636"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"TMC1\",\"Hgnc\":\"16513\",\"OrphaNet\":\"ORPHA90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"600974\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function.\",\"author\":\"Kurima K\",\"pubdate\":\"2002 Mar\",\"source\":\"Nat Genet\",\"uid\":\"11850618\"},{\"title\":\"Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7/11.\",\"author\":\"Hilgert N\",\"pubdate\":\"2008 Sep\",\"source\":\"Clin Genet\",\"uid\":\"18616530\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"10.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"22.5\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function.\",\"author\":\"Kurima K\",\"pubdate\":\"2002 Mar\",\"source\":\"Nat Genet\",\"uid\":\"11850618\"},{\"title\":\"Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7/11.\",\"author\":\"Hilgert N\",\"pubdate\":\"2008 Sep\",\"source\":\"Clin Genet\",\"uid\":\"18616530\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function.\",\"author\":\"Kurima K\",\"pubdate\":\"2002 Mar\",\"source\":\"Nat Genet\",\"uid\":\"11850618\"},{\"title\":\"Tip-link protein protocadherin 15 interacts with transmembrane channel-like proteins TMC1 and TMC2.\",\"author\":\"Maeda R\",\"pubdate\":\"2014 Sep 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"25114259\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Tmc1 is necessary for normal functional maturation and survival of inner and outer hair cells in the mouse cochlea.\",\"author\":\"Marcotti W\",\"pubdate\":\"2006 Aug 1\",\"source\":\"J Physiol\",\"uid\":\"16627570\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"5.5\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function.\",\"author\":\"Kurima K\",\"pubdate\":\"2002 Mar\",\"source\":\"Nat Genet\",\"uid\":\"11850618\"},{\"title\":\"Tmc gene therapy restores auditory function in deaf mice.\",\"author\":\"Askew C\",\"pubdate\":\"2015 Jul 8\",\"source\":\"Sci Transl Med\",\"uid\":\"26157030\"},{\"title\":\"Mechanotransduction in mouse inner ear hair cells requires transmembrane channel-like genes.\",\"author\":\"Kawashima Y\",\"pubdate\":\"2011 Dec\",\"source\":\"J Clin Invest\",\"uid\":\"22105175\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08/26/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/15/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1487145600,
    "dateISO8601": "2017-02-15T00:00:00",
    "dateFormated": "Feb 15, 2017"
  },
  "5660": {
    "title": "USH1G Usher syndrome type 1",
    "label": "Usher syndrome type 1",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "16356": {
        "ontology": "HGNC",
        "curie": "HGNC:16356",
        "uri": "HGNC16356"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010168"
      },
      "OMIM606943": {
        "ontology": "OMIM",
        "curie": "OMIM:606943",
        "uri": "OMIM606943",
        "iri": "http://purl.obolibrary.org/obo/OMIM_606943"
      },
      "ORPHA231169": {
        "ontology": "ORPHA",
        "curie": "ORPHA:231169",
        "uri": "ORPHA231169",
        "iri": "http://www.orpha.net/ORDO/Orphanet_231169"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"USH1G\",\"Hgnc\":\"16356\",\"OrphaNet\":\"ORPHA231169\",\"Disease\":\"Usher Syndrome, Type 1\",\"Omim\":\"606943\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"A novel locus for Usher syndrome type I, USH1G, maps to chromosome 17q24-25.\",\"author\":\"Mustapha M\",\"pubdate\":\"2002 Apr\",\"source\":\"Hum Genet\",\"uid\":\"11941484\"},{\"title\":\"Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin.\",\"author\":\"Weil D\",\"pubdate\":\"2003 Mar 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"12588794\"},{\"title\":\"Diversity of the Genes Implicated in Algerian Patients Affected by Usher Syndrome.\",\"author\":\"Abdi S\",\"pubdate\":\"2016 Sep 1\",\"source\":\"PLoS One\",\"uid\":\"27583663\"},{\"title\":\"Whole exome sequencing identifies mutations in Usher syndrome genes in profoundly deaf Tunisian patients.\",\"author\":\"Riahi Z\",\"pubdate\":\"2015 Mar 23\",\"source\":\"PLoS One\",\"uid\":\"25798947\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"8.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"A novel locus for Usher syndrome type I, USH1G, maps to chromosome 17q24-25.\",\"author\":\"Mustapha M\",\"pubdate\":\"2002 Apr\",\"source\":\"Hum Genet\",\"uid\":\"11941484\"},{\"title\":\"Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin.\",\"author\":\"Weil D\",\"pubdate\":\"2003 Mar 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"12588794\"},{\"title\":\"Whole exome sequencing identifies mutations in Usher syndrome genes in profoundly deaf Tunisian patients.\",\"author\":\"Riahi Z\",\"pubdate\":\"2015 Mar 23\",\"source\":\"PLoS One\",\"uid\":\"25798947\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin.\",\"author\":\"Weil D\",\"pubdate\":\"2003 Mar 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"12588794\"},{\"title\":\"Phosphorylation of the Usher syndrome 1G protein SANS controls Magi2-mediated endocytosis.\",\"author\":\"Bau\\u00df K\",\"pubdate\":\"2014 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"24608321\"},{\"title\":\"SANS (USH1G) expression in developing and mature mammalian retina.\",\"author\":\"Overlack N\",\"pubdate\":\"2008 Feb\",\"source\":\"Vision Res\",\"uid\":\"17923142\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"6.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Heterozygous mutation of Ush1g/Sans in mice causes early-onset progressive hearing loss, which is recovered by reconstituting the strain-specific mutation in Cdh23.\",\"author\":\"Miyasaka Y\",\"pubdate\":\"2016 May 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"26936824\"},{\"title\":\"Phosphorylation of the Usher syndrome 1G protein SANS controls Magi2-mediated endocytosis.\",\"author\":\"Bau\\u00df K\",\"pubdate\":\"2014 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"24608321\"},{\"title\":\"Digenic inheritance of deafness caused by 8J allele of myosin-VIIA and mutations in other Usher I genes.\",\"author\":\"Zheng QY\",\"pubdate\":\"2012 Jun 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"22381527\"},{\"title\":\"Usher type 1G protein sans is a critical component of the tip-link complex, a structure controlling actin polymerization in stereocilia.\",\"author\":\"Caberlotto E\",\"pubdate\":\"2011 Apr 5\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"21436032\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09/21/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/15/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1487145600,
    "dateISO8601": "2017-02-15T00:00:00",
    "dateFormated": "Feb 15, 2017"
  },
  "5661": {
    "title": "USH2A Usher syndrome type 2",
    "label": "Usher syndrome type 2",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "12601": {
        "ontology": "HGNC",
        "curie": "HGNC:12601",
        "uri": "HGNC12601"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016484"
      },
      "OMIM276901": {
        "ontology": "OMIM",
        "curie": "OMIM:276901",
        "uri": "OMIM276901",
        "iri": "http://purl.obolibrary.org/obo/OMIM_276901"
      },
      "ORPHA231178": {
        "ontology": "ORPHA",
        "curie": "ORPHA:231178",
        "uri": "ORPHA231178",
        "iri": "http://www.orpha.net/ORDO/Orphanet_231178"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"USH2A\",\"Hgnc\":\"12601\",\"OrphaNet\":\"ORPHA231178\",\"Disease\":\"Usher syndrome type 2\",\"Omim\":\"276901\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa.\",\"author\":\"Eudy JD\",\"pubdate\":\"1998 Jun 12\",\"source\":\"Science\",\"uid\":\"9624053\"},{\"title\":\"Molecular genetics of the Usher syndrome in Lebanon: identification of 11 novel protein truncating mutations by whole exome sequencing.\",\"author\":\"Reddy R\",\"pubdate\":\"2014 Sep 11\",\"source\":\"PLoS One\",\"uid\":\"25211151\"},{\"title\":\"Functional analysis of splicing mutations in MYO7A and USH2A genes.\",\"author\":\"Jaijo T\",\"pubdate\":\"2011 Mar\",\"source\":\"Clin Genet\",\"uid\":\"20497194\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"14.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"9.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa.\",\"author\":\"Eudy JD\",\"pubdate\":\"1998 Jun 12\",\"source\":\"Science\",\"uid\":\"9624053\"},{\"title\":\"Molecular genetics of the Usher syndrome in Lebanon: identification of 11 novel protein truncating mutations by whole exome sequencing.\",\"author\":\"Reddy R\",\"pubdate\":\"2014 Sep 11\",\"source\":\"PLoS One\",\"uid\":\"25211151\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.5\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells.\",\"author\":\"Adato A\",\"pubdate\":\"2005 Dec 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"16301217\"},{\"title\":\"Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations.\",\"author\":\"Garcia-Garcia G\",\"pubdate\":\"2011 Oct 17\",\"source\":\"Orphanet J Rare Dis\",\"uid\":\"22004887\"},{\"title\":\"Functional analysis of splicing mutations in MYO7A and USH2A genes.\",\"author\":\"Jaijo T\",\"pubdate\":\"2011 Mar\",\"source\":\"Clin Genet\",\"uid\":\"20497194\"},{\"title\":\"Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells.\",\"author\":\"Liu X\",\"pubdate\":\"2007 Mar 13\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"17360538\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"0\"},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Cell transplantation to arrest early changes in an ush2a animal model.\",\"author\":\"Lu B\",\"pubdate\":\"2010 Apr\",\"source\":\"Invest Ophthalmol Vis Sci\",\"uid\":\"19959642\"},{\"title\":\"Individual USH2 proteins make distinct contributions to the ankle link complex during development of the mouse cochlear stereociliary bundle.\",\"author\":\"Zou J\",\"pubdate\":\"2015 Dec 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"26401052\"},{\"title\":\"Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells.\",\"author\":\"Liu X\",\"pubdate\":\"2007 Mar 13\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"17360538\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09/22/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/15/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1487145600,
    "dateISO8601": "2017-02-15T00:00:00",
    "dateFormated": "Feb 15, 2017"
  },
  "5662": {
    "title": "LRTOMT: Nonsyndromic sensorineural hearing loss",
    "label": "Nonsyndromic sensorineural hearing loss",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "25033": {
        "ontology": "HGNC",
        "curie": "HGNC:25033",
        "uri": "HGNC25033"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0012670"
      },
      "OMIM611451": {
        "ontology": "OMIM",
        "curie": "OMIM:611451",
        "uri": "OMIM611451",
        "iri": "http://purl.obolibrary.org/obo/OMIM_611451"
      },
      "ORPHA90636": {
        "ontology": "ORPHA",
        "curie": "ORPHA:90636",
        "uri": "ORPHA90636",
        "iri": "http://www.orpha.net/ORDO/Orphanet_90636"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"LRTOMT\",\"Hgnc\":\"25033\",\"OrphaNet\":\"ORPHA90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"611451\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2008 Nov\",\"source\":\"Nat Genet\",\"uid\":\"18953341\"},{\"title\":\"A catechol-O-methyltransferase that is essential for auditory function in mice and humans.\",\"author\":\"Du X\",\"pubdate\":\"2008 Sep 23\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18794526\"},{\"title\":\"A 1 bp deletion in the dual reading frame deafness gene LRTOMT causes a frameshift from the first into the second reading frame.\",\"author\":\"Vanwesemael M\",\"pubdate\":\"2011 Aug\",\"source\":\"Am J Med Genet A\",\"uid\":\"21739586\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"10.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"18.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2008 Nov\",\"source\":\"Nat Genet\",\"uid\":\"18953341\"},{\"title\":\"A catechol-O-methyltransferase that is essential for auditory function in mice and humans.\",\"author\":\"Du X\",\"pubdate\":\"2008 Sep 23\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18794526\"},{\"title\":\"A 1 bp deletion in the dual reading frame deafness gene LRTOMT causes a frameshift from the first into the second reading frame.\",\"author\":\"Vanwesemael M\",\"pubdate\":\"2011 Aug\",\"source\":\"Am J Med Genet A\",\"uid\":\"21739586\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"The c.242G>A mutation in LRTOMT gene is responsible for a high prevalence of deafness in the Moroccan population.\",\"author\":\"Charif M\",\"pubdate\":\"2012 Dec\",\"source\":\"Mol Biol Rep\",\"uid\":\"23053991\"}],\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"A catechol-O-methyltransferase that is essential for auditory function in mice and humans.\",\"author\":\"Du X\",\"pubdate\":\"2008 Sep 23\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18794526\"},{\"title\":\"Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans.\",\"author\":\"Ahmed ZM\",\"pubdate\":\"2008 Nov\",\"source\":\"Nat Genet\",\"uid\":\"18953341\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A catechol-O-methyltransferase that is essential for auditory function in mice and humans.\",\"author\":\"Du X\",\"pubdate\":\"2008 Sep 23\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18794526\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"15\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09/30/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/15/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1487145600,
    "dateISO8601": "2017-02-15T00:00:00",
    "dateFormated": "Feb 15, 2017"
  },
  "5664": {
    "title": "USH1C Usher syndrome type 1",
    "label": "Usher syndrome type 1",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "12597": {
        "ontology": "HGNC",
        "curie": "HGNC:12597",
        "uri": "HGNC12597"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010168"
      },
      "OMIM276904": {
        "ontology": "OMIM",
        "curie": "OMIM:276904",
        "uri": "OMIM276904",
        "iri": "http://purl.obolibrary.org/obo/OMIM_276904"
      },
      "ORPHA231169": {
        "ontology": "ORPHA",
        "curie": "ORPHA:231169",
        "uri": "ORPHA231169",
        "iri": "http://www.orpha.net/ORDO/Orphanet_231169"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"USH1C\",\"Hgnc\":\"12597\",\"OrphaNet\":\"ORPHA231169\",\"Disease\":\"Usher Syndrome, Type 1\",\"Omim\":\"276904\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C.\",\"author\":\"Verpy E\",\"pubdate\":\"2000 Sep\",\"source\":\"Nat Genet\",\"uid\":\"10973247\"},{\"title\":\"A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene.\",\"author\":\"Bitner-Glindzicz M\",\"pubdate\":\"2000 Sep\",\"source\":\"Nat Genet\",\"uid\":\"10973248\"},{\"title\":\"Two families from New England with usher syndrome type IC with distinct haplotypes.\",\"author\":\"DeAngelis MM\",\"pubdate\":\"2001 Mar\",\"source\":\"Am J Ophthalmol\",\"uid\":\"11239869\"},{\"title\":\"Novel mutations in the USH1C gene in Usher syndrome patients.\",\"author\":\"Aparisi MJ\",\"pubdate\":\"2010 Dec 31\",\"source\":\"Mol Vis\",\"uid\":\"21203349\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"10.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C.\",\"author\":\"Verpy E\",\"pubdate\":\"2000 Sep\",\"source\":\"Nat Genet\",\"uid\":\"10973247\"},{\"title\":\"A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene.\",\"author\":\"Bitner-Glindzicz M\",\"pubdate\":\"2000 Sep\",\"source\":\"Nat Genet\",\"uid\":\"10973248\"},{\"title\":\"Two families from New England with usher syndrome type IC with distinct haplotypes.\",\"author\":\"DeAngelis MM\",\"pubdate\":\"2001 Mar\",\"source\":\"Am J Ophthalmol\",\"uid\":\"11239869\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\"},\"ModelsRescue\":{\"value\":\"5.0\",\"tally\":\"4\"}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08/29/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/15/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1487145600,
    "dateISO8601": "2017-02-15T00:00:00",
    "dateFormated": "Feb 15, 2017"
  },
  "6235": {
    "title": "DNMT1 DNMT1 methylopathy",
    "label": "DNMT1 methylopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "2976": {
        "ontology": "HGNC",
        "curie": "HGNC:2976",
        "uri": "HGNC2976"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011397"
      },
      "OMIM604121": {
        "ontology": "OMIM",
        "curie": "OMIM:604121",
        "uri": "OMIM604121",
        "iri": "http://purl.obolibrary.org/obo/OMIM_604121"
      },
      "ORPHA314404": {
        "ontology": "ORPHA",
        "curie": "ORPHA:314404",
        "uri": "ORPHA314404",
        "iri": "http://www.orpha.net/ORDO/Orphanet_314404"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"DNMT1\",\"Hgnc\":\"2976\",\"OrphaNet\":\" ORPHA314404\",\"Disease\":\"DNMT1 Methylopathy\",\"Omim\":\"604121\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"8.0\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy.\",\"author\":\"Winkelmann J\",\"pubdate\":\"2012 May 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"22328086\"},{\"title\":\"Identification of a methylation profile for DNMT1-associated autosomal dominant cerebellar ataxia, deafness, and narcolepsy.\",\"author\":\"Kernohan KD\",\"pubdate\":\"2016 Sep 5\",\"source\":\"Clin Epigenetics\",\"uid\":\"27602171\"},{\"title\":\"Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.\",\"author\":\"Klein CJ\",\"pubdate\":\"2011 Jun\",\"source\":\"Nat Genet\",\"uid\":\"21532572\"},{\"title\":\"Novel mutation in the replication focus targeting sequence domain of DNMT1 causes hereditary sensory and autonomic neuropathy IE.\",\"author\":\"Yuan J\",\"pubdate\":\"2013 Mar\",\"source\":\"J Peripher Nerv Syst\",\"uid\":\"23521649\"},{\"title\":\"DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing loss.\",\"author\":\"Klein CJ\",\"pubdate\":\"2013 Feb 26\",\"source\":\"Neurology\",\"uid\":\"23365052\"}],\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy.\",\"author\":\"Winkelmann J\",\"pubdate\":\"2012 May 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"22328086\"},{\"title\":\"A novel de novo exon 21 DNMT1 mutation causes cerebellar ataxia, deafness, and narcolepsy in a Brazilian patient.\",\"author\":\"Pedroso JL\",\"pubdate\":\"2013 Aug 1\",\"source\":\"Sleep\",\"uid\":\"23904686\"},{\"title\":\"Narcolepsy is a common phenotype in HSAN IE and ADCA-DN.\",\"author\":\"Moghadam KK\",\"pubdate\":\"2014 Jun\",\"source\":\"Brain\",\"uid\":\"24727570\"},{\"title\":\"Defects of mutant DNMT1 are linked to a spectrum of neurological disorders.\",\"author\":\"Baets J\",\"pubdate\":\"2015 Apr\",\"source\":\"Brain\",\"uid\":\"25678562\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.\",\"author\":\"Klein CJ\",\"pubdate\":\"2011 Jun\",\"source\":\"Nat Genet\",\"uid\":\"21532572\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.\",\"author\":\"Klein CJ\",\"pubdate\":\"2011 Jun\",\"source\":\"Nat Genet\",\"uid\":\"21532572\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"3.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Identification of a methylation profile for DNMT1-associated autosomal dominant cerebellar ataxia, deafness, and narcolepsy.\",\"author\":\"Kernohan KD\",\"pubdate\":\"2016 Sep 5\",\"source\":\"Clin Epigenetics\",\"uid\":\"27602171\"},{\"title\":\"Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.\",\"author\":\"Klein CJ\",\"pubdate\":\"2011 Jun\",\"source\":\"Nat Genet\",\"uid\":\"21532572\"},{\"title\":\"Aberrant signature methylome by DNMT1 hot spot mutation in hereditary sensory and autonomic neuropathy 1E.\",\"author\":\"Sun Z\",\"pubdate\":\"2014 Aug\",\"source\":\"Epigenetics\",\"uid\":\"25033457\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10/14/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/10/2017\",\"FinalClassificationNotes\":\"Clinical features of DNMT1 methylopathy include cerebellar ataxia, deafness, and narcolepsy. Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1486713600,
    "dateISO8601": "2017-02-10T00:00:00",
    "dateFormated": "Feb 10, 2017"
  },
  "6238": {
    "title": "ALMS1 Alstrom syndrome",
    "label": "Alstrom syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "428": {
        "ontology": "HGNC",
        "curie": "HGNC:428",
        "uri": "HGNC428"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0008763"
      },
      "OMIM203800": {
        "ontology": "OMIM",
        "curie": "OMIM:203800",
        "uri": "OMIM203800",
        "iri": "http://purl.obolibrary.org/obo/OMIM_203800"
      },
      "ORPHA64": {
        "ontology": "ORPHA",
        "curie": "ORPHA:64",
        "uri": "ORPHA64",
        "iri": "http://www.orpha.net/ORDO/Orphanet_64"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"ALMS1\",\"Hgnc\":\"428\",\"OrphaNet\":\"ORPHA64\",\"Disease\":\"Alstrom syndrome\",\"Omim\":\"203800\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstr\\u00f6m syndrome.\",\"author\":\"Collin GB\",\"pubdate\":\"2002 May\",\"source\":\"Nat Genet\",\"uid\":\"11941369\"},{\"title\":\"Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstr\\u00f6m syndrome.\",\"author\":\"Hearn T\",\"pubdate\":\"2002 May\",\"source\":\"Nat Genet\",\"uid\":\"11941370\"},{\"title\":\"Long-term clinical follow-up and molecular testing for diagnosis of the first Tunisian family with Alstr\\u00f6m syndrome.\",\"author\":\"Chakroun A\",\"pubdate\":\"2016 Sep\",\"source\":\"Eur J Med Genet\",\"uid\":\"27523285\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"20.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstr\\u00f6m syndrome.\",\"author\":\"Collin GB\",\"pubdate\":\"2002 May\",\"source\":\"Nat Genet\",\"uid\":\"11941369\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Alms1-disrupted mice recapitulate human Alstr\\u00f6m syndrome.\",\"author\":\"Collin GB\",\"pubdate\":\"2005 Aug 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"16000322\"},{\"title\":\"Alstr\\u00f6m Syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity.\",\"author\":\"Jagger D\",\"pubdate\":\"2011 Feb 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"21071598\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10/13/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/10/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1486713600,
    "dateISO8601": "2017-02-10T00:00:00",
    "dateFormated": "Feb 10, 2017"
  },
  "8149": {
    "title": "CEP78 Cone-rod dystrophy and hearing loss",
    "label": "Cone-rod dystrophy and hearing loss",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "25740": {
        "ontology": "HGNC",
        "curie": "HGNC:25740",
        "uri": "HGNC25740"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0014980"
      },
      "OMIM617236": {
        "ontology": "OMIM",
        "curie": "OMIM:617236",
        "uri": "OMIM617236",
        "iri": "http://purl.obolibrary.org/obo/OMIM_617236"
      },
      "ORPHA": {
        "ontology": "ORPHA",
        "curie": "ORPHA:",
        "uri": "ORPHA",
        "iri": "http://www.orpha.net/ORDO/Orphanet_"
      }
    },
    "scores": {
      "3978": {
        "label": "Strong"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CEP78\",\"Hgnc\":\"25740\",\"OrphaNet\":\"\",\"Disease\":\"Cone-rod dystrophy and hearing loss\",\"Omim\":\"617236\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"Novel Candidate Genes and a Wide Spectrum of Structural and Point Mutations Responsible for Inherited Retinal Dystrophies Revealed by Exome Sequencing.\",\"author\":\"de Castro-Mir\\u00f3 M\",\"pubdate\":\"2016\",\"source\":\"PLoS One\",\"uid\":\"28005958\"},{\"title\":\"Mutations in CEP78 Cause Cone-Rod Dystrophy and Hearing Loss Associated with Primary-Cilia Defects.\",\"author\":\"Nikopoulos K\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Am J Hum Genet\",\"uid\":\"27588451\"},{\"title\":\"Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss.\",\"author\":\"Namburi P\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Am J Hum Genet\",\"uid\":\"27588452\"},{\"title\":\"<i>CEP78</i> is mutated in a distinct type of Usher syndrome.\",\"author\":\"Fu Q\",\"pubdate\":\"2017 Mar\",\"source\":\"J Med Genet\",\"uid\":\"27627988\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"<i>CEP78</i> is mutated in a distinct type of Usher syndrome.\",\"author\":\"Fu Q\",\"pubdate\":\"2017 Mar\",\"source\":\"J Med Genet\",\"uid\":\"27627988\"},{\"title\":\"Mutations in CEP78 Cause Cone-Rod Dystrophy and Hearing Loss Associated with Primary-Cilia Defects.\",\"author\":\"Nikopoulos K\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Am J Hum Genet\",\"uid\":\"27588451\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in CEP78 Cause Cone-Rod Dystrophy and Hearing Loss Associated with Primary-Cilia Defects.\",\"author\":\"Nikopoulos K\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Am J Hum Genet\",\"uid\":\"27588451\"},{\"title\":\"Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss.\",\"author\":\"Namburi P\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Am J Hum Genet\",\"uid\":\"27588452\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"11\",\"GeneticEvidencePointsTotal\":\"11\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"12.5\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"12/27/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"04/12/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1491980400,
    "dateISO8601": "2017-04-12T00:00:00",
    "dateFormated": "Apr 12, 2017"
  },
  "8151": {
    "title": "WHRN: Usher syndrome type 2",
    "label": "Usher syndrome type 2",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "16361": {
        "ontology": "HGNC",
        "curie": "HGNC:16361",
        "uri": "HGNC16361"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0012662"
      },
      "OMIM611383": {
        "ontology": "OMIM",
        "curie": "OMIM:611383",
        "uri": "OMIM611383",
        "iri": "http://purl.obolibrary.org/obo/OMIM_611383"
      },
      "ORPHA231178": {
        "ontology": "ORPHA",
        "curie": "ORPHA:231178",
        "uri": "ORPHA231178",
        "iri": "http://www.orpha.net/ORDO/Orphanet_231178"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"WHRN\",\"Hgnc\":\"16361\",\"OrphaNet\":\"231178\",\"Disease\":\"Usher syndrome type 2\",\"Omim\":\"611383\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.\",\"author\":\"Ebermann I\",\"pubdate\":\"2007 Apr\",\"source\":\"Hum Genet\",\"uid\":\"17171570\"},{\"title\":\"A novel DFNB31 mutation associated with Usher type 2 syndrome showing variable degrees of auditory loss in a consanguineous Portuguese family.\",\"author\":\"Audo I\",\"pubdate\":\"2011\",\"source\":\"Mol Vis\",\"uid\":\"21738389\"},{\"title\":\"Non-USH2A mutations in USH2 patients.\",\"author\":\"Besnard T\",\"pubdate\":\"2012 Mar\",\"source\":\"Hum Mutat\",\"uid\":\"22147658\"},{\"title\":\"Comprehensive molecular diagnosis of 67 Chinese Usher syndrome probands: high rate of ethnicity specific mutations in Chinese USH patients.\",\"author\":\"Jiang L\",\"pubdate\":\"2015 Sep 4\",\"source\":\"Orphanet J Rare Dis\",\"uid\":\"26338283\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"10.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.\",\"author\":\"Ebermann I\",\"pubdate\":\"2007 Apr\",\"source\":\"Hum Genet\",\"uid\":\"17171570\"},{\"title\":\"A novel DFNB31 mutation associated with Usher type 2 syndrome showing variable degrees of auditory loss in a consanguineous Portuguese family.\",\"author\":\"Audo I\",\"pubdate\":\"2011\",\"source\":\"Mol Vis\",\"uid\":\"21738389\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31.\",\"author\":\"Mburu P\",\"pubdate\":\"2003 Aug\",\"source\":\"Nat Genet\",\"uid\":\"12833159\"},{\"title\":\"The DFNB31 gene product whirlin connects to the Usher protein network in the cochlea and retina by direct association with USH2A and VLGR1.\",\"author\":\"van Wijk E\",\"pubdate\":\"2006 Mar 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"16434480\"},{\"title\":\"Ablation of whirlin long isoform disrupts the USH2 protein complex and causes vision and hearing loss.\",\"author\":\"Yang J\",\"pubdate\":\"2010 May 20\",\"source\":\"PLoS Genet\",\"uid\":\"20502675\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"8.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31.\",\"author\":\"Mburu P\",\"pubdate\":\"2003 Aug\",\"source\":\"Nat Genet\",\"uid\":\"12833159\"},{\"title\":\"Ablation of whirlin long isoform disrupts the USH2 protein complex and causes vision and hearing loss.\",\"author\":\"Yang J\",\"pubdate\":\"2010 May 20\",\"source\":\"PLoS Genet\",\"uid\":\"20502675\"},{\"title\":\"Gene Therapy Restores Balance and Auditory Functions in a Mouse Model of Usher Syndrome.\",\"author\":\"Isgrig K\",\"pubdate\":\"2017 Mar 1\",\"source\":\"Mol Ther\",\"uid\":\"28254438\"},{\"title\":\"Alternative Splice Forms Influence Functions of Whirlin in Mechanosensory Hair Cell Stereocilia.\",\"author\":\"Ebrahim S\",\"pubdate\":\"2016 May 3\",\"source\":\"Cell Rep\",\"uid\":\"27117407\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"03/30/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"05/10/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1494399600,
    "dateISO8601": "2017-05-10T00:00:00",
    "dateFormated": "May 10, 2017"
  },
  "8152": {
    "title": "ADCY1: Nonsyndromic sensorineural hearing loss",
    "label": "Nonsyndromic sensorineural hearing loss",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "232": {
        "ontology": "HGNC",
        "curie": "HGNC:232",
        "uri": "HGNC232"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019588"
      },
      "OMIM610154": {
        "ontology": "OMIM",
        "curie": "OMIM:610154",
        "uri": "OMIM610154",
        "iri": "http://purl.obolibrary.org/obo/OMIM_610154"
      },
      "ORPHA90636": {
        "ontology": "ORPHA",
        "curie": "ORPHA:90636",
        "uri": "ORPHA90636",
        "iri": "http://www.orpha.net/ORDO/Orphanet_90636"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"ADCY1\",\"Hgnc\":\"232\",\"OrphaNet\":\"ORPHA90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"610154\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Adenylate cyclase 1 (ADCY1) mutations cause recessive hearing impairment in humans and defects in hair cell function and hearing in zebrafish.\",\"author\":\"Santos-Cortez RL\",\"pubdate\":\"2014 Jun 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"24482543\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Adenylate cyclase 1 (ADCY1) mutations cause recessive hearing impairment in humans and defects in hair cell function and hearing in zebrafish.\",\"author\":\"Santos-Cortez RL\",\"pubdate\":\"2014 Jun 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"24482543\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Adenylate cyclase 1 (ADCY1) mutations cause recessive hearing impairment in humans and defects in hair cell function and hearing in zebrafish.\",\"author\":\"Santos-Cortez RL\",\"pubdate\":\"2014 Jun 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"24482543\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Adenylate cyclase 1 (ADCY1) mutations cause recessive hearing impairment in humans and defects in hair cell function and hearing in zebrafish.\",\"author\":\"Santos-Cortez RL\",\"pubdate\":\"2014 Jun 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"24482543\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Adenylate cyclase 1 (ADCY1) mutations cause recessive hearing impairment in humans and defects in hair cell function and hearing in zebrafish.\",\"author\":\"Santos-Cortez RL\",\"pubdate\":\"2014 Jun 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"24482543\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"8\",\"GeneticEvidencePointsTotal\":\"8\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"10\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"12/16/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"05/10/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1494399600,
    "dateISO8601": "2017-05-10T00:00:00",
    "dateFormated": "May 10, 2017"
  },
  "8249": {
    "title": "ACTA2 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:130": {
        "ontology": "HGNC",
        "curie": "HGNC:130",
        "uri": "HGNC130"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM102620": {
        "ontology": "OMIM",
        "curie": "OMIM:102620",
        "uri": "OMIM102620",
        "iri": "http://purl.obolibrary.org/obo/OMIM_102620"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"ACTA2\",\"Hgnc\":\"130\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"102620\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"14.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2007 Dec\",\"source\":\"Nat Genet\",\"uid\":\"17994018\"},{\"title\":\"Clinical, pathological, and genetic analysis of a Korean family with thoracic aortic aneurysms and dissections carrying a novel Asp26Tyr mutation.\",\"author\":\"Yoo EH\",\"pubdate\":\"2010 Summer\",\"source\":\"Ann Clin Lab Sci\",\"uid\":\"20689142\"},{\"title\":\"Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD).\",\"author\":\"Morisaki H\",\"pubdate\":\"2009 Oct\",\"source\":\"Hum Mutat\",\"uid\":\"19639654\"},{\"title\":\"Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease.\",\"author\":\"Guo DC\",\"pubdate\":\"2009 May\",\"source\":\"Am J Hum Genet\",\"uid\":\"19409525\"}],\"notes\":{\"note\":\"17994018: 6 probands * 2 points + 8 probands  * 1 point\\r\\nAdditional PMIDs with probands and segregation data\\r\\n19409525 \\r\\n19639654 \\r\\n20689142\\r\\nThe curation is not comprehensive as maximum genetic score was reached.\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"10.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2007 Dec\",\"source\":\"Nat Genet\",\"uid\":\"17994018\"}],\"notes\":{\"note\":\"17994018: All family members with Thoracic aortic aneurysm and dissection (TAAD) also exhibited livedo reticularius. Fine mapping with 31 microsatellite markers on 27 family members on  10q23-24 ->LOD 4.4 (TAAD+ Livedo reticularis) . Analysis of recombinants ->17.2Mb region with  candidate gene seq-> ACTA2 R149C. Segregation of this variant with livedo reticularis ->LOD 5.8. 5 points\\r\\n\\r\\nLinkage analysis of TAAD with ACTA2 mutations revealed a LOD score of 4.17 in 14 families of European descent.\\r\\nPoints: 5\\r\\n\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Severe Molecular Defects Exhibited by the R179H Mutation in Human Vascular Smooth Muscle \\u03b1-Actin.\",\"author\":\"Lu H\",\"pubdate\":\"2016 Oct 7\",\"source\":\"J Biol Chem\",\"uid\":\"27551047\"},{\"title\":\"Vascular disease-causing mutation R258C in ACTA2 disrupts actin dynamics and interaction with myosin.\",\"author\":\"Lu H\",\"pubdate\":\"2015 Aug 4\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"26153420\"}],\"notes\":{\"note\":\"27551047: The R179H mutation in SM \\u03b1-actin shows severe defects in many facets of actin function including its inability to readily polymerize, with R179H mutant requiring forty-fold more actin to form filaments relative to wild type. \\r\\n26153420: ACTA2(R258C)  mutant actin shows multiple defects, including impaired interaction with myosin, formation of less stable filaments, and enhanced levels of monomer. These defects are likely to decrease cellular force production and initiate aberrant mechanosensing pathways that culminate in the disease. \"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2007 Dec\",\"source\":\"Nat Genet\",\"uid\":\"17994018\"}],\"notes\":{\"note\":\"ACTA2-Antibdy and phalliodin staining of ACTA2 filaments in aortic SMCs derived from two individuals with TAAD who were heterozygous for ACTA2 revealed an absence of ACTA2-containing filaments and an increased pool of unpolymerized ACTA2.\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse.\",\"author\":\"Schildmeyer LA\",\"pubdate\":\"2000 Nov\",\"source\":\"FASEB J\",\"uid\":\"11053242\"}],\"notes\":{\"note\":\"Mouse model : Referenced in http://www.informatics.jax.org/allele/MGI:3665248 Defective aortic morphology and highly compromised vascular contractility. \"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"17\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"07/13/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"07/13/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"09/27/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\n\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1474959600,
    "dateISO8601": "2016-09-27T00:00:00",
    "dateFormated": "Sep 27, 2016"
  },
  "8251": {
    "title": "FBN1 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:3603": {
        "ontology": "HGNC",
        "curie": "HGNC:3603",
        "uri": "HGNC3603"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM134797": {
        "ontology": "OMIM",
        "curie": "OMIM:134797",
        "uri": "OMIM134797",
        "iri": "http://purl.obolibrary.org/obo/OMIM_134797"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"FBN1\",\"Hgnc\":\"3603\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"134797\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms.\",\"author\":\"Milewicz DM\",\"pubdate\":\"1996 Dec 1\",\"source\":\"Circulation\",\"uid\":\"8941093\"},{\"title\":\"TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies.\",\"author\":\"Katzke S\",\"pubdate\":\"2002 Sep\",\"source\":\"Hum Mutat\",\"uid\":\"12203992\"},{\"title\":\"A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection.\",\"author\":\"Francke U\",\"pubdate\":\"1995 Jun\",\"source\":\"Am J Hum Genet\",\"uid\":\"7762551\"}],\"notes\":{\"note\":\"PMID 8941093: Two novel FBN1 alterations were identified in individuals with Thoracic Aortic Aneurysms (TAAs) involving the ascending thoracic aorta. Dermal fibroblasts from one of the affected individual were used to study the effect of the missense mutation D1155N on fibrillin-1 cellular processing. The mutation decreased the amount of fibrillin-1 deposited into the pericellular matrix. Points 1.5 + 0.5\\r\\nPMID 12203992: 19 probands with syndromic Aortic dissection/aneurysm/dilation. One with possible isolated TAA with other features not satisfying Ghent nosology for Marfan's syndrome . The others manifest variable degrees of Marfan's. Points 1\\r\\nPMID 7762551: A Gly1127Ser substitution was present in 9 of 10 affected family members and in 1 young unaffected member but was not found in other unaffected members. Functional studies show reduced FBN deposition in ECM in cultured fibroblasts. Points 1.5\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection.\",\"author\":\"Francke U\",\"pubdate\":\"1995 Jun\",\"source\":\"Am J Hum Genet\",\"uid\":\"7762551\"}],\"notes\":{\"note\":\"10 individuals in two generations are affected with abnormalities of\\r\\nthe ascending aorta, ranging from mild root dilatation\\r\\nto aortic aneurysm or dissection. See Figure 5 for pedigree. \"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection.\",\"author\":\"Francke U\",\"pubdate\":\"1995 Jun\",\"source\":\"Am J Hum Genet\",\"uid\":\"7762551\"},{\"title\":\"Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms.\",\"author\":\"Milewicz DM\",\"pubdate\":\"1996 Dec 1\",\"source\":\"Circulation\",\"uid\":\"8941093\"}],\"notes\":{\"note\":\"PMID 7762551: Functional studies show reduced FBN deposition in extra cellular matrix in cultured fibroblasts from a carrier with Gly1127Ser\\r\\nPMID 8941093 The D1155N mutation decreased the amount of fibrillin-1 deposited into the pericellular matrix\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome.\",\"author\":\"Pereira L\",\"pubdate\":\"1997 Oct\",\"source\":\"Nat Genet\",\"uid\":\"9326947\"},{\"title\":\"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.\",\"author\":\"Neptune ER\",\"pubdate\":\"2003 Mar\",\"source\":\"Nat Genet\",\"uid\":\"12598898\"},{\"title\":\"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.\",\"author\":\"Judge DP\",\"pubdate\":\"2004 Jul\",\"source\":\"J Clin Invest\",\"uid\":\"15254584\"}],\"notes\":{\"note\":\"PMID: 9326947\\r\\nTargeted partial deletion of mouse FBN1.\\r\\nAlthough homozygous mutants did not display skeletal abnormalities , all animals \\r\\ndied suddenly of cardiovascular complications. All showed vascular compromise of some sort\\r\\nIncluding focal fragmentation of elastic fibers, thinning of wall of proximal ascending aorta etc.\\r\\nIt did not seem to affect elastic matrix assembly.\\r\\nPMID 12598898 , using the above mice model, observed developmental impairment of distal \\r\\nalveolar septation. By 6 months of age, Fbn1mgR/mgR mice developed marked airspace dilatation associated with destructive changes, peribronchiolar inflammation and greater expression of matrix metalloproteases , recapitulating the pathologic findings of human emphysema.\\r\\nPMID 15254584: Mice heterozygous for a  comparable missense mutation (C1039G) revealed impaired microfibrillar deposition, skeletal deformity, and progressive deterioration of aortic wall architecture, comparable to  characteristics of the human phenotype. Introduction of a WT FBN1 transgene on a heterozygous  C1039G background rescued aortic phenotype.\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"9\",\"GeneticEvidencePointsTotal\":\"9\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"15\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"01/04/2017\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"01/04/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01/23/2017\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1485158400,
    "dateISO8601": "2017-01-23T00:00:00",
    "dateFormated": "Jan 23, 2017"
  },
  "8252": {
    "title": "MYH11 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:7569": {
        "ontology": "HGNC",
        "curie": "HGNC:7569",
        "uri": "HGNC7569"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM160745": {
        "ontology": "OMIM",
        "curie": "OMIM:160745",
        "uri": "OMIM160745",
        "iri": "http://purl.obolibrary.org/obo/OMIM_160745"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MYH11\",\"Hgnc\":\"7569\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"160745\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II.\",\"author\":\"Pannu H\",\"pubdate\":\"2007 Oct 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"17666408\"},{\"title\":\"Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGF\\u03b2 signaling in FTAAD.\",\"author\":\"Renard M\",\"pubdate\":\"2013 May 10\",\"source\":\"Int J Cardiol\",\"uid\":\"21937134\"},{\"title\":\"Incomplete segregation of MYH11 variants with thoracic aortic aneurysms and dissections and patent ductus arteriosus.\",\"author\":\"Harakalova M\",\"pubdate\":\"2013 May\",\"source\":\"Eur J Hum Genet\",\"uid\":\"22968129\"},{\"title\":\"TGF\\u03b2RIIb mutations trigger aortic aneurysm pathogenesis by altering transforming growth factor \\u03b22 signal transduction.\",\"author\":\"Bee KJ\",\"pubdate\":\"2012 Dec\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"23099432\"},{\"title\":\"A deleterious MYH11 mutation causing familial thoracic aortic dissection.\",\"author\":\"Takeda N\",\"pubdate\":\"2015\",\"source\":\"Hum Genome Var\",\"uid\":\"27081537\"},{\"title\":\"Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus.\",\"author\":\"Zhu L\",\"pubdate\":\"2006 Mar\",\"source\":\"Nat Genet\",\"uid\":\"16444274\"}],\"notes\":{\"note\":\"PMID 16444274: Systematic mutation screening identified two cis heterozygous mutations affecting in the French kindred\\r\\nIVS32+1GT (splice-donor site of intron 32), p.R1758Q(exon 37) Both mutations were identified in all subjects carrying the disease haplotype, but neither was found in 340 normal chromosomes. Also absent in ExAC. Probands 1 . Points=1\\r\\n\\r\\n17666408 Variants L1264P and R1275L in coiled coiled domain coseggregated with Thoracic aortic aneurysm and aortic dissection (TAAD) in 3 Generation family. Structural analysis suggested that the mutations found in the TAAD/PDA families are predicted to be deleterious to protein function. Probands 1, Points 0.5 \\r\\n\\r\\nPMID 21937134:  In 1 family with TAAD associated with PDA, a causal aberration in MYH11 was found in one family : IVS32+1G  mutation in intron 32. This variant was previously reported by PMID 16444274 .ExAC Allele Frequency:0.02% 1 proband, Points=0.5 \\r\\n\\r\\nPMID 22968129: Two different novel heterozygote MYH11 variants were detected\\r\\nin the probands two large Dutch families with TAAD/PDA. However, these variants incomplete segregation with the TAAD/PDA in 3 out of 11 cases in family 1 and in 2 out of 6 cases of family 2. One missense and one inframe deletion was identified. p.K78E was absent in ExAC.No other evidence in support of pathogenicity of variant.However this variant was also identified in a Japanese pedigree (PMID:26056961) segregating TAAD. Number of Probands: 1, Points=0.5 \\r\\n\\r\\nPMID 23099432: MYH11 mutations were identified in three unrelated probands. No other functional tests supporting variant pathogenicity.\\r\\nNumber of probands from this study: 1 (p.R1590Q ), Points=0.5\\r\\n\\r\\nPMID 26056961 : Heterozygous in frame deletion p.K1256del was identified in affected members of two Japanese pedigrees. Cosegregation was shown in one pedigree. One pediatric case with this variant had  TAA + PDA but the rest were non syndromic. <0.0001% in ExAC Variant is in a conserved residue of a functional (rod) domain.# of probands from this study : 1 points=0.5\\r\\n\\r\\nPMID 27081537: Familial case of non-syndromic TAAD with a MYH11 L1264P mutation, \\r\\nin which PDA was not observed. (Authors performed genetic analyses of mutations of the TAAD related genes including FBN1, TGFBR1, TGFBR2, SMAD3, TGFB2, ACTA2 and MYH11)\\r\\nCo-segregation was shown in a 17 member three generation  pedigree.\\r\\nThis variant was recurrent ( also observed in PMID 17666408)\\r\\nAbsent in ExAC. Variant is in a conserved residue of a functional domain.\\r\\n# of probands= 1, Points=1\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12.2-p13.13.\",\"author\":\"Khau Van Kien P\",\"pubdate\":\"2005 Jul 12\",\"source\":\"Circulation\",\"uid\":\"15998682\"},{\"title\":\"MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II.\",\"author\":\"Pannu H\",\"pubdate\":\"2007 Oct 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"17666408\"},{\"title\":\"Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGF\\u03b2 signaling in FTAAD.\",\"author\":\"Renard M\",\"pubdate\":\"2013 May 10\",\"source\":\"Int J Cardiol\",\"uid\":\"21937134\"},{\"title\":\"TGF\\u03b2RIIb mutations trigger aortic aneurysm pathogenesis by altering transforming growth factor \\u03b22 signal transduction.\",\"author\":\"Bee KJ\",\"pubdate\":\"2012 Dec\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"23099432\"}],\"notes\":{\"note\":\"15998682: 3-generation French family with TAAD, patent ductus arteriosus (PDA), or both. Considering only the 7 TAAD cases, max LOD score of 2.73 was obtained at  \\u03b8=0, at 16p12.2\\u2013p13.3 region. If the 5 PDA cases are considered affected, stronger values were observed at this region, with a maximum LOD score of 3. Points 4\\r\\n17666408: segregation data from family TAA027 was included in the curation. Included but there was PDA in two individuals.  Points=1\\r\\n\\r\\n\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus.\",\"author\":\"Zhu L\",\"pubdate\":\"2006 Mar\",\"source\":\"Nat Genet\",\"uid\":\"16444274\"}],\"notes\":{\"note\":\"Expression: PMID 16444274: Immunoblotting of  proteins extracted from pathological aorta confirmed presence of similar amounts of wild type and mutant SM-MHC. Points 0.5\\r\\n \\r\\n\"}}},\"FunctionalAlteration\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus.\",\"author\":\"Zhu L\",\"pubdate\":\"2006 Mar\",\"source\":\"Nat Genet\",\"uid\":\"16444274\"},{\"title\":\"MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II.\",\"author\":\"Pannu H\",\"pubdate\":\"2007 Oct 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"17666408\"}],\"notes\":{\"note\":\"Patient cells.\\r\\nPMID 16444274: Orcein staining of elastic fibers from probands harboring MYH11 mutations shows decrease in number and rupture of elastic fibers. Actin labelling and alcian staining revealed abnormalities of SMCs and  deposition of mucopolysaccharides where SMCs were lost.\\r\\nPMID 17666408 Histopathological analysis of aortic sections from two individuals with MYH11 mutations revealed SMC disarray and focal hyperplasia of SMCs in the aortic media. \"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells.\",\"author\":\"Kuang SQ\",\"pubdate\":\"2012 May 25\",\"source\":\"Circ Res\",\"uid\":\"22511748\"},{\"title\":\"Myh11(R247C/R247C) mutations increase thoracic aorta vulnerability to intramural damage despite a general biomechanical adaptivity.\",\"author\":\"Bellini C\",\"pubdate\":\"2015 Jan 2\",\"source\":\"J Biomech\",\"uid\":\"25433566\"}],\"notes\":{\"note\":\"Mild phenotypes\\r\\nPMID 22511748 Myh11 R247C/R247C knock in mice exhibited normal growth, reproduction, and aortic histology but decreased aortic contraction. The decrease in aortic contractility was not associated with aortic pathology in these mice and suggests that decreased aortic contractility alone may not be sufficient to cause thoracic aortic disease.\\r\\n25433566: The mutant aortas were generally  normal , under  hypertensive hemodynamics, there was intramural delaminations or premature deaths in 20% of R247C knock-in mice.\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"CuratorModifyCalculation\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"9\",\"GeneticEvidencePointsTotal\":\"9\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"12\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"04/04/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"04/04/2016\",\"CuratorClassificationNotes\":\"Considering only isolated TAAD. \",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"07/03/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nAssociation with TAA is  strong if patients with Patent Ductus Arteriosus and TAAD are considered together. \"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1467529200,
    "dateISO8601": "2016-07-03T00:00:00",
    "dateFormated": "Jul 03, 2016"
  },
  "8253": {
    "title": "SMAD3 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:6769": {
        "ontology": "HGNC",
        "curie": "HGNC:6769",
        "uri": "HGNC6769"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM603109": {
        "ontology": "OMIM",
        "curie": "OMIM:603109",
        "uri": "OMIM603109",
        "iri": "http://purl.obolibrary.org/obo/OMIM_603109"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SMAD3\",\"Hgnc\":\"6769\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"603109\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.\",\"author\":\"Regalado ES\",\"pubdate\":\"2011 Sep 2\",\"source\":\"Circ Res\",\"uid\":\"21778426\"}],\"notes\":{\"note\":\"A frameshift mutation (p.N218fs) introducing a premature stop codon was present in all individuals with vascular disease in a 4 generation family, including Thoracic aortic aneurysm and dissection (TAAD), Intracranial aneurysms, Abdominal aortic aneurysm (AAA), and bilateral iliac aneurysms. The SMAD3 mutation segregated with vascular diseases in the family with a LOD score of 2.52 and was absent from approximately 2300 control exomes.  Total points .5\\r\\n\\r\\nSMAD3 exons and flanking introns were amplified and sequenced as a candidate gene for FTAAD using DNA from 181 unrelated FTAAD probands. Sequencing identified 3 additional variants in four families of European descent: p.R279K (c.836G>A, exon 6) in families TAA071 and TAA072, p.E239K (c.715G>A, exon 6) in family TAA365, and p.A112V (c.235C>T, exon 2) in TAA115.  Total points in absence of functional studies=1.5\"}}},\"ProbandWithLOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Multiple aneurysms in a patient with aneurysms-osteoarthritis syndrome.\",\"author\":\"Martens T\",\"pubdate\":\"2013 Jan\",\"source\":\"Ann Thorac Surg\",\"uid\":\"23272854\"}],\"notes\":{\"note\":\"PMID 23272854: Identified in a single affected individual with no reported family history; variant de novo\\r\\n\"}}},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"}],\"notes\":{\"note\":\"Linkage analysis using 250K SNP arrays in family 1. We obtained a significant multipoint log^sub 10^ odds (LOD) score of 3.6 on chromosome 15q. Haplotype analysis confirmed that all 12 individuals with arterial aneurysms and 10 individuals with skeletal and/or cutaneous anomalies (not included in the GWLA) shared the disease-associated haplotype. Note that the linkage analysis was done with 12 individuals with arterial aneurysms and hence included and assigned 4 points*-\\r\\n\\r\\n21778426: A novel frame shift mutation, p. N218fs (c.652delA), was identified in the SMAD3 gene and segregated with the vascular diseases in this family with a LOD score of 2.52. However this is not specific to TAAD. Assigned 2 points\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS.\",\"author\":\"Tan CK\",\"pubdate\":\"2013 Jun 19\",\"source\":\"J Am Heart Assoc\",\"uid\":\"23782924\"},{\"title\":\"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.\",\"author\":\"van de Laar IM\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21217753\"}],\"notes\":{\"note\":\"Biochemical function: PMID 23782924: in vitro study showed that SMAD3 regulates the transcriptional activity of the iNOS promoter via C/EBP\\u03b2 (9134219);  in vivo ChIP using anti\\u2010C/EBP\\u03b2 antibodies on primary vascular cells isolated from untreated S3KO (SMAD3-knockout mice) and WT aorta revealed increased association of C/EBP\\u03b2 with a putative C/EBP binding site spanning \\u2212515 to \\u2212318 bp within the iNOS promoter in S3KO cells; Consistent with phenotype: Lack of Smad3p causes aberrant upregulation of inducible nitric oxide synthase (iNOS)\\u2013derived nitric oxide production and activation of elastolytic matrix metalloproteinases 2 and 9. Administration of clodronate\\u2010liposomes and iNOS inhibitor completely abrogated these aortic conditions\\r\\nExpression\\r\\nPMID 1217753: SMAD3 mutaions lead to increased aortic expression of several key players in the TGF-\\u03b2 pathway, including SMAD3; ; observed increased labeling intensity of all these markers (SMAD3, phophorylated and non-phosphorylated, phophorylated SMAD2, TGF-beta1, CTGF) in two individuals with the mutation resulting in p.Arg287Trp\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency.\",\"author\":\"Ye P\",\"pubdate\":\"2013 May\",\"source\":\"J Clin Invest\",\"uid\":\"23585475\"},{\"title\":\"SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS.\",\"author\":\"Tan CK\",\"pubdate\":\"2013 Jun 19\",\"source\":\"J Am Heart Assoc\",\"uid\":\"23782924\"}],\"notes\":{\"note\":\"PMID 23585475: mice lacking\\u00a0Smad3\\u00a0had a vascular phenotype similar to AOS, marked by the progressive development of aneurysms\\r\\nPMID 23782924: Using uniaxial tensile and contractility tests, authors showed that\\u00a0SMAD3\\u00a0deficiency resulted in defective aortic biomechanics and physiological functions, which caused weakening of the aortic wall and predisposed the mice to aortic aneurysms\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"9\",\"GeneticEvidencePointsTotal\":\"9\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"15\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"12/20/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"12/20/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/22/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1482393600,
    "dateISO8601": "2016-12-22T00:00:00",
    "dateFormated": "Dec 22, 2016"
  },
  "8254": {
    "title": "TGFB2 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:11768": {
        "ontology": "HGNC",
        "curie": "HGNC:11768",
        "uri": "HGNC11768"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM190220": {
        "ontology": "OMIM",
        "curie": "OMIM:190220",
        "uri": "OMIM190220",
        "iri": "http://purl.obolibrary.org/obo/OMIM_190220"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"TGFB2\",\"Hgnc\":\"11768\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"190220\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"},{\"title\":\"A 1-bp duplication in TGFB2 in three family members with a syndromic form of thoracic aortic aneurysm.\",\"author\":\"Leutermann R\",\"pubdate\":\"2014 Jul\",\"source\":\"Eur J Hum Genet\",\"uid\":\"24193348\"}],\"notes\":{\"note\":\"PMID 22772368: 2 probands with p.Pro366His, p.Arg237Trp,  \\r\\nPMID 24193348: 1 bp duplication.\\r\\nAll these cases were associated with syndromic features unlike PMID 22772371\"}}},\"ProbandWithLOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"}],\"notes\":{\"note\":\"3 de novo mutations (2 large deletions; 1 missense (p.Arg330Cys))\\r\\n\"}}},\"VariantIsDeNovo\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome.\",\"author\":\"Boileau C\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772371\"},{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"}],\"notes\":{\"note\":\"PMID 22772371: Two large unrelated families segregating Thoracic aortic aneurysm (TAA). They harbored frameshift and nonsense mutations and 2 further  cases in familial TAA cohort p.Glu102* & p.Asn297*\\r\\nPMID 22772368: p.Tyr369Cysfs*26, p.Ala100_Tyr104del, p.Tyr99* variants were found to co-segregate with TAA in the families.\\r\\n\"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome.\",\"author\":\"Boileau C\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772371\"},{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"}],\"notes\":{\"note\":\"PMID 22772371: 2 large families where loss-of-function mutations (p.Tyr341Cysfs*25 & p. Cys229*) clearly segregate with aortic disease. Family 1: 14 known carriers; 11 had TAA(D); 2 had cerebrovascular disease & 1 apparently unaffected (LOD score 3.3)\\r\\nFamily 2: 6 known carriers; 3 obligate carriers 1 child apparently still unaffected (LOD score 4.4)\\r\\nPMID 22772368: 8 families: All showed complete segregation of aortic phenotype with mutation (penetrance 100%)\\r\\n\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome.\",\"author\":\"Boileau C\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772371\"},{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"}],\"notes\":{\"note\":\"PMID  22772368 Binds TGFB receptors; tissue from patients with loss of function variants show up-regulation of TGFB signalling (inc pSMAD, also inc expression of downstream effector genes eg CTGF, collagens \\r\\nPMIDs 22772368 and 22772371:Evidence for reduced circulating TGBF2 ; increased TGFB2 expression in aortic tissue & increased pSMAD.\\r\\n\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome.\",\"author\":\"Boileau C\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772371\"}],\"notes\":{\"note\":\"Patient cells: Reduced levels of TGFB2 proprotein in cellular lysates from patient aortas .\"}}},\"ModelsRescue\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.\",\"author\":\"Lindsay ME\",\"pubdate\":\"2012 Jul 8\",\"source\":\"Nat Genet\",\"uid\":\"22772368\"}],\"notes\":{\"note\":\"Heterozygous mouse model (TGFB2+/-) develops aneurysm by 8 months (2 points) ; TGFB2+/- FBN+/C1039G double het displays worse aortic phenotype (1 point)\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"05/06/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"05/16/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"05/16/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nDefinitive for both non syndromic and syndromic forms. Patients primarily present with aortic disease.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1462518000,
    "dateISO8601": "2016-05-06T00:00:00",
    "dateFormated": "May 06, 2016"
  },
  "8255": {
    "title": "TGFBR1 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:11772": {
        "ontology": "HGNC",
        "curie": "HGNC:11772",
        "uri": "HGNC11772"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM190181": {
        "ontology": "OMIM",
        "curie": "OMIM:190181",
        "uri": "OMIM190181",
        "iri": "http://purl.obolibrary.org/obo/OMIM_190181"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"TGFBR1\",\"Hgnc\":\"11772\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"190181\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting.\",\"author\":\"Ziganshin BA\",\"pubdate\":\"2015 Nov\",\"source\":\"Ann Thorac Surg\",\"uid\":\"26188975\"},{\"title\":\"Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations.\",\"author\":\"Tran-Fadulu V\",\"pubdate\":\"2009 Sep\",\"source\":\"J Med Genet\",\"uid\":\"19542084\"},{\"title\":\"Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations.\",\"author\":\"Poninska JK\",\"pubdate\":\"2016 May 4\",\"source\":\"J Transl Med\",\"uid\":\"27146836\"},{\"title\":\"Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders.\",\"author\":\"M\\u00e1ty\\u00e1s G\",\"pubdate\":\"2006 Aug\",\"source\":\"Hum Mutat\",\"uid\":\"16791849\"},{\"title\":\"Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders.\",\"author\":\"Stheneur C\",\"pubdate\":\"2008 Nov\",\"source\":\"Hum Mutat\",\"uid\":\"18781618\"}],\"notes\":{\"note\":\"PMID 26188975 : One proband with segregation evidence with Thoracic aortic aneurysm and dissection (TAAD) . Variant G188V Points for TAAD, isolated : 0.5\\r\\n19542084: Two families had missense mutations in exon 9, TAA009 (R487W) and TAA023 (L486S), and two had mutations in exon 5: TAA336 ( H315R), and TAA339 (G312S).\\r\\n# of probands =4 points: 0.5*3 +1=2.5\\r\\nPMID 27146836: Two probands with isolated TAAD  harboring A202V, Y282H. With some weak segregation data. 0.25*2=0.5\\r\\nPMID 16791849 : Identified one patient with negative family history of TAAD. A heterozygous R487Q mutation was present in a patient with TAAD; variant R487P had been previously reported in a family whose phenotype was identified as Loeys-Dietz syndrome. Points=0.5\\r\\nPMID 18781618: 1/14 Probands with isolated TAAD harbored  p.Glu218Lys with positive family history. Points=0.25\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders.\",\"author\":\"M\\u00e1ty\\u00e1s G\",\"pubdate\":\"2006 Aug\",\"source\":\"Hum Mutat\",\"uid\":\"16791849\"}],\"notes\":{\"note\":\"1 proband with a de novo missense mutation in TGFBR1 c.1460G>A; pR487Q\"}}},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting.\",\"author\":\"Ziganshin BA\",\"pubdate\":\"2015 Nov\",\"source\":\"Ann Thorac Surg\",\"uid\":\"26188975\"},{\"title\":\"Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations.\",\"author\":\"Tran-Fadulu V\",\"pubdate\":\"2009 Sep\",\"source\":\"J Med Genet\",\"uid\":\"19542084\"}],\"notes\":{\"note\":\"PMID 26188975: Inferred LOD from pedigree based on 4 segregations. 1.5 points\\r\\nPMID 19542084: Inferred LOD from pedigree based on 6 segregations from family TAA023. 2.5 points\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"TGFBR1 mutations associated with Loeys-Dietz syndrome are inactivating.\",\"author\":\"Cardoso S\",\"pubdate\":\"2012 Jun\",\"source\":\"J Recept Signal Transduct Res\",\"uid\":\"22414221\"}],\"notes\":{\"note\":\"Non patient cells: Receptor function was tested by co-transfection with a luciferase reporter or EGFP-tagged SMAD2 in HEK293 cells. All of the TGFBR1 mutations were found to be inactivating for canonical TGF-\\u03b2 signaling. Points: 2*1(non patient cells)\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Smooth muscle cell-specific Tgfbr1 deficiency promotes aortic aneurysm formation by stimulating multiple signaling events.\",\"author\":\"Yang P\",\"pubdate\":\"2016 Oct 14\",\"source\":\"Sci Rep\",\"uid\":\"27739498\"},{\"title\":\"Angiotensin II-dependent TGF-\\u03b2 signaling contributes to Loeys-Dietz syndrome vascular pathogenesis.\",\"author\":\"Gallo EM\",\"pubdate\":\"2014 Jan\",\"source\":\"J Clin Invest\",\"uid\":\"24355923\"}],\"notes\":{\"note\":\"PMID 27739498: Deletion of smooth muscle cell-specific\\u00a0Tgfbr1\\u00a0in adult mice rapidly causes aneurysmal degeneration of the thoracic aorta + drug induced rescue.  \\r\\nPMID 24355923: mice carrying heterozygous missense LDS mutations, but not mice haploinsufficient for TGF-\\u03b2 receptor alleles, phenotypically recapitulate LDS. Aortic root size and growth in Tgfbr1+/\\u2013 mice was similar to that observed in wild-type mice, while Tgfbr1 M318R/+ mice showed enlarged aortas and accelerated aortic root growth.\\r\\nPoints=4\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"10.5\",\"GeneticEvidencePointsTotal\":\"10.5\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"16.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10/12/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"10/18/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nDefinitive for both syndromic and non-syndromic TAAD.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1476255600,
    "dateISO8601": "2016-10-12T00:00:00",
    "dateFormated": "Oct 12, 2016"
  },
  "8256": {
    "title": "TGFBR2 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:11773": {
        "ontology": "HGNC",
        "curie": "HGNC:11773",
        "uri": "HGNC11773"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM190182": {
        "ontology": "OMIM",
        "curie": "OMIM:190182",
        "uri": "OMIM190182",
        "iri": "http://purl.obolibrary.org/obo/OMIM_190182"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"TGFBR2\",\"Hgnc\":\"11773\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"190182\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections.\",\"author\":\"Pannu H\",\"pubdate\":\"2005 Jul 26\",\"source\":\"Circulation\",\"uid\":\"16027248\"},{\"title\":\"Clinical features in a family with an R460H mutation in transforming growth factor beta receptor 2 gene.\",\"author\":\"Law C\",\"pubdate\":\"2006 Dec\",\"source\":\"J Med Genet\",\"uid\":\"16885183\"},{\"title\":\"Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders.\",\"author\":\"Stheneur C\",\"pubdate\":\"2008 Nov\",\"source\":\"Hum Mutat\",\"uid\":\"18781618\"},{\"title\":\"Novel TGFBR2 and known missense SMAD3 mutations: two case reports of thoracic aortic aneurysms.\",\"author\":\"Panesi P\",\"pubdate\":\"2015 Jan\",\"source\":\"Ann Thorac Surg\",\"uid\":\"25555948\"}],\"notes\":{\"note\":\"PMID 16027248: Family TAA035, a large thoracic aortic aneurysm and aortic dissection (TAAD) kindred whose data were used to map the TAAD2 locus to 3p24\\u201325, was found to have the TGFBR2 missense mutation 1378C to T in exon 5, resulting in the substitution of cysteine for an arginine at amino acid 460 (R460C). The same TGFBR2 mutation was present in the proband from another family . The proband presented at 41 years of age with an ascending aneurysm and mitral valve prolapse. The proband was a member of a 4-generation family with autosomal dominant inheritance of TAAD. Points 1.\\r\\nA second mutation was observed in two unrelated probands in two families with some evidence of co-segregation. Points=1 \\r\\nPMID 16885183 TGFBR2 R460H  mutations in 1 large multi-generation family with TAAD and not fulfilling Marfan / LDS criteria. Point =0.5\\r\\nPMID 18781618: TGFBR2 mutations in 1 TAAD(p.R537C)  case and 6 \\u201cincomplete MFS\\u201d phenotypes. points=0.25\\r\\n25555948: TGFBR2 mutation (5'untranslated region (c.-59C>T), predicted to be a exonic splice enhancer and shown by qRTPCR in one male with TAAD (abnormal expression in aorta). points=0.25\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders.\",\"author\":\"M\\u00e1ty\\u00e1s G\",\"pubdate\":\"2006 Aug\",\"source\":\"Hum Mutat\",\"uid\":\"16791849\"}],\"notes\":{\"note\":\"1 proband with a de novo missense variant (c.1657T>A; pS553T)\"}}},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25.\",\"author\":\"Hasham SN\",\"pubdate\":\"2003 Jul 1\",\"source\":\"Circulation\",\"uid\":\"12821554\"},{\"title\":\"Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections.\",\"author\":\"Pannu H\",\"pubdate\":\"2005 Jul 26\",\"source\":\"Circulation\",\"uid\":\"16027248\"}],\"notes\":{\"note\":\"PMID 12821554: 4-generation family with dominant mode of inheritance of TAAD was studied. Affected status was determined by dilation of the ascending aorta, surgical repair of an aneurysm or dissection, or death as the result of aortic dissection. None of the family members evaluated met the diagnostic criteria for Marfan syndrome. After exclusion of known loci for familial TAAD, a genome-wide scan was carried out to map the defective gene causing the disease in the family. A locus was mapped to a 25-cM region on 3p24-25 with a maximum multipoint logarithm of the odds score of 4.28. Subsequently the causative locus was identified as TGFBR2 mutation (PMID 16027248). Points =5\\r\\n\\r\\nPMID 16027248 A TGFBR2 mutation, 1379G to A, altering arginine\\r\\n460  to a histidine (R460H), was identified in 2 large TAAD kindred. LOD scores were estimated from the combined family. Points =1 \"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Inamoto S\",\"pubdate\":\"2010 Dec 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"20628007\"},{\"title\":\"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.\",\"author\":\"Loeys BL\",\"pubdate\":\"2005 Mar\",\"source\":\"Nat Genet\",\"uid\":\"15731757\"},{\"title\":\"Transforming growth factor beta in cardiovascular development and function.\",\"author\":\"Azhar M\",\"pubdate\":\"2003 Oct\",\"source\":\"Cytokine Growth Factor Rev\",\"uid\":\"12948523\"},{\"title\":\"Postnatal Deletion of the Type II Transforming Growth Factor-\\u03b2 Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice.\",\"author\":\"Hu JH\",\"pubdate\":\"2015 Dec\",\"source\":\"Arterioscler Thromb Vasc Biol\",\"uid\":\"26494233\"}],\"notes\":{\"note\":\"Biochemical Function: PMID 20628007: Induction of contractile smooth muscle cell  phenotype - Inamoto et al showed reduced expression of contractile proteins & blunted response to TGFB1. Cells explanted from patients with TGFBR2 mutations + aortic tissue from these patients + transgenic mice with TGFBR2 variants showed reduced expression of VSMC contractile proteins & failed to increase expression in response to TGFB1\\r\\n\\r\\nPMID 15731757: Increased pSMAD2 in patients with TGFBR2 mutations;\\r\\n\\r\\nExpression: PMID 12948523 : Expressed highly in vascular smooth muscle (SMC); expressed in pharyngeal arches during cardiac development. \\r\\n\\r\\nProtein Interaction: PMID 20628007 :  With Col3A1 \\u2013 Inamoto et al showed altered expression in patients with TGFBR2 mutations; PMID 21979435 showed altered expression in SMC-specific TGFBR2 knockouts.\\r\\nWith TGFBR1 \\u2013 Physical interaction to form heterodimer\\r\\nPMID 20628007: With MYH11, ACTA2 \\u2013 showed that SMC-specific TGFBR2 knockouts show reduced expression of these contractile proteins. \\r\\nPMID 26494233: TGFBR3, Tgfb2, Tgfb3, and Smad7 \\u2013 Expression of all increased after post-natal loss of TGFBR2 in mice\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Inamoto S\",\"pubdate\":\"2010 Dec 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"20628007\"},{\"title\":\"Heterozygous TGFBR2 mutations in Marfan syndrome.\",\"author\":\"Mizuguchi T\",\"pubdate\":\"2004 Aug\",\"source\":\"Nat Genet\",\"uid\":\"15235604\"},{\"title\":\"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.\",\"author\":\"Loeys BL\",\"pubdate\":\"2005 Mar\",\"source\":\"Nat Genet\",\"uid\":\"15731757\"}],\"notes\":{\"note\":\"Patient Cells: \\r\\nPMID 20628007: aortic SMCs from patients show decreased expression of SMC contractile proteins\\r\\nPMID 15731757:increased collagen expression, increased nuclear pSMAD2  and increased CTGF in patients with TGFBR2 mutations\\r\\nNon Patient Cells: \\r\\nPMID 15235604:transfected HEK293 cells with disease-causing variant \\u2013 caused loss of TGFB stimulated extracellular matrix producation\\r\\nPMID 20628007: transfected mouse meseenchymal stem cells with TGFBR2 variant constructs \\u2013 these failed to differentiate into an SMC phenotype with TGFB1 stimulation (control cells differentiate).\\r\\n\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Transforming growth factor-\\u03b2 signaling in myogenic cells regulates vascular morphogenesis, differentiation, and matrix synthesis.\",\"author\":\"Jaffe M\",\"pubdate\":\"2012 Jan\",\"source\":\"Arterioscler Thromb Vasc Biol\",\"uid\":\"21979435\"},{\"title\":\"Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis.\",\"author\":\"Li W\",\"pubdate\":\"2014 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"24401272\"},{\"title\":\"Postnatal Deletion of the Type II Transforming Growth Factor-\\u03b2 Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice.\",\"author\":\"Hu JH\",\"pubdate\":\"2015 Dec\",\"source\":\"Arterioscler Thromb Vasc Biol\",\"uid\":\"26494233\"},{\"title\":\"Angiotensin II-dependent TGF-\\u03b2 signaling contributes to Loeys-Dietz syndrome vascular pathogenesis.\",\"author\":\"Gallo EM\",\"pubdate\":\"2014 Jan\",\"source\":\"J Clin Invest\",\"uid\":\"24355923\"}],\"notes\":{\"note\":\"PMID 24401272: post-natal conditional inactivation of TGFBR2 resulting in aortopathy\\r\\nPMID 26494233: post-natal, SMC-specific knockout of TGFBR2 causes severe aortopathy.\\r\\nPMID 24355923: knock-in mice for Tgfbr2 (G357W) recapitulate aortic phenotype; \\r\\nPMID 21979435: smooth muscle-specific knockout of TGFBR2 in mouse model resulting in abnormal extracellular matrix deposition in aorta; Also differentiationSmooth muscle cell differentiation markers altered in expression in this mouse model.\\r\\n\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"10\",\"GeneticEvidencePointsTotal\":\"10\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"01/25/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"01/25/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/15/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\n\\r\\nConsiderable phenotypic variability humans and mice with different genetic background. Definitive for both LDS and nonsyndromic HTAAD.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1455523200,
    "dateISO8601": "2016-02-15T00:00:00",
    "dateFormated": "Feb 15, 2016"
  },
  "8257": {
    "title": "MYLK : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:7590": {
        "ontology": "HGNC",
        "curie": "HGNC:7590",
        "uri": "HGNC7590"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM600922": {
        "ontology": "OMIM",
        "curie": "OMIM:600922",
        "uri": "OMIM600922",
        "iri": "http://purl.obolibrary.org/obo/OMIM_600922"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3978": {
        "label": "Strong"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MYLK\",\"Hgnc\":\"7590\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"600922\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin light chain kinase cause familial aortic dissections.\",\"author\":\"Wang L\",\"pubdate\":\"2010 Nov 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"21055718\"},{\"title\":\"Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting.\",\"author\":\"Ziganshin BA\",\"pubdate\":\"2015 Nov\",\"source\":\"Ann Thorac Surg\",\"uid\":\"26188975\"},{\"title\":\"Performant Mutation Identification Using Targeted Next-Generation Sequencing of 14 Thoracic Aortic Aneurysm Genes.\",\"author\":\"Proost D\",\"pubdate\":\"2015 Aug\",\"source\":\"Hum Mutat\",\"uid\":\"25907466\"}],\"notes\":{\"note\":\"PMID 21055718: Panel sequencing of a few candidate genes in 94 probands from families with thoracic aortic aneurysm and aortic dissection (TAAD). 1 variant in MYLK absent in ethnically matched controls (+ 4 others) p.S1759P. Also identified a p.R1480X in an unrelated proband. Additional 3 variants in 3 other probands: p.A1754T,  p.V1213M p.E1399K not present in ethnically-matched controls but no family data . Points =1 due to lack of gene impact evidence (ignored the latter three missense variants). \\r\\nPMID 26188975:  Found a mutation (p.P1759S) reported earlier in 1 proband; segregated with disease in her family. Points= 0.5\\r\\nPMID 25907466: Identified one proband with p.R1487* . Points=0.5\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin light chain kinase cause familial aortic dissections.\",\"author\":\"Wang L\",\"pubdate\":\"2010 Nov 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"21055718\"},{\"title\":\"Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting.\",\"author\":\"Ziganshin BA\",\"pubdate\":\"2015 Nov\",\"source\":\"Ann Thorac Surg\",\"uid\":\"26188975\"}],\"notes\":{\"note\":\"PMID 21055718: Panel sequencing of a few candidate genes in 94 probands from families with TAAD\\r\\n1 variant in MYLK absent in ethnically matched controls (+ 4 others) p.S1759P segregated with disease in family (3 probands).\\r\\nFurther sequencing of MYLK in 99 probands with additional TAAD \\u2013 found another variant \\r\\n(p.R1480X) that segregated with disease in family LOD score 1.2 (increased to 1.8 with addition of family members who had sudden death)  Points 3\\r\\nPMID 26188975: weak segregation data. Less than 4 convincing segregations. 1 point.\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Signaling through myosin light chain kinase in smooth muscles.\",\"author\":\"Gao N\",\"pubdate\":\"2013 Mar 15\",\"source\":\"J Biol Chem\",\"uid\":\"23362260\"},{\"title\":\"Notch transcriptional control of vascular smooth muscle regulatory gene expression and function.\",\"author\":\"Basu S\",\"pubdate\":\"2013 Apr 19\",\"source\":\"J Biol Chem\",\"uid\":\"23482558\"},{\"title\":\"Autoregulatory Control of Smooth Muscle Myosin Light Chain Kinase Promoter by Notch Signaling.\",\"author\":\"Basu S\",\"pubdate\":\"2016 Feb 5\",\"source\":\"J Biol Chem\",\"uid\":\"26703474\"}],\"notes\":{\"note\":\"PMID 23362260: A 50% decrease in MLCK (=MYLK) in aortic smooth muscle resulted in 40% inhibition of myosin regulatory light chain phosphorylation and aorta contractile responses, whereas a 90% decrease profoundly inhibited both responses. \\r\\nPMID 23482558: Demonstrated that NOTCH1 induced MYLK expression. Knocked out NOTCH1 signaling in vascular smooth muscle cells (vSMC) in mice. This reduced MYLK expression and activity. Supported by report of NOTCH1-responsive element in MYLK promoter\\r\\nPMID 26703474 showed co-immunoprecipitation of MYLK promoter and JAGGED1 ligand & also MYLK promoter with NOTCH1-enhanced myocardin/SRF complex, & demonstrated each of these enhanced MYLK expression.\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin light chain kinase cause familial aortic dissections.\",\"author\":\"Wang L\",\"pubdate\":\"2010 Nov 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"21055718\"}],\"notes\":{\"note\":\"Patient cells: \\r\\nAuthors transfected COS7 cells with mutations p.S1759P and p.A1754T. Demonstrated significantly reduced (p.1754T) ) or abolished (p.S1759P) calmodulin binding in transfected cells & reduced kinase activity.\\r\\n\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in myosin light chain kinase cause familial aortic dissections.\",\"author\":\"Wang L\",\"pubdate\":\"2010 Nov 12\",\"source\":\"Am J Hum Genet\",\"uid\":\"21055718\"}],\"notes\":{\"note\":\"Authors generated a tamoxifen-induced, SMC specific knockout of MYLK & examined aortas after 13 days.\\r\\nIncreased proteoglycan deposition in aortic media\\r\\nIncreased collagen deposition in adventitia\\r\\nIncreased expression of MMP2\\r\\nNo aortic phenotype (mice with SMC \\u2013 specific k/o usually die due to low BP, reduced gut mobility, airway constriction and urinary dysfunction)  - note low BP similar to ACTA2 k/o effects\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"6\",\"GeneticEvidencePointsTotal\":\"6\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"11\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"04/06/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"MODERATE\",\"CuratorClassificationDate\":\"04/06/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"12/18/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group. \\r\\nExperts added 1 point, originally moderate classification. \"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1482048000,
    "dateISO8601": "2016-12-18T00:00:00",
    "dateFormated": "Dec 18, 2016"
  },
  "8258": {
    "title": "LOX : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:6664": {
        "ontology": "HGNC",
        "curie": "HGNC:6664",
        "uri": "HGNC6664"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM153455": {
        "ontology": "OMIM",
        "curie": "OMIM:153455",
        "uri": "OMIM153455",
        "iri": "http://purl.obolibrary.org/obo/OMIM_153455"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3978": {
        "label": "Strong"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"LOX\",\"Hgnc\":\"6664\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"153455\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2016 Mar 18\",\"source\":\"Circ Res\",\"uid\":\"26838787\"},{\"title\":\"Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.\",\"author\":\"Lee VS\",\"pubdate\":\"2016 Aug 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"27432961\"}],\"notes\":{\"note\":\"PMID 26838787: WES in one family with thoracic aortic aneurysm and aortic dissection (TAAD) identified a rare coding variant in LOX; exome and/or Sanger sequencing of LOX performed in an additional 410 probands from unrelated families.\\r\\n8 rare coding variants identified - 6 probands with variants predicted to be damaging to protein (4 missense mutations were considered to be affecting the final protein) . Points=3 *0.5+ 1\\r\\n\\r\\n\\r\\nPMID 27432961: WES in two first cousins with TAAD identified a rare missense mutation in LOX that co-segregated with disease in a family with a two-generational history of aortic dissection. Points=.5\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2016 Mar 18\",\"source\":\"Circ Res\",\"uid\":\"26838787\"}],\"notes\":{\"note\":\"Two nonsense mutations early in the protein W42* and G202*. Points=3\"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2016 Mar 18\",\"source\":\"Circ Res\",\"uid\":\"26838787\"},{\"title\":\"Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.\",\"author\":\"Lee VS\",\"pubdate\":\"2016 Aug 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"27432961\"}],\"notes\":{\"note\":\"PMIDs 26838787 and 27432961: Only family with p.Ser280Arg considered for segregation evidence( TAA602). Inferred LOD score from 6 segregations (combined families). Point= 3\\r\\n\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2016 Mar 18\",\"source\":\"Circ Res\",\"uid\":\"26838787\"},{\"title\":\"Immunohistochemical localization of lysyl oxidase with monoclonal antibodies.\",\"author\":\"Wakasaki H\",\"pubdate\":\"1990 Sep\",\"source\":\"Lab Invest\",\"uid\":\"1975633\"},{\"title\":\"Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.\",\"author\":\"Lee VS\",\"pubdate\":\"2016 Aug 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"27432961\"}],\"notes\":{\"note\":\"Biochemical Function:\\r\\nPMID 26838787: Aortas from two patients with LOX variants, Ser280Arg and Gly202*, showed mild medial degeneration characterized by focal loss of elastin fibers and smooth muscle cells (SMCs) but limited deposition of proteoglycans.\\r\\nPMID 27432961: Histopathological analysis of resected aortic tissue (II-1) showed cystic medial necrosis with a disorganized appearance of collagen and elastic lamellae.\\r\\n\\r\\nExpression:\\r\\nPMID 1975633: Localization of lysyl oxidase investigated in various tissues and cultured cells using an immunofluorescent antibody method; monoclonal antibodies showed strong immunostaining in the aorta and dermal connective tissue suggesting a close relation to elastin and collagen.\\r\\n\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2016 Mar 18\",\"source\":\"Circ Res\",\"uid\":\"26838787\"},{\"title\":\"Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.\",\"author\":\"Lee VS\",\"pubdate\":\"2016 Aug 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"27432961\"}],\"notes\":{\"note\":\"Non-patient cells\\r\\n\\r\\nPMID 26838787: Mutant LOX constructs expressed in Hela cells assayed for lysyl oxidase activity; Thr248Ile, Ser280Arg, and Ser348Arg had lysyl oxidase activity levels that were 92%, 50%, and 79% of that of WT LOX, respectively.\\r\\nPMID 27432961:Lox activity in MEFs cultured from WT animals significantly higher than that from homozygous mutant knock-in animals.\\r\\n\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.\",\"author\":\"M\\u00e4ki JM\",\"pubdate\":\"2002 Nov 5\",\"source\":\"Circulation\",\"uid\":\"12417550\"},{\"title\":\"Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.\",\"author\":\"M\\u00e4ki JM\",\"pubdate\":\"2002 Nov 5\",\"source\":\"Circulation\",\"uid\":\"12417550\"},{\"title\":\"Lysyl oxidase is required for vascular and diaphragmatic development in mice.\",\"author\":\"Hornstra IK\",\"pubdate\":\"2003 Apr 18\",\"source\":\"J Biol Chem\",\"uid\":\"12473682\"}],\"notes\":{\"note\":\"PMID 12417550: Cre-Lox mediated targeted deletion of first exon; mixed 129/SvJ \\u00d7 C57BL/6 background\\r\\nLOX(\\u2212/\\u2212) mice died at the end of gestation or as neonates; necropsy of the live-born pups revealed large aortic aneurysms\\r\\nMicroscopic analysis of the aorta demonstrated highly fragmented elastic fibers and discontinuity in the smooth muscle cell layers\\r\\nPMID 12473682: LoxP mediated disruption of first exon; mixed 129/SvJ \\u00d7 C57BL/6 background\\r\\nLOX(\\u2212/\\u2212) mice died soon after parturition, exhibiting cardiovascular instability with ruptured arterial aneurysms and diaphragmatic rupture. Microscopic analysis of the aorta demonstrated fragmented elastic fiber architecture\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"9\",\"GeneticEvidencePointsTotal\":\"9\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"15\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"05/13/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"STRONG\",\"CuratorClassificationDate\":\"05/13/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"07/25/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1469430000,
    "dateISO8601": "2016-07-25T00:00:00",
    "dateFormated": "Jul 25, 2016"
  },
  "8259": {
    "title": "PRKG1 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:9414": {
        "ontology": "HGNC",
        "curie": "HGNC:9414",
        "uri": "HGNC9414"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM176894": {
        "ontology": "OMIM",
        "curie": "OMIM:176894",
        "uri": "OMIM176894",
        "iri": "http://purl.obolibrary.org/obo/OMIM_176894"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3978": {
        "label": "Strong"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PRKG1\",\"Hgnc\":\"9414\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"176894\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"7.5\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2013 Aug 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"23910461\"},{\"title\":\"PRKG1 and genetic diagnosis of early-onset thoracic aortic disease.\",\"author\":\"Gago-D\\u00edaz M\",\"pubdate\":\"2016 Sep\",\"source\":\"Eur J Clin Invest\",\"uid\":\"27442293\"}],\"notes\":{\"note\":\" PMID 23910461: Exome sequencing of distant relatives affected by thoracic aortic disease and subsequent Sanger sequencing of additional probands with familial thoracic aortic disease identified the same rare variant,  c.530G>A (p.Arg177Gln), in four families. This mutation segregated with aortic disease in these families with a combined two-point LOD score of 7.88. Also the GOF property of this mutation was demonstrated by functional assays. Proband  score=4 *1.5=6\\r\\nPMID 27442293: One proband with the Arg177Gln mutation ,segregating in 7 affected and 5 unaffected members. Points=1 *1.5 \"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2013 Aug 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"23910461\"}],\"notes\":{\"note\":\"PMID 23910461: PRKG1 c.530G>A (p.Arg177Gln) segregated with aortic disease in these families with a combined two-point LOD score of 7.88. \"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2013 Aug 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"23910461\"}],\"notes\":{\"note\":\"Biochemical function:\\r\\nRegulation of control of VSMC relaxation via phosphorylation of myosin regulatory light chain. Similar to disease mechanisms from MYLK, MYH11, ACTA2 mutations known to cause disease. Points=0.5\\r\\nProtein Interaction:\\r\\nPhysical interaction with myosin (phosphorylation via regulation of phosphatase). Regulation of smooth muscle contractile apparatus similar to MYLK, a gene strongly associated with thoracic aortic aneurysm (TAA) and aortic dissection. Points=0.5\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.\",\"author\":\"Guo DC\",\"pubdate\":\"2013 Aug 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"23910461\"}],\"notes\":{\"note\":\"Patient cells:\\r\\nReduced phosphorylated myosin regulatory light chain in patient fibroblasts compared with controls. Points 1\\r\\nNon patient cells:\\r\\nTransfection of HEK cells with mutations in PRKG1  increases cGMP-controlled kinase activity suggesting gain of function property. Points=1\"}}},\"ModelsRescue\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Defective smooth muscle regulation in cGMP kinase I-deficient mice.\",\"author\":\"Pfeifer A\",\"pubdate\":\"1998 Jun 1\",\"source\":\"EMBO J\",\"uid\":\"9606187\"}],\"notes\":{\"note\":\"PRKG1-k/o mice: PRKG1 k/o showed reduced responsiveness of aortic rings to acetylcholine \\u2013 reduced relaxation\\r\\nPRKG1 k/o were hypertensive.\\r\\nMouse model: 1pts (abnormalities of aortic function but no TAA phenotype)\\r\\nClear abnormal aortic phenotype but not directly mimicking human disease - 1 point.\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4.5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4.5\",\"EvidencePointsTotal\":\"16.5\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"07/12/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"STRONG\",\"CuratorClassificationDate\":\"07/12/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"12/22/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group. \\r\\nOne point subtracted for weak mouse model phenotype (does not recapitulate gain of function) .\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1482393600,
    "dateISO8601": "2016-12-22T00:00:00",
    "dateFormated": "Dec 22, 2016"
  },
  "8260": {
    "title": "BGN : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:1044": {
        "ontology": "HGNC",
        "curie": "HGNC:1044",
        "uri": "HGNC1044"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM301870": {
        "ontology": "OMIM",
        "curie": "OMIM:301870",
        "uri": "OMIM301870",
        "iri": "http://purl.obolibrary.org/obo/OMIM_301870"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"BGN\",\"Hgnc\":\"1044\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"301870\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections.\",\"author\":\"Meester JA\",\"pubdate\":\"2017 Apr\",\"source\":\"Genet Med\",\"uid\":\"27632686\"}],\"notes\":{\"note\":\"marfanoid skeletal features in sister; aortic root echocardiographic dimensions at the upper limits of normal in the mother. variant: c.908A>C, p.Gln303Pro . Points=1.5\\r\\nProband with c.238G>A, p.Gly80Ser wih syndromic TAAD. Points =1.5\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections.\",\"author\":\"Meester JA\",\"pubdate\":\"2017 Apr\",\"source\":\"Genet Med\",\"uid\":\"27632686\"}],\"notes\":{\"note\":\"All following probands associated with syndromic thoracic aortic aneurysm and aortic dissection (TAAD).\\r\\nc.5G>A, p.Trp2* variant in a proband with some segregation evidence.\\r\\n21 kb del: chrX:152767424-152787984\\r\\n28 kb del: chrX:152768438-152795976\"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections.\",\"author\":\"Meester JA\",\"pubdate\":\"2017 Apr\",\"source\":\"Genet Med\",\"uid\":\"27632686\"}],\"notes\":{\"note\":\"Based on 5 segregations of 21 kb deletion with syndromic form of TAAD. LOD 1.5\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}},\"TotalGeneticEvidencePoints\":{\"notes\":\"Only the proband with isolated TAAD was scored\"}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Biglycan deficiency causes spontaneous aortic dissection and rupture in mice.\",\"author\":\"Heegaard AM\",\"pubdate\":\"2007 May 29\",\"source\":\"Circulation\",\"uid\":\"17502576\"}],\"notes\":{\"note\":\"Expression:\\r\\nPMID 17502576: BGN localization in the aortas of WT mice was determined by immunohistochemistry and immuno-electron microscopy; BGN detected in all 3 layers of the aortic wall with adventitia the major site of BGN deposition in the mouse. Points 0.5\\r\\n\\r\\nBiochemical Function:\\r\\nPMID 17502576:Resistance to radial elongation of aortic ring specimens from male bgn-KO and WT mice was compared; The maximum load withstood by KO aortic specimens and their maximum stiffness were significantly lower compared with WT. Points= 0.5\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections.\",\"author\":\"Meester JA\",\"pubdate\":\"2017 Apr\",\"source\":\"Genet Med\",\"uid\":\"27632686\"}],\"notes\":{\"note\":\"Patient cells:\\r\\nThree alternatively spliced products were observed in cDNA from cultured skin fibroblasts ; major splice products introduce a premature stop codon leading to NMD.\\r\\n\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Biglycan deficiency causes spontaneous aortic dissection and rupture in mice.\",\"author\":\"Heegaard AM\",\"pubdate\":\"2007 May 29\",\"source\":\"Circulation\",\"uid\":\"17502576\"}],\"notes\":{\"note\":\"Biglycan deficiency in male BALB/cA mice has been shown to lead to sudden death due to aortic rupture.\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"1.5\",\"GeneticEvidencePointsTotal\":\"1.5\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"5.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"11/17/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/22/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nStrong\\u201d for syndromic , X-linked TAAD and \\u201climited\\u201d for isolated TAAD.\\r\\nThe curation shows strong assertion with syndromic TAAD. There was 1 reported proband with isolated TAAD harboring variant in this gene. Given this, the association with isolated TAAD should be limited.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1482393600,
    "dateISO8601": "2016-12-22T00:00:00",
    "dateFormated": "Dec 22, 2016"
  },
  "8261": {
    "title": "FOXE3 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:3808": {
        "ontology": "HGNC",
        "curie": "HGNC:3808",
        "uri": "HGNC3808"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM601094": {
        "ontology": "OMIM",
        "curie": "OMIM:601094",
        "uri": "OMIM601094",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601094"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"FOXE3\",\"Hgnc\":\"3808\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"601094\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Kuang SQ\",\"pubdate\":\"2016 Mar 1\",\"source\":\"J Clin Invest\",\"uid\":\"26854927\"}],\"notes\":{\"note\":\"FOXE3 c.457G>C (p.Asp153His), segregated with aortic disease in TAA337. This variant is present once in 13,000 chromosomes in the ESP database and disrupts an evolutionarily conserved amino acid. Proband from this family is considered.\\r\\n\\r\\nExome and Sanger sequencing of 564 unrelated FTAAD probands identified 7 additional FOXE3 rare variants predicted to disrupt the protein: p.Pro112Ser, p.Gly137Asp, p.Asp156Asn, p.Arg164Ser, p.Gly196Ala, p.Pro202Leu, and p.Ser300Gly. Variant p.Gly137Asp was identified in affected members of a small family with aortic root dilatation ; no additional samples were available from the other families.  Thus considering only these two probands with a total point of 2.\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Kuang SQ\",\"pubdate\":\"2016 Mar 1\",\"source\":\"J Clin Invest\",\"uid\":\"26854927\"}],\"notes\":{\"note\":\"FOXE3 c.457G>C (p.Asp153His), segregated with aortic disease in TAA337 . Segregation of the FOXE3 variant with aortic disease in this family revealed a lod score of 3.00. \\r\\n\\r\\n\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Kuang SQ\",\"pubdate\":\"2016 Mar 1\",\"source\":\"J Clin Invest\",\"uid\":\"26854927\"}],\"notes\":{\"note\":\"Expression:\\r\\nFoxe3 expression induced in aortas of WT mice stressed with TAC 1 points.\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"5.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.\",\"author\":\"Kuang SQ\",\"pubdate\":\"2016 Mar 1\",\"source\":\"J Clin Invest\",\"uid\":\"26854927\"}],\"notes\":{\"note\":\"Model System:\\r\\n1) Morpholino knock-down in Zebrafish resulting in Disrupted aortic arches. Clear effect on aortic development; direct parallel with aortic dissection unclear. \\r\\n2) Rescue in engineered equivalent;\\r\\nSignificant rescue of phenotype with wild-type copy; only partial rescue with patient variant.Not technically a cellular phenotype, but clearly phenotype in model organism which is relevant to disease - perhaps strong enough to note but not earning \\\"maximum\\\" points for rescue. \\r\\n3) Mouse KO model with  reduced smooth muscle cell number and density; on further stressing with transverse aortic constriction (TAC), evidence of aortic rupture, intramural haematoma. Model shows clear parallel phenotype - but also suggests knockout may not by itself be sufficient for phenotype.\\r\\n4 points for model system, 1 point for rescue.\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"CuratorModifyCalculation\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"7\",\"GeneticEvidencePointsTotal\":\"7\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"12\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"03/09/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"06/15/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\n\\r\\nRecent gene, no strong replication of the data so far. Additional data to confirm clinically relevant HTAAD required  - 1 point subtracted\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1465974000,
    "dateISO8601": "2016-06-15T00:00:00",
    "dateFormated": "Jun 15, 2016"
  },
  "8262": {
    "title": "HCN4 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:16882": {
        "ontology": "HGNC",
        "curie": "HGNC:16882",
        "uri": "HGNC16882"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM605206": {
        "ontology": "OMIM",
        "curie": "OMIM:605206",
        "uri": "OMIM605206",
        "iri": "http://purl.obolibrary.org/obo/OMIM_605206"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"HCN4\",\"Hgnc\":\"16882\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"3.5\",\"tally\":\"3.5\",\"pmid\":{\"publications\":[{\"title\":\"Dilation of the Aorta Ascendens Forms Part of the Clinical Spectrum of HCN4 Mutations.\",\"author\":\"Vermeer AM\",\"pubdate\":\"2016 May 17\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"27173043\"}],\"notes\":{\"note\":\"7 unrelated probands  with dilated aorta asecendens and/or aortic root. with 5 missense variants in HCN4. 7*0.5=3.5\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Dilation of the Aorta Ascendens Forms Part of the Clinical Spectrum of HCN4 Mutations.\",\"author\":\"Vermeer AM\",\"pubdate\":\"2016 May 17\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"27173043\"}],\"notes\":{\"note\":\"Proband with dilated aorta asecendens and/or aortic root with predicted null : c.1920_1932dupCAGCGTGCTCACC; p.Ser695Ter \"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Dilation of the Aorta Ascendens Forms Part of the Clinical Spectrum of HCN4 Mutations.\",\"author\":\"Vermeer AM\",\"pubdate\":\"2016 May 17\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"27173043\"}],\"notes\":{\"note\":\"Three families together were assigned 1.5 based on segregation.\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"HCN4 dynamically marks the first heart field and conduction system precursors.\",\"author\":\"Liang X\",\"pubdate\":\"2013 Aug 2\",\"source\":\"Circ Res\",\"uid\":\"23743334\"}],\"notes\":{\"note\":\"Expression:\\r\\nMice with nuclear localized LacZ or H2BGFP knocked into the endogenous HCN4 locus and analyzed reporter expression in the heart during development;\\r\\nAt E12.5, HCN4-H2BGFP was expressed in endothelial cells of the aorta and pulmonary artery and co-expressed with PECAM, an endothelial cell marker.\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"0.0\",\"tally\":\"\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0.5\",\"GeneticEvidenceTotal\":\"6.5\",\"GeneticEvidencePointsTotal\":\"6.5\",\"ExperimentalEvidencePointsTotal\":\"0.5\",\"EvidencePointsTotal\":\"7\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"10/17/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/22/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group. \\r\\n1 point subtracted due to absence of dissection and lack of longitudinal data on aortic growth.\\r\\nRecent gene - needs further data in support of clinically relevant aortic disease.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1482393600,
    "dateISO8601": "2016-12-22T00:00:00",
    "dateFormated": "Dec 22, 2016"
  },
  "8263": {
    "title": "MAT2A : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:6904": {
        "ontology": "HGNC",
        "curie": "HGNC:6904",
        "uri": "HGNC6904"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM601468": {
        "ontology": "OMIM",
        "curie": "OMIM:601468",
        "uri": "OMIM601468",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601468"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MAT2A\",\"Hgnc\":\"6904\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"601468\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"MAT2A mutations predispose individuals to thoracic aortic aneurysms.\",\"author\":\"Guo DC\",\"pubdate\":\"2015 Jan 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"25557781\"}],\"notes\":{\"note\":\"DNA from two affected family members was used for whole-exome sequencing to identify a rare variant c.1031A>C; (p.Glu344Ala) in MAT2A. \\r\\nVariant is predicted to be damaging by six in silico algorithms + CADD score of 24.\\r\\nSegregates with aortic disease. Proband point=1.5\\r\\nAdditional screening of  individuals with familial thoracic aortic aneurysm and aortic dissection (FTAAD) (78 exome sequencing  and 447 Sanger for all MAT2A exons) identified p.Arg356His variant in one individual. However same individual harbors a rare missense variant in ACTA2. This variant was predicted to be damaging buy six bioinformatic tools.  The functionality of the mutations were tested in zebrafish by morpholino KO and coinjection with  human wild type and mutant mRNA .\\r\\nPoints=0.5\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"MAT2A mutations predispose individuals to thoracic aortic aneurysms.\",\"author\":\"Guo DC\",\"pubdate\":\"2015 Jan 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"25557781\"}],\"notes\":{\"note\":\"Linkage analysis of thoracic aortic disease with the MAT2A variant\\r\\n(c.1031A>C) in TAA059 generated a two-point LOD score of 2.31. \\r\\n\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"MAT2A mutations predispose individuals to thoracic aortic aneurysms.\",\"author\":\"Guo DC\",\"pubdate\":\"2015 Jan 8\",\"source\":\"Am J Hum Genet\",\"uid\":\"25557781\"}],\"notes\":{\"note\":\"Morpholino KO in zebrafish leading to pericardial edema and rescue by human MAT2a. Points=2 (model system) +2 (rescue). \"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"6\",\"GeneticEvidencePointsTotal\":\"6\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"10\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"07/03/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"MODERATE\",\"CuratorClassificationDate\":\"07/03/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"07/03/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group. Recent gene - no additional mutations in a cohort from unpublished data on >400 patients - points subtracted giving it a final limited classification.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1467529200,
    "dateISO8601": "2016-07-03T00:00:00",
    "dateFormated": "Jul 03, 2016"
  },
  "8264": {
    "title": "MFAP5 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:29673": {
        "ontology": "HGNC",
        "curie": "HGNC:29673",
        "uri": "HGNC29673"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM601103": {
        "ontology": "OMIM",
        "curie": "OMIM:601103",
        "uri": "OMIM601103",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601103"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MFAP5\",\"Hgnc\":\"29673\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"601103\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections.\",\"author\":\"Barbier M\",\"pubdate\":\"2014 Dec 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"25434006\"}],\"notes\":{\"note\":\"c.62G>T (p.Trp21Leu) mutation segregating in a three generation family.  Points 1\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections.\",\"author\":\"Barbier M\",\"pubdate\":\"2014 Dec 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"25434006\"}],\"notes\":{\"note\":\"c.472C>T (p.Arg158\\u2217) segregating  with disease in a large 3 generation family. Functional assays showed that c.472C>T leads to pure haploinsufficiency in heterozygous individuals.\"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections.\",\"author\":\"Barbier M\",\"pubdate\":\"2014 Dec 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"25434006\"}],\"notes\":{\"note\":\"Points inferred based on estimated LOD score from  combined  segregations from two families.\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Further characterization of proteins associated with elastic fiber microfibrils including the molecular cloning of MAGP-2 (MP25)\",\"author\":\"Gibson MA\",\"pubdate\":\"1996 Jan 12\",\"source\":\"J Biol Chem\",\"uid\":\"8557636\"},{\"title\":\"Microfibril-associated glycoprotein-2 specifically interacts with a range of bovine and human cell types via alphaVbeta3 integrin.\",\"author\":\"Gibson MA\",\"pubdate\":\"1999 May 7\",\"source\":\"J Biol Chem\",\"uid\":\"10224057\"},{\"title\":\"Microfibril-associated glycoprotein 2 (MAGP2) loss of function has pleiotropic effects in vivo.\",\"author\":\"Combs MD\",\"pubdate\":\"2013 Oct 4\",\"source\":\"J Biol Chem\",\"uid\":\"23963447\"},{\"title\":\"Microfibril-associated MAGP-2 stimulates elastic fiber assembly.\",\"author\":\"Lemaire R\",\"pubdate\":\"2007 Jan 5\",\"source\":\"J Biol Chem\",\"uid\":\"17099216\"},{\"title\":\"Pathway analysis of differentially expressed genes in patients with acute aortic dissection.\",\"author\":\"Mohamed SA\",\"pubdate\":\"2009 May 6\",\"source\":\"Biomark Insights\",\"uid\":\"19652764\"},{\"title\":\"Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly.\",\"author\":\"Penner AS\",\"pubdate\":\"2002 Sep 20\",\"source\":\"J Biol Chem\",\"uid\":\"12122015\"}],\"notes\":{\"note\":\"Biochemical Function:\\r\\nPMIDs 8557636 and 10224057: Binding to extracellular matrix components (FBN1-containing microfibrils); adhesion of aortic smooth muscle and other vascular cells to extra cellular matrix (ECM) components and migration.\\r\\n\\r\\nPMID 17099216: Formation of elastin - containing elastic fibres. \\r\\nPMID 23963447: Binding to TGFB1 and TGFB2 - regulation of cell-cell signalling and TGFB pathway.\\r\\n\\r\\nProtein interaction:\\r\\nPMID: 8557636: adhesion to FBN1 - containing microfibrils\\r\\nPMID: 17099216: interaction with elastin\\r\\nPMID 23963447: interaction with TGFB1 and TGFB2 by binding\\r\\nPMID: 12122015: Binding to FBN1.\\r\\nExpression:\\r\\nPMID 19652764: downregulation of expression in aortic wall of patients with acute aortic dissection\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections.\",\"author\":\"Barbier M\",\"pubdate\":\"2014 Dec 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"25434006\"}],\"notes\":{\"note\":\"Reduced expression of MFAP5 in patient cells; also reduced TGF-Beta signaling in patient tissue (increased TGFB1 and increased pSMAD2/3)\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Microfibril-associated glycoprotein 2 (MAGP2) loss of function has pleiotropic effects in vivo.\",\"author\":\"Combs MD\",\"pubdate\":\"2013 Oct 4\",\"source\":\"J Biol Chem\",\"uid\":\"23963447\"}],\"notes\":{\"note\":\"Mouse model: MFAP5-/- mice have no specific CV phenotype; double k/o MFAP 2-/-: MFAP5 -/- mice have age-dependent aortic dilatation\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"6\",\"GeneticEvidencePointsTotal\":\"6\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"10\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"MODERATE\",\"CuratorClassificationDate\":\"07/04/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"12/22/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1482393600,
    "dateISO8601": "2016-12-22T00:00:00",
    "dateFormated": "Dec 22, 2016"
  },
  "8265": {
    "title": "SMAD2 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:6768": {
        "ontology": "HGNC",
        "curie": "HGNC:6768",
        "uri": "HGNC6768"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM601366": {
        "ontology": "OMIM",
        "curie": "OMIM:601366",
        "uri": "OMIM601366",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601366"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SMAD2\",\"Hgnc\":\"6768\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"601366\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"SMAD2 Mutations Are Associated with Arterial Aneurysms and Dissections.\",\"author\":\"Micha D\",\"pubdate\":\"2015 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"26247899\"}],\"notes\":{\"note\":\"Confirmed de novo . p.(Leu449Ser) in a female with Aortic root dilatation. Some skeletal features - Marfanoid - pes planus, genu valgi, high palate, narrow face, wrist sign, mild scoliosis. \"}}},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"SMAD2 Mutations Are Associated with Arterial Aneurysms and Dissections.\",\"author\":\"Micha D\",\"pubdate\":\"2015 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"26247899\"},{\"title\":\"Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling.\",\"author\":\"Wu JW\",\"pubdate\":\"2001 Dec\",\"source\":\"Mol Cell\",\"uid\":\"11779503\"},{\"title\":\"MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling.\",\"author\":\"Mac\\u00edas-Silva M\",\"pubdate\":\"1996 Dec 27\",\"source\":\"Cell\",\"uid\":\"8980228\"},{\"title\":\"SMAD proteins control DROSHA-mediated microRNA maturation.\",\"author\":\"Davis BN\",\"pubdate\":\"2008 Jul 3\",\"source\":\"Nature\",\"uid\":\"18548003\"},{\"title\":\"TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.\",\"author\":\"Nakao A\",\"pubdate\":\"1997 Sep 1\",\"source\":\"EMBO J\",\"uid\":\"9311995\"},{\"title\":\"Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway.\",\"author\":\"Gomez D\",\"pubdate\":\"2009 May\",\"source\":\"J Pathol\",\"uid\":\"19224541\"}],\"notes\":{\"note\":\"Biochemical function: \\r\\nRole in TGF-Beta canonical signalling:\\r\\nPMID 26247899: Western blot of dermal fibroblasts from pt with p.Gly457Arg  showed increased pSMAD2 & pSMAD3 after stimulation with TGFB1. \\r\\n\\r\\nPMID 11779503: used crystal structure and immunoblotting to demonstrate homo-and hetero-trimerisation of SMAD2 with SMAD3.\\r\\nPMID 8980228:  used immunoblots to demonstrate transient association of SMAD2 with TGFBR1 and TGFBR2 (the receptor complex), & that this results in SMAD2 phosphorylation.\\r\\nPMID 18548003 showed that SMAD2 is required for miRNA -controlled induction of contractile phenotype in vascular smooth muscle cells \\u2013 used RNA-chromatin immunoprecipitation analysis on Cos7 cells co-transfected with pCMV-miR-21 and Flag-tagged SMAD1, SMAD3 or SMAD2; demonstrated that stimulation with TGFB induced SMAD2 binding of pri-miR-21 and therefore increased recruitment of DROSHA complexes (which in turn regulate further miRNAs controlling contractile phenotype).\\r\\n\\r\\nProtein Interaction\\r\\nPMID 11779503:  demonstrated heterotrimerisation of SMAD2 + SMAD3 in vitro and in vivo (immunoblotting) (1/2 pt)\\r\\nPMID 9311995 used immunoprecipitation & immunoblotting to demonstrate heteromer formation of SMAD2 with SMAD4 when a constitutively active form of TGFBR1 was expressed: interaction with TGFBR1 (1/2 pt) + SMAD4 (1/2 pt)\\r\\nPMID 8980228:  used immunoblots to demonstrate transient association of SMAD2 with TGFBR1 and TGFBR2 (the receptor complex) (1 pt)\\r\\nExpression:\\r\\nPMID 19224541:  showed increased SMAD2 mRNA levels in aortic aneurysm tissues from all causes and increased pSMAD2.\\t\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"SMAD2 Mutations Are Associated with Arterial Aneurysms and Dissections.\",\"author\":\"Micha D\",\"pubdate\":\"2015 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"26247899\"}],\"notes\":{\"note\":\" Western blot of dermal fibroblasts from patient with p.Gly457Arg  showed increased pSMAD2&3 after stimulation with TGFB1.\\r\\n\"}}},\"ModelsRescue\":{\"value\":\"0.0\",\"tally\":\"\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"2\",\"GeneticEvidencePointsTotal\":\"2\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"05/03/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"05/03/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/22/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nRecent gene - additional data awaited to confirm/refute clinical relevance in familial thoracic aortic aneurysm and aortic dissection.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1491807600,
    "dateISO8601": "2017-04-10T00:00:00",
    "dateFormated": "Apr 10, 2017"
  },
  "8266": {
    "title": "TGFB3 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:11769": {
        "ontology": "HGNC",
        "curie": "HGNC:11769",
        "uri": "HGNC11769"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM190230": {
        "ontology": "OMIM",
        "curie": "OMIM:190230",
        "uri": "OMIM190230",
        "iri": "http://purl.obolibrary.org/obo/OMIM_190230"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"TGFB3\",\"Hgnc\":\"11769\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"190230\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in a TGF-\\u03b2 ligand, TGFB3, cause syndromic aortic aneurysms and dissections.\",\"author\":\"Bertoli-Avella AM\",\"pubdate\":\"2015 Apr 7\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"25835445\"}],\"notes\":{\"note\":\"In 120 TAAD patients, a targeted analysis of thoracic aortic aneurysm and aortic dissection (TAAD) candidate genes after whole-exome sequencing was performed. This revealed 3 heterozygous TGFB3 mutations in unrelated individuals. However in absence of data other than in silico prediction the number of points assigned for non-syndromic TAAD =1.  \"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with Marfan and Loeys-Dietz syndrome.\",\"author\":\"Rienhoff HY Jr\",\"pubdate\":\"2013 Aug\",\"source\":\"Am J Med Genet A\",\"uid\":\"23824657\"},{\"title\":\"Mutations in a TGF-\\u03b2 ligand, TGFB3, cause syndromic aortic aneurysms and dissections.\",\"author\":\"Bertoli-Avella AM\",\"pubdate\":\"2015 Apr 7\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"25835445\"},{\"title\":\"Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm.\",\"author\":\"Nataatmadja M\",\"pubdate\":\"2006 Jul 4\",\"source\":\"Circulation\",\"uid\":\"16820603\"}],\"notes\":{\"note\":\"Biochemical function:\\r\\n23824657: TGFB3-dependent pSMAD2 and pERK1/2 signals are significantly diminished with increasing amounts of the mutant RNA (G1226A) relative to wild-type in Xenopus embryos.\\r\\nPMID 25835445: Microscopic examination of the dissected aortic wall from patient, obtained at the time of surgery , showed elastic fiber fragmentation with higher collagen and proteoglycan deposition.\\r\\nAlso evidence of paradoxically enhanced TGF-\\u03b2 signaling in the aortic wall of a TGFB3 mutant patient (3-III:1), as shown by increased pSMAD2 (canonical TGF-\\u03b2 signaling), pERK (noncanonical TGF-\\u03b2 signaling), and elevated TGFB1 messenger RNA.\\r\\nExpression:\\r\\nPMID 16820603: Increased expression of each of the 3 human TGF-\\u03b2 isoforms in aneurysm tissue and in cultured vascular smooth muscle cells (VSMC) and fibroblasts derived from aorta and skin of MFS patients, compared with controls; did not reach significance for TGF\\u03b22 and \\u03b23 in aneurysm tissue or for TGF\\u03b23 in cultured VSMCs .\\r\\nWestern blot studies showed 3-fold increase in the expression of TGF\\u03b21, \\u03b22, and \\u03b23 in SF and VSMC derived from Marfan syndrome patients in comparison to controls, consistent with the immunohistochemical findings in aortic tissue and cultured cells.\\r\\n\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"0.0\",\"tally\":\"\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"CuratorModifyCalculation\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"1\",\"GeneticEvidencePointsTotal\":\"1\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"3\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07/11/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"07/11/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/22/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nLimited clinical evidence for association with non syndromic TAAD. Convincing evidence for association with syndromic aortic aneurysms as shown in PMID 25835445.\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1482393600,
    "dateISO8601": "2016-12-22T00:00:00",
    "dateFormated": "Dec 22, 2016"
  },
  "8267": {
    "title": "EFEMP2 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:3219": {
        "ontology": "HGNC",
        "curie": "HGNC:3219",
        "uri": "HGNC3219"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM604633": {
        "ontology": "OMIM",
        "curie": "OMIM:604633",
        "uri": "OMIM604633",
        "iri": "http://purl.obolibrary.org/obo/OMIM_604633"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"EFEMP2\",\"Hgnc\":\"3219\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"604633\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Recessively inherited severe aortic aneurysm caused by mutated EFEMP2.\",\"author\":\"Al-Hassnan ZN\",\"pubdate\":\"2012 Jun 1\",\"source\":\"Am J Cardiol\",\"uid\":\"22440127\"}],\"notes\":{\"note\":\"9 patients, from 4 unrelated consanguineous families, with recessively inherited AA. Echocardiogram revealed a wide spectrum of severity of the AA, with a Z-score varying from 5 to 33.\\r\\nIn 1 family, genome-wide single-nucleotide polymorphism analysis detected a homozygous block, shared by 2 affected siblings, on chromosome 11 at q13. Sequence analysis of EFEMP2 , located on chromosome 11 at q13, identified a novel homozygous mutation (p.E161K) in all 9 affected subjects.\\r\\nClinical features reported not complete (e.g no explanation for cyanosis as presenting feature reported - lung- peripheral artery- and pulmonary artery involvement unclear.\\r\\n\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"publications\":[{\"title\":\"Recessively inherited severe aortic aneurysm caused by mutated EFEMP2.\",\"author\":\"Al-Hassnan ZN\",\"pubdate\":\"2012 Jun 1\",\"source\":\"Am J Cardiol\",\"uid\":\"22440127\"}],\"notes\":{\"note\":\"Combined family segregations to estimate. Points 3*1\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Decreased expression of fibulin-4 in aortic wall of aortic dissection.\",\"author\":\"Huawei P\",\"pubdate\":\"2014 Feb\",\"source\":\"Vascular\",\"uid\":\"23518852\"},{\"title\":\"Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase.\",\"author\":\"Horiguchi M\",\"pubdate\":\"2009 Nov 10\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"19855011\"}],\"notes\":{\"note\":\"Expression: PMID 23518852: in aortic wall of ascending aortic dissection from 10 patients , the expression of fibulin-4 protein was significantly reduced.\\r\\nProtein interaction\\r\\nPMID 19855011: In vitro  N-terminal domain of FBLN4 interacts with the propeptide domain of LOX.  Also immunostaining of cultured human skin fibroblasts revealed colocalization of LOX +FBLN4.\\r\\n\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Loss of fibulin-4 disrupts collagen synthesis and maturation: implications for pathology resulting from EFEMP2 mutations.\",\"author\":\"Papke CL\",\"pubdate\":\"2015 Oct 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"26220971\"}],\"notes\":{\"note\":\"Non patient cells:\\r\\nFibulin-4 is important for the integrity of aortic collagen in addition to elastin. Smooth muscle-specific Efemp2 loss in mouse (SMKO) resulted in altered fibrillar collagen localization with larger, poorly organized fibrils. LOX activity was decreased in Efemp2-null cells, and collagen cross-linking was diminished in SMKO aortas.\\r\\n\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice.\",\"author\":\"McLaughlin PJ\",\"pubdate\":\"2006 Mar\",\"source\":\"Mol Cell Biol\",\"uid\":\"16478991\"},{\"title\":\"Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice.\",\"author\":\"Hanada K\",\"pubdate\":\"2007 Mar 16\",\"source\":\"Circ Res\",\"uid\":\"17293478\"},{\"title\":\"Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase.\",\"author\":\"Horiguchi M\",\"pubdate\":\"2009 Nov 10\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"19855011\"},{\"title\":\"Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression.\",\"author\":\"Huang J\",\"pubdate\":\"2010 Feb 19\",\"source\":\"Circ Res\",\"uid\":\"20019329\"},{\"title\":\"Fibulin-4 E57K Knock-in Mice Recapitulate Cutaneous, Vascular and Skeletal Defects of Recessive Cutis Laxa 1B with both Elastic Fiber and Collagen Fibril Abnormalities.\",\"author\":\"Igoucheva O\",\"pubdate\":\"2015 Aug 28\",\"source\":\"J Biol Chem\",\"uid\":\"26178373\"}],\"notes\":{\"note\":\"PMID 16478991 fibulin-4 knock out (KO) mice exhibited severe lung and vascular defects including emphysema, artery tortuosity, irregularity, aneurysm, rupture, and resulting hemorrhages. \\r\\nPMID 17293478: Fibulin-4 knockdown mice with a hypomorphic expression allele. Mice homozygous for the Fibulin-4 reduced expression allele show dilatation of the ascending aorta and a tortuous and stiffened aorta, resulting from disorganized elastic fiber networks. \\r\\nPMID: 19855011(conditional KO), 20019329 (tissue specific KO), 26178373(variant E57K  Knock-in) All result in aneurysmal dialation/dissection of aorta.\\r\\n\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"3\",\"GeneticEvidencePointsTotal\":\"3\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"9\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"08/04/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"MODERATE\",\"CuratorClassificationDate\":\"08/04/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"12/22/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nDefinitive association with cutis laxa phenotype, association with HTAAD less well established - no mutations identified in large cohorts  of patients presenting with HTAAD. EFEMP2 may be predictive of thoracic aortic enlargement without evidence of progression to aortic dissection so far\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1482393600,
    "dateISO8601": "2016-12-22T00:00:00",
    "dateFormated": "Dec 22, 2016"
  },
  "8268": {
    "title": "FBN2 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:3604": {
        "ontology": "HGNC",
        "curie": "HGNC:3604",
        "uri": "HGNC3604"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM612570": {
        "ontology": "OMIM",
        "curie": "OMIM:612570",
        "uri": "OMIM612570",
        "iri": "http://purl.obolibrary.org/obo/OMIM_612570"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"FBN2\",\"Hgnc\":\"3604\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"612570\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: report of 14 novel mutations and review of the literature.\",\"author\":\"Callewaert BL\",\"pubdate\":\"2009 Mar\",\"source\":\"Hum Mutat\",\"uid\":\"19006240\"},{\"title\":\"Congenital contractural arachnodactyly complicated with aortic dilatation and dissection: Case report and review of literature.\",\"author\":\"Takeda N\",\"pubdate\":\"2015 Oct\",\"source\":\"Am J Med Genet A\",\"uid\":\"25975422\"},{\"title\":\"Clustering of FBN2 mutations in patients with congenital contractural arachnodactyly indicates an important role of the domains encoded by exons 24 through 34 during human development.\",\"author\":\"Park ES\",\"pubdate\":\"1998 Jul 24\",\"source\":\"Am J Med Genet\",\"uid\":\"9714438\"}],\"notes\":{\"note\":\"19006240 Proband with mild aortic dilation harboring p.Ser1122Pro\\r\\n25975422 Proband with mild aortic dilation harboring IVS 32 + 5 G>A\\r\\n9714438 Paediatric aortic root dilatation. Variant IVS31+1G>C\\r\\n Weak evidence . Total points for isolated thoracic aortic aneurysm and aortic dissection (TAAD) =1\\r\\n\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Fibrillins 1 and 2 perform partially overlapping functions during aortic development.\",\"author\":\"Carta L\",\"pubdate\":\"2006 Mar 24\",\"source\":\"J Biol Chem\",\"uid\":\"16407178\"},{\"title\":\"Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices.\",\"author\":\"Zhang H\",\"pubdate\":\"1994 Mar\",\"source\":\"J Cell Biol\",\"uid\":\"8120105\"},{\"title\":\"Structure and function of the mammalian fibrillin gene family: implications for human connective tissue diseases.\",\"author\":\"Davis MR\",\"pubdate\":\"2012 Dec\",\"source\":\"Mol Genet Metab\",\"uid\":\"22921888\"}],\"notes\":{\"note\":\"Biochemical function\\r\\nPMID 16407178: FBN2-/- ;FBN1+/- mice have impaired elastogenesis compared with FBN1-/- alone - implies synergistic roles of FBN1 and 2 in fibre formation.\\r\\nPMID 8120105: immunohistochemistry and ultrastructural analysis localise FBN2 to formation of microfibrils in human and bovine fetal tissue, presence enriched in elastic fibre-rich areas eg aortic media.\\r\\nPMID 22921888: immunohistochemistry to show that FBN2 forms microfibrils. \\r\\nExpression\\r\\nPMID 8120105: expression enriched in elastic fibre-rich areas eg aortic media\\r\\nProtein interaction\\r\\nPMID 16407178: FBN2-/- ;FBN1+/- mice have impaired elastogenesis compared with FBN1-/- alone - implies synergistic roles of FBN1 and 2 in fibre formation.\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Fibrillins 1 and 2 perform partially overlapping functions during aortic development.\",\"author\":\"Carta L\",\"pubdate\":\"2006 Mar 24\",\"source\":\"J Biol Chem\",\"uid\":\"16407178\"}],\"notes\":{\"note\":\"FBN2-/- ;FBN1+/- mice have impaired elastogenesis compared with FBN1-/- alone - implies synergistic roles of FBN1 and 2 in fibre formation. Double knockouts (FBN1-/-;FBN2-/-) are  non-viable just after embryonic day 14.5.\\t\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"CuratorModifyCalculation\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"1\",\"GeneticEvidencePointsTotal\":\"1\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"4\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"04/17/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"04/17/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/22/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group.\\r\\nFBN2 is clearly associated with congenital contractural arachnodactyly, however, not with HTAAD. FBN2 could be predictive of thoracic aortic enlargement without evidence of progression to aortic dissection so far\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1482393600,
    "dateISO8601": "2016-12-22T00:00:00",
    "dateFormated": "Dec 22, 2016"
  },
  "8269": {
    "title": "NOTCH1 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:7881": {
        "ontology": "HGNC",
        "curie": "HGNC:7881",
        "uri": "HGNC7881"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM190198": {
        "ontology": "OMIM",
        "curie": "OMIM:190198",
        "uri": "OMIM190198",
        "iri": "http://purl.obolibrary.org/obo/OMIM_190198"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"NOTCH1\",\"Hgnc\":\"7881\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"190198\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve.\",\"author\":\"Mohamed SA\",\"pubdate\":\"2006 Jul 14\",\"source\":\"Biochem Biophys Res Commun\",\"uid\":\"16729972\"}],\"notes\":{\"note\":\"Analysis of NOTCH1 mutation frequency and spectrum in  48 patients with sporadic BAV.\\r\\n12 patients had Aneurysm of ascending aorta.\\r\\n\\r\\nPotential relevant pathogenic mutations identified \\r\\np.P1797H: Absent in ExAC. Pt with this mutation: aortic valve calcified and insufficient  + ascending aortic aneurysm. Points =0.5\\r\\n\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Cardiovascular malformations caused by NOTCH1 mutations do not keep left: data on 428 probands with left-sided CHD and their families.\",\"author\":\"Kerstjens-Frederikse WS\",\"pubdate\":\"2016 Sep\",\"source\":\"Genet Med\",\"uid\":\"26820064\"}],\"notes\":{\"note\":\"A cohort of 427 patients (286 male, 141 female) with non-syndromic LVOTO\\r\\n    147 of 427 probands (34%) the heart defect was familial. \\r\\n    13 novel pathogenic NOTCH1 mutations in 427 index patients (probands) (3%): eight\\r\\ntruncating (nonsense or frameshift) mutations, four RNA splicing mutations and one whole gene.\\r\\nDeletion. Their phenotypes included not only LVOTO, but also conotruncal malformations and thoracic aortic aneurysms (TAA)\\r\\np.(Arg1984*): 1 proband. Aortic valve defects + TAA\\r\\np.(Ser2486Leufs*21): 1 proband . TAA+ Aortic valve defects \\r\\n(NOTE: the mutation is in last Exon. ) otal points given is 1 as no isolated TAA was observed.\\r\\n\"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in NOTCH1 cause aortic valve disease.\",\"author\":\"Garg V\",\"pubdate\":\"2005 Sep 8\",\"source\":\"Nature\",\"uid\":\"16025100\"}],\"notes\":{\"note\":\"Expression: Activation of Notch signaling is increased in the aortic wall of DTAAD patients\\r\\n\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Notch-dependent EMT is attenuated in patients with aortic aneurysm and bicuspid aortic valve.\",\"author\":\"Kostina AS\",\"pubdate\":\"2016 Apr\",\"source\":\"Biochim Biophys Acta\",\"uid\":\"26876948\"}],\"notes\":{\"note\":\"Patient cells:\\r\\nNotch-dependent endothelial-to-mesenchymal transition is attenuated in patients with aortic aneurysm and bicuspid aortic valve\\r\\n\"}}},\"ModelsRescue\":{\"value\":\"0.0\",\"tally\":\"\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"1.5\",\"GeneticEvidencePointsTotal\":\"1.5\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"3\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"03/27/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"04/06/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group. \\r\\nAssociation with BAV is strong but not isolated HTAAD.NOTCH1 may be predictive of thoracic aortic enlargement without evidence of progression to aortic dissection so far\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1459926000,
    "dateISO8601": "2016-04-06T00:00:00",
    "dateFormated": "Apr 06, 2016"
  },
  "8270": {
    "title": "SLC2A10 : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:13444": {
        "ontology": "HGNC",
        "curie": "HGNC:13444",
        "uri": "HGNC13444"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM606145": {
        "ontology": "OMIM",
        "curie": "OMIM:606145",
        "uri": "OMIM606145",
        "iri": "http://purl.obolibrary.org/obo/OMIM_606145"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SLC2A10\",\"Hgnc\":\"13444\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\" 606145\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"0\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"TotalGeneticEvidencePoints\":{\"notes\":\"No probands with isolated TAA were noted. But definitive evidence for Arterial Tortuosity syndrome.\"}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Mitochondrial GLUT10 facilitates dehydroascorbic acid import and protects cells against oxidative stress: mechanistic insight into arterial tortuosity syndrome.\",\"author\":\"Lee YC\",\"pubdate\":\"2010 Oct 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"20639396\"},{\"title\":\"Homozygosity mapping of a gene for arterial tortuosity syndrome to chromosome 20q13.\",\"author\":\"Coucke PJ\",\"pubdate\":\"2003 Oct\",\"source\":\"J Med Genet\",\"uid\":\"14569121\"}],\"notes\":{\"note\":\"Biochemical Function\\r\\nPMID 20639396: GLUT10 acts as a mitochondrial DHA transporter. Lack/reduced GLUT10 results in increased oxidative stress.\\r\\nProtein Interaction\\r\\nPMID 14569121: Disruption of SLC2A10 leads to TGF-beta signaling activation\\r\\nExpression:\\r\\nPMID 20639396: GLUT10 mRNA is highly expressed in aortic smooth muscle cells in humans and mice. In A10 rat aortic smooth muscle cells, Glut10 localized mainly to mitochondria \\r\\nPMID 14569121: qPCR of samples derived from individuals with ATS homozygous for premature stop codon mutations demonstrated a near-absence of SLC2A10 mRNA in vascular smooth muscle cells as well as in fibroblasts.\\r\\n\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"CuratorModifyCalculation\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"1.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"03/08/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"NO REPORTED EVIDENCE\",\"CuratorClassificationDate\":\"05/08/2016\",\"CuratorClassificationNotes\":\"No probands with isolated TAA was noted. But definitive evidence for Arterial Tortuosity syndrome. Functional evidence: There are contradictory reports in mouse model in PMID: 19028722 and 18693279. Hence not included.\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"04/17/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group. Though experimental data may be available supporting a potential role for SLC2A10 in HTAAD, no probands with isolated TAAD have been reported to date. ATS patients should, however, be screened for TAA.Genes predictive of thoracic aortic enlargement without evidence of progression to aortic dissection so far. SLC2A10 may be predictive of thoracic aortic enlargement without evidence of progression to aortic dissection so far\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1460876400,
    "dateISO8601": "2016-04-17T00:00:00",
    "dateFormated": "Apr 17, 2016"
  },
  "8274": {
    "title": "FLNA : Familial thoracic aortic aneurysm and aortic dissection",
    "label": "Familial thoracic aortic aneurysm and aortic dissection",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "HGNC:3754": {
        "ontology": "HGNC",
        "curie": "HGNC:3754",
        "uri": "HGNC3754"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019625"
      },
      "OMIM300017": {
        "ontology": "OMIM",
        "curie": "OMIM:300017",
        "uri": "OMIM300017",
        "iri": "http://purl.obolibrary.org/obo/OMIM_300017"
      },
      "ORPHA91387": {
        "ontology": "ORPHA",
        "curie": "ORPHA:91387",
        "uri": "ORPHA91387",
        "iri": "http://www.orpha.net/ORDO/Orphanet_91387"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"FLNA\",\"Hgnc\":\"3754\",\"OrphaNet\":\"91387\",\"Disease\":\"Familial thoracic aortic aneurysm and aortic dissection\",\"Omim\":\"300017\",\"ModeOfInheritance\":\"X-Linked inheritance (HP:0001417)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"publications\":[{\"title\":\"Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A.\",\"author\":\"Reinstein E\",\"pubdate\":\"2013 May\",\"source\":\"Eur J Hum Genet\",\"uid\":\"23032111\"}],\"notes\":{\"note\":\"Case M3 = 2 month old male\\r\\nde novo c.5498_5504delCACCCACinsAC indel\\r\\nCyanotic post-natally; marked dilatation of whole length of aorta, pulmonary arteries (PAs), Ventricular Septal Defect, Atrial Septal Defect, Patent Ductus Arteriosus. Also post-mortem showed intestinal malrotation.\\r\\nIntractable pulmonary hypertension; died sepsis. \\r\\nNot scored - syndromic - other presenting features\\r\\nCase F3= 6 yo female\\r\\nReferred for murmur; gross dilatation of PA + also aorta + head and neck branches\\r\\np.Tyr731X variant; family study showed this was de novo. Brain MRI shows PNH. \\r\\nNot scored - other presenting features\\r\\n\"}}},\"VariantIsDeNovo\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A.\",\"author\":\"Reinstein E\",\"pubdate\":\"2013 May\",\"source\":\"Eur J Hum Genet\",\"uid\":\"23032111\"},{\"title\":\"Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting.\",\"author\":\"Ziganshin BA\",\"pubdate\":\"2015 Nov\",\"source\":\"Ann Thorac Surg\",\"uid\":\"26188975\"}],\"notes\":{\"note\":\"PMID 23032111\\r\\nCase 1 = 38 yo female; SoV aneurysm. Daughter has R subclavian aneurysm; no aortic involvement\\r\\nPeriventricular Nodular Heterotopia on brain MRI; no seizures\\r\\nNonsense mutation in FLNA - p.Asn296Glu fs*38; immunohistochemistry showed 2 fibroblast populations, one of which had no FLNA expression. \\r\\n0.5pt nonsense mutation with evidence of functional effect\\r\\nCase F5 = 23 y/o female\\r\\nProgressive aortic root dilatation at age 7 (Ix for peripheral cyanosis) + dilated PA\\r\\nSeizures in teens; PNH on brain scan. Joint laxity with recurrent hip subluxations. \\r\\nNonsense variant: c.7813delC (p.Leu2605fs)\\r\\nNot scored (other presenting features)\\r\\nPMID 26188975: Tested 102 patients by WES; reporting of panel of TAA genes. 1 pt found to have nonsense mutation in FLNA (Y1324X). Family pedigree not reported \\u2013 no segregation information. Not in ExAC (synonymous variant at same location)\\r\\n0.5 pt (Due to high pLI score for FLNA, scored 0.5 pt for this proband despite limited info)\\r\\nPMID 15668422: F2 = 16 y/o F with TAA and EDS \\u2013 like joint laxity /skin features. Variant = c. 4147 del G\\r\\nTAA major feature; no neurology. No segregation. \\r\\n0.5 pt\"}}},\"TwoNon-LOFVariantsInTrans\":{\"value\":\"0.0\",\"tally\":\"0\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"},\"AggregateVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Proteomic analysis in aortic media of patients with Marfan syndrome reveals increased activity of calpain 2 in aortic aneurysms.\",\"author\":\"Pilop C\",\"pubdate\":\"2009 Sep 15\",\"source\":\"Circulation\",\"uid\":\"19720936\"},{\"title\":\"Calpain-2 compensation promotes angiotensin II-induced ascending and abdominal aortic aneurysms in calpain-1 deficient mice.\",\"author\":\"Subramanian V\",\"pubdate\":\"2013\",\"source\":\"PLoS One\",\"uid\":\"23977256\"}],\"notes\":{\"note\":\"Biochemical Function:\\r\\nPMID 19720936: Role in aortic wall integrity. Increased levels of C terminal fragments of FLNA in dilated aortic walls from BAV and MFS patients.\\r\\nProtein Interactions:\\r\\nPMID 23977256: interaction with angiotensin II: increased C terminal fragmentation with ANgII infusion\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"\"},\"ModelsRescue\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis.\",\"author\":\"Feng Y\",\"pubdate\":\"2006 Dec 26\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"17172441\"},{\"title\":\"Arterial Myogenic Activation through Smooth Muscle Filamin A.\",\"author\":\"Retailleau K\",\"pubdate\":\"2016 Mar 8\",\"source\":\"Cell Rep\",\"uid\":\"26923587\"},{\"title\":\"Smooth muscle filamin A is a major determinant of conduit artery structure and function at the adult stage.\",\"author\":\"Retailleau K\",\"pubdate\":\"2016 Jul\",\"source\":\"Pflugers Arch\",\"uid\":\"27023351\"}],\"notes\":{\"note\":\"PMID 26923587: Mouse with smooth muscle-specific deletion of FLNA at adult stage. Loss of myogenic tone in caudal artery; impaired stretch activation of calcium influx was blunted in the absence of smFlnA: loss of pressure-depndent regulation of arterial tone.\\r\\n\\r\\n\\r\\nPMID 17172441: conditional knockout at adult stage in smooth muscle causes hypertrophic remodeling and increased aortic diameter.\\r\\nPMID 27023351: smooth muscle-specific knockout: hemizygous males die by E14.5 from vascular rupture and fragility.; abnormal cell-cell junctions; failure of vascular remodelling.\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"1\",\"GeneticEvidencePointsTotal\":\"1\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"6\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07/03/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"07/03/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/22/2016\",\"FinalClassificationNotes\":\"Assertion made by the Aortopathy working group. Initial scoring curator was downsized. Case 1 was allocated only 1 pt based on the fact that the functional evidence was limited and that it was difficult to assess segregation with regards to TAA. Cases present with syndromic pathology (OPD/Melnick needles) and should not be given any points. Of the remaining female cases, most have neurological problems. FLNA causes cardiac valvular dysplasia with low risk for thoracic aortic disease and primarily diagnosed based on non-vascular features\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1482393600,
    "dateISO8601": "2016-12-22T00:00:00",
    "dateFormated": "Dec 22, 2016"
  },
  "8397": {
    "title": "BRCA2: Familial breast-ovarian cancer susceptibility",
    "label": "Familial breast-ovarian cancer susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "1101": {
        "ontology": "HGNC",
        "curie": "HGNC:1101",
        "uri": "HGNC1101"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0012933"
      },
      "OMIM612555": {
        "ontology": "OMIM",
        "curie": "OMIM:612555",
        "uri": "OMIM612555",
        "iri": "http://purl.obolibrary.org/obo/OMIM_612555"
      },
      "ORPHA145": {
        "ontology": "ORPHA",
        "curie": "ORPHA:145",
        "uri": "ORPHA145",
        "iri": "http://www.orpha.net/ORDO/Orphanet_145"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"BRCA2\",\"Hgnc\":\"1101\",\"OrphaNet\":\"145\",\"Disease\":\"Familial breast-ovarian cancer susceptibility\",\"Omim\":\"612555\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"9.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.\",\"author\":\"Tavtigian SV\",\"pubdate\":\"1996 Mar\",\"source\":\"Nat Genet\",\"uid\":\"8589730\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"14.0\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.\",\"author\":\"Antoniou AC\",\"pubdate\":\"2008 Apr\",\"source\":\"Am J Hum Genet\",\"uid\":\"18355772\"},{\"title\":\"Identification of the breast cancer susceptibility gene BRCA2.\",\"author\":\"Wooster R\",\"pubdate\":\"1995 Dec 21-28\",\"source\":\"Nature\",\"uid\":\"8524414\"},{\"title\":\"The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.\",\"author\":\"Tavtigian SV\",\"pubdate\":\"1996 Mar\",\"source\":\"Nat Genet\",\"uid\":\"8589730\"},{\"title\":\"Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.\",\"author\":\"Lilyquist J\",\"pubdate\":\"2017 Nov\",\"source\":\"Gynecol Oncol\",\"uid\":\"28888541\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"3.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.\",\"author\":\"Chen J\",\"pubdate\":\"1998 Sep\",\"source\":\"Mol Cell\",\"uid\":\"9774970\"},{\"title\":\"Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2.\",\"author\":\"Sharan SK\",\"pubdate\":\"1997 Apr 24\",\"source\":\"Nature\",\"uid\":\"9126738\"},{\"title\":\"Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.\",\"author\":\"Schlacher K\",\"pubdate\":\"2011 May 13\",\"source\":\"Cell\",\"uid\":\"21565612\"},{\"title\":\"Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.\",\"author\":\"King TA\",\"pubdate\":\"2007 Sep\",\"source\":\"Ann Surg Oncol\",\"uid\":\"17597348\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.\",\"author\":\"Jonkers J\",\"pubdate\":\"2001 Dec\",\"source\":\"Nat Genet\",\"uid\":\"11694875\"},{\"title\":\"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.\",\"author\":\"Perets R\",\"pubdate\":\"2013 Dec 9\",\"source\":\"Cancer Cell\",\"uid\":\"24332043\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09/13/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"09/13/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1505286000,
    "dateISO8601": "2017-09-13T00:00:00",
    "dateFormated": "Sep 13, 2017"
  },
  "8399": {
    "title": "GJB2: Nonsyndromic sensorineural hearing loss (DFNB1)",
    "label": "Nonsyndromic sensorineural hearing loss",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "4284": {
        "ontology": "HGNC",
        "curie": "HGNC:4284",
        "uri": "HGNC4284"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019588"
      },
      "OMIM220290": {
        "ontology": "OMIM",
        "curie": "OMIM:220290",
        "uri": "OMIM220290",
        "iri": "http://purl.obolibrary.org/obo/OMIM_220290"
      },
      "ORPHA90636": {
        "ontology": "ORPHA",
        "curie": "ORPHA:90636",
        "uri": "ORPHA90636",
        "iri": "http://www.orpha.net/ORDO/Orphanet_90636"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"GJB2\",\"Hgnc\":\"4284\",\"OrphaNet\":\"90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"220290\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"Connexin 26 mutations in hereditary non-syndromic sensorineural deafness.\",\"author\":\"Kelsell DP\",\"pubdate\":\"1997 May 1\",\"source\":\"Nature\",\"uid\":\"9139825\"},{\"title\":\"Connexin-26 mutations in sporadic and inherited sensorineural deafness.\",\"author\":\"Estivill X\",\"pubdate\":\"1998 Feb 7\",\"source\":\"Lancet\",\"uid\":\"9482292\"},{\"title\":\"A Moroccan family with autosomal recessive sensorineural hearing loss caused by a mutation in the gap junction protein gene connexin 26 (GJB2).\",\"author\":\"Lench NJ\",\"pubdate\":\"1998 Feb\",\"source\":\"J Med Genet\",\"uid\":\"9507396\"},{\"title\":\"Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss.\",\"author\":\"Kelley PM\",\"pubdate\":\"1998 Apr\",\"source\":\"Am J Hum Genet\",\"uid\":\"9529365\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"12.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"12.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Connexin 26 mutations in hereditary non-syndromic sensorineural deafness.\",\"author\":\"Kelsell DP\",\"pubdate\":\"1997 May 1\",\"source\":\"Nature\",\"uid\":\"9139825\"},{\"title\":\"Connexin-26 mutations in sporadic and inherited sensorineural deafness.\",\"author\":\"Estivill X\",\"pubdate\":\"1998 Feb 7\",\"source\":\"Lancet\",\"uid\":\"9482292\"},{\"title\":\"A Moroccan family with autosomal recessive sensorineural hearing loss caused by a mutation in the gap junction protein gene connexin 26 (GJB2).\",\"author\":\"Lench NJ\",\"pubdate\":\"1998 Feb\",\"source\":\"J Med Genet\",\"uid\":\"9507396\"},{\"title\":\"Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss.\",\"author\":\"Kelley PM\",\"pubdate\":\"1998 Apr\",\"source\":\"Am J Hum Genet\",\"uid\":\"9529365\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"BAAV mediated GJB2 gene transfer restores gap junction coupling in cochlear organotypic cultures from deaf Cx26Sox10Cre mice.\",\"author\":\"Crispino G\",\"pubdate\":\"2011\",\"source\":\"PLoS One\",\"uid\":\"21876744\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Altered gating properties of functional Cx26 mutants associated with recessive non-syndromic hearing loss.\",\"author\":\"Me\\u015fe G\",\"pubdate\":\"2004 Aug\",\"source\":\"Hum Genet\",\"uid\":\"15241677\"},{\"title\":\"Hearing loss: frequency and functional studies of the most common connexin26 alleles.\",\"author\":\"D\",\"pubdate\":\"2002 Aug 23\",\"source\":\"Biochem Biophys Res Commun\",\"uid\":\"12176036\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.5\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"BAAV mediated GJB2 gene transfer restores gap junction coupling in cochlear organotypic cultures from deaf Cx26Sox10Cre mice.\",\"author\":\"Crispino G\",\"pubdate\":\"2011\",\"source\":\"PLoS One\",\"uid\":\"21876744\"},{\"title\":\"Perinatal Gjb2 gene transfer rescues hearing in a mouse model of hereditary deafness.\",\"author\":\"Iizuka T\",\"pubdate\":\"2015 Jul 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"25801282\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08/15/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"03/02/2017\",\"FinalClassificationNotes\":\"DFNB1 accounts for approximately 50% of congenital severe to profound autosomal recessive nonsyndromic hearing loss in the US, Britain, France, and Australia/New Zealand (Angeli 2008, Azaiez 2004, Green 1999). Reviewed by the ClinGen Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1488441600,
    "dateISO8601": "2017-03-02T00:00:00",
    "dateFormated": "Mar 02, 2017"
  },
  "8400": {
    "title": "CLRN1: Usher syndrome type 3",
    "label": "Usher syndrome type 3",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "12605": {
        "ontology": "HGNC",
        "curie": "HGNC:12605",
        "uri": "HGNC12605"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016485"
      },
      "OMIM606397": {
        "ontology": "OMIM",
        "curie": "OMIM:606397",
        "uri": "OMIM606397",
        "iri": "http://purl.obolibrary.org/obo/OMIM_606397"
      },
      "ORPHA231183": {
        "ontology": "ORPHA",
        "curie": "ORPHA:231183",
        "uri": "ORPHA231183",
        "iri": "http://www.orpha.net/ORDO/Orphanet_231183"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CLRN1\",\"Hgnc\":\"12605\",\"OrphaNet\":\"231183\",\"Disease\":\"Usher syndrome type 3\",\"Omim\":\"606397\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"2.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3.\",\"author\":\"Joensuu T\",\"pubdate\":\"2001 Oct\",\"source\":\"Am J Hum Genet\",\"uid\":\"11524702\"},{\"title\":\"Strategies for genetic study of hearing loss in the Brazilian northeastern region.\",\"author\":\"Melo US\",\"pubdate\":\"2014\",\"source\":\"Int J Mol Epidemiol Genet\",\"uid\":\"24596593\"},{\"title\":\"Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher Study.\",\"author\":\"Le Quesne Stabej P\",\"pubdate\":\"2012 Jan\",\"source\":\"J Med Genet\",\"uid\":\"22135276\"},{\"title\":\"A novel 5-bp deletion in Clarin 1 in a family with Usher syndrome.\",\"author\":\"Akoury E\",\"pubdate\":\"2011 Nov\",\"source\":\"Ophthalmic Genet\",\"uid\":\"21675857\"},{\"title\":\"Disease-causing mutations in the CLRN1 gene alter normal CLRN1 protein trafficking to the plasma membrane.\",\"author\":\"Isosomppi J\",\"pubdate\":\"2009 Sep 8\",\"source\":\"Mol Vis\",\"uid\":\"19753315\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3.\",\"author\":\"Joensuu T\",\"pubdate\":\"2001 Oct\",\"source\":\"Am J Hum Genet\",\"uid\":\"11524702\"},{\"title\":\"Strategies for genetic study of hearing loss in the Brazilian northeastern region.\",\"author\":\"Melo US\",\"pubdate\":\"2014\",\"source\":\"Int J Mol Epidemiol Genet\",\"uid\":\"24596593\"},{\"title\":\"A novel 5-bp deletion in Clarin 1 in a family with Usher syndrome.\",\"author\":\"Akoury E\",\"pubdate\":\"2011 Nov\",\"source\":\"Ophthalmic Genet\",\"uid\":\"21675857\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Role for a novel Usher protein complex in hair cell synaptic maturation.\",\"author\":\"Zallocchi M\",\"pubdate\":\"2012\",\"source\":\"PLoS One\",\"uid\":\"22363448\"},{\"title\":\"Localization and expression of clarin-1, the Clrn1 gene product, in auditory hair cells and photoreceptors.\",\"author\":\"Zallocchi M\",\"pubdate\":\"2009 Sep\",\"source\":\"Hear Res\",\"uid\":\"19539019\"},{\"title\":\"The cone-dominant retina and the inner ear of zebrafish express the ortholog of CLRN1, the causative gene of human Usher syndrome type 3A.\",\"author\":\"Phillips JB\",\"pubdate\":\"2013 Dec\",\"source\":\"Gene Expr Patterns\",\"uid\":\"24045267\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Disease-causing mutations in the CLRN1 gene alter normal CLRN1 protein trafficking to the plasma membrane.\",\"author\":\"Isosomppi J\",\"pubdate\":\"2009 Sep 8\",\"source\":\"Mol Vis\",\"uid\":\"19753315\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"A small molecule mitigates hearing loss in a mouse model of Usher syndrome III.\",\"author\":\"Alagramam KN\",\"pubdate\":\"2016 Jun\",\"source\":\"Nat Chem Biol\",\"uid\":\"27110679\"},{\"title\":\"Impairment of Vision in a Mouse Model of Usher Syndrome Type III.\",\"author\":\"Tian G\",\"pubdate\":\"2016 Mar\",\"source\":\"Invest Ophthalmol Vis Sci\",\"uid\":\"26943149\"},{\"title\":\"The mechanosensory structure of the hair cell requires clarin-1, a protein encoded by Usher syndrome III causative gene.\",\"author\":\"Geng R\",\"pubdate\":\"2012 Jul 11\",\"source\":\"J Neurosci\",\"uid\":\"22787034\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09/30/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"03/02/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hereditary Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1488441600,
    "dateISO8601": "2017-03-02T00:00:00",
    "dateFormated": "Mar 02, 2017"
  },
  "8404": {
    "title": "PTPRQ: Nonsyndromic sensorineural hearing loss",
    "label": "Nonsyndromic sensorineural hearing loss",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "9679": {
        "ontology": "HGNC",
        "curie": "HGNC:9679",
        "uri": "HGNC9679"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019588"
      },
      "OMIM603317": {
        "ontology": "OMIM",
        "curie": "OMIM:603317",
        "uri": "OMIM603317",
        "iri": "http://purl.obolibrary.org/obo/OMIM_603317"
      },
      "ORPHA90636": {
        "ontology": "ORPHA",
        "curie": "ORPHA:90636",
        "uri": "ORPHA90636",
        "iri": "http://www.orpha.net/ORDO/Orphanet_90636"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PTPRQ\",\"Hgnc\":\"9679\",\"OrphaNet\":\"ORPHA90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"603317\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"1.5\",\"tally\":\"5.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction.\",\"author\":\"Schraders M\",\"pubdate\":\"2010 Apr 9\",\"source\":\"Am J Hum Genet\",\"uid\":\"20346435\"},{\"title\":\"Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84.\",\"author\":\"Shahin H\",\"pubdate\":\"2010 Sep\",\"source\":\"J Med Genet\",\"uid\":\"20472657\"},{\"title\":\"Identification of Two Novel Compound Heterozygous PTPRQ Mutations Associated with Autosomal Recessive Hearing Loss in a Chinese Family.\",\"author\":\"Gao X\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"25919374\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"4.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"8.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction.\",\"author\":\"Schraders M\",\"pubdate\":\"2010 Apr 9\",\"source\":\"Am J Hum Genet\",\"uid\":\"20346435\"},{\"title\":\"Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84.\",\"author\":\"Shahin H\",\"pubdate\":\"2010 Sep\",\"source\":\"J Med Genet\",\"uid\":\"20472657\"},{\"title\":\"Identification of Two Novel Compound Heterozygous PTPRQ Mutations Associated with Autosomal Recessive Hearing Loss in a Chinese Family.\",\"author\":\"Gao X\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"25919374\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A receptor-like inositol lipid phosphatase is required for the maturation of developing cochlear hair bundles.\",\"author\":\"Goodyear RJ\",\"pubdate\":\"2003 Oct 8\",\"source\":\"J Neurosci\",\"uid\":\"14534255\"},{\"title\":\"Dynamic compartmentalization of protein tyrosine phosphatase receptor Q at the proximal end of stereocilia: implication of myosin VI-based transport.\",\"author\":\"Sakaguchi H\",\"pubdate\":\"2008 Jul\",\"source\":\"Cell Motil Cytoskeleton\",\"uid\":\"18412156\"},{\"title\":\"CLIC5 stabilizes membrane-actin filament linkages at the base of hair cell stereocilia in a molecular complex with radixin, taperin, and myosin VI.\",\"author\":\"Salles FT\",\"pubdate\":\"2014 Jan\",\"source\":\"Cytoskeleton (Hoboken)\",\"uid\":\"24285636\"},{\"title\":\"A reduction in Ptprq associated with specific features of the deafness phenotype of the miR-96 mutant mouse diminuendo.\",\"author\":\"Chen J\",\"pubdate\":\"2014 Mar\",\"source\":\"Eur J Neurosci\",\"uid\":\"24446963\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A receptor-like inositol lipid phosphatase is required for the maturation of developing cochlear hair bundles.\",\"author\":\"Goodyear RJ\",\"pubdate\":\"2003 Oct 8\",\"source\":\"J Neurosci\",\"uid\":\"14534255\"},{\"title\":\"Hair bundle defects and loss of function in the vestibular end organs of mice lacking the receptor-like inositol lipid phosphatase PTPRQ.\",\"author\":\"Goodyear RJ\",\"pubdate\":\"2012 Feb 22\",\"source\":\"J Neurosci\",\"uid\":\"22357859\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10/25/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/23/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1487836800,
    "dateISO8601": "2017-02-23T00:00:00",
    "dateFormated": "Feb 23, 2017"
  },
  "8405": {
    "title": "S1PR2: Nonsyndromic sensorineural hearing loss",
    "label": "Nonsyndromic sensorineural hearing loss",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "3169": {
        "ontology": "HGNC",
        "curie": "HGNC:3169",
        "uri": "HGNC3169"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019497"
      },
      "OMIM610419": {
        "ontology": "OMIM",
        "curie": "OMIM:610419",
        "uri": "OMIM610419",
        "iri": "http://purl.obolibrary.org/obo/OMIM_610419"
      },
      "ORPHA90636": {
        "ontology": "ORPHA",
        "curie": "ORPHA:90636",
        "uri": "ORPHA90636",
        "iri": "http://www.orpha.net/ORDO/Orphanet_90636"
      }
    },
    "scores": {
      "3978": {
        "label": "Strong"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"S1PR2\",\"Hgnc\":\"3169\",\"OrphaNet\":\"90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"610419\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"2.0\",\"tally\":\"2\"},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"10.0\",\"tally\":\"7\"}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function.\",\"author\":\"MacLennan AJ\",\"pubdate\":\"2006 Oct\",\"source\":\"Hear Res\",\"uid\":\"16945494\"},{\"title\":\"Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2.\",\"author\":\"Herr DR\",\"pubdate\":\"2007 Feb 7\",\"source\":\"J Neurosci\",\"uid\":\"17287522\"},{\"title\":\"Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy.\",\"author\":\"Herr DR\",\"pubdate\":\"2016 Apr 15\",\"source\":\"Sci Rep\",\"uid\":\"27080739\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"6.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function.\",\"author\":\"MacLennan AJ\",\"pubdate\":\"2006 Oct\",\"source\":\"Hear Res\",\"uid\":\"16945494\"},{\"title\":\"Deafness and stria vascularis defects in S1P2 receptor-null mice.\",\"author\":\"Kono M\",\"pubdate\":\"2007 Apr 6\",\"source\":\"J Biol Chem\",\"uid\":\"17284444\"},{\"title\":\"Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2.\",\"author\":\"Herr DR\",\"pubdate\":\"2007 Feb 7\",\"source\":\"J Neurosci\",\"uid\":\"17287522\"},{\"title\":\"Gene miles-apart is required for formation of otic vesicle and hair cells in zebrafish.\",\"author\":\"Hu ZY\",\"pubdate\":\"2013 Oct 31\",\"source\":\"Cell Death Dis\",\"uid\":\"24176858\"},{\"title\":\"S1PR2 variants associated with auditory function in humans and endocochlear potential decline in mouse.\",\"author\":\"Ingham NJ\",\"pubdate\":\"2016 Jul 7\",\"source\":\"Sci Rep\",\"uid\":\"27383011\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4.5\",\"GeneticEvidenceTotal\":\"9\",\"GeneticEvidencePointsTotal\":\"9\",\"ExperimentalEvidencePointsTotal\":\"4.5\",\"EvidencePointsTotal\":\"13.5\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"11/03/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"03/02/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hereditary Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1488441600,
    "dateISO8601": "2017-03-02T00:00:00",
    "dateFormated": "Mar 02, 2017"
  },
  "8406": {
    "title": "PDZD7: Nonsyndromic sensorineural hearing loss",
    "label": "Nonsyndromic sensorineural hearing loss",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "26257": {
        "ontology": "HGNC",
        "curie": "HGNC:26257",
        "uri": "HGNC26257"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019588"
      },
      "OMIM612971": {
        "ontology": "OMIM",
        "curie": "OMIM:612971",
        "uri": "OMIM612971",
        "iri": "http://purl.obolibrary.org/obo/OMIM_612971"
      },
      "ORPHA90636": {
        "ontology": "ORPHA",
        "curie": "ORPHA:90636",
        "uri": "ORPHA90636",
        "iri": "http://www.orpha.net/ORDO/Orphanet_90636"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PDZD7\",\"Hgnc\":\"26257\",\"OrphaNet\":\"90636\",\"Disease\":\"Sensorineural hearing loss\",\"Omim\":\"612971\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"8.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Homozygous disruption of PDZD7 by reciprocal translocation in a consanguineous family: a new member of the Usher syndrome protein interactome causing congenital hearing impairment.\",\"author\":\"Schneider E\",\"pubdate\":\"2009 Feb 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"19028668\"},{\"title\":\"PDZD7 and hearing loss: More than just a modifier.\",\"author\":\"Booth KT\",\"pubdate\":\"2015 Dec\",\"source\":\"Am J Med Genet A\",\"uid\":\"26416264\"},{\"title\":\"Confirmation of PDZD7 as a Nonsyndromic Hearing Loss Gene.\",\"author\":\"Vona B\",\"pubdate\":\"2016 Jul-Aug\",\"source\":\"Ear Hear\",\"uid\":\"26849169\"},{\"title\":\"DNA Diagnostics of Hereditary Hearing Loss: A Targeted Resequencing Approach Combined with a Mutation Classification System.\",\"author\":\"Sommen M\",\"pubdate\":\"2016 Aug\",\"source\":\"Hum Mutat\",\"uid\":\"27068579\"},{\"title\":\"Characterising the spectrum of autosomal recessive hereditary hearing loss in Iran.\",\"author\":\"Sloan-Heggen CM\",\"pubdate\":\"2015 Dec\",\"source\":\"J Med Genet\",\"uid\":\"26445815\"},{\"title\":\"An example of the utility of genomic analysis for fast and accurate clinical diagnosis of complex rare phenotypes.\",\"author\":\"Le Quesne Stabej P\",\"pubdate\":\"2017 Feb 7\",\"source\":\"Orphanet J Rare Dis\",\"uid\":\"28173822\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"2.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"11.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"PDZD7 and hearing loss: More than just a modifier.\",\"author\":\"Booth KT\",\"pubdate\":\"2015 Dec\",\"source\":\"Am J Med Genet A\",\"uid\":\"26416264\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.5\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"PDZD7-MYO7A complex identified in enriched stereocilia membranes.\",\"author\":\"Morgan CP\",\"pubdate\":\"2016 Aug 15\",\"source\":\"Elife\",\"uid\":\"27525485\"},{\"title\":\"Deletion of PDZD7 disrupts the Usher syndrome type 2 protein complex in cochlear hair cells and causes hearing loss in mice.\",\"author\":\"Zou J\",\"pubdate\":\"2014 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"24334608\"},{\"title\":\"Characterization of transcriptomes of cochlear inner and outer hair cells.\",\"author\":\"Liu H\",\"pubdate\":\"2014 Aug 13\",\"source\":\"J Neurosci\",\"uid\":\"25122905\"},{\"title\":\"Localization of PDZD7 to the stereocilia ankle-link associates this scaffolding protein with the Usher syndrome protein network.\",\"author\":\"Grati M\",\"pubdate\":\"2012 Oct 10\",\"source\":\"J Neurosci\",\"uid\":\"23055499\"},{\"title\":\"Homozygous disruption of PDZD7 by reciprocal translocation in a consanguineous family: a new member of the Usher syndrome protein interactome causing congenital hearing impairment.\",\"author\":\"Schneider E\",\"pubdate\":\"2009 Feb 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"19028668\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Deletion of PDZD7 disrupts the Usher syndrome type 2 protein complex in cochlear hair cells and causes hearing loss in mice.\",\"author\":\"Zou J\",\"pubdate\":\"2014 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"24334608\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"11/25/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"04/26/2017\",\"FinalClassificationNotes\":\"Reviewed by the ClinGen Hereditary Hearing Loss Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1493190000,
    "dateISO8601": "2017-04-26T00:00:00",
    "dateFormated": "Apr 26, 2017"
  },
  "8430": {
    "title": "BARD1: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "HGNC:952": {
        "ontology": "HGNC",
        "curie": "HGNC:952",
        "uri": "HGNC952"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"BARD1\",\"Hgnc\":\"952\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.\",\"author\":\"Esteban-Jurado C\",\"pubdate\":\"2015 Feb\",\"source\":\"Genet Med\",\"uid\":\"25058500\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome.\",\"author\":\"Zhang YQ\",\"pubdate\":\"2012 Aug 7\",\"source\":\"Br J Cancer\",\"uid\":\"22814582\"},{\"title\":\"Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1.\",\"author\":\"Wang Q\",\"pubdate\":\"2001 Aug 2\",\"source\":\"Oncogene\",\"uid\":\"11498787\"},{\"title\":\"Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.\",\"author\":\"Ozden O\",\"pubdate\":\"2016 May 20\",\"source\":\"Sci Rep\",\"uid\":\"27197561\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"0.5\",\"GeneticEvidencePointsTotal\":\"0.5\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"1.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"08/23/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"06/08/2017\",\"FinalClassificationNotes\":\"Assertion made by the Hereditary Cancer Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1496905200,
    "dateISO8601": "2017-06-08T00:00:00",
    "dateFormated": "Jun 08, 2017"
  },
  "8431": {
    "title": "EPHX1: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "HGNC:3401": {
        "ontology": "HGNC",
        "curie": "HGNC:3401",
        "uri": "HGNC3401"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"EPHX1\",\"Hgnc\":\"3401\",\"OrphaNet\":\"ORPHA:443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.1\",\"tally\":\"0.1\",\"pmid\":{\"publications\":[{\"title\":\"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.\",\"author\":\"Esteban-Jurado C\",\"pubdate\":\"2015 Feb\",\"source\":\"Genet Med\",\"uid\":\"25058500\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants.\",\"author\":\"Hassett C\",\"pubdate\":\"1994 Mar\",\"source\":\"Hum Mol Genet\",\"uid\":\"7516776\"},{\"title\":\"Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours.\",\"author\":\"Coller JK\",\"pubdate\":\"2001 Jun\",\"source\":\"Histochem J\",\"uid\":\"11758809\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"0.1\",\"GeneticEvidencePointsTotal\":\"0.1\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"1.1\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"11/08/2016\",\"CalculatedClassificationNotes\":null,\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/08/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1478592000,
    "dateISO8601": "2016-11-08T00:00:00",
    "dateFormated": "Nov 08, 2016"
  },
  "8432": {
    "title": "EXO1: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "HGNC:3511": {
        "ontology": "HGNC",
        "curie": "HGNC:3511",
        "uri": "HGNC3511"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      },
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"EXO1\",\"Hgnc\":\"3511\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system. In vivo interaction through the C-terminal domains of hEXO1 and hMSH2 and comparative expression analysis.\",\"author\":\"Rasmussen LJ\",\"pubdate\":\"2000 Jun 30\",\"source\":\"Mutat Res\",\"uid\":\"10856833\"},{\"title\":\"HNPCC mutations in the human DNA mismatch repair gene hMLH1 influence assembly of hMutLalpha and hMLH1-hEXO1 complexes.\",\"author\":\"J\\u00e4ger AC\",\"pubdate\":\"2001 Jun 14\",\"source\":\"Oncogene\",\"uid\":\"11429708\"},{\"title\":\"Functional alterations of human exonuclease 1 mutants identified in atypical hereditary nonpolyposis colorectal cancer syndrome.\",\"author\":\"Sun X\",\"pubdate\":\"2002 Nov 1\",\"source\":\"Cancer Res\",\"uid\":\"12414623\"},{\"title\":\"Molecular characteristics of mismatch repair genes in sporadic colorectal tumors in Czech patients.\",\"author\":\"Vymetalkova VP\",\"pubdate\":\"2014 Jan 31\",\"source\":\"BMC Med Genet\",\"uid\":\"24484585\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies.\",\"author\":\"Kucherlapati M\",\"pubdate\":\"2007 Sep 20\",\"source\":\"Oncogene\",\"uid\":\"17452984\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"ValidContradictoryEvidence\":{\"YesNo\":\"YES\",\"pmid\":{\"publications\":{\"1523543953916\":{\"title\":\"EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer.\",\"author\":\"Jagmohan-Changur S\",\"pubdate\":\"2003 Jan 1\",\"source\":\"Cancer Res\",\"uid\":\"12517792\"}},\"notes\":{\"note\":\"\"}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"2.5\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"2.5\",\"EvidencePointsTotal\":\"2.5\",\"CalculatedClassification\":\"CONFLICTING EVIDENCE REPORTED\",\"CalculatedClassificationDate\":\"11/22/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/22/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1496905200,
    "dateISO8601": "2017-06-08T00:00:00",
    "dateFormated": "Jun 08, 2017"
  },
  "8433": {
    "title": "CDH1: Hereditary colorectal cancer",
    "label": "Hereditary colorectal cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "HGNC:1748": {
        "ontology": "HGNC",
        "curie": "HGNC:1748",
        "uri": "HGNC1748"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM192090": {
        "ontology": "OMIM",
        "curie": "OMIM:192090",
        "uri": "OMIM192090",
        "iri": "http://purl.obolibrary.org/obo/OMIM_192090"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CDH1\",\"Hgnc\":\"1748\",\"OrphaNet\":\"ORPHA443909\",\"Disease\":\"Colorectal Cancer\",\"Omim\":\"OMIM: 192090\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"E-cadherin germline mutations in familial gastric cancer.\",\"author\":\"Guilford P\",\"pubdate\":\"1998 Mar 26\",\"source\":\"Nature\",\"uid\":\"9537325\"},{\"title\":\"Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.\",\"author\":\"Richards FM\",\"pubdate\":\"1999 Apr\",\"source\":\"Hum Mol Genet\",\"uid\":\"10072428\"},{\"title\":\"Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene.\",\"author\":\"More H\",\"pubdate\":\"2007 Feb\",\"source\":\"Hum Mutat\",\"uid\":\"17221870\"},{\"title\":\"Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.\",\"author\":\"Oliveira C\",\"pubdate\":\"2002 May\",\"source\":\"Hum Mutat\",\"uid\":\"11968083\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis.\",\"author\":\"Kim SA\",\"pubdate\":\"2016 Jan 19\",\"source\":\"Br J Cancer\",\"uid\":\"26742007\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells.\",\"author\":\"Efstathiou JA\",\"pubdate\":\"1999 Mar 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"10051639\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"2\",\"GeneticEvidencePointsTotal\":\"2\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"3\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"10/25/2016\",\"FinalClassificationNotes\":\"Assertion made by the Hereditary Cancer Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1496905200,
    "dateISO8601": "2017-06-08T00:00:00",
    "dateFormated": "Jun 08, 2017"
  },
  "8434": {
    "title": "CDKN1B: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "HGNC:1785": {
        "ontology": "HGNC",
        "curie": "HGNC:1785",
        "uri": "HGNC1785"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CDKN1B\",\"Hgnc\":\"1785\",\"OrphaNet\":\"ORPHA443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"0.1\",\"pmid\":{\"publications\":[{\"title\":\"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.\",\"author\":\"Esteban-Jurado C\",\"pubdate\":\"2015 Feb\",\"source\":\"Genet Med\",\"uid\":\"25058500\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"0.0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.\",\"author\":\"Smartt HJ\",\"pubdate\":\"2007 Jul\",\"source\":\"Gastroenterology\",\"uid\":\"17631145\"},{\"title\":\"p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability.\",\"author\":\"Payne SR\",\"pubdate\":\"2008 Jan\",\"source\":\"Mol Cell Biol\",\"uid\":\"17954563\"},{\"title\":\"Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases.\",\"author\":\"Thomas GV\",\"pubdate\":\"1998 Sep\",\"source\":\"Am J Pathol\",\"uid\":\"9736017\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"The murine gene p27Kip1 is haplo-insufficient for tumour suppression.\",\"author\":\"Fero ML\",\"pubdate\":\"1998 Nov 12\",\"source\":\"Nature\",\"uid\":\"9823898\"},{\"title\":\"Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice.\",\"author\":\"Philipp-Staheli J\",\"pubdate\":\"2002 May\",\"source\":\"Cancer Cell\",\"uid\":\"12086850\"},{\"title\":\"Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.\",\"author\":\"Damo LA\",\"pubdate\":\"2005 Feb\",\"source\":\"Mol Carcinog\",\"uid\":\"15584024\"},{\"title\":\"Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells.\",\"author\":\"Yamamoto H\",\"pubdate\":\"1999 Jan 7\",\"source\":\"Oncogene\",\"uid\":\"9926925\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"0.1\",\"GeneticEvidencePointsTotal\":\"0.1\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"4.1\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01/10/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"06/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1496905200,
    "dateISO8601": "2017-06-08T00:00:00",
    "dateFormated": "Jun 08, 2017"
  },
  "8435": {
    "title": "GALNT12: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "HGNC:19877": {
        "ontology": "HGNC",
        "curie": "HGNC:19877",
        "uri": "HGNC19877"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0012132"
      },
      "OMIM608812": {
        "ontology": "OMIM",
        "curie": "OMIM:608812",
        "uri": "OMIM608812",
        "iri": "http://purl.obolibrary.org/obo/OMIM_608812"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"GALNT12\",\"Hgnc\":\"19877\",\"OrphaNet\":\"ORPHA443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"608812\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.\",\"author\":\"Guda K\",\"pubdate\":\"2009 Aug 4\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"19617566\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.\",\"author\":\"Guda K\",\"pubdate\":\"2009 Aug 4\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"19617566\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-12 in gastric and colonic cancer cell lines and in human colorectal cancer.\",\"author\":\"Guo JM\",\"pubdate\":\"2004\",\"source\":\"Oncology\",\"uid\":\"15557789\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0.5\",\"GeneticEvidenceTotal\":\"4\",\"GeneticEvidencePointsTotal\":\"4\",\"ExperimentalEvidencePointsTotal\":\"0.5\",\"EvidencePointsTotal\":\"4.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"09/13/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"06/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1496905200,
    "dateISO8601": "2017-06-08T00:00:00",
    "dateFormated": "Jun 08, 2017"
  },
  "8436": {
    "title": "RPS20: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "HGNC:10405": {
        "ontology": "HGNC",
        "curie": "HGNC:10405",
        "uri": "HGNC10405"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RPS20\",\"Hgnc\":\"10405\",\"OrphaNet\":\"ORPHA443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.\",\"author\":\"Nieminen TT\",\"pubdate\":\"2014 Sep\",\"source\":\"Gastroenterology\",\"uid\":\"24941021\"},{\"title\":\"Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.\",\"author\":\"Broderick P\",\"pubdate\":\"2017 Jan\",\"source\":\"Gastroenterology\",\"uid\":\"27713038\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.\",\"author\":\"Nieminen TT\",\"pubdate\":\"2014 Sep\",\"source\":\"Gastroenterology\",\"uid\":\"24941021\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.\",\"author\":\"Nieminen TT\",\"pubdate\":\"2014 Sep\",\"source\":\"Gastroenterology\",\"uid\":\"24941021\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0.5\",\"GeneticEvidenceTotal\":\"4.5\",\"GeneticEvidencePointsTotal\":\"4.5\",\"ExperimentalEvidencePointsTotal\":\"0.5\",\"EvidencePointsTotal\":\"5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"11/08/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"06/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1496905200,
    "dateISO8601": "2017-06-08T00:00:00",
    "dateFormated": "Jun 08, 2017"
  },
  "8439": {
    "title": "AXIN2: Oligodontia-colorectal cancer syndrome",
    "label": "Oligodontia-colorectal cancer syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "HGNC:904": {
        "ontology": "HGNC",
        "curie": "HGNC:904",
        "uri": "HGNC904"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0012075"
      },
      "OMIM608615": {
        "ontology": "OMIM",
        "curie": "OMIM:608615",
        "uri": "OMIM608615",
        "iri": "http://purl.obolibrary.org/obo/OMIM_608615"
      },
      "ORPHA401911": {
        "ontology": "ORPHA",
        "curie": "ORPHA:401911",
        "uri": "ORPHA401911",
        "iri": "http://www.orpha.net/ORDO/Orphanet_401911"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"AXIN2\",\"Hgnc\":\"904\",\"OrphaNet\":\"401911\",\"Disease\":\"Oligodontia-colorectal cancer syndrome\",\"Omim\":\"608615\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing.\",\"author\":\"Rohlin A\",\"pubdate\":\"2017 Apr\",\"source\":\"Fam Cancer\",\"uid\":\"27696107\"},{\"title\":\"AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome.\",\"author\":\"Marvin ML\",\"pubdate\":\"2011 Apr\",\"source\":\"Am J Med Genet A\",\"uid\":\"21416598\"},{\"title\":\"Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer.\",\"author\":\"Lammi L\",\"pubdate\":\"2004 May\",\"source\":\"Am J Hum Genet\",\"uid\":\"15042511\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer.\",\"author\":\"Lammi L\",\"pubdate\":\"2004 May\",\"source\":\"Am J Hum Genet\",\"uid\":\"15042511\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity.\",\"author\":\"Wu ZQ\",\"pubdate\":\"2012 Jul 10\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"22745173\"},{\"title\":\"Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer.\",\"author\":\"Hadjihannas MV\",\"pubdate\":\"2006 Jul 11\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"16815967\"},{\"title\":\"Expression and localization of axin 2 in colorectal carcinoma and its clinical implication.\",\"author\":\"Schaal U\",\"pubdate\":\"2013 Nov\",\"source\":\"Int J Colorectal Dis\",\"uid\":\"23702820\"},{\"title\":\"Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability.\",\"author\":\"Koinuma K\",\"pubdate\":\"2006 Jan 5\",\"source\":\"Oncogene\",\"uid\":\"16247484\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability.\",\"author\":\"Koinuma K\",\"pubdate\":\"2006 Jan 5\",\"source\":\"Oncogene\",\"uid\":\"16247484\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2.5\",\"GeneticEvidenceTotal\":\"8.5\",\"GeneticEvidencePointsTotal\":\"8.5\",\"ExperimentalEvidencePointsTotal\":\"2.5\",\"EvidencePointsTotal\":\"11\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"01/24/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"01/24/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1496905200,
    "dateISO8601": "2017-06-08T00:00:00",
    "dateFormated": "Jun 08, 2017"
  },
  "8441": {
    "title": "POLD1: Colorectal cancer/Polyposis Susceptibility",
    "label": "Colorectal cancer/Polyposis Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "HGNC:9175": {
        "ontology": "HGNC",
        "curie": "HGNC:9175",
        "uri": "HGNC9175"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018653"
      },
      "OMIM612591": {
        "ontology": "OMIM",
        "curie": "OMIM:612591",
        "uri": "OMIM612591",
        "iri": "http://purl.obolibrary.org/obo/OMIM_612591"
      },
      "ORPHA447877": {
        "ontology": "ORPHA",
        "curie": "ORPHA:447877",
        "uri": "ORPHA447877",
        "iri": "http://www.orpha.net/ORDO/Orphanet_447877"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"POLD1\",\"Hgnc\":\"9175\",\"OrphaNet\":\"447877\",\"Disease\":\"Colorectal cancer/Polyposis Susceptbility \",\"Omim\":\"612591\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance.\",\"author\":\"Bellido F\",\"pubdate\":\"2016 Apr\",\"source\":\"Genet Med\",\"uid\":\"26133394\"},{\"title\":\"Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.\",\"author\":\"Chubb D\",\"pubdate\":\"2015 Feb 10\",\"source\":\"J Clin Oncol\",\"uid\":\"25559809\"},{\"title\":\"Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.\",\"author\":\"Palles C\",\"pubdate\":\"2013 Feb\",\"source\":\"Nat Genet\",\"uid\":\"23263490\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.\",\"author\":\"Palles C\",\"pubdate\":\"2013 Feb\",\"source\":\"Nat Genet\",\"uid\":\"23263490\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells.\",\"author\":\"Ogi T\",\"pubdate\":\"2010 Mar 12\",\"source\":\"Mol Cell\",\"uid\":\"20227374\"},{\"title\":\"Human POLD1 modulates cell cycle progression and DNA damage repair.\",\"author\":\"Song J\",\"pubdate\":\"2015 Jun 19\",\"source\":\"BMC Biochem\",\"uid\":\"26087769\"},{\"title\":\"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.\",\"author\":\"Fagerberg L\",\"pubdate\":\"2014 Feb\",\"source\":\"Mol Cell Proteomics\",\"uid\":\"24309898\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A method to select for mutator DNA polymerase deltas in Saccharomyces cerevisiae.\",\"author\":\"Murphy K\",\"pubdate\":\"2006 Apr\",\"source\":\"Genome\",\"uid\":\"16699561\"},{\"title\":\"Increased rates of genomic deletions generated by mutations in the yeast gene encoding DNA polymerase delta or by decreases in the cellular levels of DNA polymerase delta.\",\"author\":\"Kokoska RJ\",\"pubdate\":\"2000 Oct\",\"source\":\"Mol Cell Biol\",\"uid\":\"11003646\"},{\"title\":\"A cancer-associated DNA polymerase delta variant modeled in yeast causes a catastrophic increase in genomic instability.\",\"author\":\"Daee DL\",\"pubdate\":\"2010 Jan 5\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"19966286\"},{\"title\":\"Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication.\",\"author\":\"Shinbrot E\",\"pubdate\":\"2014 Nov\",\"source\":\"Genome Res\",\"uid\":\"25228659\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice.\",\"author\":\"Albertson TM\",\"pubdate\":\"2009 Oct 6\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"19805137\"},{\"title\":\"High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading.\",\"author\":\"Goldsby RE\",\"pubdate\":\"2002 Nov 26\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"12429860\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5.5\",\"GeneticEvidenceTotal\":\"8.5\",\"GeneticEvidencePointsTotal\":\"8.5\",\"ExperimentalEvidencePointsTotal\":\"5.5\",\"EvidencePointsTotal\":\"14\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"04/10/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"04/10/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1491807600,
    "dateISO8601": "2017-04-10T00:00:00",
    "dateFormated": "Apr 10, 2017"
  },
  "8442": {
    "title": "POLE: Colorectal cancer/Polyposis Susceptibility",
    "label": "Colorectal cancer/Polyposis Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "HGNC:9177": {
        "ontology": "HGNC",
        "curie": "HGNC:9177",
        "uri": "HGNC9177"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018653"
      },
      "OMIM615083": {
        "ontology": "OMIM",
        "curie": "OMIM:615083",
        "uri": "OMIM615083",
        "iri": "http://purl.obolibrary.org/obo/OMIM_615083"
      },
      "ORPHA447877": {
        "ontology": "ORPHA",
        "curie": "ORPHA:447877",
        "uri": "ORPHA447877",
        "iri": "http://www.orpha.net/ORDO/Orphanet_447877"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"POLE\",\"Hgnc\":\"9177\",\"OrphaNet\":\"447877\",\"Disease\":\"Colorectal cancer/Polyposis Susceptbility\",\"Omim\":\"615083\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas.\",\"author\":\"Spier I\",\"pubdate\":\"2015 Jul 15\",\"source\":\"Int J Cancer\",\"uid\":\"25529843\"}],\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis.\",\"author\":\"Valle L\",\"pubdate\":\"2014 Jul 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"24501277\"},{\"title\":\"A mutation in POLE predisposing to a multi-tumour phenotype.\",\"author\":\"Rohlin A\",\"pubdate\":\"2014 Jul\",\"source\":\"Int J Oncol\",\"uid\":\"24788313\"},{\"title\":\"Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer.\",\"author\":\"Elsayed FA\",\"pubdate\":\"2015 Aug\",\"source\":\"Eur J Hum Genet\",\"uid\":\"25370038\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.\",\"author\":\"Palles C\",\"pubdate\":\"2013 Feb\",\"source\":\"Nat Genet\",\"uid\":\"23263490\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.\",\"author\":\"Palles C\",\"pubdate\":\"2013 Feb\",\"source\":\"Nat Genet\",\"uid\":\"23263490\"}],\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Significant contribution of the 3\",\"author\":\"Zahurancik WJ\",\"pubdate\":\"2014 Dec 16\",\"source\":\"Nucleic Acids Res\",\"uid\":\"25414327\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication.\",\"author\":\"Shinbrot E\",\"pubdate\":\"2014 Nov\",\"source\":\"Genome Res\",\"uid\":\"25228659\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice.\",\"author\":\"Albertson TM\",\"pubdate\":\"2009 Oct 6\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"19805137\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"15\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"12/11/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/11/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1512979200,
    "dateISO8601": "2017-12-11T00:00:00",
    "dateFormated": "Dec 11, 2017"
  },
  "8444": {
    "title": "GREM1: Hereditary Mixed Polyposis Syndrome",
    "label": "Hereditary Mixed Polyposis Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "HGNC:2001": {
        "ontology": "HGNC",
        "curie": "HGNC:2001",
        "uri": "HGNC2001"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011023"
      },
      "OMIM601228": {
        "ontology": "OMIM",
        "curie": "OMIM:601228",
        "uri": "OMIM601228",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601228"
      },
      "ORPHA157794": {
        "ontology": "ORPHA",
        "curie": "ORPHA:157794",
        "uri": "ORPHA157794",
        "iri": "http://www.orpha.net/ORDO/Orphanet_157794"
      }
    },
    "scores": {
      "3978": {
        "label": "Strong"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"GREM1\",\"Hgnc\":\"2001\",\"OrphaNet\":\"157794\",\"Disease\":\"Hereditary Mixed Polyposis Syndrome\",\"Omim\":\"601228\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"8.5\",\"tally\":\"8.5\",\"pmid\":{\"publications\":[{\"title\":\"An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome.\",\"author\":\"Jaeger EE\",\"pubdate\":\"2003 May\",\"source\":\"Am J Hum Genet\",\"uid\":\"12696020\"},{\"title\":\"Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients.\",\"author\":\"Venkatachalam R\",\"pubdate\":\"2011 Oct 1\",\"source\":\"Int J Cancer\",\"uid\":\"21128281\"},{\"title\":\"GREM1 germline mutation screening in Ashkenazi Jewish patients with familial colorectal cancer.\",\"author\":\"Laitman Y\",\"pubdate\":\"2015 May 20\",\"source\":\"Genet Res (Camb)\",\"uid\":\"25992589\"},{\"title\":\"GREM1 and POLE variants in hereditary colorectal cancer syndromes.\",\"author\":\"Rohlin A\",\"pubdate\":\"2016 Jan\",\"source\":\"Genes Chromosomes Cancer\",\"uid\":\"26493165\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein.\",\"author\":\"Namkoong H\",\"pubdate\":\"2006 Mar 18\",\"source\":\"BMC Cancer\",\"uid\":\"16545136\"},{\"title\":\"Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors.\",\"author\":\"Kosinski C\",\"pubdate\":\"2007 Sep 25\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"17881565\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"3.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"GREM1 and POLE variants in hereditary colorectal cancer syndromes.\",\"author\":\"Rohlin A\",\"pubdate\":\"2016 Jan\",\"source\":\"Genes Chromosomes Cancer\",\"uid\":\"26493165\"},{\"title\":\"Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1.\",\"author\":\"Jaeger E\",\"pubdate\":\"2012 May 6\",\"source\":\"Nat Genet\",\"uid\":\"22561515\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.\",\"author\":\"Davis H\",\"pubdate\":\"2015 Jan\",\"source\":\"Nat Med\",\"uid\":\"25419707\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"8.5\",\"GeneticEvidencePointsTotal\":\"8.5\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"14.5\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"10/11/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"10/11/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1476169200,
    "dateISO8601": "2016-10-11T00:00:00",
    "dateFormated": "Oct 11, 2016"
  },
  "8499": {
    "title": "MYL3: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:7584": {
        "ontology": "HGNC",
        "curie": "HGNC:7584",
        "uri": "HGNC7584"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM608751": {
        "ontology": "OMIM",
        "curie": "OMIM:608751",
        "uri": "OMIM608751",
        "iri": "http://purl.obolibrary.org/obo/OMIM_608751"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1528228451\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"MYL3\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:7584\",\"uri\":\"HGNC7584\"},\"condition\":{\"name\":\"Hypertrophic Cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:608751\",\"uri\":\"OMIM608751\"}},\"title\":\"MYL3 Hypertrophic Cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"7.00\",\"Tally\":\"7\",\"evidence\":{\"publications\":[{\"title\":\"Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.\",\"author\":\"Poetter K\",\"pubdate\":\"1996 May\",\"source\":\"Nat Genet\",\"uid\":\"8673105\"},{\"title\":\"Gene mutations in apical hypertrophic cardiomyopathy.\",\"author\":\"Arad M\",\"pubdate\":\"2005 Nov 1\",\"source\":\"Circulation\",\"uid\":\"16267253\"},{\"title\":\"A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy.\",\"author\":\"Fokstuen S\",\"pubdate\":\"2008 Jun\",\"source\":\"Hum Mutat\",\"uid\":\"18409188\"},{\"title\":\"Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.\",\"author\":\"Nomura A\",\"pubdate\":\"2016 Feb\",\"source\":\"J Cardiol\",\"uid\":\"26443374\"},{\"title\":\"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity.\",\"author\":\"Alfares AA\",\"pubdate\":\"2015 Nov\",\"source\":\"Genet Med\",\"uid\":\"25611685\"},{\"title\":\"Different expressivity of a ventricular essential myosin light chain gene Ala57Gly mutation in familial hypertrophic cardiomyopathy.\",\"author\":\"Lee W\",\"pubdate\":\"2001 Feb\",\"source\":\"Am Heart J\",\"uid\":\"11174330\"},{\"title\":\"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.\",\"author\":\"Richard P\",\"pubdate\":\"2003 May 6\",\"source\":\"Circulation\",\"uid\":\"12707239\"},{\"title\":\"Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice.\",\"author\":\"Fokstuen S\",\"pubdate\":\"2011 Aug\",\"source\":\"J Med Genet\",\"uid\":\"21239446\"},{\"title\":\"Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy.\",\"author\":\"Almaas VM\",\"pubdate\":\"2013 Sep\",\"source\":\"Europace\",\"uid\":\"23426552\"},{\"title\":\"Genetic profile of hypertrophic cardiomyopathy in Tunisia: Is it different?\",\"author\":\"Jaafar N\",\"pubdate\":\"2015\",\"source\":\"Glob Cardiol Sci Pract\",\"uid\":\"26779504\"},{\"title\":\"A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort.\",\"author\":\"Rubattu S\",\"pubdate\":\"2016 Jul 30\",\"source\":\"Int J Mol Sci\",\"uid\":\"27483260\"},{\"title\":\"Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.\",\"author\":\"Andersen PS\",\"pubdate\":\"2009 Mar\",\"source\":\"Hum Mutat\",\"uid\":\"19035361\"},{\"title\":\"Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.\",\"author\":\"Chiou KR\",\"pubdate\":\"2015 Mar\",\"source\":\"J Cardiol\",\"uid\":\"25086479\"},{\"title\":\"Shared genetic causes of cardiac hypertrophy in children and adults.\",\"author\":\"Morita H\",\"pubdate\":\"2008 May 1\",\"source\":\"N Engl J Med\",\"uid\":\"18403758\"}],\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"2.50\",\"Tally\":\"2.5\",\"1\":{\"evidence\":{\"publications\":{\"1528169330136\":{\"title\":\"Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.\",\"author\":\"Poetter K\",\"pubdate\":\"1996 May\",\"source\":\"Nat Genet\",\"uid\":\"8673105\"},\"1528169352071\":{\"title\":\"Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.\",\"author\":\"Nomura A\",\"pubdate\":\"2016 Feb\",\"source\":\"J Cardiol\",\"uid\":\"26443374\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"2\",\"AggregateVariantAnalysis\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1528228480450\":{\"title\":\"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.\",\"author\":\"Walsh R\",\"pubdate\":\"2017 Feb\",\"source\":\"Genet Med\",\"uid\":\"27532257\"}}}}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"11.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"1.5\",\"ProteinInteraction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1528169453238\":{\"title\":\"Human essential myosin light chain isoforms revealed distinct myosin binding, sarcomeric sorting, and inotropic activity.\",\"author\":\"Petzhold D\",\"pubdate\":\"2011 Jun 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"21262909\"},\"1528169479091\":{\"title\":\"Minigenes encoding N-terminal domains of human cardiac myosin light chain-1 improve heart function of transgenic rats.\",\"author\":\"Haase H\",\"pubdate\":\"2006 May\",\"source\":\"FASEB J\",\"uid\":\"16675844\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1528169391781\":{\"title\":\"Novel monoclonal antibodies specific for human cardiac myosin light-chain 1: useful tools for analysis of normal and pathological hearts.\",\"author\":\"Fujimoto K\",\"pubdate\":\"1993 Jan\",\"source\":\"J Histochem Cytochem\",\"uid\":\"8417110\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"1.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"1\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1528169565155\":{\"title\":\"The stretch-activation response may be critical to the proper functioning of the mammalian heart.\",\"author\":\"Vemuri R\",\"pubdate\":\"1999 Feb 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"9927691\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"11.5\",\"ExperimentalEvidenceTotal\":\"2.5\",\"EvidencePointsTotal\":\"14\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/22/2017\",\"FinalClassificationNotes\":\"This classification was approved by the Hypertrophic Cardiomyopathy Gene Curation Expert Panel.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1475564400,
    "dateISO8601": "2016-10-04T00:00:00",
    "dateFormated": "Oct 04, 2016"
  },
  "8502": {
    "title": "CDH1: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "1748": {
        "ontology": "HGNC",
        "curie": "HGNC:1748",
        "uri": "HGNC1748"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM114480": {
        "ontology": "OMIM",
        "curie": "OMIM:114480",
        "uri": "OMIM114480",
        "iri": "http://purl.obolibrary.org/obo/OMIM_114480"
      },
      "ORPHA26106": {
        "ontology": "ORPHA",
        "curie": "ORPHA:26106",
        "uri": "ORPHA26106",
        "iri": "http://www.orpha.net/ORDO/Orphanet_26106"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CDH1\",\"Hgnc\":\"1748\",\"OrphaNet\":\"26106\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"114480\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"10.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer.\",\"author\":\"Xie ZM\",\"pubdate\":\"2011 Jul 15\",\"source\":\"Cancer\",\"uid\":\"21271559\"},{\"title\":\"Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.\",\"author\":\"Hansford S\",\"pubdate\":\"2015 Apr\",\"source\":\"JAMA Oncol\",\"uid\":\"26182300\"},{\"title\":\"CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.\",\"author\":\"Benusiglio PR\",\"pubdate\":\"2013 Jul\",\"source\":\"J Med Genet\",\"uid\":\"23709761\"},{\"title\":\"Germline CDH1 mutations in bilateral lobular carcinoma in situ.\",\"author\":\"Petridis C\",\"pubdate\":\"2014 Feb 18\",\"source\":\"Br J Cancer\",\"uid\":\"24366306\"},{\"title\":\"Germline E-cadherin mutations in familial lobular breast cancer.\",\"author\":\"Masciari S\",\"pubdate\":\"2007 Nov\",\"source\":\"J Med Genet\",\"uid\":\"17660459\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer.\",\"author\":\"Xie ZM\",\"pubdate\":\"2011 Jul 15\",\"source\":\"Cancer\",\"uid\":\"21271559\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.\",\"author\":\"Kurian AW\",\"pubdate\":\"2014 Jul 1\",\"source\":\"J Clin Oncol\",\"uid\":\"24733792\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast.\",\"author\":\"Kanai Y\",\"pubdate\":\"1994 Oct\",\"source\":\"Jpn J Cancer Res\",\"uid\":\"7961105\"},{\"title\":\"E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.\",\"author\":\"Frixen UH\",\"pubdate\":\"1991 Apr\",\"source\":\"J Cell Biol\",\"uid\":\"2007622\"},{\"title\":\"Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14.\",\"author\":\"Jaspersen SL\",\"pubdate\":\"1999 Mar 11\",\"source\":\"Curr Biol\",\"uid\":\"10074450\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.\",\"author\":\"van Horssen R\",\"pubdate\":\"2012 Nov\",\"source\":\"Breast Cancer Res Treat\",\"uid\":\"23053649\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.\",\"author\":\"Frixen UH\",\"pubdate\":\"1991 Apr\",\"source\":\"J Cell Biol\",\"uid\":\"2007622\"},{\"title\":\"Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.\",\"author\":\"Derksen PW\",\"pubdate\":\"2006 Nov\",\"source\":\"Cancer Cell\",\"uid\":\"17097565\"},{\"title\":\"The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC.\",\"author\":\"Figueiredo J\",\"pubdate\":\"2013 Mar\",\"source\":\"Eur J Hum Genet\",\"uid\":\"22850631\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"01/25/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"01/25/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1485331200,
    "dateISO8601": "2017-01-25T00:00:00",
    "dateFormated": "Jan 25, 2017"
  },
  "8503": {
    "title": "CDH1: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:1748": {
        "ontology": "HGNC",
        "curie": "HGNC:1748",
        "uri": "HGNC1748"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CDH1\",\"Hgnc\":\"1748\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"01/25/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"08/03/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1501743600,
    "dateISO8601": "2017-08-03T00:00:00",
    "dateFormated": "Aug 03, 2017"
  },
  "8504": {
    "title": "CHEK1: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:1925": {
        "ontology": "HGNC",
        "curie": "HGNC:1925",
        "uri": "HGNC1925"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CHEK1\",\"Hgnc\":\"1925\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"10/12/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"10/12/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1476255600,
    "dateISO8601": "2016-10-12T00:00:00",
    "dateFormated": "Oct 12, 2016"
  },
  "8505": {
    "title": "CHEK1: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:1925": {
        "ontology": "HGNC",
        "curie": "HGNC:1925",
        "uri": "HGNC1925"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CHEK1\",\"Hgnc\":\"1925\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"10/12/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"10/12/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1476255600,
    "dateISO8601": "2016-10-12T00:00:00",
    "dateFormated": "Oct 12, 2016"
  },
  "8522": {
    "title": "CHEK2: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:16627": {
        "ontology": "HGNC",
        "curie": "HGNC:16627",
        "uri": "HGNC16627"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM114480": {
        "ontology": "OMIM",
        "curie": "OMIM:114480",
        "uri": "OMIM114480",
        "iri": "http://purl.obolibrary.org/obo/OMIM_114480"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CHEK2\",\"Hgnc\":\"16627\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"114480\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"8.0\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland.\",\"author\":\"B\\u0105k A\",\"pubdate\":\"2014 Apr 8\",\"source\":\"Hered Cancer Clin Pract\",\"uid\":\"24713400\"},{\"title\":\"Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study.\",\"author\":\"N\\u00e4slund-Koch C\",\"pubdate\":\"2016 Apr 10\",\"source\":\"J Clin Oncol\",\"uid\":\"26884562\"},{\"title\":\"PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.\",\"author\":\"Southey MC\",\"pubdate\":\"2016 Dec\",\"source\":\"J Med Genet\",\"uid\":\"27595995\"}],\"notes\":{\"note\":\"\"}}},\"AggregateVariantAnalysis\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.\",\"author\":\"Cybulski C\",\"pubdate\":\"2011 Oct 1\",\"source\":\"J Clin Oncol\",\"uid\":\"21876083\"}]}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.5\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response.\",\"author\":\"Lee JS\",\"pubdate\":\"2000 Mar 9\",\"source\":\"Nature\",\"uid\":\"10724175\"},{\"title\":\"A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.\",\"author\":\"Vahteristo P\",\"pubdate\":\"2002 Aug\",\"source\":\"Am J Hum Genet\",\"uid\":\"12094328\"},{\"title\":\"Concomitant inactivation of p53 and Chk2 in breast cancer.\",\"author\":\"Sullivan A\",\"pubdate\":\"2002 Feb 21\",\"source\":\"Oncogene\",\"uid\":\"11857075\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications.\",\"author\":\"Muranen TA\",\"pubdate\":\"2011 Sep 20\",\"source\":\"Breast Cancer Res\",\"uid\":\"21542898\"},{\"title\":\"DNA damage-induced activation of p53 by the checkpoint kinase Chk2.\",\"author\":\"Hirao A\",\"pubdate\":\"2000 Mar 10\",\"source\":\"Science\",\"uid\":\"10710310\"},{\"title\":\"Concomitant inactivation of p53 and Chk2 in breast cancer.\",\"author\":\"Sullivan A\",\"pubdate\":\"2002 Feb 21\",\"source\":\"Oncogene\",\"uid\":\"11857075\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\"}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5.5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"5.5\",\"EvidencePointsTotal\":\"17.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"12/14/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/14/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1481702400,
    "dateISO8601": "2016-12-14T00:00:00",
    "dateFormated": "Dec 14, 2016"
  },
  "8523": {
    "title": "CHEK2: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:16627": {
        "ontology": "HGNC",
        "curie": "HGNC:16627",
        "uri": "HGNC16627"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CHEK2\",\"Hgnc\":\"16627\",\"OrphaNet\":\"ORPHA213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response.\",\"author\":\"Lee JS\",\"pubdate\":\"2000 Mar 9\",\"source\":\"Nature\",\"uid\":\"10724175\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"DNA damage-induced activation of p53 by the checkpoint kinase Chk2.\",\"author\":\"Hirao A\",\"pubdate\":\"2000 Mar 10\",\"source\":\"Science\",\"uid\":\"10710310\"},{\"title\":\"Concomitant inactivation of p53 and Chk2 in breast cancer.\",\"author\":\"Sullivan A\",\"pubdate\":\"2002 Feb 21\",\"source\":\"Oncogene\",\"uid\":\"11857075\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"ValidContradictoryEvidence\":{\"YesNo\":\"YES\",\"pmid\":{\"publications\":{\"1507147645981\":{\"title\":\"High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients.\",\"author\":\"Suspitsin EN\",\"pubdate\":\"2009 Feb 25\",\"source\":\"Hered Cancer Clin Pract\",\"uid\":\"19338682\"},\"1507147658981\":{\"title\":\"Analysis of CHEK2 gene for ovarian cancer susceptibility.\",\"author\":\"Baysal BE\",\"pubdate\":\"2004 Oct\",\"source\":\"Gynecol Oncol\",\"uid\":\"15385111\"},\"1507147680277\":{\"title\":\"CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.\",\"author\":\"Szymanska-Pasternak J\",\"pubdate\":\"2006 Sep\",\"source\":\"Gynecol Oncol\",\"uid\":\"16828850\"}},\"notes\":{\"note\":\"Suggests no association with ovarian cancer\"}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"2\",\"CalculatedClassification\":\"CONFLICTING EVIDENCE REPORTED\",\"CalculatedClassificationDate\":\"12/14/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"12/14/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1481702400,
    "dateISO8601": "2016-12-14T00:00:00",
    "dateFormated": "Dec 14, 2016"
  },
  "8524": {
    "title": "MCPH1: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:6954": {
        "ontology": "HGNC",
        "curie": "HGNC:6954",
        "uri": "HGNC6954"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MCPH1\",\"Hgnc\":\"6954\",\"OrphaNet\":\"ORPHA227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.\",\"author\":\"Mantere T\",\"pubdate\":\"2016 Jan\",\"source\":\"PLoS Genet\",\"uid\":\"26820313\"}],\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly.\",\"author\":\"Lin SY\",\"pubdate\":\"2005 Oct 18\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"16217032\"},{\"title\":\"BRIT1/MCPH1 links chromatin remodelling to DNA damage response.\",\"author\":\"Peng G\",\"pubdate\":\"2009 Jul\",\"source\":\"Nat Cell Biol\",\"uid\":\"19525936\"},{\"title\":\"BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.\",\"author\":\"Rai R\",\"pubdate\":\"2006 Aug\",\"source\":\"Cancer Cell\",\"uid\":\"16872911\"},{\"title\":\"Microcephalin regulates BRCA2 and Rad51-associated DNA double-strand break repair.\",\"author\":\"Wu X\",\"pubdate\":\"2009 Jul 1\",\"source\":\"Cancer Res\",\"uid\":\"19549900\"},{\"title\":\"BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer.\",\"author\":\"Zhang B\",\"pubdate\":\"2013 Oct\",\"source\":\"Carcinogenesis\",\"uid\":\"23729656\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.\",\"author\":\"Mantere T\",\"pubdate\":\"2016 Jan\",\"source\":\"PLoS Genet\",\"uid\":\"26820313\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.\",\"author\":\"Rai R\",\"pubdate\":\"2006 Aug\",\"source\":\"Cancer Cell\",\"uid\":\"16872911\"},{\"title\":\"Mcph1/Brit1 deficiency promotes genomic instability and tumor formation in a mouse model.\",\"author\":\"Liang Y\",\"pubdate\":\"2015 Aug 13\",\"source\":\"Oncogene\",\"uid\":\"25362854\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"2\",\"GeneticEvidencePointsTotal\":\"2\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"6\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01/11/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"01/11/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1484121600,
    "dateISO8601": "2017-01-11T00:00:00",
    "dateFormated": "Jan 11, 2017"
  },
  "8525": {
    "title": "MCPH1: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:6954": {
        "ontology": "HGNC",
        "curie": "HGNC:6954",
        "uri": "HGNC6954"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MCPH1\",\"Hgnc\":\"6954\",\"OrphaNet\":\"ORPHA213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"01/11/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"01/11/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1484121600,
    "dateISO8601": "2017-01-11T00:00:00",
    "dateFormated": "Jan 11, 2017"
  },
  "8526": {
    "title": "MLH1: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:7127": {
        "ontology": "HGNC",
        "curie": "HGNC:7127",
        "uri": "HGNC7127"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MLH1\",\"Hgnc\":\"7127\",\"OrphaNet\":\"ORPHA227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.\",\"author\":\"Scott RJ\",\"pubdate\":\"2001 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"11112663\"},{\"title\":\"Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.\",\"author\":\"Win AK\",\"pubdate\":\"2012 Mar 20\",\"source\":\"J Clin Oncol\",\"uid\":\"22331944\"},{\"title\":\"Risks of less common cancers in proven mutation carriers with lynch syndrome.\",\"author\":\"Engel C\",\"pubdate\":\"2012 Dec 10\",\"source\":\"J Clin Oncol\",\"uid\":\"23091106\"},{\"title\":\"Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study.\",\"author\":\"Harkness EF\",\"pubdate\":\"2015 Aug\",\"source\":\"J Med Genet\",\"uid\":\"26101330\"},{\"title\":\"The extracolonic cancer spectrum in females with the common \",\"author\":\"Blokhuis MM\",\"pubdate\":\"2008\",\"source\":\"Fam Cancer\",\"uid\":\"18049911\"},{\"title\":\"Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.\",\"author\":\"Couch FJ\",\"pubdate\":\"2017 Sep 1\",\"source\":\"JAMA Oncol\",\"uid\":\"28418444\"}],\"notes\":{\"note\":\"\"}}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"ValidContradictoryEvidence\":{\"YesNo\":\"YES\",\"pmid\":{\"publications\":{\"1507149593745\":{\"title\":\"Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.\",\"author\":\"Couch FJ\",\"pubdate\":\"2017 Sep 1\",\"source\":\"JAMA Oncol\",\"uid\":\"28418444\"}},\"notes\":{\"note\":\"\"}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"6\",\"GeneticEvidencePointsTotal\":\"6\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"6\",\"CalculatedClassification\":\"CONFLICTING EVIDENCE REPORTED\",\"CalculatedClassificationDate\":\"06/14/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"06/14/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1497423600,
    "dateISO8601": "2017-06-14T00:00:00",
    "dateFormated": "Jun 14, 2017"
  },
  "8527": {
    "title": "EPCAM: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:11529": {
        "ontology": "HGNC",
        "curie": "HGNC:11529",
        "uri": "HGNC11529"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"EPCAM\",\"Hgnc\":\"11529\",\"OrphaNet\":\"ORPHA227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"04/12/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"04/12/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1491980400,
    "dateISO8601": "2017-04-12T00:00:00",
    "dateFormated": "Apr 12, 2017"
  },
  "8531": {
    "title": "MSH6: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:7329": {
        "ontology": "HGNC",
        "curie": "HGNC:7329",
        "uri": "HGNC7329"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MSH6\",\"Hgnc\":\"7329\",\"OrphaNet\":\"ORPHA227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer.\",\"author\":\"Roberts ME\",\"pubdate\":\"2018 Jan 18\",\"source\":\"Genet Med\",\"uid\":\"29345684\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"ValidContradictoryEvidence\":{\"YesNo\":\"YES\",\"pmid\":{\"publications\":{\"1507227754985\":{\"title\":\"Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.\",\"author\":\"Tung N\",\"pubdate\":\"2016 May 1\",\"source\":\"J Clin Oncol\",\"uid\":\"26976419\"},\"1507227772001\":{\"title\":\"Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer.\",\"author\":\"M\\u00fcller A\",\"pubdate\":\"2002 Feb 15\",\"source\":\"Cancer Res\",\"uid\":\"11861375\"},\"1507227786744\":{\"title\":\"No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer.\",\"author\":\"Vahteristo P\",\"pubdate\":\"2005 Apr\",\"source\":\"J Med Genet\",\"uid\":\"15805151\"}},\"notes\":{\"note\":\"\"}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"2\",\"GeneticEvidencePointsTotal\":\"2\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"4\",\"CalculatedClassification\":\"CONFLICTING EVIDENCE REPORTED\",\"CalculatedClassificationDate\":\"07/26/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"07/26/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1501052400,
    "dateISO8601": "2017-07-26T00:00:00",
    "dateFormated": "Jul 26, 2017"
  },
  "8691": {
    "title": "GEN1: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGCN:26881": {
        "ontology": "HGNC",
        "curie": "HGNC:26881",
        "uri": "HGNC26881"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"GEN1\",\"Hgnc\":\"26881\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Expression and localization of GEN1 in mouse mammary epithelial cells.\",\"author\":\"Sun L\",\"pubdate\":\"2014 Oct\",\"source\":\"J Biochem Mol Toxicol\",\"uid\":\"24980922\"},{\"title\":\"Aberrant chromosome morphology in human cells defective for Holliday junction resolution.\",\"author\":\"Wechsler T\",\"pubdate\":\"2011 Mar 31\",\"source\":\"Nature\",\"uid\":\"21399624\"},{\"title\":\"Coordinated actions of SLX1-SLX4 and MUS81-EME1 for Holliday junction resolution in human cells.\",\"author\":\"Wyatt HD\",\"pubdate\":\"2013 Oct 24\",\"source\":\"Mol Cell\",\"uid\":\"24076221\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Effect of GEN1 interference on the chemosensitivity of the breast cancer MCF-7 and SKBR3 cell lines.\",\"author\":\"Wu Y\",\"pubdate\":\"2016 Jun\",\"source\":\"Oncol Lett\",\"uid\":\"27284361\"},{\"title\":\"A novel role of human holliday junction resolvase GEN1 in the maintenance of centrosome integrity.\",\"author\":\"Gao M\",\"pubdate\":\"2012\",\"source\":\"PLoS One\",\"uid\":\"23166748\"},{\"title\":\"The RAD51 paralogs ensure cellular protection against mitotic defects and aneuploidy.\",\"author\":\"Rodrigue A\",\"pubdate\":\"2013 Jan 1\",\"source\":\"J Cell Sci\",\"uid\":\"23108668\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2.5\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"2.5\",\"EvidencePointsTotal\":\"2.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"08/24/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"12/13/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1513152000,
    "dateISO8601": "2017-12-13T00:00:00",
    "dateFormated": "Dec 13, 2017"
  },
  "8692": {
    "title": "GEN1: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:26881": {
        "ontology": "HGNC",
        "curie": "HGNC:26881",
        "uri": "HGNC26881"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"GEN1\",\"Hgnc\":\"26881\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"01/11/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"01/11/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1484121600,
    "dateISO8601": "2017-01-11T00:00:00",
    "dateFormated": "Jan 11, 2017"
  },
  "8693": {
    "title": "PIK3CA: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:8975": {
        "ontology": "HGNC",
        "curie": "HGNC:8975",
        "uri": "HGNC8975"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PIK3CA\",\"Hgnc\":\"8975\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"02/08/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"02/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1486540800,
    "dateISO8601": "2017-02-08T00:00:00",
    "dateFormated": "Feb 08, 2017"
  },
  "8694": {
    "title": "PIK3CA: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:8975": {
        "ontology": "HGNC",
        "curie": "HGNC:8975",
        "uri": "HGNC8975"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PIK3CA\",\"Hgnc\":\"8975\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"02/08/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"02/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1486540800,
    "dateISO8601": "2017-02-08T00:00:00",
    "dateFormated": "Feb 08, 2017"
  },
  "8695": {
    "title": "RAD50: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:9816": {
        "ontology": "HGNC",
        "curie": "HGNC:9816",
        "uri": "HGNC9816"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      },
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RAD50\",\"Hgnc\":\"9816\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.\",\"author\":\"Heikkinen K\",\"pubdate\":\"2006 Aug\",\"source\":\"Carcinogenesis\",\"uid\":\"16474176\"}],\"notes\":{\"note\":\"\"}}},\"AggregateVariantAnalysis\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility.\",\"author\":\"Heikkinen K\",\"pubdate\":\"2003 Dec\",\"source\":\"J Med Genet\",\"uid\":\"14684699\"}]}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Evaluation of RAD50 in familial breast cancer predisposition.\",\"author\":\"Tommiska J\",\"pubdate\":\"2006 Jun 1\",\"source\":\"Int J Cancer\",\"uid\":\"16385572\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Normal expression of DNA repair proteins, hMre11, Rad50 and Rad51 but protracted formation of Rad50 containing foci in X-irradiated skin fibroblasts from radiosensitive cancer patients.\",\"author\":\"Djuzenova C\",\"pubdate\":\"2004 Jun 14\",\"source\":\"Br J Cancer\",\"uid\":\"15150571\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"3.5\",\"GeneticEvidencePointsTotal\":\"3.5\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"5.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"12/14/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/14/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1481702400,
    "dateISO8601": "2016-12-14T00:00:00",
    "dateFormated": "Dec 14, 2016"
  },
  "8696": {
    "title": "RAD50: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:9816": {
        "ontology": "HGNC",
        "curie": "HGNC:9816",
        "uri": "HGNC9816"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RAD50\",\"Hgnc\":\"9816\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"ValidContradictoryEvidence\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"CONFLICTING EVIDENCE REPORTED\",\"CalculatedClassificationDate\":\"10/26/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"12/13/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1477465200,
    "dateISO8601": "2016-10-26T00:00:00",
    "dateFormated": "Oct 26, 2016"
  },
  "8697": {
    "title": "RAD51C: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:9820": {
        "ontology": "HGNC",
        "curie": "HGNC:9820",
        "uri": "HGNC9820"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RAD51C\",\"Hgnc\":\"9820\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.\",\"author\":\"Somyajit K\",\"pubdate\":\"2012 Jan 27\",\"source\":\"J Biol Chem\",\"uid\":\"22167183\"},{\"title\":\"Node retraction during patterning of the urinary collecting duct system.\",\"author\":\"Lindstr\\u00f6m NO\",\"pubdate\":\"2015 Jan\",\"source\":\"J Anat\",\"uid\":\"25292187\"},{\"title\":\"RAD51C germline mutations in breast and ovarian cancer cases from high-risk families.\",\"author\":\"Clague J\",\"pubdate\":\"2011\",\"source\":\"PLoS One\",\"uid\":\"21980511\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families.\",\"author\":\"Osorio A\",\"pubdate\":\"2012 Jul 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"22451500\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.\",\"author\":\"Meindl A\",\"pubdate\":\"2010 May\",\"source\":\"Nat Genet\",\"uid\":\"20400964\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"ValidContradictoryEvidence\":{\"YesNo\":\"YES\",\"pmid\":{\"publications\":{\"1530804519337\":{\"title\":\"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.\",\"author\":\"Meindl A\",\"pubdate\":\"2010 May\",\"source\":\"Nat Genet\",\"uid\":\"20400964\"},\"1530804536808\":{\"title\":\"Germline RAD51C mutations confer susceptibility to ovarian cancer.\",\"author\":\"Loveday C\",\"pubdate\":\"2012 Apr 26\",\"source\":\"Nat Genet\",\"uid\":\"22538716\"},\"1530804551744\":{\"title\":\"Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.\",\"author\":\"Couch FJ\",\"pubdate\":\"2017 Sep 1\",\"source\":\"JAMA Oncol\",\"uid\":\"28418444\"}},\"notes\":{\"note\":\"\"}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"5\",\"CalculatedClassification\":\"CONFLICTING EVIDENCE REPORTED\",\"CalculatedClassificationDate\":\"05/10/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"05/10/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1494399600,
    "dateISO8601": "2017-05-10T00:00:00",
    "dateFormated": "May 10, 2017"
  },
  "8699": {
    "title": "RAD51C: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:9820": {
        "ontology": "HGNC",
        "curie": "HGNC:9820",
        "uri": "HGNC9820"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RAD51C\",\"Hgnc\":\"9820\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarial cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"RAD51C is a susceptibility gene for ovarian cancer.\",\"author\":\"Pelttari LM\",\"pubdate\":\"2011 Aug 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"21616938\"}],\"notes\":{\"note\":\"\"}}},\"AggregateVariantAnalysis\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.\",\"author\":\"Song H\",\"pubdate\":\"2015 Sep 10\",\"source\":\"J Clin Oncol\",\"uid\":\"26261251\"},{\"title\":\"Germline RAD51C mutations confer susceptibility to ovarian cancer.\",\"author\":\"Loveday C\",\"pubdate\":\"2012 Apr 26\",\"source\":\"Nat Genet\",\"uid\":\"22538716\"}]}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.\",\"author\":\"Somyajit K\",\"pubdate\":\"2012 Jan 27\",\"source\":\"J Biol Chem\",\"uid\":\"22167183\"},{\"title\":\"Node retraction during patterning of the urinary collecting duct system.\",\"author\":\"Lindstr\\u00f6m NO\",\"pubdate\":\"2015 Jan\",\"source\":\"J Anat\",\"uid\":\"25292187\"},{\"title\":\"RAD51C germline mutations in breast and ovarian cancer cases from high-risk families.\",\"author\":\"Clague J\",\"pubdate\":\"2011\",\"source\":\"PLoS One\",\"uid\":\"21980511\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families.\",\"author\":\"Osorio A\",\"pubdate\":\"2012 Jul 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"22451500\"},{\"title\":\"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.\",\"author\":\"Meindl A\",\"pubdate\":\"2010 May\",\"source\":\"Nat Genet\",\"uid\":\"20400964\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.\",\"author\":\"Meindl A\",\"pubdate\":\"2010 May\",\"source\":\"Nat Genet\",\"uid\":\"20400964\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"04/12/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"04/12/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1491980400,
    "dateISO8601": "2017-04-12T00:00:00",
    "dateFormated": "Apr 12, 2017"
  },
  "8700": {
    "title": "RECQL: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:9948": {
        "ontology": "HGNC",
        "curie": "HGNC:9948",
        "uri": "HGNC9948"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RECQL\",\"Hgnc\":\"9948\",\"OrphaNet\":\"ORPHA227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Germline RECQL mutations are associated with breast cancer susceptibility.\",\"author\":\"Cybulski C\",\"pubdate\":\"2015 Jun\",\"source\":\"Nat Genet\",\"uid\":\"25915596\"}],\"notes\":{\"note\":\"\"}}},\"AggregateVariantAnalysis\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.\",\"author\":\"Sun J\",\"pubdate\":\"2015 May\",\"source\":\"PLoS Genet\",\"uid\":\"25945795\"},{\"title\":\"Germline RECQL mutations are associated with breast cancer susceptibility.\",\"author\":\"Cybulski C\",\"pubdate\":\"2015 Jun\",\"source\":\"Nat Genet\",\"uid\":\"25915596\"}]}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges.\",\"author\":\"Sharma S\",\"pubdate\":\"2007 Dec 12\",\"source\":\"PLoS One\",\"uid\":\"18074021\"},{\"title\":\"RECQ1 helicase interacts with human mismatch repair factors that regulate genetic recombination.\",\"author\":\"Doherty KM\",\"pubdate\":\"2005 Jul 29\",\"source\":\"J Biol Chem\",\"uid\":\"15886194\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges.\",\"author\":\"Sharma S\",\"pubdate\":\"2007 Dec 12\",\"source\":\"PLoS One\",\"uid\":\"18074021\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"RECQL, a member of the RecQ family of DNA helicases, suppresses chromosomal instability.\",\"author\":\"Sharma S\",\"pubdate\":\"2007 Mar\",\"source\":\"Mol Cell Biol\",\"uid\":\"17158923\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"8\",\"GeneticEvidencePointsTotal\":\"8\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"10\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"09/28/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"09/28/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1475046000,
    "dateISO8601": "2016-09-28T00:00:00",
    "dateFormated": "Sep 28, 2016"
  },
  "8701": {
    "title": "RECQL: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:9948": {
        "ontology": "HGNC",
        "curie": "HGNC:9948",
        "uri": "HGNC9948"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RECQL\",\"Hgnc\":\"9948\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"09/14/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"09/14/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1473836400,
    "dateISO8601": "2016-09-14T00:00:00",
    "dateFormated": "Sep 14, 2016"
  },
  "8702": {
    "title": "RINT1: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:21876": {
        "ontology": "HGNC",
        "curie": "HGNC:21876",
        "uri": "HGNC21876"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RINT1\",\"Hgnc\":\"21876\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"2.5\",\"tally\":\"2.5\",\"pmid\":{\"publications\":[{\"title\":\"Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.\",\"author\":\"Park DJ\",\"pubdate\":\"2014 Jul\",\"source\":\"Cancer Discov\",\"uid\":\"25050558\"}],\"notes\":{\"note\":\"\"}}}}}},\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.\",\"author\":\"Park DJ\",\"pubdate\":\"2014 Jul\",\"source\":\"Cancer Discov\",\"uid\":\"25050558\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"RINT-1 serves as a tumor suppressor and maintains Golgi dynamics and centrosome integrity for cell survival.\",\"author\":\"Lin X\",\"pubdate\":\"2007 Jul\",\"source\":\"Mol Cell Biol\",\"uid\":\"17470549\"},{\"title\":\"RINT-1, a novel Rad50-interacting protein, participates in radiation-induced G(2)/M checkpoint control.\",\"author\":\"Xiao J\",\"pubdate\":\"2001 Mar 2\",\"source\":\"J Biol Chem\",\"uid\":\"11096100\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"RINT-1 serves as a tumor suppressor and maintains Golgi dynamics and centrosome integrity for cell survival.\",\"author\":\"Lin X\",\"pubdate\":\"2007 Jul\",\"source\":\"Mol Cell Biol\",\"uid\":\"17470549\"},{\"title\":\"Rint1 inactivation triggers genomic instability, ER stress and autophagy inhibition in the brain.\",\"author\":\"Grigaravicius P\",\"pubdate\":\"2016 Mar\",\"source\":\"Cell Death Differ\",\"uid\":\"26383973\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"ValidContradictoryEvidence\":{\"YesNo\":\"YES\",\"pmid\":{\"publications\":{\"1508504468093\":{\"title\":\"Reevaluation of RINT1 as a breast cancer predisposition gene.\",\"author\":\"Li N\",\"pubdate\":\"2016 Sep\",\"source\":\"Breast Cancer Res Treat\",\"uid\":\"27544226\"}},\"notes\":{\"note\":\"\"}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"4.5\",\"GeneticEvidencePointsTotal\":\"4.5\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"7.5\",\"CalculatedClassification\":\"CONFLICTING EVIDENCE REPORTED\",\"CalculatedClassificationDate\":\"09/26/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"09/26/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1474873200,
    "dateISO8601": "2016-09-26T00:00:00",
    "dateFormated": "Sep 26, 2016"
  },
  "8703": {
    "title": "RINT1: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:21876": {
        "ontology": "HGNC",
        "curie": "HGNC:21876",
        "uri": "HGNC21876"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RINT1\",\"Hgnc\":\"21876\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"09/14/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"09/14/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1473836400,
    "dateISO8601": "2016-09-14T00:00:00",
    "dateFormated": "Sep 14, 2016"
  },
  "8704": {
    "title": "SLX4: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:23845": {
        "ontology": "HGNC",
        "curie": "HGNC:23845",
        "uri": "HGNC23845"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SLX4\",\"Hgnc\":\"23845\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0\",\"pmid\":{\"publications\":[{\"title\":\"Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families.\",\"author\":\"de Garibay GR\",\"pubdate\":\"2013 Aug\",\"source\":\"Eur J Hum Genet\",\"uid\":\"23211700\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"0.5\",\"tally\":\"0.55\",\"pmid\":{\"publications\":[{\"title\":\"Assessment of SLX4 Mutations in Hereditary Breast Cancers.\",\"author\":\"Shah S\",\"pubdate\":\"2013\",\"source\":\"PLoS One\",\"uid\":\"23840564\"},{\"title\":\"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.\",\"author\":\"Kurian AW\",\"pubdate\":\"2014 Jul 1\",\"source\":\"J Clin Oncol\",\"uid\":\"24733792\"},{\"title\":\"Next-generation sequencing in familial breast cancer patients from Lebanon.\",\"author\":\"Jalkh N\",\"pubdate\":\"2017 Feb 15\",\"source\":\"BMC Med Genomics\",\"uid\":\"28202063\"},{\"title\":\"Analysis of the novel fanconi anemia gene SLX4/FANCP in familial breast cancer cases.\",\"author\":\"Bakker JL\",\"pubdate\":\"2013 Jan\",\"source\":\"Hum Mutat\",\"uid\":\"22911665\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Mouse SLX4 is a tumor suppressor that stimulates the activity of the nuclease XPF-ERCC1 in DNA crosslink repair.\",\"author\":\"Hodskinson MR\",\"pubdate\":\"2014 May 8\",\"source\":\"Mol Cell\",\"uid\":\"24726326\"},{\"title\":\"Analysis of the novel fanconi anemia gene SLX4/FANCP in familial breast cancer cases.\",\"author\":\"Bakker JL\",\"pubdate\":\"2013 Jan\",\"source\":\"Hum Mutat\",\"uid\":\"22911665\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.\",\"author\":\"Stoepker C\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21240277\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia.\",\"author\":\"Crossan GP\",\"pubdate\":\"2011 Feb\",\"source\":\"Nat Genet\",\"uid\":\"21240276\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"0.55\",\"GeneticEvidencePointsTotal\":\"0.55\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"5.55\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"03/08/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"03/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1488960000,
    "dateISO8601": "2017-03-08T00:00:00",
    "dateFormated": "Mar 08, 2017"
  },
  "8705": {
    "title": "SLX4: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:23845": {
        "ontology": "HGNC",
        "curie": "HGNC:23845",
        "uri": "HGNC23845"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SLX4\",\"Hgnc\":\"23845\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"03/08/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"03/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1488960000,
    "dateISO8601": "2017-03-08T00:00:00",
    "dateFormated": "Mar 08, 2017"
  },
  "8706": {
    "title": "XRCC2: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:12829": {
        "ontology": "HGNC",
        "curie": "HGNC:12829",
        "uri": "HGNC12829"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"XRCC2\",\"Hgnc\":\"12829\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Rare mutations in XRCC2 increase the risk of breast cancer.\",\"author\":\"Park DJ\",\"pubdate\":\"2012 Apr 6\",\"source\":\"Am J Hum Genet\",\"uid\":\"22464251\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice.\",\"author\":\"Deans B\",\"pubdate\":\"2000 Dec 15\",\"source\":\"EMBO J\",\"uid\":\"11118202\"},{\"title\":\"Homologous recombination deficiency leads to profound genetic instability in cells derived from Xrcc2-knockout mice.\",\"author\":\"Deans B\",\"pubdate\":\"2003 Dec 1\",\"source\":\"Cancer Res\",\"uid\":\"14678973\"},{\"title\":\"The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells.\",\"author\":\"Cui X\",\"pubdate\":\"1999 Jun 23\",\"source\":\"Mutat Res\",\"uid\":\"10422536\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"0.5\",\"GeneticEvidencePointsTotal\":\"0.5\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"2.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"05/10/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"05/10/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1494399600,
    "dateISO8601": "2017-05-10T00:00:00",
    "dateFormated": "May 10, 2017"
  },
  "8707": {
    "title": "XRCC2: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:12829": {
        "ontology": "HGNC",
        "curie": "HGNC:12829",
        "uri": "HGNC12829"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"XRCC2\",\"Hgnc\":\"12829\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"04/26/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"04/26/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1493190000,
    "dateISO8601": "2017-04-26T00:00:00",
    "dateFormated": "Apr 26, 2017"
  },
  "8708": {
    "title": "STK11: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "HGNC:11389": {
        "ontology": "HGNC",
        "curie": "HGNC:11389",
        "uri": "HGNC11389"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"STK11\",\"Hgnc\":\"11389\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"10/26/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"10/26/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1477465200,
    "dateISO8601": "2016-10-26T00:00:00",
    "dateFormated": "Oct 26, 2016"
  },
  "8760": {
    "title": "TNNC2: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:11944": {
        "ontology": "HGNC",
        "curie": "HGNC:11944",
        "uri": "HGNC11944"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM191039": {
        "ontology": "OMIM",
        "curie": "OMIM:191039",
        "uri": "OMIM191039",
        "iri": "http://purl.obolibrary.org/obo/OMIM_191039"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527780726\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TNNC2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:11944\",\"uri\":\"HGNC11944\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:191039\",\"uri\":\"OMIM191039\"}},\"title\":\"TNNC2 Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"\",\"ExperimentalEvidenceTotal\":\"\",\"EvidencePointsTotal\":\"\",\"CalculatedClassification\":\"\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"NO REPORTED EVIDENCE\",\"CuratorClassificationDate\":\"01/31/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"04/04/2017\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1491289200,
    "dateISO8601": "2017-04-04T00:00:00",
    "dateFormated": "Apr 04, 2017"
  },
  "8761": {
    "title": "TCAP: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:11610": {
        "ontology": "HGNC",
        "curie": "HGNC:11610",
        "uri": "HGNC11610"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM607487": {
        "ontology": "OMIM",
        "curie": "OMIM:607487",
        "uri": "OMIM607487",
        "iri": "http://purl.obolibrary.org/obo/OMIM_607487"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1529512886\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TCAP\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:11610\",\"uri\":\"HGNC11610\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:607487\",\"uri\":\"OMIM607487\"}},\"title\":\"TCAP Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.20\",\"Tally\":\"0.2\",\"evidence\":{\"publications\":[{\"title\":\"Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy.\",\"author\":\"Hayashi T\",\"pubdate\":\"2004 Dec 7\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"15582318\"},{\"title\":\"Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.\",\"author\":\"Bos JM\",\"pubdate\":\"2006 May\",\"source\":\"Mol Genet Metab\",\"uid\":\"16352453\"}],\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.2\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527780476938\":{\"title\":\"The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy.\",\"author\":\"Kn\\u00f6ll R\",\"pubdate\":\"2002 Dec 27\",\"source\":\"Cell\",\"uid\":\"12507422\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527780499776\":{\"title\":\"Telethonin, a novel sarcomeric protein of heart and skeletal muscle.\",\"author\":\"Valle G\",\"pubdate\":\"1997 Sep 29\",\"source\":\"FEBS Lett\",\"uid\":\"9350988\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.2\",\"ExperimentalEvidenceTotal\":\"1\",\"EvidencePointsTotal\":\"1.2\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"04/10/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/01/2016\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1491807600,
    "dateISO8601": "2017-04-10T00:00:00",
    "dateFormated": "Apr 10, 2017"
  },
  "8762": {
    "title": "VCL: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:12665": {
        "ontology": "HGNC",
        "curie": "HGNC:12665",
        "uri": "HGNC12665"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM613255": {
        "ontology": "OMIM",
        "curie": "OMIM:613255",
        "uri": "OMIM613255",
        "iri": "http://purl.obolibrary.org/obo/OMIM_613255"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527786053\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"VCL\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:12665\",\"uri\":\"HGNC12665\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:613255\",\"uri\":\"OMIM613255\"}},\"title\":\"VCL Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":[{\"title\":\"Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy.\",\"author\":\"Theis JL\",\"pubdate\":\"2006 Dec 29\",\"source\":\"Biochem Biophys Res Commun\",\"uid\":\"17097056\"}],\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527782098196\":{\"title\":\"Obstructive hypertrophic cardiomyopathy is associated with reduced expression of vinculin in the intercalated disc.\",\"author\":\"Vasile VC\",\"pubdate\":\"2006 Oct 20\",\"source\":\"Biochem Biophys Res Commun\",\"uid\":\"16949038\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527781716512\":{\"title\":\"Differential lipid binding of vinculin isoforms promotes quasi-equivalent dimerization.\",\"author\":\"Chinthalapudi K\",\"pubdate\":\"2016 Aug 23\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"27503891\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.5\",\"ExperimentalEvidenceTotal\":\"1\",\"EvidencePointsTotal\":\"1.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"06/01/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"10/18/2016\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1496300400,
    "dateISO8601": "2017-06-01T00:00:00",
    "dateFormated": "Jun 01, 2017"
  },
  "8763": {
    "title": "ALPK3: Hypertrophic cardiomyopathy (recessive)",
    "label": "Hypertrophic cardiomyopathy (recessive)",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:17574": {
        "ontology": "HGNC",
        "curie": "HGNC:17574",
        "uri": "HGNC17574"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM617608": {
        "ontology": "OMIM",
        "curie": "OMIM:617608",
        "uri": "OMIM617608",
        "iri": "http://purl.obolibrary.org/obo/OMIM_617608"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3977": {
        "label": "Strong"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"ALPK3\",\"Hgnc\":\"17574\",\"OrphaNet\":\"217569\",\"Disease\":\"Hypertrophic cardiomyopathy\",\"Omim\":\"617608\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric Cardiomyopathy.\",\"author\":\"Almomani R\",\"pubdate\":\"2016 Feb 9\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"26846950\"},{\"title\":\"ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy.\",\"author\":\"Phelan DG\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Eur Heart J\",\"uid\":\"27106955\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"8.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy.\",\"author\":\"Phelan DG\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Eur Heart J\",\"uid\":\"27106955\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes.\",\"author\":\"Hosoda T\",\"pubdate\":\"2001 Sep 21\",\"source\":\"J Biol Chem\",\"uid\":\"11418590\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes.\",\"author\":\"Hosoda T\",\"pubdate\":\"2001 Sep 21\",\"source\":\"J Biol Chem\",\"uid\":\"11418590\"},{\"title\":\"ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy.\",\"author\":\"Phelan DG\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Eur Heart J\",\"uid\":\"27106955\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy.\",\"author\":\"Phelan DG\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Eur Heart J\",\"uid\":\"27106955\"},{\"title\":\"Cardiomyopathy in \\u03b1-kinase 3 (ALPK3)-deficient mice.\",\"author\":\"Van Sligtenhorst I\",\"pubdate\":\"2012 Jan\",\"source\":\"Vet Pathol\",\"uid\":\"21441111\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3.5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"3.5\",\"EvidencePointsTotal\":\"15.5\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"01/11/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"02/07/2017\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"}}",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527795610\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"ALPK3\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:17574\",\"uri\":\"HGNC17574\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:617608\",\"uri\":\"OMIM617608\"}},\"title\":\"ALPK3 Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"8.00\",\"evidence\":{\"publications\":{\"1527795771741\":{\"title\":\"Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric Cardiomyopathy.\",\"author\":\"Almomani R\",\"pubdate\":\"2016 Feb 9\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"26846950\"},\"1527795784020\":{\"title\":\"ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy.\",\"author\":\"Phelan DG\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Eur Heart J\",\"uid\":\"27106955\"}}}},\"Tally\":\"8\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"1\":{\"evidence\":{\"publications\":{\"1527795788769\":{\"title\":\"ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy.\",\"author\":\"Phelan DG\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Eur Heart J\",\"uid\":\"27106955\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"9\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527796021728\":{\"title\":\"A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes.\",\"author\":\"Hosoda T\",\"pubdate\":\"2001 Sep 21\",\"source\":\"J Biol Chem\",\"uid\":\"11418590\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527796032704\":{\"title\":\"A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes.\",\"author\":\"Hosoda T\",\"pubdate\":\"2001 Sep 21\",\"source\":\"J Biol Chem\",\"uid\":\"11418590\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527796074446\":{\"title\":\"ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy.\",\"author\":\"Phelan DG\",\"pubdate\":\"2016 Sep 1\",\"source\":\"Eur Heart J\",\"uid\":\"27106955\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527796054547\":{\"title\":\"A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes.\",\"author\":\"Hosoda T\",\"pubdate\":\"2001 Sep 21\",\"source\":\"J Biol Chem\",\"uid\":\"11418590\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"1.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"1\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527796127216\":{\"title\":\"Cardiomyopathy in \\u03b1-kinase 3 (ALPK3)-deficient mice.\",\"author\":\"Van Sligtenhorst I\",\"pubdate\":\"2012 Jan\",\"source\":\"Vet Pathol\",\"uid\":\"21441111\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"3.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"9\",\"ExperimentalEvidenceTotal\":\"3.5\",\"EvidencePointsTotal\":\"12.5\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"12/16/2016\",\"CuratorClassification\":\"STRONG\",\"CuratorClassificationDate\":\"01/11/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"02/07/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1486512000,
    "dateISO8601": "2017-02-07T16:00:00",
    "dateFormated": "Feb 07, 2017"
  },
  "8765": {
    "title": "TNNC1: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:11943": {
        "ontology": "HGNC",
        "curie": "HGNC:11943",
        "uri": "HGNC11943"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM613243": {
        "ontology": "OMIM",
        "curie": "OMIM:613243",
        "uri": "OMIM613243",
        "iri": "http://purl.obolibrary.org/obo/OMIM_613243"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527785975\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TNNC1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:11943\",\"uri\":\"HGNC11943\"},\"condition\":{\"name\":\"Hypertrophic Cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:613243\",\"uri\":\"OMIM613243\"}},\"title\":\"TNNC1 Hypertrophic Cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":[{\"title\":\"Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.\",\"author\":\"Landstrom AP\",\"pubdate\":\"2008 Aug\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"18572189\"}],\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":[{\"title\":\"Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden death.\",\"author\":\"Chung WK\",\"pubdate\":\"2011 Jun\",\"source\":\"Cardiol Young\",\"uid\":\"21262074\"}],\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"evidence\":{\"publications\":[{\"title\":\"First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy.\",\"author\":\"Hoffmann B\",\"pubdate\":\"2001 Jun\",\"source\":\"Hum Mutat\",\"uid\":\"11385718\"},{\"title\":\"Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.\",\"author\":\"Landstrom AP\",\"pubdate\":\"2008 Aug\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"18572189\"},{\"title\":\"A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.\",\"author\":\"Parvatiyar MS\",\"pubdate\":\"2012 Sep 14\",\"source\":\"J Biol Chem\",\"uid\":\"22815480\"},{\"title\":\"Genetic profile of hypertrophic cardiomyopathy in Tunisia: Is it different?\",\"author\":\"Jaafar N\",\"pubdate\":\"2015\",\"source\":\"Glob Cardiol Sci Pract\",\"uid\":\"26779504\"}],\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"4\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527783727289\":{\"title\":\"Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C.\",\"author\":\"Schmidtmann A\",\"pubdate\":\"2005 Dec\",\"source\":\"FEBS J\",\"uid\":\"16302972\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"2\",\"NonPatientCells\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1527783784244\":{\"title\":\"Familial hypertrophic cardiomyopathy related cardiac troponin C L29Q mutation alters length-dependent activation and functional effects of phosphomimetic troponin I*.\",\"author\":\"Li AY\",\"pubdate\":\"2013\",\"source\":\"PLoS One\",\"uid\":\"24260207\"},\"1527783847209\":{\"title\":\"Predicting cardiomyopathic phenotypes by altering Ca2+ affinity of cardiac troponin C.\",\"author\":\"Parvatiyar MS\",\"pubdate\":\"2010 Sep 3\",\"source\":\"J Biol Chem\",\"uid\":\"20566645\"},\"1527783878221\":{\"title\":\"Enhanced troponin I binding explains the functional changes produced by the hypertrophic cardiomyopathy mutation A8V of cardiac troponin C.\",\"author\":\"Zot HG\",\"pubdate\":\"2016 Jul 1\",\"source\":\"Arch Biochem Biophys\",\"uid\":\"26976709\"},\"1527783902266\":{\"title\":\"The structural and functional effects of the familial hypertrophic cardiomyopathy-linked cardiac troponin C mutation, L29Q.\",\"author\":\"Robertson IM\",\"pubdate\":\"2015 Oct\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"26341255\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.50\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"2.5\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527783950418\":{\"title\":\"In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene.\",\"author\":\"Martins AS\",\"pubdate\":\"2015 Oct\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"26304555\"},\"1527783972874\":{\"title\":\"Distinct troponin C isoform requirements in cardiac and skeletal muscle.\",\"author\":\"Sogah VM\",\"pubdate\":\"2010 Nov\",\"source\":\"Dev Dyn\",\"uid\":\"20925115\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"4\",\"ExperimentalEvidenceTotal\":\"5\",\"EvidencePointsTotal\":\"9\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"11/01/2016\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"11/01/2016\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1478041200,
    "dateISO8601": "2016-11-01T16:00:00",
    "dateFormated": "Nov 01, 2016"
  },
  "8766": {
    "title": "ACTC1: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:143": {
        "ontology": "HGNC",
        "curie": "HGNC:143",
        "uri": "HGNC143"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM612098": {
        "ontology": "OMIM",
        "curie": "OMIM:612098",
        "uri": "OMIM612098",
        "iri": "http://purl.obolibrary.org/obo/OMIM_612098"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527866915\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"ACTC1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:143\",\"uri\":\"HGNC143\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:612098\",\"uri\":\"OMIM612098\"}},\"title\":\"ACTC1 Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"6.00\",\"Tally\":\"6\",\"evidence\":{\"publications\":{\"1527866453247\":{\"title\":\"Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy.\",\"author\":\"Olson TM\",\"pubdate\":\"2000 Sep\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"10966831\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"5.00\",\"Tally\":\"5\",\"evidence\":{\"publications\":{\"1527866499554\":{\"title\":\"Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy.\",\"author\":\"Mogensen J\",\"pubdate\":\"1999 May 15\",\"source\":\"J Clin Invest\",\"uid\":\"10330430\"},\"1527866793320\":{\"title\":\"Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy.\",\"author\":\"Olson TM\",\"pubdate\":\"2000 Sep\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"10966831\"},\"1527866817272\":{\"title\":\"Gene mutations in apical hypertrophic cardiomyopathy.\",\"author\":\"Arad M\",\"pubdate\":\"2005 Nov 1\",\"source\":\"Circulation\",\"uid\":\"16267253\"},\"1527866837408\":{\"title\":\"Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects.\",\"author\":\"Monserrat L\",\"pubdate\":\"2007 Aug\",\"source\":\"Eur Heart J\",\"uid\":\"17611253\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.50\",\"Tally\":\"1.5\",\"2\":{\"evidence\":{\"publications\":{\"1527866587734\":{\"title\":\"Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy.\",\"author\":\"Olson TM\",\"pubdate\":\"2000 Sep\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"10966831\"},\"1527866867961\":{\"title\":\"Gene mutations in apical hypertrophic cardiomyopathy.\",\"author\":\"Arad M\",\"pubdate\":\"2005 Nov 1\",\"source\":\"Circulation\",\"uid\":\"16267253\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"2\",\"AggregateVariantAnalysis\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1527866707781\":{\"title\":\"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.\",\"author\":\"Walsh R\",\"pubdate\":\"2017 Feb\",\"source\":\"Genet Med\",\"uid\":\"27532257\"}},\"notes\":{\"note\":\"\"}}}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527867037995\":{\"title\":\"Altered interactions between cardiac myosin binding protein-C and \\u03b1-cardiac actin variants associated with cardiomyopathies.\",\"author\":\"Chow ML\",\"pubdate\":\"2014 May 15\",\"source\":\"Arch Biochem Biophys\",\"uid\":\"24736382\"},\"1527867054075\":{\"title\":\"Minigenes encoding N-terminal domains of human cardiac myosin light chain-1 improve heart function of transgenic rats.\",\"author\":\"Haase H\",\"pubdate\":\"2006 May\",\"source\":\"FASEB J\",\"uid\":\"16675844\"}}}},\"Expression\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527866928240\":{\"title\":\"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.\",\"author\":\"Fagerberg L\",\"pubdate\":\"2014 Feb\",\"source\":\"Mol Cell Proteomics\",\"uid\":\"24309898\"}}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527867157681\":{\"title\":\"Functional characterization of the human \\u03b1-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy.\",\"author\":\"M\\u00fcller M\",\"pubdate\":\"2012 Oct\",\"source\":\"Cell Mol Life Sci\",\"uid\":\"22643837\"}}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"3.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"3\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527867111029\":{\"title\":\"Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.\",\"author\":\"Song W\",\"pubdate\":\"2011 Aug 5\",\"source\":\"J Biol Chem\",\"uid\":\"21622575\"},\"1527867126655\":{\"title\":\"Mechanical and energetic properties of papillary muscle from ACTC E99K transgenic mouse models of hypertrophic cardiomyopathy.\",\"author\":\"Song W\",\"pubdate\":\"2013 Jun 1\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"23604709\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"5.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"5.5\",\"EvidencePointsTotal\":\"17.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"09/05/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"09/05/2017\",\"FinalClassificationNotes\":\"This classification was approved by the Hypertrophic Cardiomyopathy Gene Curation Expert Panel.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1508792400,
    "dateISO8601": "2017-10-23T14:00:00",
    "dateFormated": "Oct 23, 2017"
  },
  "8768": {
    "title": "MYL2: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:7583": {
        "ontology": "HGNC",
        "curie": "HGNC:7583",
        "uri": "HGNC7583"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0012112"
      },
      "OMIM608758": {
        "ontology": "OMIM",
        "curie": "OMIM:608758",
        "uri": "OMIM608758",
        "iri": "http://purl.obolibrary.org/obo/OMIM_608758"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MYL2\",\"Hgnc\":\"7583\",\"OrphaNet\":\"217569\",\"Disease\":\"Hypertrophic Cardiomyopathy\",\"Omim\":\"608758\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"11.5\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Genetics of hypertrophic cardiomyopathy in Norway.\",\"author\":\"Berge KE\",\"pubdate\":\"2014 Oct\",\"source\":\"Clin Genet\",\"uid\":\"24111713\"},{\"title\":\"Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy.\",\"author\":\"Flavigny J\",\"pubdate\":\"1998 Mar\",\"source\":\"J Mol Med (Berl)\",\"uid\":\"9535554\"},{\"title\":\"Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.\",\"author\":\"Kabaeva ZT\",\"pubdate\":\"2002 Nov\",\"source\":\"Eur J Hum Genet\",\"uid\":\"12404107\"},{\"title\":\"Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden.\",\"author\":\"M\\u00f6rner S\",\"pubdate\":\"2003 Jul\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"12818575\"},{\"title\":\"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.\",\"author\":\"Richard P\",\"pubdate\":\"2003 May 6\",\"source\":\"Circulation\",\"uid\":\"12707239\"},{\"title\":\"Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.\",\"author\":\"Lopes LR\",\"pubdate\":\"2015 Feb\",\"source\":\"Heart\",\"uid\":\"25351510\"},{\"title\":\"Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.\",\"author\":\"Poetter K\",\"pubdate\":\"1996 May\",\"source\":\"Nat Genet\",\"uid\":\"8673105\"},{\"title\":\"Genetic basis of end-stage hypertrophic cardiomyopathy.\",\"author\":\"Garcia-Pavia P\",\"pubdate\":\"2011 Nov\",\"source\":\"Eur J Heart Fail\",\"uid\":\"21896538\"},{\"title\":\"Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers.\",\"author\":\"Claes GR\",\"pubdate\":\"2016 Jun 14\",\"source\":\"Eur Heart J\",\"uid\":\"26497160\"}],\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"0.0\",\"tally\":\"0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy.\",\"author\":\"Flavigny J\",\"pubdate\":\"1998 Mar\",\"source\":\"J Mol Med (Berl)\",\"uid\":\"9535554\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.\",\"author\":\"Walsh R\",\"pubdate\":\"2017 Feb\",\"source\":\"Genet Med\",\"uid\":\"27532257\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation.\",\"author\":\"Szczesna D\",\"pubdate\":\"2001 Mar 9\",\"source\":\"J Biol Chem\",\"uid\":\"11102452\"},{\"title\":\"Human atrial and ventricular myosin light-chains subunits in the adult and during development.\",\"author\":\"Price KM\",\"pubdate\":\"1980 Nov 1\",\"source\":\"Biochem J\",\"uid\":\"7236212\"},{\"title\":\"Three-dimensional structure of myosin subfragment-1: a molecular motor.\",\"author\":\"Rayment I\",\"pubdate\":\"1993 Jul 2\",\"source\":\"Science\",\"uid\":\"8316857\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"0\"},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.\",\"author\":\"Wang Y\",\"pubdate\":\"2006 Aug 11\",\"source\":\"J Mol Biol\",\"uid\":\"16837010\"},{\"title\":\"The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.\",\"author\":\"Szczesna-Cordary D\",\"pubdate\":\"2005 Aug 15\",\"source\":\"J Cell Sci\",\"uid\":\"16076902\"},{\"title\":\"Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.\",\"author\":\"Kerrick WG\",\"pubdate\":\"2009 Mar\",\"source\":\"FASEB J\",\"uid\":\"18987303\"},{\"title\":\"Molecular and Functional Effects of a Splice Site Mutation in the MYL2 Gene Associated with Cardioskeletal Myopathy and Early Cardiac Death in Infants.\",\"author\":\"Zhou Z\",\"pubdate\":\"2016\",\"source\":\"Front Physiol\",\"uid\":\"27378946\"},{\"title\":\"Fine-tuning in Ca2+ homeostasis underlies progression of cardiomyopathy in myocytes derived from genetically modified embryonic stem cells.\",\"author\":\"Grey C\",\"pubdate\":\"2005 May 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"15829506\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"9.5\",\"GeneticEvidencePointsTotal\":\"9.5\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"15.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"02/07/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/07/2017\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1486512000,
    "dateISO8601": "2017-02-07T16:00:00",
    "dateFormated": "Feb 07, 2017"
  },
  "8769": {
    "title": "TNNI3: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:11947": {
        "ontology": "HGNC",
        "curie": "HGNC:11947",
        "uri": "HGNC11947"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM613690": {
        "ontology": "OMIM",
        "curie": "OMIM:613690",
        "uri": "OMIM613690",
        "iri": "http://purl.obolibrary.org/obo/OMIM_613690"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527785008\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TNNI3\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:11947\",\"uri\":\"HGNC11947\"},\"condition\":{\"name\":\"Hypertrophic Cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:613690\",\"uri\":\"OMIM613690\"}},\"title\":\"TNNI3 Hypertrophic Cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"2.00\",\"Tally\":\"2\",\"evidence\":{\"publications\":{\"1527785186039\":{\"title\":\"Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.\",\"author\":\"Kimura A\",\"pubdate\":\"1997 Aug\",\"source\":\"Nat Genet\",\"uid\":\"9241277\"},\"1527785208922\":{\"title\":\"Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.\",\"author\":\"Doolan A\",\"pubdate\":\"2005 Feb\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"15698845\"}}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"7.00\",\"Tally\":\"7\",\"evidence\":{\"publications\":[{\"title\":\"Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.\",\"author\":\"Kimura A\",\"pubdate\":\"1997 Aug\",\"source\":\"Nat Genet\",\"uid\":\"9241277\"},{\"title\":\"High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians.\",\"author\":\"Rani DS\",\"pubdate\":\"2012 Aug 10\",\"source\":\"BMC Med Genet\",\"uid\":\"22876777\"},{\"title\":\"Long-term outcome of 4 Korean families with hypertrophic cardiomyopathy caused by 4 different mutations.\",\"author\":\"Choi JO\",\"pubdate\":\"2010 Jul\",\"source\":\"Clin Cardiol\",\"uid\":\"20641121\"},{\"title\":\"Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.\",\"author\":\"Doolan A\",\"pubdate\":\"2005 Feb\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"15698845\"},{\"title\":\"Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.\",\"author\":\"Andersen PS\",\"pubdate\":\"2009 Mar\",\"source\":\"Hum Mutat\",\"uid\":\"19035361\"},{\"title\":\"Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.\",\"author\":\"Mogensen J\",\"pubdate\":\"2004 Dec 21\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"15607392\"}],\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.50\",\"Tally\":\"1.5\",\"3\":{\"evidence\":{\"publications\":{\"1527785267112\":{\"title\":\"Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.\",\"author\":\"Kimura A\",\"pubdate\":\"1997 Aug\",\"source\":\"Nat Genet\",\"uid\":\"9241277\"},\"1527785284327\":{\"title\":\"High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians.\",\"author\":\"Rani DS\",\"pubdate\":\"2012 Aug 10\",\"source\":\"BMC Med Genet\",\"uid\":\"22876777\"},\"1527785303035\":{\"title\":\"Long-term outcome of 4 Korean families with hypertrophic cardiomyopathy caused by 4 different mutations.\",\"author\":\"Choi JO\",\"pubdate\":\"2010 Jul\",\"source\":\"Clin Cardiol\",\"uid\":\"20641121\"},\"1527785361268\":{\"title\":\"Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.\",\"author\":\"Mogensen J\",\"pubdate\":\"2004 Dec 21\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"15607392\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1527785508813\":{\"title\":\"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.\",\"author\":\"Walsh R\",\"pubdate\":\"2017 Feb\",\"source\":\"Genet Med\",\"uid\":\"27532257\"}}}},\"Tally\":\"2\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527785546832\":{\"title\":\"Myofilament calcium sensitivity and cardiac disease: insights from troponin I isoforms and mutants.\",\"author\":\"Westfall MV\",\"pubdate\":\"2002 Sep 20\",\"source\":\"Circ Res\",\"uid\":\"12242271\"},\"1527785632162\":{\"title\":\"Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.\",\"author\":\"Tsoutsman T\",\"pubdate\":\"2006 Oct\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"16950368\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527785641869\":{\"title\":\"Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.\",\"author\":\"Tsoutsman T\",\"pubdate\":\"2006 Oct\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"16950368\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527785687430\":{\"title\":\"Differential protein expression profiling of myocardial tissue in a mouse model of hypertrophic cardiomyopathy.\",\"author\":\"Lam L\",\"pubdate\":\"2010 May\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"19715700\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"4.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527785561349\":{\"title\":\"Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy.\",\"author\":\"James J\",\"pubdate\":\"2000 Oct 27\",\"source\":\"Circ Res\",\"uid\":\"11055985\"},\"1527785596649\":{\"title\":\"Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy.\",\"author\":\"Sanbe A\",\"pubdate\":\"2005 May 10\",\"source\":\"Circulation\",\"uid\":\"15867176\"},\"1527785611357\":{\"title\":\"Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.\",\"author\":\"Tsoutsman T\",\"pubdate\":\"2006 Oct\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"16950368\"},\"1527785666477\":{\"title\":\"Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy.\",\"author\":\"Wang Y\",\"pubdate\":\"2012 Jan 13\",\"source\":\"J Biol Chem\",\"uid\":\"22086914\"},\"1527785729865\":{\"title\":\"Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice.\",\"author\":\"Wen Y\",\"pubdate\":\"2008 Jul 18\",\"source\":\"J Biol Chem\",\"uid\":\"18430738\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"6\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"12/12/2016\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"09/05/2017\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1504652400,
    "dateISO8601": "2017-09-05T16:00:00",
    "dateFormated": "Sep 05, 2017"
  },
  "8770": {
    "title": "TNNT2: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:11949": {
        "ontology": "HGNC",
        "curie": "HGNC:11949",
        "uri": "HGNC11949"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM115195": {
        "ontology": "OMIM",
        "curie": "OMIM:115195",
        "uri": "OMIM115195",
        "iri": "http://purl.obolibrary.org/obo/OMIM_115195"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527786276\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TNNT2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:11949\",\"uri\":\"HGNC11949\"},\"condition\":{\"name\":\"Hypertrophic Cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:115195\",\"uri\":\"OMIM115195\"}},\"title\":\"TNNT2 Hypertrophic Cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"7.00\",\"Tally\":\"7\",\"evidence\":{\"publications\":{\"0\":{\"title\":\"Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.\",\"author\":\"Thierfelder L\",\"pubdate\":\"1994 Jun 3\",\"source\":\"Cell\",\"uid\":\"8205619\"},\"1\":{\"title\":\"Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy.\",\"author\":\"Fujita E\",\"pubdate\":\"2013 Nov\",\"source\":\"Heart Vessels\",\"uid\":\"23494605\"},\"1527786633291\":{\"title\":\"Prevalence and clinical profile of troponin T mutations among patients with hypertrophic cardiomyopathy in tuscany.\",\"author\":\"Torricelli F\",\"pubdate\":\"2003 Dec 1\",\"source\":\"Am J Cardiol\",\"uid\":\"14636924\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"3\":{\"evidence\":{\"publications\":{\"1527786668627\":{\"title\":\"Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.\",\"author\":\"Thierfelder L\",\"pubdate\":\"1994 Jun 3\",\"source\":\"Cell\",\"uid\":\"8205619\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"2\",\"AggregateVariantAnalysis\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":[{\"title\":\"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.\",\"author\":\"Walsh R\",\"pubdate\":\"2017 Feb\",\"source\":\"Genet Med\",\"uid\":\"27532257\"}],\"notes\":{\"note\":\"\"}}}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527786765731\":{\"title\":\"Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype.\",\"author\":\"Marques MA\",\"pubdate\":\"2016\",\"source\":\"Front Physiol\",\"uid\":\"27721798\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527786715451\":{\"title\":\"Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle.\",\"author\":\"Anderson PA\",\"pubdate\":\"1991 Nov\",\"source\":\"Circ Res\",\"uid\":\"1934353\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527786747668\":{\"title\":\"Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins.\",\"author\":\"Rust EM\",\"pubdate\":\"1999 May 15\",\"source\":\"J Clin Invest\",\"uid\":\"10330428\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"NonPatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527786732345\":{\"title\":\"Functional consequences of a carboxyl terminal missense mutation Arg278Cys in human cardiac troponin T.\",\"author\":\"Morimoto S\",\"pubdate\":\"1999 Jul 22\",\"source\":\"Biochem Biophys Res Commun\",\"uid\":\"10405326\"},\"1527786813025\":{\"title\":\"Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation.\",\"author\":\"Miller T\",\"pubdate\":\"2001 Feb 9\",\"source\":\"J Biol Chem\",\"uid\":\"11060294\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.50\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"2.5\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527786795562\":{\"title\":\"A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy.\",\"author\":\"Tardiff JC\",\"pubdate\":\"1998 Jun 15\",\"source\":\"J Clin Invest\",\"uid\":\"9637714\"},\"1527786833441\":{\"title\":\"Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.\",\"author\":\"Tardiff JC\",\"pubdate\":\"1999 Aug\",\"source\":\"J Clin Invest\",\"uid\":\"10449439\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"6\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"04/12/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"11/07/2017\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1510099200,
    "dateISO8601": "2017-11-07T16:00:00",
    "dateFormated": "Nov 07, 2017"
  },
  "8771": {
    "title": "TPM1: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:12010": {
        "ontology": "HGNC",
        "curie": "HGNC:12010",
        "uri": "HGNC12010"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM115196": {
        "ontology": "OMIM",
        "curie": "OMIM:115196",
        "uri": "OMIM115196",
        "iri": "http://purl.obolibrary.org/obo/OMIM_115196"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527787076\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TPM1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:12010\",\"uri\":\"HGNC12010\"},\"condition\":{\"name\":\"Hypertrophic Cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:115196\",\"uri\":\"OMIM115196\"}},\"title\":\"TPM1 Hypertrophic Cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1527787181983\":{\"title\":\"A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy.\",\"author\":\"Watkins H\",\"pubdate\":\"1995 May 1\",\"source\":\"Circulation\",\"uid\":\"7729014\"}}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"7.00\",\"Tally\":\"7\",\"evidence\":{\"publications\":{\"0\":{\"title\":\"Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.\",\"author\":\"Thierfelder L\",\"pubdate\":\"1994 Jun 3\",\"source\":\"Cell\",\"uid\":\"8205619\"},\"1\":{\"title\":\"A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2.\",\"author\":\"Thierfelder L\",\"pubdate\":\"1993 Jul 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"8327508\"},\"3\":{\"title\":\"Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene.\",\"author\":\"Yamauchi-Takihara K\",\"pubdate\":\"1996 Jul\",\"source\":\"Heart\",\"uid\":\"8774330\"},\"4\":{\"title\":\"Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy.\",\"author\":\"Nakajima-Taniguchi C\",\"pubdate\":\"1995 Sep\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"8523464\"},\"5\":{\"title\":\"The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population.\",\"author\":\"J\\u00e4\\u00e4skel\\u00e4inen P\",\"pubdate\":\"1998 Nov 15\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"9822100\"},\"6\":{\"title\":\"Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.\",\"author\":\"Karibe A\",\"pubdate\":\"2001 Jan 2\",\"source\":\"Circulation\",\"uid\":\"11136687\"},\"7\":{\"title\":\"Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy.\",\"author\":\"Jongbloed RJ\",\"pubdate\":\"2003 Mar 19\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"12651045\"},\"8\":{\"title\":\"A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood.\",\"author\":\"Van Driest SL\",\"pubdate\":\"2002 Nov 15\",\"source\":\"Am J Cardiol\",\"uid\":\"12423715\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"3\":{\"evidence\":{\"publications\":{\"1527787263432\":{\"title\":\"Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.\",\"author\":\"Thierfelder L\",\"pubdate\":\"1994 Jun 3\",\"source\":\"Cell\",\"uid\":\"8205619\"},\"1527787276731\":{\"title\":\"A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2.\",\"author\":\"Thierfelder L\",\"pubdate\":\"1993 Jul 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"8327508\"},\"1527787296735\":{\"title\":\"The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population.\",\"author\":\"J\\u00e4\\u00e4skel\\u00e4inen P\",\"pubdate\":\"1998 Nov 15\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"9822100\"},\"1527787314727\":{\"title\":\"Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.\",\"author\":\"Karibe A\",\"pubdate\":\"2001 Jan 2\",\"source\":\"Circulation\",\"uid\":\"11136687\"},\"1527787332528\":{\"title\":\"Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy.\",\"author\":\"Jongbloed RJ\",\"pubdate\":\"2003 Mar 19\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"12651045\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1527787362336\":{\"title\":\"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.\",\"author\":\"Walsh R\",\"pubdate\":\"2017 Feb\",\"source\":\"Genet Med\",\"uid\":\"27532257\"}}}},\"Tally\":\"2\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527787491437\":{\"title\":\"Mechanistic heterogeneity in contractile properties of \\u03b1-tropomyosin (TPM1) mutants associated with inherited cardiomyopathies.\",\"author\":\"Gupte TM\",\"pubdate\":\"2015 Mar 13\",\"source\":\"J Biol Chem\",\"uid\":\"25548289\"},\"1527787804321\":{\"title\":\"Hypertrophic cardiomyopathy-causing Asp175asn and Glu180gly Tpm1 mutations shift tropomyosin strands further towards the open position during the ATPase cycle.\",\"author\":\"Borovikov YS\",\"pubdate\":\"2011 Apr 1\",\"source\":\"Biochem Biophys Res Commun\",\"uid\":\"21376702\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1527787452957\":{\"title\":\"Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.\",\"author\":\"Sequeira V\",\"pubdate\":\"2013 May 24\",\"source\":\"Circ Res\",\"uid\":\"23508784\"},\"1527787470333\":{\"title\":\"Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or \\u03b1-Tropomyosin Mutation for Hypertrophic Cardiomyopathy.\",\"author\":\"Ojala M\",\"pubdate\":\"2016\",\"source\":\"Stem Cells Int\",\"uid\":\"27057166\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527787438553\":{\"title\":\"Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations.\",\"author\":\"Coutu P\",\"pubdate\":\"2004 May 14\",\"source\":\"Circ Res\",\"uid\":\"15059934\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.00\"},\"CellCultureModel\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527787786897\":{\"title\":\"Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin\",\"author\":\"Bai F\",\"pubdate\":\"2011 Feb 16\",\"source\":\"Biophys J\",\"uid\":\"21320446\"}},\"notes\":{\"note\":\"\"}}}},\"ModelsRescue\":{\"Tally\":\"3\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527787391833\":{\"title\":\"A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.\",\"author\":\"Prabhakar R\",\"pubdate\":\"2001 Oct\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"11603924\"},\"1527787509110\":{\"title\":\"Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy.\",\"author\":\"Evans CC\",\"pubdate\":\"2000 Nov\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"11045979\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"6\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"11/14/2016\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/20/2016\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1482278400,
    "dateISO8601": "2016-12-20T16:00:00",
    "dateFormated": "Dec 20, 2016"
  },
  "9507": {
    "title": "ACSL4: X-Linked Intellectual Disability",
    "label": "X-Linked Intellectual Disability",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "3571": {
        "ontology": "HGNC",
        "curie": "HGNC:3571",
        "uri": "HGNC3571"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019181"
      },
      "OMIM300157": {
        "ontology": "OMIM",
        "curie": "OMIM:300157",
        "uri": "OMIM300157",
        "iri": "http://purl.obolibrary.org/obo/OMIM_300157"
      },
      "ORPHA777": {
        "ontology": "ORPHA",
        "curie": "ORPHA:777",
        "uri": "ORPHA777",
        "iri": "http://www.orpha.net/ORDO/Orphanet_777"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1518113355\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"ACSL4\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:3571\",\"uri\":\"HGNC3571\"},\"condition\":{\"name\":\"X-Linked Intellectual Disability\",\"OrphaNet\":{\"curie\":\"ORPHA:777\",\"uri\":\"ORPHA777\"},\"MONDO\":{\"curie\":\"MONDO:0019181\",\"uri\":\"MONDO0019181\"},\"OMIM\":{\"curie\":\"OMIM:300157\",\"uri\":\"OMIM300157\"}},\"title\":\"ACSL4 X-Linked Intellectual Disability\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"evidence\":{\"publications\":{\"1518122999539\":{\"title\":\"FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation.\",\"author\":\"Meloni I\",\"pubdate\":\"2002 Apr\",\"source\":\"Nat Genet\",\"uid\":\"11889465\"},\"1518123043921\":{\"title\":\"Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability.\",\"author\":\"Grozeva D\",\"pubdate\":\"2015 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"26350204\"}}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"2.00\",\"Tally\":\"2\",\"evidence\":{\"publications\":{\"1518122981597\":{\"title\":\"FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation.\",\"author\":\"Meloni I\",\"pubdate\":\"2002 Apr\",\"source\":\"Nat Genet\",\"uid\":\"11889465\"},\"1518123018451\":{\"title\":\"A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene: proposal of a rapid enzymatic assay for screening mentally retarded patients.\",\"author\":\"Longo I\",\"pubdate\":\"2003 Jan\",\"source\":\"J Med Genet\",\"uid\":\"12525535\"}}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"0.00\",\"Tally\":\"0\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1518123066036\":{\"title\":\"dAcsl, the Drosophila ortholog of acyl-CoA synthetase long-chain family member 3 and 4, inhibits synapse growth by attenuating bone morphogenetic protein signaling via endocytic recycling.\",\"author\":\"Liu Z\",\"pubdate\":\"2014 Feb 19\",\"source\":\"J Neurosci\",\"uid\":\"24553921\"}}}},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.00\",\"evidence\":{\"publications\":{\"1518123078468\":{\"title\":\"FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation.\",\"author\":\"Meloni I\",\"pubdate\":\"2002 Apr\",\"source\":\"Nat Genet\",\"uid\":\"11889465\"}}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"2.00\"},\"Tally\":\"2\",\"NonPatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1518123092348\":{\"title\":\"The XLMR gene ACSL4 plays a role in dendritic spine architecture.\",\"author\":\"Meloni I\",\"pubdate\":\"2009 Mar 17\",\"source\":\"Neuroscience\",\"uid\":\"19166906\"},\"1518123122250\":{\"title\":\"Acsl, the Drosophila ortholog of intellectual-disability-related ACSL4, inhibits synaptic growth by altered lipids.\",\"author\":\"Huang Y\",\"pubdate\":\"2016 Nov 1\",\"source\":\"J Cell Sci\",\"uid\":\"27656110\"}}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"1\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1518123135505\":{\"title\":\"Analyses of mental dysfunction-related ACSl4 in Drosophila reveal its requirement for Dpp/BMP production and visual wiring in the brain.\",\"author\":\"Zhang Y\",\"pubdate\":\"2009 Oct 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"19617635\"}}}},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"3.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"5\",\"ExperimentalEvidenceTotal\":\"3.5\",\"EvidencePointsTotal\":\"8.5\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"MODERATE\",\"CuratorClassificationDate\":\"07/05/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"10/20/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1508482800,
    "dateISO8601": "2017-10-20T00:00:00",
    "dateFormated": "Oct 20, 2017"
  },
  "9508": {
    "title": "AFF2: Non-Syndromic X-Linked Intellectual Disability",
    "label": "Non-Syndromic X-Linked Intellectual Disability",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "3776": {
        "ontology": "HGNC",
        "curie": "HGNC:3776",
        "uri": "HGNC3776"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010659"
      },
      "OMIM309548": {
        "ontology": "OMIM",
        "curie": "OMIM:309548",
        "uri": "OMIM309548",
        "iri": "http://purl.obolibrary.org/obo/OMIM_309548"
      },
      "ORPHA777": {
        "ontology": "ORPHA",
        "curie": "ORPHA:777",
        "uri": "ORPHA777",
        "iri": "http://www.orpha.net/ORDO/Orphanet_777"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1518123607\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"AFF2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:3776\",\"uri\":\"HGNC3776\"},\"condition\":{\"name\":\"Non-Syndromic X-Linked Intellectual Disability\",\"OrphaNet\":{\"curie\":\"ORPHA:777\",\"uri\":\"ORPHA777\"},\"MONDO\":{\"curie\":\"MONDO:100973\",\"uri\":\"MONDO100973\"},\"OMIM\":{\"curie\":\"OMIM:309548\",\"uri\":\"OMIM309548\"}},\"title\":\"AFF2 Non-Syndromic X-Linked Intellectual Disability\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"10.00\",\"Tally\":\"10\",\"evidence\":{\"publications\":{\"1518124260611\":{\"title\":\"Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation.\",\"author\":\"Knight SJ\",\"pubdate\":\"1993 Jul 16\",\"source\":\"Cell\",\"uid\":\"8334699\"},\"1518124359048\":{\"title\":\"FRAXE and mental retardation.\",\"author\":\"Mulley JC\",\"pubdate\":\"1995 Mar\",\"source\":\"J Med Genet\",\"uid\":\"7783162\"},\"1518124378528\":{\"title\":\"Clinical, cytogenetic, and molecular analysis of three families with FRAXE.\",\"author\":\"Barnicoat AJ\",\"pubdate\":\"1997 Jan\",\"source\":\"J Med Genet\",\"uid\":\"9032643\"},\"1518124392624\":{\"title\":\"Overlapping submicroscopic deletions in Xq28 in two unrelated boys with developmental disorders: identification of a gene near FRAXE.\",\"author\":\"Gedeon AK\",\"pubdate\":\"1995 Apr\",\"source\":\"Am J Hum Genet\",\"uid\":\"7536393\"},\"1518124407432\":{\"title\":\"Screening for FMR1 and FMR2 mutations in 222 individuals from Spanish special schools: identification of a case of FRAXE-associated mental retardation.\",\"author\":\"Mil\\u00e0 M\",\"pubdate\":\"1997 Oct\",\"source\":\"Hum Genet\",\"uid\":\"9341861\"},\"1518124440520\":{\"title\":\"Molecular characterization of FRAXE-positive subjects with mental impairement in two unrelated Italian families.\",\"author\":\"Russo S\",\"pubdate\":\"1998 Jan 23\",\"source\":\"Am J Med Genet\",\"uid\":\"9475603\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.00\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"7.00\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1518124202691\":{\"title\":\"Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation.\",\"author\":\"Knight SJ\",\"pubdate\":\"1993 Jul 16\",\"source\":\"Cell\",\"uid\":\"8334699\"},\"1518124280362\":{\"title\":\"Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap.\",\"author\":\"Knight SJ\",\"pubdate\":\"1994 Jul\",\"source\":\"Am J Hum Genet\",\"uid\":\"8023854\"},\"1518124425760\":{\"title\":\"Molecular characterization of FRAXE-positive subjects with mental impairement in two unrelated Italian families.\",\"author\":\"Russo S\",\"pubdate\":\"1998 Jan 23\",\"source\":\"Am J Med Genet\",\"uid\":\"9475603\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1518124293640\":{\"title\":\"Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap.\",\"author\":\"Knight SJ\",\"pubdate\":\"1994 Jul\",\"source\":\"Am J Hum Genet\",\"uid\":\"8023854\"},\"1518124335457\":{\"title\":\"FRAXE and mental retardation.\",\"author\":\"Mulley JC\",\"pubdate\":\"1995 Mar\",\"source\":\"J Med Genet\",\"uid\":\"7783162\"},\"1518124550294\":{\"title\":\"Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island.\",\"author\":\"Gu Y\",\"pubdate\":\"1996 May\",\"source\":\"Nat Genet\",\"uid\":\"8673086\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1518124562390\":{\"title\":\"Loss of FMR2 further emphasizes the link between deregulation of immediate early response genes FOS and JUN and intellectual disability.\",\"author\":\"Melko M\",\"pubdate\":\"2013 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"23562910\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"1.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"1\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1518124574533\":{\"title\":\"FMR2 function: insight from a mouse knockout model.\",\"author\":\"Gu Y\",\"pubdate\":\"2003\",\"source\":\"Cytogenet Genome Res\",\"uid\":\"14526173\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"2.5\",\"EvidencePointsTotal\":\"14.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08/03/2017\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"08/03/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"10/20/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1508482800,
    "dateISO8601": "2017-10-20T00:00:00",
    "dateFormated": "Oct 20, 2017"
  },
  "9510": {
    "title": "ATP7A: Menkes Disease",
    "label": "Menkes Disease",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "869": {
        "ontology": "HGNC",
        "curie": "HGNC:869",
        "uri": "HGNC869"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010651"
      },
      "OMIM309400": {
        "ontology": "OMIM",
        "curie": "OMIM:309400",
        "uri": "OMIM309400",
        "iri": "http://purl.obolibrary.org/obo/OMIM_309400"
      },
      "ORPHA565": {
        "ontology": "ORPHA",
        "curie": "ORPHA:565",
        "uri": "ORPHA565",
        "iri": "http://www.orpha.net/ORDO/Orphanet_565"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1518186088\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"ATP7A\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:869\",\"uri\":\"HGNC869\"},\"condition\":{\"name\":\"Menkes disease\",\"OrphaNet\":{\"curie\":\"ORPHA:565\",\"uri\":\"ORPHA565\"},\"MONDO\":{\"curie\":\"MONDO:0010651\",\"uri\":\"MONDO0010651\"},\"OMIM\":{\"curie\":\"OMIM:309400\",\"uri\":\"OMIM309400\"}},\"title\":\"ATP7A Menkes disease\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"22.50\",\"Tally\":\"10\",\"evidence\":{\"publications\":{\"1518186518148\":{\"title\":\"Diverse mutations in patients with Menkes disease often lead to exon skipping.\",\"author\":\"Das S\",\"pubdate\":\"1994 Nov\",\"source\":\"Am J Hum Genet\",\"uid\":\"7977350\"},\"1518186533083\":{\"title\":\"Identification of a novel mutation in the ATP7A gene in a Korean patient with Menkes disease.\",\"author\":\"Kim YH\",\"pubdate\":\"2011 Jul\",\"source\":\"J Korean Med Sci\",\"uid\":\"21738351\"},\"1518186584522\":{\"title\":\"Identification of point mutations in 41 unrelated patients affected with Menkes disease.\",\"author\":\"T\\u00fcmer Z\",\"pubdate\":\"1997 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"8981948\"},\"1518186660225\":{\"title\":\"A Truncating De Novo Point Mutation in a Young Infant with Severe Menkes Disease.\",\"author\":\"Lin YJ\",\"pubdate\":\"2017 Feb\",\"source\":\"Pediatr Neonatol\",\"uid\":\"25771438\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1518186507492\":{\"title\":\"Diverse mutations in patients with Menkes disease often lead to exon skipping.\",\"author\":\"Das S\",\"pubdate\":\"1994 Nov\",\"source\":\"Am J Hum Genet\",\"uid\":\"7977350\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"10.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1518186709769\":{\"title\":\"Phenotypic diversity of Menkes disease in mottled mice is associated with defects in localisation and trafficking of the ATP7A protein.\",\"author\":\"Kim BE\",\"pubdate\":\"2007 Oct\",\"source\":\"J Med Genet\",\"uid\":\"17483305\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"4.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1518186726281\":{\"title\":\"Molecular and biochemical characterization of Mottled-dappled, an embryonic lethal Menkes disease mouse model.\",\"author\":\"Haddad MR\",\"pubdate\":\"2014 Dec\",\"source\":\"Mol Genet Metab\",\"uid\":\"25456742\"},\"1518186741552\":{\"title\":\"Correction of a mouse model of Menkes disease by the human Menkes gene.\",\"author\":\"Llanos RM\",\"pubdate\":\"2006 Apr\",\"source\":\"Biochim Biophys Acta\",\"uid\":\"16488577\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"10.5\",\"ExperimentalEvidenceTotal\":\"5\",\"EvidencePointsTotal\":\"15.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"02/07/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"02/07/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/07/2018\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1517990400,
    "dateISO8601": "2018-02-07T00:00:00",
    "dateFormated": "Feb 07, 2018"
  },
  "9512": {
    "title": "CLCN4: X-Linked Intellectual Disability",
    "label": "X-Linked Intellectual Disability",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "2022": {
        "ontology": "HGNC",
        "curie": "HGNC:2022",
        "uri": "HGNC2022"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019181"
      },
      "OMIM302910": {
        "ontology": "OMIM",
        "curie": "OMIM:302910",
        "uri": "OMIM302910",
        "iri": "http://purl.obolibrary.org/obo/OMIM_302910"
      },
      "ORPHA777": {
        "ontology": "ORPHA",
        "curie": "ORPHA:777",
        "uri": "ORPHA777",
        "iri": "http://www.orpha.net/ORDO/Orphanet_777"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1518189838\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"CLCN4\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:2022\",\"uri\":\"HGNC2022\"},\"condition\":{\"name\":\"X-Linked Intellectual Disability\",\"OrphaNet\":{\"curie\":\"ORPHA:777\",\"uri\":\"ORPHA777\"},\"MONDO\":{\"curie\":\"MONDO:0019181\",\"uri\":\"MONDO0019181\"},\"OMIM\":{\"curie\":\"OMIM:302910\",\"uri\":\"OMIM302910\"}},\"title\":\"CLCN4 X-Linked Intellectual Disability\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"17.00\",\"Tally\":\"12\",\"evidence\":{\"publications\":{\"1518191462820\":{\"title\":\"De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females.\",\"author\":\"Palmer EE\",\"pubdate\":\"2018 Feb\",\"source\":\"Mol Psychiatry\",\"uid\":\"27550844\"},\"1518191482571\":{\"title\":\"Exome sequencing reveals new causal mutations in children with epileptic encephalopathies.\",\"author\":\"Veeramah KR\",\"pubdate\":\"2013 Jul\",\"source\":\"Epilepsia\",\"uid\":\"23647072\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"4.50\",\"Tally\":\"4.5\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"2.00\",\"Tally\":\"2\",\"evidence\":{\"publications\":{\"1518191357094\":{\"title\":\"X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes.\",\"author\":\"Hu H\",\"pubdate\":\"2016 Jan\",\"source\":\"Mol Psychiatry\",\"uid\":\"25644381\"},\"1518191377364\":{\"title\":\"De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females.\",\"author\":\"Palmer EE\",\"pubdate\":\"2018 Feb\",\"source\":\"Mol Psychiatry\",\"uid\":\"27550844\"},\"1518191430604\":{\"title\":\"De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females.\",\"author\":\"Palmer EE\",\"pubdate\":\"2018 Feb\",\"source\":\"Mol Psychiatry\",\"uid\":\"27550844\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"11.75\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1518191387261\":{\"title\":\"X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes.\",\"author\":\"Hu H\",\"pubdate\":\"2016 Jan\",\"source\":\"Mol Psychiatry\",\"uid\":\"25644381\"},\"1518191433275\":{\"title\":\"De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females.\",\"author\":\"Palmer EE\",\"pubdate\":\"2018 Feb\",\"source\":\"Mol Psychiatry\",\"uid\":\"27550844\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"1.00\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"0.75\",\"NonPatientCells\":{\"Value\":\"0.75\",\"evidence\":{\"publications\":{\"1518191513483\":{\"title\":\"X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes.\",\"author\":\"Hu H\",\"pubdate\":\"2016 Jan\",\"source\":\"Mol Psychiatry\",\"uid\":\"25644381\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"1\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1518191531371\":{\"title\":\"X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes.\",\"author\":\"Hu H\",\"pubdate\":\"2016 Jan\",\"source\":\"Mol Psychiatry\",\"uid\":\"25644381\"}},\"notes\":{\"note\":\"\"}}},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2.75\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"2.75\",\"EvidencePointsTotal\":\"14.75\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"02/09/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"05/09/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"10/20/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1508482800,
    "dateISO8601": "2017-10-20T00:00:00",
    "dateFormated": "Oct 20, 2017"
  },
  "9513": {
    "title": "FGD1: Aarskog-Scott Syndrome",
    "label": "Aarskog-Scott Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "3663": {
        "ontology": "HGNC",
        "curie": "HGNC:3663",
        "uri": "HGNC3663"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010589"
      },
      "OMIM305400": {
        "ontology": "OMIM",
        "curie": "OMIM:305400",
        "uri": "OMIM305400",
        "iri": "http://purl.obolibrary.org/obo/OMIM_305400"
      },
      "ORPHA915": {
        "ontology": "ORPHA",
        "curie": "ORPHA:915",
        "uri": "ORPHA915",
        "iri": "http://www.orpha.net/ORDO/Orphanet_915"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1518446733\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"FGD1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:3663\",\"uri\":\"HGNC3663\"},\"condition\":{\"name\":\"Aarskog-Scott Syndrome\",\"MONDO\":{\"curie\":\"MONDO:0010589\",\"uri\":\"MONDO0010589\"},\"OMIM\":{\"curie\":\"OMIM:305400\",\"uri\":\"OMIM305400\"}},\"title\":\"FGD1 Aarskog-Scott Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"2.00\",\"Tally\":\"2\",\"evidence\":{\"publications\":{\"1518447008242\":{\"title\":\"Fraternal twins with Aarskog-Scott syndrome due to maternal germline mosaicism.\",\"author\":\"Pilozzi-Edmonds L\",\"pubdate\":\"2011 Aug\",\"source\":\"Am J Med Genet A\",\"uid\":\"21739585\"}}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"13.50\",\"Tally\":\"10\",\"evidence\":{\"publications\":{\"1518446902636\":{\"title\":\"A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an Italian family with faciogenital dysplasia (Aarskog-Scott syndrome).\",\"author\":\"Orrico A\",\"pubdate\":\"2000 Aug 4\",\"source\":\"FEBS Lett\",\"uid\":\"10930571\"},\"1518446943874\":{\"title\":\"Clinical variation of Aarskog syndrome in a large family with 2189delA in the FGD1 gene.\",\"author\":\"Shalev SA\",\"pubdate\":\"2006 Jan 15\",\"source\":\"Am J Med Genet A\",\"uid\":\"16353258\"},\"1518446979234\":{\"title\":\"Aarskog-Scott syndrome: clinical update and report of nine novel mutations of the FGD1 gene.\",\"author\":\"Orrico A\",\"pubdate\":\"2010 Feb\",\"source\":\"Am J Med Genet A\",\"uid\":\"20082460\"},\"1518447078400\":{\"title\":\"Two novel mutations confirm FGD1 is responsible for the Aarskog syndrome.\",\"author\":\"Schwartz CE\",\"pubdate\":\"2000 Nov\",\"source\":\"Eur J Hum Genet\",\"uid\":\"11093277\"},\"1518447090624\":{\"title\":\"Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: a putative Rho/Rac guanine nucleotide exchange factor.\",\"author\":\"Pasteris NG\",\"pubdate\":\"1994 Nov 18\",\"source\":\"Cell\",\"uid\":\"7954831\"}}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.00\",\"Tally\":\"0.1\",\"evidence\":{\"publications\":{\"1518447028946\":{\"title\":\"A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an Italian family with faciogenital dysplasia (Aarskog-Scott syndrome).\",\"author\":\"Orrico A\",\"pubdate\":\"2000 Aug 4\",\"source\":\"FEBS Lett\",\"uid\":\"10930571\"}}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"0.00\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.00\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"0\",\"EvidencePointsTotal\":\"12\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"02/12/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"12/06/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/06/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1512547200,
    "dateISO8601": "2017-12-06T00:00:00",
    "dateFormated": "Dec 06, 2017"
  },
  "9515": {
    "title": "FTSJ1: Non-Syndromic X-Linked Intellectual Disability",
    "label": "Non-Syndromic X-Linked Intellectual Disability",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "13254": {
        "ontology": "HGNC",
        "curie": "HGNC:13254",
        "uri": "HGNC13254"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019181"
      },
      "OMIM309549": {
        "ontology": "OMIM",
        "curie": "OMIM:309549",
        "uri": "OMIM309549",
        "iri": "http://purl.obolibrary.org/obo/OMIM_309549"
      },
      "ORPHA777": {
        "ontology": "ORPHA",
        "curie": "ORPHA:777",
        "uri": "ORPHA777",
        "iri": "http://www.orpha.net/ORDO/Orphanet_777"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1518471237\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"FTSJ1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:13254\",\"uri\":\"HGNC13254\"},\"condition\":{\"name\":\"Non-sydromic X-Linked Intellectual Disability\",\"OrphaNet\":{\"curie\":\"ORPHA:777\",\"uri\":\"ORPHA777\"},\"MONDO\":{\"curie\":\"MONDO:0019181\",\"uri\":\"MONDO0019181\"},\"OMIM\":{\"curie\":\"OMIM:309549\",\"uri\":\"OMIM309549\"}},\"title\":\"FTSJ1 Non-sydromic X-Linked Intellectual Disability\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"7.00\",\"Tally\":\"7\",\"evidence\":{\"publications\":{\"1518448477243\":{\"title\":\"A splice site mutation in the methyltransferase gene FTSJ1 in Xp11.23 is associated with non-syndromic mental retardation in a large Belgian family (MRX9).\",\"author\":\"Ramser J\",\"pubdate\":\"2004 Sep\",\"source\":\"J Med Genet\",\"uid\":\"15342698\"},\"1518448484178\":{\"title\":\"Localization of a gene responsible for nonspecific mental retardation (MRX9) to the pericentromeric region of the X chromosome.\",\"author\":\"Willems P\",\"pubdate\":\"1993 Nov\",\"source\":\"Genomics\",\"uid\":\"8288232\"},\"1518448495186\":{\"title\":\"Family MRX9 revisited: further evidence for locus heterogeneity in MRX.\",\"author\":\"Winnepenninckx B\",\"pubdate\":\"2002 Sep 15\",\"source\":\"Am J Med Genet\",\"uid\":\"12239714\"},\"1518448897278\":{\"title\":\"A loss-of-function mutation in the FTSJ1 gene causes nonsyndromic X-linked mental retardation in a Japanese family.\",\"author\":\"Takano K\",\"pubdate\":\"2008 Jun 5\",\"source\":\"Am J Med Genet B Neuropsychiatr Genet\",\"uid\":\"18081026\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1518448608992\":{\"title\":\"Four families (MRX43, MRX44, MRX45, MRX52) with nonspecific X-linked mental retardation: clinical and psychometric data and results of linkage analysis.\",\"author\":\"Hamel BC\",\"pubdate\":\"1999 Jul 30\",\"source\":\"Am J Med Genet\",\"uid\":\"10398246\"},\"1518448851464\":{\"title\":\"Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation.\",\"author\":\"Freude K\",\"pubdate\":\"2004 Aug\",\"source\":\"Am J Hum Genet\",\"uid\":\"15162322\"},\"1518448865208\":{\"title\":\"Defects in tRNA Anticodon Loop 2\",\"author\":\"Guy MP\",\"pubdate\":\"2015 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"26310293\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"7.00\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1518448517857\":{\"title\":\"A splice site mutation in the methyltransferase gene FTSJ1 in Xp11.23 is associated with non-syndromic mental retardation in a large Belgian family (MRX9).\",\"author\":\"Ramser J\",\"pubdate\":\"2004 Sep\",\"source\":\"J Med Genet\",\"uid\":\"15342698\"},\"1518448530856\":{\"title\":\"Four families (MRX43, MRX44, MRX45, MRX52) with nonspecific X-linked mental retardation: clinical and psychometric data and results of linkage analysis.\",\"author\":\"Hamel BC\",\"pubdate\":\"1999 Jul 30\",\"source\":\"Am J Med Genet\",\"uid\":\"10398246\"},\"1518448815113\":{\"title\":\"Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation.\",\"author\":\"Freude K\",\"pubdate\":\"2004 Aug\",\"source\":\"Am J Hum Genet\",\"uid\":\"15162322\"}},\"notes\":{\"note\":\"\"}}},\"2\":{\"evidence\":{\"publications\":{\"1518448599394\":{\"title\":\"Four families (MRX43, MRX44, MRX45, MRX52) with nonspecific X-linked mental retardation: clinical and psychometric data and results of linkage analysis.\",\"author\":\"Hamel BC\",\"pubdate\":\"1999 Jul 30\",\"source\":\"Am J Med Genet\",\"uid\":\"10398246\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"11\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1518448724464\":{\"title\":\"Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation.\",\"author\":\"Freude K\",\"pubdate\":\"2004 Aug\",\"source\":\"Am J Hum Genet\",\"uid\":\"15162322\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1518448692568\":{\"title\":\"Defects in tRNA Anticodon Loop 2\",\"author\":\"Guy MP\",\"pubdate\":\"2015 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"26310293\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"11\",\"ExperimentalEvidenceTotal\":\"1.5\",\"EvidencePointsTotal\":\"12.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"02/12/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"01/17/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"01/17/2018\",\"FinalClassificationNotes\":\"The segregation evidence in the curation was provided in two publications. The first publication (PMID: 15342698) in family MRX9 is calculated by GCI with LOD 1.8. The second publication (PMID: 15162322) in family MRX44 has author-generated LOD 2.9 by a previous publication studying the same family (PMID:10398246). Because the two LOD scores calculated were by sequencing of candidate gene, instead of exome/genome or sequencing all genes in the linkage regions, the LOD score should be adjusted according to the revised SOP. The segregation point given to the corrected summed LOD (4.7) should be 1 point. This will bring to total score of the curation to 10.5, which should be categorized as MODERATE.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1516176000,
    "dateISO8601": "2018-01-17T00:00:00",
    "dateFormated": "Jan 17, 2018"
  },
  "9518": {
    "title": "HUWE1: Syndromic X-Linked Intellectual Disability",
    "label": "Syndromic X-Linked Intellectual Disability",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "30892": {
        "ontology": "HGNC",
        "curie": "HGNC:30892",
        "uri": "HGNC30892"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019181"
      },
      "OMIM300849": {
        "ontology": "OMIM",
        "curie": "OMIM:300849",
        "uri": "OMIM300849",
        "iri": "http://purl.obolibrary.org/obo/OMIM_300849"
      },
      "ORPHA777": {
        "ontology": "ORPHA",
        "curie": "ORPHA:777",
        "uri": "ORPHA777",
        "iri": "http://www.orpha.net/ORDO/Orphanet_777"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1518451630\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"HUWE1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:30892\",\"uri\":\"HGNC30892\"},\"condition\":{\"name\":\"Syndromic X-Linked Intellectual Disability\",\"OrphaNet\":{\"curie\":\"ORPHA:777\",\"uri\":\"ORPHA777\"},\"MONDO\":{\"curie\":\"MONDO:0060309\",\"uri\":\"MONDO0060309\"},\"OMIM\":{\"curie\":\"OMIM:300849\",\"uri\":\"OMIM300849\"}},\"title\":\"HUWE1 Syndromic X-Linked Intellectual Disability\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"2.00\",\"Tally\":\"2\",\"evidence\":{\"publications\":{\"1518452137621\":{\"title\":\"Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE.\",\"author\":\"Nava C\",\"pubdate\":\"2012 Oct 23\",\"source\":\"Transl Psychiatry\",\"uid\":\"23092983\"},\"1518452205700\":{\"title\":\"Application of whole-exome sequencing to unravel the molecular basis of undiagnosed syndromic congenital neutropenia with intellectual disability.\",\"author\":\"Gauthier-Vasserot A\",\"pubdate\":\"2017 Jan\",\"source\":\"Am J Med Genet A\",\"uid\":\"27615324\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"2.50\",\"Tally\":\"2.5\",\"evidence\":{\"publications\":{\"1518452044425\":{\"title\":\"Copy-number gains of HUWE1 due to replication- and recombination-based rearrangements.\",\"author\":\"Froyen G\",\"pubdate\":\"2012 Aug 10\",\"source\":\"Am J Hum Genet\",\"uid\":\"22840365\"},\"1518452049222\":{\"title\":\"Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation.\",\"author\":\"Froyen G\",\"pubdate\":\"2008 Feb\",\"source\":\"Am J Hum Genet\",\"uid\":\"18252223\"},\"1518452080454\":{\"title\":\"Novel microduplications at Xp11.22 including HUWE1: clinical and molecular insights into these genomic rearrangements associated with intellectual disability.\",\"author\":\"Santos-Rebou\\u00e7as CB\",\"pubdate\":\"2015 Apr\",\"source\":\"J Hum Genet\",\"uid\":\"25652354\"},\"1518452102260\":{\"title\":\"Xp11.22 Microduplications Including HUWE1: Case Report and Literature Review.\",\"author\":\"Orivoli S\",\"pubdate\":\"2016 Jan\",\"source\":\"Neuropediatrics\",\"uid\":\"26587761\"},\"1518452125469\":{\"title\":\"Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation.\",\"author\":\"Froyen G\",\"pubdate\":\"2008 Feb\",\"source\":\"Am J Hum Genet\",\"uid\":\"18252223\"},\"1518452195213\":{\"title\":\"HUWE1 mutations in Juberg-Marsidi and Brooks syndromes: the results of an X-chromosome exome sequencing study.\",\"author\":\"Friez MJ\",\"pubdate\":\"2016 Apr 29\",\"source\":\"BMJ Open\",\"uid\":\"27130160\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"4.00\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1518452158774\":{\"title\":\"HUWE1 mutation explains phenotypic severity in a case of familial idiopathic intellectual disability.\",\"author\":\"Isrie M\",\"pubdate\":\"2013 Jul\",\"source\":\"Eur J Med Genet\",\"uid\":\"23721686\"},\"1518452234108\":{\"title\":\"Copy-number gains of HUWE1 due to replication- and recombination-based rearrangements.\",\"author\":\"Froyen G\",\"pubdate\":\"2012 Aug 10\",\"source\":\"Am J Hum Genet\",\"uid\":\"22840365\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"7.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.00\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1518452177590\":{\"title\":\"HUWE1 mutations in Juberg-Marsidi and Brooks syndromes: the results of an X-chromosome exome sequencing study.\",\"author\":\"Friez MJ\",\"pubdate\":\"2016 Apr 29\",\"source\":\"BMJ Open\",\"uid\":\"27130160\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"0.00\",\"evidence\":{\"publications\":{\"1518452306884\":{\"title\":\"Shh signaling protects Atoh1 from degradation mediated by the E3 ubiquitin ligase Huwe1 in neural precursors.\",\"author\":\"Forget A\",\"pubdate\":\"2014 Jun 23\",\"source\":\"Dev Cell\",\"uid\":\"24960692\"},\"1518452319163\":{\"title\":\"The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein.\",\"author\":\"Zhao X\",\"pubdate\":\"2008 Jun\",\"source\":\"Nat Cell Biol\",\"uid\":\"18488021\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"4.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1518452273397\":{\"title\":\"Ubiquitin ligase HUWE1 regulates axon branching through the Wnt/\\u03b2-catenin pathway in a Drosophila model for intellectual disability.\",\"author\":\"Vandewalle J\",\"pubdate\":\"2013\",\"source\":\"PLoS One\",\"uid\":\"24303071\"},\"1518452279131\":{\"title\":\"The HECT Family Ubiquitin Ligase EEL-1 Regulates Neuronal Function and Development.\",\"author\":\"Opperman KJ\",\"pubdate\":\"2017 Apr 25\",\"source\":\"Cell Rep\",\"uid\":\"28445732\"},\"1518452327387\":{\"title\":\"The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain.\",\"author\":\"Zhao X\",\"pubdate\":\"2009 Aug\",\"source\":\"Dev Cell\",\"uid\":\"19686682\"},\"1518452336523\":{\"title\":\"Huwe1 ubiquitin ligase is essential to synchronize neuronal and glial differentiation in the developing cerebellum.\",\"author\":\"D\",\"pubdate\":\"2010 Mar 30\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"20231446\"},\"1518452342754\":{\"title\":\"Return to quiescence of mouse neural stem cells by degradation of a proactivation protein.\",\"author\":\"Urb\\u00e1n N\",\"pubdate\":\"2016 Jul 15\",\"source\":\"Science\",\"uid\":\"27418510\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"7.5\",\"ExperimentalEvidenceTotal\":\"5\",\"EvidencePointsTotal\":\"12.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"02/12/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"07/19/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"10/20/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1508482800,
    "dateISO8601": "2017-10-20T00:00:00",
    "dateFormated": "Oct 20, 2017"
  },
  "9520": {
    "title": "NHS: Nance-Horan Syndrome",
    "label": "Nance-Horan Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "7820": {
        "ontology": "HGNC",
        "curie": "HGNC:7820",
        "uri": "HGNC7820"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010545"
      },
      "OMIM302350": {
        "ontology": "OMIM",
        "curie": "OMIM:302350",
        "uri": "OMIM302350",
        "iri": "http://purl.obolibrary.org/obo/OMIM_302350"
      },
      "ORPHA627": {
        "ontology": "ORPHA",
        "curie": "ORPHA:627",
        "uri": "ORPHA627",
        "iri": "http://www.orpha.net/ORDO/Orphanet_627"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1518454097\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"NHS\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:7820\",\"uri\":\"HGNC7820\"},\"condition\":{\"name\":\"Nance-Horan syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:627\",\"uri\":\"ORPHA627\"},\"MONDO\":{\"curie\":\"MONDO:0010545\",\"uri\":\"MONDO0010545\"},\"OMIM\":{\"curie\":\"OMIM:302350\",\"uri\":\"OMIM302350\"}},\"title\":\"NHS Nance-Horan syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"16.50\",\"Tally\":\"10\",\"evidence\":{\"publications\":{\"1518454481400\":{\"title\":\"Mutations in a novel gene, NHS, cause the pleiotropic effects of Nance-Horan syndrome, including severe congenital cataract, dental anomalies, and mental retardation.\",\"author\":\"Burdon KP\",\"pubdate\":\"2003 Nov\",\"source\":\"Am J Hum Genet\",\"uid\":\"14564667\"},\"1518454505966\":{\"title\":\"Novel causative mutations in patients with Nance-Horan syndrome and altered localization of the mutant NHS-A protein isoform.\",\"author\":\"Sharma S\",\"pubdate\":\"2008\",\"source\":\"Mol Vis\",\"uid\":\"18949062\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.00\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"6.50\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1518454678512\":{\"title\":\"Mutations in a novel gene, NHS, cause the pleiotropic effects of Nance-Horan syndrome, including severe congenital cataract, dental anomalies, and mental retardation.\",\"author\":\"Burdon KP\",\"pubdate\":\"2003 Nov\",\"source\":\"Am J Hum Genet\",\"uid\":\"14564667\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1518454487231\":{\"title\":\"Mutations in a novel gene, NHS, cause the pleiotropic effects of Nance-Horan syndrome, including severe congenital cataract, dental anomalies, and mental retardation.\",\"author\":\"Burdon KP\",\"pubdate\":\"2003 Nov\",\"source\":\"Am J Hum Genet\",\"uid\":\"14564667\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1518454579974\":{\"title\":\"The Nance-Horan syndrome protein encodes a functional WAVE homology domain (WHD) and is important for co-ordinating actin remodelling and maintaining cell morphology.\",\"author\":\"Brooks SP\",\"pubdate\":\"2010 Jun 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"20332100\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"1.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"2\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1518454531743\":{\"title\":\"Xcat, a novel mouse model for Nance-Horan syndrome inhibits expression of the cytoplasmic-targeted Nhs1 isoform.\",\"author\":\"Huang KM\",\"pubdate\":\"2006 Jan 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"16357105\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1518454542263\":{\"title\":\"The Nance-Horan syndrome protein encodes a functional WAVE homology domain (WHD) and is important for co-ordinating actin remodelling and maintaining cell morphology.\",\"author\":\"Brooks SP\",\"pubdate\":\"2010 Jun 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"20332100\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"3.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"3.5\",\"EvidencePointsTotal\":\"15.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"02/12/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"07/05/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"10/20/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1508482800,
    "dateISO8601": "2017-10-20T00:00:00",
    "dateFormated": "Oct 20, 2017"
  },
  "9521": {
    "title": "SYP: Non-Syndromic X-Linked Intellectual Disability",
    "label": "Non-Syndromic X-Linked Intellectual Disability",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "11506": {
        "ontology": "HGNC",
        "curie": "HGNC:11506",
        "uri": "HGNC11506"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019181"
      },
      "OMIM300802": {
        "ontology": "OMIM",
        "curie": "OMIM:300802",
        "uri": "OMIM300802",
        "iri": "http://purl.obolibrary.org/obo/OMIM_300802"
      },
      "ORPHA777": {
        "ontology": "ORPHA",
        "curie": "ORPHA:777",
        "uri": "ORPHA777",
        "iri": "http://www.orpha.net/ORDO/Orphanet_777"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1518459993\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SYP\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:11506\",\"uri\":\"HGNC11506\"},\"condition\":{\"name\":\"Non-Syndromic X-Linked Intellectual Disability\",\"MONDO\":{\"curie\":\"MONDO:0019181\",\"uri\":\"MONDO0019181\"}},\"title\":\"SYP Non-Syndromic X-Linked Intellectual Disability\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"evidence\":{\"publications\":{\"1518459687866\":{\"title\":\"A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation.\",\"author\":\"Tarpey PS\",\"pubdate\":\"2009 May\",\"source\":\"Nat Genet\",\"uid\":\"19377476\"},\"1518459720521\":{\"title\":\"X-linked intellectual disability-associated mutations in synaptophysin disrupt synaptobrevin II retrieval.\",\"author\":\"Gordon SL\",\"pubdate\":\"2013 Aug 21\",\"source\":\"J Neurosci\",\"uid\":\"23966691\"},\"1518459729959\":{\"title\":\"Altered synaptobrevin-II trafficking in neurons expressing a synaptophysin mutation associated with a severe neurodevelopmental disorder.\",\"author\":\"Harper CB\",\"pubdate\":\"2017 Dec\",\"source\":\"Neurobiol Dis\",\"uid\":\"28887151\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"0.00\",\"Tally\":\"0\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"3\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1518459706754\":{\"title\":\"Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons.\",\"author\":\"Kwon SE\",\"pubdate\":\"2011 Jun 9\",\"source\":\"Neuron\",\"uid\":\"21658579\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1518459774647\":{\"title\":\"Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons.\",\"author\":\"Kwon SE\",\"pubdate\":\"2011 Jun 9\",\"source\":\"Neuron\",\"uid\":\"21658579\"}},\"notes\":{\"note\":\"\"}}}},\"ModelsRescue\":{\"Tally\":\"1\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"3\",\"ExperimentalEvidenceTotal\":\"1.5\",\"EvidencePointsTotal\":\"4.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"02/12/2018\",\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"12/20/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/20/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1513756800,
    "dateISO8601": "2017-12-20T00:00:00",
    "dateFormated": "Dec 20, 2017"
  },
  "9543": {
    "title": "TRIOBP: nonsyndromic sensorineural deafness",
    "label": "nonsyndromic sensorineural deafness",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "HGNC:17009": {
        "ontology": "HGNC",
        "curie": "HGNC:17009",
        "uri": "HGNC17009"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019588"
      },
      "OMIM609823": {
        "ontology": "OMIM",
        "curie": "OMIM:609823",
        "uri": "OMIM609823",
        "iri": "http://purl.obolibrary.org/obo/OMIM_609823"
      },
      "ORPHA90636": {
        "ontology": "ORPHA",
        "curie": "ORPHA:90636",
        "uri": "ORPHA90636",
        "iri": "http://www.orpha.net/ORDO/Orphanet_90636"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1520285000\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TRIOBP\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:17009\",\"uri\":\"HGNC17009\"},\"condition\":{\"name\":\"nonsyndromic sensorineural deafness\",\"OrphaNet\":{\"curie\":\"ORPHA:90636\",\"uri\":\"ORPHA90636\"},\"MONDO\":{\"curie\":\"MONDO:0012355\",\"uri\":\"MONDO0012355\"},\"OMIM\":{\"curie\":\"OMIM:609823\",\"uri\":\"OMIM609823\"}},\"title\":\"TRIOBP nonsyndromic sensorineural deafness\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.00\",\"Tally\":\"0\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"21.00\",\"evidence\":{\"publications\":{\"1519327904090\":{\"title\":\"Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss.\",\"author\":\"Shahin H\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385458\"},\"1519327920711\":{\"title\":\"Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness.\",\"author\":\"Riazuddin S\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385457\"},\"1519327937782\":{\"title\":\"Whole-exome sequencing efficiently detects rare mutations in autosomal recessive nonsyndromic hearing loss.\",\"author\":\"Diaz-Horta O\",\"pubdate\":\"2012\",\"source\":\"PLoS One\",\"uid\":\"23226338\"},\"1519327949084\":{\"title\":\"Autosomal Recessive Nonsyndromic Hearing Loss: A Case Report with a Mutation in TRIOBP Gene.\",\"author\":\"Fardaei M\",\"pubdate\":\"2015 Fall\",\"source\":\"Int J Mol Cell Med\",\"uid\":\"27014650\"},\"1519327963380\":{\"title\":\"Genetic testing for sporadic hearing loss using targeted massively parallel sequencing identifies 10 novel mutations.\",\"author\":\"Gu X\",\"pubdate\":\"2015 Jun\",\"source\":\"Clin Genet\",\"uid\":\"24853665\"},\"1519327978281\":{\"title\":\"Spectrum of DNA variants for non-syndromic deafness in a large cohort from multiple continents.\",\"author\":\"Yan D\",\"pubdate\":\"2016 Aug\",\"source\":\"Hum Genet\",\"uid\":\"27344577\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"12\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.50\",\"Tally\":\"1.5\",\"1\":{\"evidence\":{\"publications\":{\"1519328220708\":{\"title\":\"Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss.\",\"author\":\"Shahin H\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385458\"},\"1519328232572\":{\"title\":\"Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness.\",\"author\":\"Riazuddin S\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385457\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\",\"evidence\":{\"publications\":{\"1519328300911\":{\"title\":\"A Large Genome-Wide Association Study of Age-Related Hearing Impairment Using Electronic Health Records.\",\"author\":\"Hoffmann TJ\",\"pubdate\":\"2016 Oct\",\"source\":\"PLoS Genet\",\"uid\":\"27764096\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"Unscored case-control analysis\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1519328465603\":{\"title\":\"Actin-bundling protein TRIOBP forms resilient rootlets of hair cell stereocilia essential for hearing.\",\"author\":\"Kitajiri S\",\"pubdate\":\"2010 May 28\",\"source\":\"Cell\",\"uid\":\"20510926\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1519328451756\":{\"title\":\"Actin-bundling protein TRIOBP forms resilient rootlets of hair cell stereocilia essential for hearing.\",\"author\":\"Kitajiri S\",\"pubdate\":\"2010 May 28\",\"source\":\"Cell\",\"uid\":\"20510926\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1519328426942\":{\"title\":\"Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss.\",\"author\":\"Shahin H\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385458\"},\"1519328433462\":{\"title\":\"Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness.\",\"author\":\"Riazuddin S\",\"pubdate\":\"2006 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"16385457\"},\"1519328443300\":{\"title\":\"Actin-bundling protein TRIOBP forms resilient rootlets of hair cell stereocilia essential for hearing.\",\"author\":\"Kitajiri S\",\"pubdate\":\"2010 May 28\",\"source\":\"Cell\",\"uid\":\"20510926\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"0\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"2\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1519328470788\":{\"title\":\"Actin-bundling protein TRIOBP forms resilient rootlets of hair cell stereocilia essential for hearing.\",\"author\":\"Kitajiri S\",\"pubdate\":\"2010 May 28\",\"source\":\"Cell\",\"uid\":\"20510926\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"4\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"06/09/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"06/26/2017\",\"FinalClassificationNotes\":\"The TRIOBP gene has been associated with ARNSHL in 24 probands in 6 publications. 16 unique variants (missense, nonsense, frameshift) have been reported in humans, and variants in this gene segregated with disease in >10 additional family members. TRIOBP was first associated with this disease in  humans in 2006 (Riazuddin et al. 2006, Shahin et al. 2006). This gene-disease association is supported by multiple expression and localization studies, studies showing interaction with F-actin in stereocilia, and a deaf mouse model. In summary, TRIOBP is definitively associated with ARNSHL. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hearing Loss Working Group.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1496732400,
    "dateISO8601": "2017-06-06T00:00:00",
    "dateFormated": "Jun 06, 2017"
  },
  "9547": {
    "title": "TMEM132E: nonsyndromic sensorineural deafness",
    "label": "nonsyndromic sensorineural deafness",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "HGNC:26991": {
        "ontology": "HGNC",
        "curie": "HGNC:26991",
        "uri": "HGNC26991"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019588"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA90636": {
        "ontology": "ORPHA",
        "curie": "ORPHA:90636",
        "uri": "ORPHA90636",
        "iri": "http://www.orpha.net/ORDO/Orphanet_90636"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1520284888\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TMEM132E\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:26991\",\"uri\":\"HGNC26991\"},\"condition\":{\"name\":\" nonsyndromic sensorineural deafness\",\"OrphaNet\":{\"curie\":\"ORPHA:90636\",\"uri\":\"ORPHA90636\"},\"MONDO\":{\"curie\":\"MONDO:0019588\",\"uri\":\"MONDO0019588\"}},\"title\":\"TMEM132E  nonsyndromic sensorineural deafness\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.00\",\"Tally\":\"0\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"0.25\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1519411820604\":{\"title\":\"Whole-exome sequencing identifies a variant in TMEM132E causing autosomal-recessive nonsyndromic hearing loss DFNB99.\",\"author\":\"Li J\",\"pubdate\":\"2015 Jan\",\"source\":\"Hum Mutat\",\"uid\":\"25331638\"}},\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"0.00\",\"Tally\":\"0\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.25\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1519411813013\":{\"title\":\"Whole-exome sequencing identifies a variant in TMEM132E causing autosomal-recessive nonsyndromic hearing loss DFNB99.\",\"author\":\"Li J\",\"pubdate\":\"2015 Jan\",\"source\":\"Hum Mutat\",\"uid\":\"25331638\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"0\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"3\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1519411815757\":{\"title\":\"Whole-exome sequencing identifies a variant in TMEM132E causing autosomal-recessive nonsyndromic hearing loss DFNB99.\",\"author\":\"Li J\",\"pubdate\":\"2015 Jan\",\"source\":\"Hum Mutat\",\"uid\":\"25331638\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1519411805638\":{\"title\":\"Whole-exome sequencing identifies a variant in TMEM132E causing autosomal-recessive nonsyndromic hearing loss DFNB99.\",\"author\":\"Li J\",\"pubdate\":\"2015 Jan\",\"source\":\"Hum Mutat\",\"uid\":\"25331638\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"3.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.25\",\"ExperimentalEvidenceTotal\":\"3.5\",\"EvidencePointsTotal\":\"3.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"\",\"FinalClassificationNotes\":\"The TMEM132E gene has been associated with ARNSHL in (at least) 1 proband in 1 publications. 1 unique variant (missense) haS been reported in humans, and the variant in this gene segregated with disease in 1 additional family member. TMEM312E was first associated with this disease in humans in 2015 (Li et al.). The mechanism for disease is unknown. This gene-disease association is supported by the expression of the gene in the mouse inner ear, as well as a zebrafish morpholino knockdown and rescue (Li et al. 2015). In summary, there is limited evidence to support this gene-disease association. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease association. This classification was approved by the ClinGen Hearing Loss Working Group on 11/21/2017.\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "9553": {
    "title": "IDS; Mucopolysaccharidosis Type II",
    "label": "Mucopolysaccharidosis Type II",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "5389": {
        "ontology": "HGNC",
        "curie": "HGNC:5389",
        "uri": "HGNC5389"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010674"
      },
      "OMIM309900": {
        "ontology": "OMIM",
        "curie": "OMIM:309900",
        "uri": "OMIM309900",
        "iri": "http://purl.obolibrary.org/obo/OMIM_309900"
      },
      "ORPHA580": {
        "ontology": "ORPHA",
        "curie": "ORPHA:580",
        "uri": "ORPHA580",
        "iri": "http://www.orpha.net/ORDO/Orphanet_580"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1519655448\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"IDS\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:5389\",\"uri\":\"HGNC5389\"},\"condition\":{\"name\":\"mucopolysaccharidosis II\",\"OrphaNet\":{\"curie\":\"ORPHA:580\",\"uri\":\"ORPHA580\"},\"MONDO\":{\"curie\":\"MONDO:0010674\",\"uri\":\"MONDO0010674\"},\"OMIM\":{\"curie\":\"OMIM:309900\",\"uri\":\"OMIM309900\"}},\"title\":\"IDS mucopolysaccharidosis II\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"4.50\",\"Tally\":\"4.5\",\"evidence\":{\"publications\":{\"1519655387831\":{\"title\":\"Detection of point mutations and a gross deletion in six Hunter syndrome patients.\",\"author\":\"Flomen RH\",\"pubdate\":\"1992 Jul\",\"source\":\"Genomics\",\"uid\":\"1639384\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"8.00\",\"Tally\":\"7\",\"evidence\":{\"publications\":{\"1519655296045\":{\"title\":\"Detection of point mutations and a gross deletion in six Hunter syndrome patients.\",\"author\":\"Flomen RH\",\"pubdate\":\"1992 Jul\",\"source\":\"Genomics\",\"uid\":\"1639384\"},\"1519655312090\":{\"title\":\"Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome).\",\"author\":\"Li P\",\"pubdate\":\"1999 Jan\",\"source\":\"J Med Genet\",\"uid\":\"9950361\"},\"1519655337242\":{\"title\":\"Mutation analysis in the iduronate-2-sulphatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease).\",\"author\":\"Isogai K\",\"pubdate\":\"1998 Feb\",\"source\":\"J Inherit Metab Dis\",\"uid\":\"9501270\"},\"1519655360649\":{\"title\":\"Expression studies of two novel in CIS-mutations identified in an intermediate case of Hunter syndrome.\",\"author\":\"Ricci V\",\"pubdate\":\"2003 Jul 1\",\"source\":\"Am J Med Genet A\",\"uid\":\"12794697\"},\"1519655376752\":{\"title\":\"Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.\",\"author\":\"Kosuga M\",\"pubdate\":\"2016 Jul\",\"source\":\"Mol Genet Metab\",\"uid\":\"27246110\"},\"1519655400784\":{\"title\":\"Mucopolysaccharidosis type II (Hunter syndrome): mutation \\\"hot spots\\\" in the iduronate-2-sulfatase gene.\",\"author\":\"Rathmann M\",\"pubdate\":\"1996 Dec\",\"source\":\"Am J Hum Genet\",\"uid\":\"8940265\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"0.00\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"11.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"0\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.00\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"4.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1519655419767\":{\"title\":\"Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II.\",\"author\":\"Gleitz HF\",\"pubdate\":\"2017\",\"source\":\"PLoS One\",\"uid\":\"28207863\"},\"1519655430023\":{\"title\":\"Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery.\",\"author\":\"Cardone M\",\"pubdate\":\"2006 Apr 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"16505002\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\",\"evidence\":{\"publications\":{\"1519655439752\":{\"title\":\"Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery.\",\"author\":\"Cardone M\",\"pubdate\":\"2006 Apr 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"16505002\"}},\"notes\":{\"note\":\"\"}}},\"RescueInNonHumanModelOrganism\":{\"Value\":\"2.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"4\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"11.5\",\"ExperimentalEvidenceTotal\":\"4\",\"EvidencePointsTotal\":\"15.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"02/26/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"02/20/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/21/2018\",\"FinalClassificationNotes\":\"Over 300 IDS pathogenic variants have been described in patients with MPSII. Findings in mouse models are consistent with clinical manifestations in human patients.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1519200000,
    "dateISO8601": "2018-02-21T00:00:00",
    "dateFormated": "Feb 21, 2018"
  },
  "9554": {
    "title": "CREBBP; Rubinstein-Taybi Syndrome",
    "label": "Rubinstein-Taybi Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "2348": {
        "ontology": "HGNC",
        "curie": "HGNC:2348",
        "uri": "HGNC2348"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0008393"
      },
      "OMIM180849": {
        "ontology": "OMIM",
        "curie": "OMIM:180849",
        "uri": "OMIM180849",
        "iri": "http://purl.obolibrary.org/obo/OMIM_180849"
      },
      "ORPHA783": {
        "ontology": "ORPHA",
        "curie": "ORPHA:783",
        "uri": "ORPHA783",
        "iri": "http://www.orpha.net/ORDO/Orphanet_783"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1519656352\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"CREBBP\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:2348\",\"uri\":\"HGNC2348\"},\"condition\":{\"name\":\"Rubinstein-Taybi Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:783\",\"uri\":\"ORPHA783\"},\"MONDO\":{\"curie\":\"MONDO:0019188\",\"uri\":\"MONDO0019188\"},\"OMIM\":{\"curie\":\"OMIM:180849\",\"uri\":\"OMIM180849\"}},\"title\":\"CREBBP Rubinstein-Taybi syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"14.00\",\"Tally\":\"12\",\"evidence\":{\"publications\":{\"1519656454099\":{\"title\":\"Genotype-phenotype correlations in Rubinstein-Taybi syndrome.\",\"author\":\"Schorry EK\",\"pubdate\":\"2008 Oct 1\",\"source\":\"Am J Med Genet A\",\"uid\":\"18792986\"},\"1519656469130\":{\"title\":\"Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome.\",\"author\":\"Kalkhoven E\",\"pubdate\":\"2003 Feb 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"12566391\"},\"1519656485994\":{\"title\":\"Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome.\",\"author\":\"Coupry I\",\"pubdate\":\"2002 Jun\",\"source\":\"J Med Genet\",\"uid\":\"12070251\"},\"1519656497122\":{\"title\":\"Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome.\",\"author\":\"Murata T\",\"pubdate\":\"2001 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"11331617\"}}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1519656445907\":{\"title\":\"Genotype-phenotype correlations in Rubinstein-Taybi syndrome.\",\"author\":\"Schorry EK\",\"pubdate\":\"2008 Oct 1\",\"source\":\"Am J Med Genet A\",\"uid\":\"18792986\"}}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"0.00\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"2.50\",\"evidence\":{\"publications\":{\"1519656535298\":{\"title\":\"Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome.\",\"author\":\"Kalkhoven E\",\"pubdate\":\"2003 Feb 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"12566391\"},\"1519656553116\":{\"title\":\"Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome.\",\"author\":\"Murata T\",\"pubdate\":\"2001 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"11331617\"}}}},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.00\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1519656567954\":{\"title\":\"Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome.\",\"author\":\"Tanaka Y\",\"pubdate\":\"1997 Sep 16\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"9294190\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1519656604393\":{\"title\":\"A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4.\",\"author\":\"Bourtchouladze R\",\"pubdate\":\"2003 Sep 2\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"12930888\"}}}},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"6\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"02/26/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"02/21/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/21/2018\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1519200000,
    "dateISO8601": "2018-02-21T00:00:00",
    "dateFormated": "Feb 21, 2018"
  },
  "9555": {
    "title": "PHF6; Borjeson-Forssman-Lehmann syndrome",
    "label": "Borjeson-Forssman-Lehmann syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "18145": {
        "ontology": "HGNC",
        "curie": "HGNC:18145",
        "uri": "HGNC18145"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010537"
      },
      "OMIM301900": {
        "ontology": "OMIM",
        "curie": "OMIM:301900",
        "uri": "OMIM301900",
        "iri": "http://purl.obolibrary.org/obo/OMIM_301900"
      },
      "ORPHA127": {
        "ontology": "ORPHA",
        "curie": "ORPHA:127",
        "uri": "ORPHA127",
        "iri": "http://www.orpha.net/ORDO/Orphanet_127"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1519658162\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"PHF6\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:18145\",\"uri\":\"HGNC18145\"},\"condition\":{\"name\":\"Borjeson-Forssman-Lehmann Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:127\",\"uri\":\"ORPHA127\"},\"MONDO\":{\"curie\":\"MONDO:0010537\",\"uri\":\"MONDO0010537\"},\"OMIM\":{\"curie\":\"OMIM:301900\",\"uri\":\"OMIM301900\"}},\"title\":\"PHF6 Borjeson-Forssman-Lehmann Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"6.00\",\"Tally\":\"6\",\"evidence\":{\"publications\":{\"1519658802366\":{\"title\":\"Mutations in PHF6 are associated with B\\u00f6rjeson-Forssman-Lehmann syndrome.\",\"author\":\"Lower KM\",\"pubdate\":\"2002 Dec\",\"source\":\"Nat Genet\",\"uid\":\"12415272\"},\"1519658812765\":{\"title\":\"A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling.\",\"author\":\"Wieczorek D\",\"pubdate\":\"2013 Dec 20\",\"source\":\"Hum Mol Genet\",\"uid\":\"23906836\"},\"1519658824517\":{\"title\":\"Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient.\",\"author\":\"Crawford J\",\"pubdate\":\"2006 Mar\",\"source\":\"J Med Genet\",\"uid\":\"15994862\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"11.00\",\"Tally\":\"10\",\"evidence\":{\"publications\":{\"1519658705568\":{\"title\":\"Mutations in PHF6 are associated with B\\u00f6rjeson-Forssman-Lehmann syndrome.\",\"author\":\"Lower KM\",\"pubdate\":\"2002 Dec\",\"source\":\"Nat Genet\",\"uid\":\"12415272\"},\"1519658758054\":{\"title\":\"A novel PHF6 mutation results in enhanced exon skipping and mild B\\u00f6rjeson-Forssman-Lehmann syndrome.\",\"author\":\"Vall\\u00e9e D\",\"pubdate\":\"2004 Oct\",\"source\":\"J Med Genet\",\"uid\":\"15466013\"},\"1519658767708\":{\"title\":\"1024C> T (R342X) is a recurrent PHF6 mutation also found in the original B\\u00f6rjeson-Forssman-Lehmann syndrome family.\",\"author\":\"Lower KM\",\"pubdate\":\"2004 Oct\",\"source\":\"Eur J Hum Genet\",\"uid\":\"15241480\"},\"1519658787982\":{\"title\":\"Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient.\",\"author\":\"Crawford J\",\"pubdate\":\"2006 Mar\",\"source\":\"J Med Genet\",\"uid\":\"15994862\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1519658690416\":{\"title\":\"Mutations in PHF6 are associated with B\\u00f6rjeson-Forssman-Lehmann syndrome.\",\"author\":\"Lower KM\",\"pubdate\":\"2002 Dec\",\"source\":\"Nat Genet\",\"uid\":\"12415272\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1519658837270\":{\"title\":\"1024C> T (R342X) is a recurrent PHF6 mutation also found in the original B\\u00f6rjeson-Forssman-Lehmann syndrome family.\",\"author\":\"Lower KM\",\"pubdate\":\"2004 Oct\",\"source\":\"Eur J Hum Genet\",\"uid\":\"15241480\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"0.00\",\"evidence\":{\"publications\":{\"1519658886118\":{\"title\":\"PHF6 interacts with the nucleosome remodeling and deacetylation (NuRD) complex.\",\"author\":\"Todd MA\",\"pubdate\":\"2012 Aug 3\",\"source\":\"J Proteome Res\",\"uid\":\"22720776\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.00\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1519658854182\":{\"title\":\"The X-linked intellectual disability protein PHF6 associates with the PAF1 complex and regulates neuronal migration in the mammalian brain.\",\"author\":\"Zhang C\",\"pubdate\":\"2013 Jun 19\",\"source\":\"Neuron\",\"uid\":\"23791194\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1519658866614\":{\"title\":\"The X-linked intellectual disability protein PHF6 associates with the PAF1 complex and regulates neuronal migration in the mammalian brain.\",\"author\":\"Zhang C\",\"pubdate\":\"2013 Jun 19\",\"source\":\"Neuron\",\"uid\":\"23791194\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"4\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"02/26/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"02/21/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/21/2018\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1519200000,
    "dateISO8601": "2018-02-21T00:00:00",
    "dateFormated": "Feb 21, 2018"
  },
  "9593": {
    "title": "MCM2: nonsyndromic sensorineural deafness",
    "label": "nonsyndromic sensorineural deafness",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10007",
      "name": "Hearing Loss"
    },
    "genes": {
      "6944": {
        "ontology": "HGNC",
        "curie": "HGNC:6944",
        "uri": "HGNC6944"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0014853"
      },
      "OMIM616968": {
        "ontology": "OMIM",
        "curie": "OMIM:616968",
        "uri": "OMIM616968",
        "iri": "http://purl.obolibrary.org/obo/OMIM_616968"
      },
      "ORPHA90635": {
        "ontology": "ORPHA",
        "curie": "ORPHA:90635",
        "uri": "ORPHA90635",
        "iri": "http://www.orpha.net/ORDO/Orphanet_90635"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1520282954\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"MCM2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6944\",\"uri\":\"HGNC6944\"},\"condition\":{\"name\":\"autosomal dominant nonsyndromic deafness 70 \",\"OrphaNet\":{\"curie\":\"ORPHA:90635\",\"uri\":\"ORPHA90635\"},\"MONDO\":{\"curie\":\"MONDO:0014853\",\"uri\":\"MONDO0014853\"},\"OMIM\":{\"curie\":\"OMIM:616968\",\"uri\":\"OMIM616968\"}},\"title\":\"MCM2 autosomal dominant nonsyndromic deafness 70 \",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1520282803619\":{\"title\":\"Whole Exome Sequencing Identified MCM2 as a Novel Causative Gene for Autosomal Dominant Nonsyndromic Deafness in a Chinese Family.\",\"author\":\"Gao J\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"26196677\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"0\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"1\":{\"evidence\":{\"publications\":{\"1520282815738\":{\"title\":\"Whole Exome Sequencing Identified MCM2 as a Novel Causative Gene for Autosomal Dominant Nonsyndromic Deafness in a Chinese Family.\",\"author\":\"Gao J\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"26196677\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"2\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1520282835969\":{\"title\":\"Whole Exome Sequencing Identified MCM2 as a Novel Causative Gene for Autosomal Dominant Nonsyndromic Deafness in a Chinese Family.\",\"author\":\"Gao J\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"26196677\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1520282841857\":{\"title\":\"Whole Exome Sequencing Identified MCM2 as a Novel Causative Gene for Autosomal Dominant Nonsyndromic Deafness in a Chinese Family.\",\"author\":\"Gao J\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"26196677\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"0\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"2\",\"ExperimentalEvidenceTotal\":\"1\",\"EvidencePointsTotal\":\"3\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"10/18/2016\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"03/29/2017\",\"FinalClassificationNotes\":\"The MCM2 gene has been associated with ADNSHL in 1 probands in 1 publication. 1 unique variant (missense) has been reported in humans, and the variant in this gene segregated with disease in 8 additional family members. MCM2 was first associated with this disease in humans in 2015 (Gao et al.). This gene-disease association is supported by its expression in guinea pig cochlea and the increase in apoptotic activity reported by Gao et al. resulting from variation induced by the human p.R44C variant in HEK293 cells. While this indicates the impact of the variant on the protien, this change in the apoptotic pathway's relation to auditory pathways is not clear. In summary, there is limited evidence to support this gene-disease association. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease association. This classification was approved by the ClinGen Hearing Loss Working Group on 3/29/2017.\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1515052800,
    "dateISO8601": "2018-01-04T00:00:00",
    "dateFormated": "Jan 04, 2018"
  },
  "9595": {
    "title": "CUL4B; X-Linked Intellectual Disability, Cabezas Type",
    "label": "X-Linked Intellectual Disability, Cabezas Type",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "2555": {
        "ontology": "HGNC",
        "curie": "HGNC:2555",
        "uri": "HGNC2555"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010306"
      },
      "OMIM300354": {
        "ontology": "OMIM",
        "curie": "OMIM:300354",
        "uri": "OMIM300354",
        "iri": "http://purl.obolibrary.org/obo/OMIM_300354"
      },
      "ORPHA85293": {
        "ontology": "ORPHA",
        "curie": "ORPHA:85293",
        "uri": "ORPHA85293",
        "iri": "http://www.orpha.net/ORDO/Orphanet_85293"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1520349431\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"CUL4B\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:2555\",\"uri\":\"HGNC2555\"},\"condition\":{\"name\":\"X-Linked Intellectual Disability, Cabezas Type\",\"OrphaNet\":{\"curie\":\"ORPHA:85293\",\"uri\":\"ORPHA85293\"},\"MONDO\":{\"curie\":\"MONDO:0010306\",\"uri\":\"MONDO0010306\"},\"OMIM\":{\"curie\":\"OMIM:300354\",\"uri\":\"OMIM300354\"}},\"title\":\"CUL4B X-Linked Intellectual Disability, Cabezas Type\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"10.50\",\"Tally\":\"10\",\"evidence\":{\"publications\":{\"1520349914119\":{\"title\":\"Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor.\",\"author\":\"Tarpey PS\",\"pubdate\":\"2007 Feb\",\"source\":\"Am J Hum Genet\",\"uid\":\"17236139\"},\"1520349931686\":{\"title\":\"Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation.\",\"author\":\"Zou Y\",\"pubdate\":\"2007 Mar\",\"source\":\"Am J Hum Genet\",\"uid\":\"17273978\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.00\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"3.00\",\"Tally\":\"3\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.00\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"2\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1520349949776\":{\"title\":\"Rescue of the genetically engineered Cul4b mutant mouse as a potential model for human X-linked mental retardation.\",\"author\":\"Chen CY\",\"pubdate\":\"2012 Oct 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"22763239\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"2\",\"EvidencePointsTotal\":\"14\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"03/06/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"02/21/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/21/2018\",\"FinalClassificationNotes\":\"Human genetic data was conclusive. One model organism paper was reviewed for this curation. Additional evidence may be available but was not explored as a definitive score had already been achieved.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1519200000,
    "dateISO8601": "2018-02-21T00:00:00",
    "dateFormated": "Feb 21, 2018"
  },
  "9597": {
    "title": "HPRT1; Lesch-Nyhan syndrome",
    "label": "Lesch-Nyhan syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "5157": {
        "ontology": "HGNC",
        "curie": "HGNC:5157",
        "uri": "HGNC5157"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010298"
      },
      "OMIM300322": {
        "ontology": "OMIM",
        "curie": "OMIM:300322",
        "uri": "OMIM300322",
        "iri": "http://purl.obolibrary.org/obo/OMIM_300322"
      },
      "ORPHA510": {
        "ontology": "ORPHA",
        "curie": "ORPHA:510",
        "uri": "ORPHA510",
        "iri": "http://www.orpha.net/ORDO/Orphanet_510"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1520544301\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"HPRT1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:5157\",\"uri\":\"HGNC5157\"},\"condition\":{\"name\":\"Lesch-Nyhan Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:510\",\"uri\":\"ORPHA510\"},\"MONDO\":{\"curie\":\"MONDO:0010298\",\"uri\":\"MONDO0010298\"},\"OMIM\":{\"curie\":\"OMIM:300322\",\"uri\":\"OMIM300322\"}},\"title\":\"HPRT1 Lesch-Nyhan Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"4.50\",\"Tally\":\"4.5\",\"evidence\":{\"publications\":{\"1520544204321\":{\"title\":\"Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA.\",\"author\":\"Gibbs RA\",\"pubdate\":\"1989 Mar\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"2928313\"},\"1520544214776\":{\"title\":\"Novel nonsense mutation in the hypoxanthine guanine phosphoribosyltransferase gene and nonrandom X-inactivation causing Lesch-Nyhan syndrome in a female patient.\",\"author\":\"Aral B\",\"pubdate\":\"1996\",\"source\":\"Hum Mutat\",\"uid\":\"8664901\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"4.50\",\"Tally\":\"4.5\",\"evidence\":{\"publications\":{\"1520544172953\":{\"title\":\"Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA.\",\"author\":\"Gibbs RA\",\"pubdate\":\"1989 Mar\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"2928313\"},\"1520544190697\":{\"title\":\"Hypoxanthine guanine phosphoribosyltransferase deficiency: nucleotide substitution causing Lesch-Nyhan syndrome identified for the first time among Japanese.\",\"author\":\"Fujimori S\",\"pubdate\":\"1990 Apr\",\"source\":\"Hum Genet\",\"uid\":\"2323782\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1520544163234\":{\"title\":\"Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA.\",\"author\":\"Gibbs RA\",\"pubdate\":\"1989 Mar\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"2928313\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"0.00\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"9.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1520544241842\":{\"title\":\"A subcellular map of the human proteome.\",\"author\":\"Thul PJ\",\"pubdate\":\"2017 May 26\",\"source\":\"Science\",\"uid\":\"28495876\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1520544255319\":{\"title\":\"A modified TALEN-based system for robust generation of knock-out human pluripotent stem cell lines and disease models.\",\"author\":\"Frank S\",\"pubdate\":\"2013 Nov 9\",\"source\":\"BMC Genomics\",\"uid\":\"24206569\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"1.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"1\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1520544291242\":{\"title\":\"A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.\",\"author\":\"Kuehn MR\",\"pubdate\":\"1987 Mar 19-25\",\"source\":\"Nature\",\"uid\":\"3029599\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"3\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"9.5\",\"ExperimentalEvidenceTotal\":\"3\",\"EvidencePointsTotal\":\"12.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"03/08/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"03/07/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"03/07/2018\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1520409600,
    "dateISO8601": "2018-03-07T00:00:00",
    "dateFormated": "Mar 07, 2018"
  },
  "9598": {
    "title": "PLP1: Pelizaeus-Merzbacher disease",
    "label": "Pelizaeus-Merzbacher disease",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "9086": {
        "ontology": "HGNC",
        "curie": "HGNC:9086",
        "uri": "HGNC9086"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010714"
      },
      "OMIM312080": {
        "ontology": "OMIM",
        "curie": "OMIM:312080",
        "uri": "OMIM312080",
        "iri": "http://purl.obolibrary.org/obo/OMIM_312080"
      },
      "ORPHA280219": {
        "ontology": "ORPHA",
        "curie": "ORPHA:280219",
        "uri": "ORPHA280219",
        "iri": "http://www.orpha.net/ORDO/Orphanet_280219"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1520601150\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"PLP1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:9086\",\"uri\":\"HGNC9086\"},\"condition\":{\"name\":\"Pelizaeus-Merzbacher disease\",\"OrphaNet\":{\"curie\":\"ORPHA:280219\",\"uri\":\"ORPHA280219\"},\"MONDO\":{\"curie\":\"MONDO:0010714\",\"uri\":\"MONDO0010714\"},\"OMIM\":{\"curie\":\"OMIM:3120808\",\"uri\":\"OMIM3120808\"}},\"title\":\"PLP1 Pelizaeus-Merzbacher disease\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1520602124654\":{\"title\":\"The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.\",\"author\":\"Hoffman-Zacharska D\",\"pubdate\":\"2013 Oct-Dec\",\"source\":\"Med Wieku Rozwoj\",\"uid\":\"24519770\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"7.00\",\"Tally\":\"7\",\"evidence\":{\"publications\":{\"1520602064783\":{\"title\":\"PLP1 gene analysis in 88 patients with leukodystrophy.\",\"author\":\"Mart\\u00ednez-Montero P\",\"pubdate\":\"2013 Dec\",\"source\":\"Clin Genet\",\"uid\":\"23347225\"},\"1520602076653\":{\"title\":\"The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.\",\"author\":\"Hoffman-Zacharska D\",\"pubdate\":\"2013 Oct-Dec\",\"source\":\"Med Wieku Rozwoj\",\"uid\":\"24519770\"},\"1520602093054\":{\"title\":\"Three new PLP1 splicing mutations demonstrate pathogenic and phenotypic diversity of Pelizaeus-Merzbacher disease.\",\"author\":\"La\\u0161\\u0161uthov\\u00e1 P\",\"pubdate\":\"2014 Jul\",\"source\":\"J Child Neurol\",\"uid\":\"23771846\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"3.25\",\"Tally\":\"3.25\",\"evidence\":{\"publications\":{\"1520601925926\":{\"title\":\"Pelizaeus-Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein.\",\"author\":\"Gencic S\",\"pubdate\":\"1989 Sep\",\"source\":\"Am J Hum Genet\",\"uid\":\"2773936\"},\"1520601936636\":{\"title\":\"Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease.\",\"author\":\"Cailloux F\",\"pubdate\":\"2000 Nov\",\"source\":\"Eur J Hum Genet\",\"uid\":\"11093273\"},\"1520601967220\":{\"title\":\"The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.\",\"author\":\"Hoffman-Zacharska D\",\"pubdate\":\"2013 Oct-Dec\",\"source\":\"Med Wieku Rozwoj\",\"uid\":\"24519770\"},\"1520601981260\":{\"title\":\"PLP1 gene analysis in 88 patients with leukodystrophy.\",\"author\":\"Mart\\u00ednez-Montero P\",\"pubdate\":\"2013 Dec\",\"source\":\"Clin Genet\",\"uid\":\"23347225\"},\"1520602027589\":{\"title\":\"Exome sequencing reveals a novel PLP1 mutation in a Moroccan family with connatal Pelizaeus-Merzbacher disease: a case report.\",\"author\":\"Lyahyai J\",\"pubdate\":\"2018 Feb 27\",\"source\":\"BMC Pediatr\",\"uid\":\"29486744\"},\"1520602042037\":{\"title\":\"A novel <i>PLP1</i> mutation F240L identified in a patient with connatal type Pelizaeus-Merzbacher disease.\",\"author\":\"Lu Y\",\"pubdate\":\"2017\",\"source\":\"Hum Genome Var\",\"uid\":\"28101371\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1520602155023\":{\"title\":\"Three new PLP1 splicing mutations demonstrate pathogenic and phenotypic diversity of Pelizaeus-Merzbacher disease.\",\"author\":\"La\\u0161\\u0161uthov\\u00e1 P\",\"pubdate\":\"2014 Jul\",\"source\":\"J Child Neurol\",\"uid\":\"23771846\"},\"1520602165156\":{\"title\":\"Exome sequencing reveals a novel PLP1 mutation in a Moroccan family with connatal Pelizaeus-Merzbacher disease: a case report.\",\"author\":\"Lyahyai J\",\"pubdate\":\"2018 Feb 27\",\"source\":\"BMC Pediatr\",\"uid\":\"29486744\"},\"1520602175614\":{\"title\":\"The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.\",\"author\":\"Hoffman-Zacharska D\",\"pubdate\":\"2013 Oct-Dec\",\"source\":\"Med Wieku Rozwoj\",\"uid\":\"24519770\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.00\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"4.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1520602442001\":{\"title\":\"Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing.\",\"author\":\"Nave KA\",\"pubdate\":\"1986 Dec\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"3466187\"},\"1520602451728\":{\"title\":\"A point mutation in the proteolipid protein gene of the \",\"author\":\"Nadon NL\",\"pubdate\":\"1990 Oct\",\"source\":\"Development\",\"uid\":\"1723945\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"4\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"03/09/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"03/07/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"03/07/2018\",\"FinalClassificationNotes\":\"Variation in PLP1 has been associated with both Pelizaeus-Merzbacher disease (PMD) and hereditary spastic paraplegia (SPG).  Evidence suggests that these disorders are at different ends of the same clinical spectrum; the curation presented here is specifically for the more severe Pelizaeus Merzbacher presentation.  The PLP1 gene encodes for 2 major alternatively spliced transcripts: a full length transcript that encodes PLP, and a transcript lacking the PLP specific domain in exon 3, known as DM20. Differing molecular mechanisms are known to cause these disorders, including overexpression of PLP/DM20 (commonly caused by large, multi-gene duplications including PLP1 and resulting in \\\"classic\\\" PMD); missense variants resulting in misfolding of both PLP and DM20 (resulting in the more severe, \\\"connatal\\\" PMD); null variants (resulting in milder presentations of PMD or \\\"complicated\\\" SPG); and milder misfolding variants (often associated with the SPG phenotype).  Note that though duplications are the most common mechanism of PMD, none are curated here (as most involve more genes than just PLP1).  Though extensive functional evidence (including additional animal models) is available to support the link between PLP1 and PMD, only a subset is presented here.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1520409600,
    "dateISO8601": "2018-03-07T00:00:00",
    "dateFormated": "Mar 07, 2018"
  },
  "9611": {
    "title": "NDP; Norrie Disease",
    "label": "Norrie Disease",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "7678": {
        "ontology": "HGNC",
        "curie": "HGNC:7678",
        "uri": "HGNC7678"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010691"
      },
      "OMIM300658": {
        "ontology": "OMIM",
        "curie": "OMIM:300658",
        "uri": "OMIM300658",
        "iri": "http://purl.obolibrary.org/obo/OMIM_300658"
      },
      "ORPHA649": {
        "ontology": "ORPHA",
        "curie": "ORPHA:649",
        "uri": "ORPHA649",
        "iri": "http://www.orpha.net/ORDO/Orphanet_649"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1521823126\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"NDP\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:7678\",\"uri\":\"HGNC7678\"},\"condition\":{\"name\":\"Norrie Disease\",\"OrphaNet\":{\"curie\":\"ORPHA:649\",\"uri\":\"ORPHA649\"},\"MONDO\":{\"curie\":\"MONDO:0010691\",\"uri\":\"MONDO0010691\"},\"OMIM\":{\"curie\":\"OMIM:300658\",\"uri\":\"OMIM300658\"}},\"title\":\"NDP Norrie Disease\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"10.00\",\"Tally\":\"10\",\"evidence\":{\"publications\":{\"1521823102615\":{\"title\":\"Mutations in the candidate gene for Norrie disease.\",\"author\":\"Berger W\",\"pubdate\":\"1992 Oct\",\"source\":\"Hum Mol Genet\",\"uid\":\"1307245\"},\"1521823117208\":{\"title\":\"Mutations in the Norrie disease gene.\",\"author\":\"Schuback DE\",\"pubdate\":\"1995\",\"source\":\"Hum Mutat\",\"uid\":\"7627181\"},\"1521823133914\":{\"title\":\"Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domain of mucins.\",\"author\":\"Meindl A\",\"pubdate\":\"1992 Oct\",\"source\":\"Nat Genet\",\"uid\":\"1303264\"},\"1521823146288\":{\"title\":\"A novel c.240_241insGG mutation in NDP gene in a family with Norrie disease.\",\"author\":\"Andarva M\",\"pubdate\":\"2018 Mar\",\"source\":\"Clin Exp Optom\",\"uid\":\"28922694\"},\"1521823163738\":{\"title\":\"Two new mutations in exon 3 of the NDP gene: S73X and S101F associated with severe and less severe ocular phenotype, respectively.\",\"author\":\"Walker JL\",\"pubdate\":\"1997\",\"source\":\"Hum Mutat\",\"uid\":\"8990009\"},\"1521823176063\":{\"title\":\"Norrie disease: extraocular clinical manifestations in 56 patients.\",\"author\":\"Smith SE\",\"pubdate\":\"2012 Aug\",\"source\":\"Am J Med Genet A\",\"uid\":\"22786811\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1521823078793\":{\"title\":\"Norrie disease gene mutation in a large Costa Rican kindred with a novel phenotype including venous insufficiency.\",\"author\":\"Rehm HL\",\"pubdate\":\"1997\",\"source\":\"Hum Mutat\",\"uid\":\"9143918\"},\"1521823092511\":{\"title\":\"Norrie disease in a family with a manifesting female carrier.\",\"author\":\"Sims KB\",\"pubdate\":\"1997 Apr\",\"source\":\"Arch Ophthalmol\",\"uid\":\"9109762\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1521823198314\":{\"title\":\"Two new mutations in exon 3 of the NDP gene: S73X and S101F associated with severe and less severe ocular phenotype, respectively.\",\"author\":\"Walker JL\",\"pubdate\":\"1997\",\"source\":\"Hum Mutat\",\"uid\":\"8990009\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1521823243857\":{\"title\":\"Norrie disease gene: characterization of deletions and possible function.\",\"author\":\"Chen ZY\",\"pubdate\":\"1993 May\",\"source\":\"Genomics\",\"uid\":\"8314592\"}}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1521823254194\":{\"title\":\"Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair.\",\"author\":\"Xu Q\",\"pubdate\":\"2004 Mar 19\",\"source\":\"Cell\",\"uid\":\"15035989\"}}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"3.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1521823265914\":{\"title\":\"An animal model for Norrie disease (ND): gene targeting of the mouse ND gene.\",\"author\":\"Berger W\",\"pubdate\":\"1996 Jan\",\"source\":\"Hum Mol Genet\",\"uid\":\"8789439\"},\"1521823277977\":{\"title\":\"Vascular defects and sensorineural deafness in a mouse model of Norrie disease.\",\"author\":\"Rehm HL\",\"pubdate\":\"2002 Jun 1\",\"source\":\"J Neurosci\",\"uid\":\"12040033\"},\"1521823291993\":{\"title\":\"Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice.\",\"author\":\"Ohlmann A\",\"pubdate\":\"2005 Feb 16\",\"source\":\"J Neurosci\",\"uid\":\"15716406\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"2.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"5.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"5.5\",\"EvidencePointsTotal\":\"17.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"03/23/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"03/20/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"03/21/2018\",\"FinalClassificationNotes\":\"Evidence Summary\\r\\n\\r\\n\\r\\nThe association between the NDP gene and Norrie disease (ND) is well-characterized, with over 100 unique variants described in HGMD, including nonsense, missense, splice, and deletion variants reported in dozens of publications. Familial segregation data is readily available; only a subset are included in this curation. Experimental evidence includes several mouse models of disease and protein interaction studies highlighting NDP's role in FZD4 interaction and Wnt signaling. NOTE: In terms of X-linked intellectual disability, ND is incompletely penetrant. The main phenotype associated with ND is abnormal vascular development within the eye, and only ~50% of patients with ND exhibit intellectual disability\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1521615600,
    "dateISO8601": "2018-03-21T00:00:00",
    "dateFormated": "Mar 21, 2018"
  },
  "9612": {
    "title": "MID1; X-linked Opitz G/BB syndrome",
    "label": "X-linked Opitz G/BB syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10006",
      "name": "Intellectual Disability and Autism"
    },
    "genes": {
      "7095": {
        "ontology": "HGNC",
        "curie": "HGNC:7095",
        "uri": "HGNC7095"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010222"
      },
      "OMIM300000": {
        "ontology": "OMIM",
        "curie": "OMIM:300000",
        "uri": "OMIM300000",
        "iri": "http://purl.obolibrary.org/obo/OMIM_300000"
      },
      "ORPHA306597": {
        "ontology": "ORPHA",
        "curie": "ORPHA:306597",
        "uri": "ORPHA306597",
        "iri": "http://www.orpha.net/ORDO/Orphanet_306597"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1521823632\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"MID1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:7095\",\"uri\":\"HGNC7095\"},\"condition\":{\"name\":\"X-linked Opitz G/BB syndrome \",\"OrphaNet\":{\"curie\":\"ORPHA:306597\",\"uri\":\"ORPHA306597\"},\"MONDO\":{\"curie\":\"MONDO:0010222\",\"uri\":\"MONDO0010222\"},\"OMIM\":{\"curie\":\"OMIM:300000\",\"uri\":\"OMIM300000\"}},\"title\":\"MID1 X-linked Opitz G/BB syndrome \",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"3.50\",\"Tally\":\"3.5\",\"evidence\":{\"publications\":{\"1521823854456\":{\"title\":\"MID1 mutation screening in a large cohort of Opitz G/BBB syndrome patients: twenty-nine novel mutations identified.\",\"author\":\"Ferrentino R\",\"pubdate\":\"2007 Feb\",\"source\":\"Hum Mutat\",\"uid\":\"17221865\"},\"1521823867870\":{\"title\":\"Embryonic expression of the human MID1 gene and its mutations in Opitz syndrome.\",\"author\":\"Pinson L\",\"pubdate\":\"2004 May\",\"source\":\"J Med Genet\",\"uid\":\"15121778\"}}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"13.50\",\"Tally\":\"10\",\"evidence\":{\"publications\":{\"1521823808374\":{\"title\":\"New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome.\",\"author\":\"Cox TC\",\"pubdate\":\"2000 Oct 12\",\"source\":\"Hum Mol Genet\",\"uid\":\"11030761\"},\"1521823831358\":{\"title\":\"X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum.\",\"author\":\"De Falco F\",\"pubdate\":\"2003 Jul 15\",\"source\":\"Am J Med Genet A\",\"uid\":\"12833403\"}}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1521823799204\":{\"title\":\"New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome.\",\"author\":\"Cox TC\",\"pubdate\":\"2000 Oct 12\",\"source\":\"Hum Mol Genet\",\"uid\":\"11030761\"}}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"0.00\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.00\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1521823894007\":{\"title\":\"Embryonic expression of the human MID1 gene and its mutations in Opitz syndrome.\",\"author\":\"Pinson L\",\"pubdate\":\"2004 May\",\"source\":\"J Med Genet\",\"uid\":\"15121778\"}}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"0.00\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"1.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"1\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1521823904493\":{\"title\":\"Lack of Mid1, the mouse ortholog of the Opitz syndrome gene, causes abnormal development of the anterior cerebellar vermis.\",\"author\":\"Lancioni A\",\"pubdate\":\"2010 Feb 24\",\"source\":\"J Neurosci\",\"uid\":\"20181585\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\"},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"1.5\",\"EvidencePointsTotal\":\"13.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"03/23/2018\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"03/21/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"03/21/2018\",\"FinalClassificationNotes\":\"Depends on different studies,  about 15%-50% of the X-linked Opitz G/BBB syndrome carrying MID1 variants have intellectual disability/developmental delay (ID/DD). A recent paper (PMID: 26788540\\r\\n) summarized the clinical phenotypes of 85 affected males and showed about one-third have ID/DD. Among the 16 cases of genetic evidence curated here, 6 have ID/DD, 7 do not have ID/DD, and 3 unknown.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1521615600,
    "dateISO8601": "2018-03-21T00:00:00",
    "dateFormated": "Mar 21, 2018"
  },

  "9807": {
    "title": "COL9A1 Stickler syndrome",
    "label": "Stickler syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10044",
      "name": "Familial Thoracic Aortic Aneurysm and Dissection"
    },
    "genes": {
      "2217": {
        "ontology": "HGNC",
        "curie": "HGNC:2217",
        "uri": "HGNC2217"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0019354"
      },
      "OMIM614134": {
        "ontology": "OMIM",
        "curie": "OMIM:614134",
        "uri": "OMIM614134",
        "iri": "http://purl.obolibrary.org/obo/OMIM_614134"
      },
      "ORPHA828": {
        "ontology": "ORPHA",
        "curie": "ORPHA:828",
        "uri": "ORPHA828",
        "iri": "http://www.orpha.net/ORDO/Orphanet_828"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1523364140\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"COL9A1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:2217\",\"uri\":\"HGNC2217\"},\"condition\":{\"name\":\"Stickler syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:828\",\"uri\":\"ORPHA828\"},\"MONDO\":{\"curie\":\"MONDO:0019354\",\"uri\":\"MONDO0019354\"},\"OMIM\":{\"curie\":\"OMIM:614134\",\"uri\":\"OMIM614134\"}},\"title\":\"COL9A1 Stickler syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1523363832544\":{\"title\":\"Autosomal recessive Stickler syndrome in two families is caused by mutations in the COL9A1 gene.\",\"author\":\"Nikopoulos K\",\"pubdate\":\"2011 Jul 1\",\"source\":\"Invest Ophthalmol Vis Sci\",\"uid\":\"21421862\"},\"1523363905764\":{\"title\":\"A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene.\",\"author\":\"Van Camp G\",\"pubdate\":\"2006 Sep\",\"source\":\"Am J Hum Genet\",\"uid\":\"16909383\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"2\":{\"evidence\":{\"publications\":{\"1523364001216\":{\"title\":\"Autosomal recessive Stickler syndrome in two families is caused by mutations in the COL9A1 gene.\",\"author\":\"Nikopoulos K\",\"pubdate\":\"2011 Jul 1\",\"source\":\"Invest Ophthalmol Vis Sci\",\"uid\":\"21421862\"},\"1523364249011\":{\"title\":\"A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene.\",\"author\":\"Van Camp G\",\"pubdate\":\"2006 Sep\",\"source\":\"Am J Hum Genet\",\"uid\":\"16909383\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"3\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1523363862910\":{\"title\":\"Characterization of an abundant COL9A1 transcript in the cochlea with a novel 3\",\"author\":\"Sivakumaran TA\",\"pubdate\":\"2006 Jun\",\"source\":\"J Assoc Res Otolaryngol\",\"uid\":\"16718610\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"1\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1523363784484\":{\"title\":\"Type IX collagen is crucial for normal hearing.\",\"author\":\"Asamura K\",\"pubdate\":\"2005\",\"source\":\"Neuroscience\",\"uid\":\"15802199\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"3\",\"ExperimentalEvidenceTotal\":\"1.5\",\"EvidencePointsTotal\":\"4.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"03/23/2018\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"03/26/2018\",\"FinalClassificationNotes\":\"The <i>COL9A1</i> gene has been associated with Stickler syndrome in two consanguineous families. The homozygous presumed loss-of-function nonsense variants in this gene segregate with disease in six affected individuals. Splicing, gain-of-function variants in the <i>COL9A1</i> gene are associated with autosomal dominant multiple epiphyseal dysplasia (MED), while the mechanism for autosomal recessive Stickler syndrome is thought to be loss of function. This gene-disease association is supported by expression data and by animal models that recapitulate certain phenotypes of the human disease. In summary, <i>COL9A1</i> limited in its association with Stickler syndrome.\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1522047600,
    "dateISO8601": "2018-03-26T00:00:00",
    "dateFormated": "Mar 26, 2018"
  },
  "9848": {
    "title": "MLH1: Lynch Syndrome",
    "label": "Lynch Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "7127": {
        "ontology": "HGNC",
        "curie": "HGNC:7127",
        "uri": "HGNC7127"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0012249"
      },
      "OMIM609310": {
        "ontology": "OMIM",
        "curie": "OMIM:609310",
        "uri": "OMIM609310",
        "iri": "http://purl.obolibrary.org/obo/OMIM_609310"
      },
      "ORPHA144": {
        "ontology": "ORPHA",
        "curie": "ORPHA:144",
        "uri": "ORPHA144",
        "iri": "http://www.orpha.net/ORDO/Orphanet_144"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MLH1\",\"Hgnc\":\"7127\",\"OrphaNet\":\"144\",\"Disease\":\"Lynch Syndrome\",\"Omim\":\"609310\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"5.5\",\"tally\":\"5.5\",\"pmid\":{\"publications\":[{\"title\":\"Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.\",\"author\":\"Pagenstecher C\",\"pubdate\":\"2006 Mar\",\"source\":\"Hum Genet\",\"uid\":\"16341550\"},{\"title\":\"Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.\",\"author\":\"Bronner CE\",\"pubdate\":\"1994 Mar 17\",\"source\":\"Nature\",\"uid\":\"8145827\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Germ line mutations of hMSH2 and hMLH1 genes in Japanese families with hereditary nonpolyposis colorectal cancer (HNPCC): usefulness of DNA analysis for screening and diagnosis of HNPCC patients.\",\"author\":\"Miyaki M\",\"pubdate\":\"1995 Oct\",\"source\":\"J Mol Med (Berl)\",\"uid\":\"8581513\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.\",\"author\":\"Bronner CE\",\"pubdate\":\"1994 Mar 17\",\"source\":\"Nature\",\"uid\":\"8145827\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.\",\"author\":\"Chubb D\",\"pubdate\":\"2016 Jun 22\",\"source\":\"Nat Commun\",\"uid\":\"27329137\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility.\",\"author\":\"Genuardi M\",\"pubdate\":\"1998 Jan\",\"source\":\"Hum Genet\",\"uid\":\"9490293\"},{\"title\":\"The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer.\",\"author\":\"Guerrette S\",\"pubdate\":\"1999 Mar 5\",\"source\":\"J Biol Chem\",\"uid\":\"10037723\"},{\"title\":\"Endonucleolytic function of MutLalpha in human mismatch repair.\",\"author\":\"Kadyrov FA\",\"pubdate\":\"2006 Jul 28\",\"source\":\"Cell\",\"uid\":\"16873062\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.\",\"author\":\"Prolla TA\",\"pubdate\":\"1998 Mar\",\"source\":\"Nat Genet\",\"uid\":\"9500552\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.\",\"author\":\"Prolla TA\",\"pubdate\":\"1998 Mar\",\"source\":\"Nat Genet\",\"uid\":\"9500552\"},{\"title\":\"Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs.\",\"author\":\"Li GM\",\"pubdate\":\"1995 Mar 14\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"7892206\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"07/10/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"07/10/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1499670000,
    "dateISO8601": "2017-07-10T00:00:00",
    "dateFormated": "Jul 10, 2017"
  },
  "9849": {
    "title": "MSH2: Lynch Syndrome",
    "label": "Lynch Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "7325": {
        "ontology": "HGNC",
        "curie": "HGNC:7325",
        "uri": "HGNC7325"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005835"
      },
      "OMIM120435": {
        "ontology": "OMIM",
        "curie": "OMIM:120435",
        "uri": "OMIM120435",
        "iri": "http://purl.obolibrary.org/obo/OMIM_120435"
      },
      "ORPHA144": {
        "ontology": "ORPHA",
        "curie": "ORPHA:144",
        "uri": "ORPHA144",
        "iri": "http://www.orpha.net/ORDO/Orphanet_144"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MSH2\",\"Hgnc\":\"7325\",\"OrphaNet\":\"144\",\"Disease\":\"Lynch Syndrome\",\"Omim\":\"120435\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.\",\"author\":\"Leach FS\",\"pubdate\":\"1993 Dec 17\",\"source\":\"Cell\",\"uid\":\"8261515\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.\",\"author\":\"Leach FS\",\"pubdate\":\"1993 Dec 17\",\"source\":\"Cell\",\"uid\":\"8261515\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.\",\"author\":\"Leach FS\",\"pubdate\":\"1993 Dec 17\",\"source\":\"Cell\",\"uid\":\"8261515\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.\",\"author\":\"Chubb D\",\"pubdate\":\"2016 Jun 22\",\"source\":\"Nat Commun\",\"uid\":\"27329137\"}],\"notes\":{\"note\":\"\"}}},\"AggregateVariantAnalysis\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Cancer risks for MLH1 and MSH2 mutation carriers.\",\"author\":\"Dowty JG\",\"pubdate\":\"2013 Mar\",\"source\":\"Hum Mutat\",\"uid\":\"23255516\"}]}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.\",\"author\":\"Ollila S\",\"pubdate\":\"2006 Nov\",\"source\":\"Gastroenterology\",\"uid\":\"17101317\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"3.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.\",\"author\":\"Ollila S\",\"pubdate\":\"2006 Nov\",\"source\":\"Gastroenterology\",\"uid\":\"17101317\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.\",\"author\":\"Reitmair AH\",\"pubdate\":\"1996 Aug 15\",\"source\":\"Cancer Res\",\"uid\":\"8706033\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09/11/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"09/11/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1505113200,
    "dateISO8601": "2017-09-11T00:00:00",
    "dateFormated": "Sep 11, 2017"
  },
  "9850": {
    "title": "MSH6: Lynch Syndrome",
    "label": "Lynch Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "7329": {
        "ontology": "HGNC",
        "curie": "HGNC:7329",
        "uri": "HGNC7329"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005835"
      },
      "OMIM614350": {
        "ontology": "OMIM",
        "curie": "OMIM:614350",
        "uri": "OMIM614350",
        "iri": "http://purl.obolibrary.org/obo/OMIM_614350"
      },
      "ORPHA144": {
        "ontology": "ORPHA",
        "curie": "ORPHA:144",
        "uri": "ORPHA144",
        "iri": "http://www.orpha.net/ORDO/Orphanet_144"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MSH6\",\"Hgnc\":\"7329\",\"OrphaNet\":\"144\",\"Disease\":\"Lynch Syndrome\",\"Omim\":\"614350\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"9.0\",\"tally\":\"9\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer.\",\"author\":\"Miyaki M\",\"pubdate\":\"1997 Nov\",\"source\":\"Nat Genet\",\"uid\":\"9354786\"},{\"title\":\"MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer.\",\"author\":\"Huang J\",\"pubdate\":\"2001 Feb 15\",\"source\":\"Cancer Res\",\"uid\":\"11245474\"},{\"title\":\"Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.\",\"author\":\"Wu Y\",\"pubdate\":\"1999 Nov\",\"source\":\"Am J Hum Genet\",\"uid\":\"10521294\"},{\"title\":\"Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.\",\"author\":\"Berends MJ\",\"pubdate\":\"2002 Jan\",\"source\":\"Am J Hum Genet\",\"uid\":\"11709755\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer.\",\"author\":\"Huang J\",\"pubdate\":\"2001 Feb 15\",\"source\":\"Cancer Res\",\"uid\":\"11245474\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells.\",\"author\":\"Drummond JT\",\"pubdate\":\"1995 Jun 30\",\"source\":\"Science\",\"uid\":\"7604264\"},{\"title\":\"GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells.\",\"author\":\"Palombo F\",\"pubdate\":\"1995 Jun 30\",\"source\":\"Science\",\"uid\":\"7604265\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"3.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Hereditary cancer-associated missense mutations in hMSH6 uncouple ATP hydrolysis from DNA mismatch binding.\",\"author\":\"Cyr JL\",\"pubdate\":\"2008 Nov 14\",\"source\":\"J Biol Chem\",\"uid\":\"18790734\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Mutation in the mismatch repair gene Msh6 causes cancer susceptibility.\",\"author\":\"Edelmann W\",\"pubdate\":\"1997 Nov 14\",\"source\":\"Cell\",\"uid\":\"9390556\"},{\"title\":\"HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions.\",\"author\":\"de Wind N\",\"pubdate\":\"1999 Nov\",\"source\":\"Nat Genet\",\"uid\":\"10545954\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09/25/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"09/25/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1506322800,
    "dateISO8601": "2017-09-25T00:00:00",
    "dateFormated": "Sep 25, 2017"
  },
  "9851": {
    "title": "PMS2: Lynch Syndrome",
    "label": "Lynch Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "9122": {
        "ontology": "HGNC",
        "curie": "HGNC:9122",
        "uri": "HGNC9122"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005835"
      },
      "ORPHA144": {
        "ontology": "ORPHA",
        "curie": "ORPHA:144",
        "uri": "ORPHA144",
        "iri": "http://www.orpha.net/ORDO/Orphanet_144"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PMS2\",\"Hgnc\":\"9122\",\"OrphaNet\":\"144\",\"Disease\":\"Lynch Syndrome\",\"Omim\":\"----\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"10.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.\",\"author\":\"Nicolaides NC\",\"pubdate\":\"1994 Sep 1\",\"source\":\"Nature\",\"uid\":\"8072530\"},{\"title\":\"Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancer.\",\"author\":\"Worthley DL\",\"pubdate\":\"2005 May\",\"source\":\"Gastroenterology\",\"uid\":\"15887124\"},{\"title\":\"Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).\",\"author\":\"Hampel H\",\"pubdate\":\"2005 May 5\",\"source\":\"N Engl J Med\",\"uid\":\"15872200\"},{\"title\":\"Long-range PCR facilitates the identification of PMS2-specific mutations.\",\"author\":\"Clendenning M\",\"pubdate\":\"2006 May\",\"source\":\"Hum Mutat\",\"uid\":\"16619239\"}],\"notes\":{\"note\":\"\"}}}}}},\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"10.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.\",\"author\":\"Senter L\",\"pubdate\":\"2008 Aug\",\"source\":\"Gastroenterology\",\"uid\":\"18602922\"},{\"title\":\"Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.\",\"author\":\"ten Broeke SW\",\"pubdate\":\"2015 Feb 1\",\"source\":\"J Clin Oncol\",\"uid\":\"25512458\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer.\",\"author\":\"Facista A\",\"pubdate\":\"2012 Apr 11\",\"source\":\"Genome Integr\",\"uid\":\"22494821\"},{\"title\":\"Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer.\",\"author\":\"Nystr\\u00f6m-Lahti M\",\"pubdate\":\"2002 Feb\",\"source\":\"Genes Chromosomes Cancer\",\"uid\":\"11793442\"},{\"title\":\"Endonucleolytic function of MutLalpha in human mismatch repair.\",\"author\":\"Kadyrov FA\",\"pubdate\":\"2006 Jul 28\",\"source\":\"Cell\",\"uid\":\"16873062\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"PMS2 endonuclease activity has distinct biological functions and is essential for genome maintenance.\",\"author\":\"van Oers JM\",\"pubdate\":\"2010 Jul 27\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"20624957\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"PMS2 endonuclease activity has distinct biological functions and is essential for genome maintenance.\",\"author\":\"van Oers JM\",\"pubdate\":\"2010 Jul 27\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"20624957\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"15\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"06/26/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"06/26/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1498460400,
    "dateISO8601": "2017-06-26T00:00:00",
    "dateFormated": "Jun 26, 2017"
  },
  "9852": {
    "title": "EPCAM: Lynch Syndrome",
    "label": "Lynch Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "11529": {
        "ontology": "HGNC",
        "curie": "HGNC:11529",
        "uri": "HGNC11529"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0013196"
      },
      "OMIM613244": {
        "ontology": "OMIM",
        "curie": "OMIM:613244",
        "uri": "OMIM613244",
        "iri": "http://purl.obolibrary.org/obo/OMIM_613244"
      },
      "ORPHA144": {
        "ontology": "ORPHA",
        "curie": "ORPHA:144",
        "uri": "ORPHA144",
        "iri": "http://www.orpha.net/ORDO/Orphanet_144"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"EPCAM\",\"Hgnc\":\"11529\",\"OrphaNet\":\"144\",\"Disease\":\"Lynch Syndrome\",\"Omim\":\"613244\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"8.0\",\"tally\":\"8\",\"pmid\":{\"publications\":[{\"title\":\"Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3\",\"author\":\"Ligtenberg MJ\",\"pubdate\":\"2009 Jan\",\"source\":\"Nat Genet\",\"uid\":\"19098912\"},{\"title\":\"Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer.\",\"author\":\"Chan TL\",\"pubdate\":\"2006 Oct\",\"source\":\"Nat Genet\",\"uid\":\"16951683\"},{\"title\":\"Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.\",\"author\":\"Kovacs ME\",\"pubdate\":\"2009 Feb\",\"source\":\"Hum Mutat\",\"uid\":\"19177550\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Identification of a founder EPCAM deletion in Spanish Lynch syndrome families.\",\"author\":\"Mur P\",\"pubdate\":\"2014 Mar\",\"source\":\"Clin Genet\",\"uid\":\"23530899\"},{\"title\":\"Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3\",\"author\":\"Ligtenberg MJ\",\"pubdate\":\"2009 Jan\",\"source\":\"Nat Genet\",\"uid\":\"19098912\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.\",\"author\":\"Fagerberg L\",\"pubdate\":\"2014 Feb\",\"source\":\"Mol Cell Proteomics\",\"uid\":\"24309898\"},{\"title\":\"Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells.\",\"author\":\"Lu TY\",\"pubdate\":\"2010 Mar 19\",\"source\":\"J Biol Chem\",\"uid\":\"20064925\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3\",\"author\":\"Ligtenberg MJ\",\"pubdate\":\"2009 Jan\",\"source\":\"Nat Genet\",\"uid\":\"19098912\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09/11/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"09/11/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1505113200,
    "dateISO8601": "2017-09-11T00:00:00",
    "dateFormated": "Sep 11, 2017"
  },
  "9853": {
    "title": "PMS1: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "9121": {
        "ontology": "HGNC",
        "curie": "HGNC:9121",
        "uri": "HGNC9121"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005835"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA144": {
        "ontology": "ORPHA",
        "curie": "ORPHA:144",
        "uri": "ORPHA144",
        "iri": "http://www.orpha.net/ORDO/Orphanet_144"
      }
    },
    "scores": {
      "3973": {
        "label": "Contradictory (refuted)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PMS1\",\"Hgnc\":\"9121\",\"OrphaNet\":\"144\",\"Disease\":\"Lynch Syndrome\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"\",\"pmid\":{\"publications\":[{\"title\":\"Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer.\",\"author\":\"Wang Q\",\"pubdate\":\"1999 Jul-Aug\",\"source\":\"Hum Genet\",\"uid\":\"10480359\"},{\"title\":\"The role of hPMS1 and hPMS2 in predisposing to colorectal cancer.\",\"author\":\"Liu T\",\"pubdate\":\"2001 Nov 1\",\"source\":\"Cancer Res\",\"uid\":\"11691795\"},{\"title\":\"Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.\",\"author\":\"Nicolaides NC\",\"pubdate\":\"1994 Sep 1\",\"source\":\"Nature\",\"uid\":\"8072530\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"FunctionalAlteration\":{\"value\":\"0.0\",\"tally\":\"0\"},\"ModelsRescue\":{\"value\":\"0.0\",\"tally\":\"\",\"pmid\":{\"publications\":[{\"title\":\"Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.\",\"author\":\"Prolla TA\",\"pubdate\":\"1998 Mar\",\"source\":\"Nat Genet\",\"uid\":\"9500552\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"ValidContradictoryEvidence\":{\"YesNo\":\"YES\",\"pmid\":{\"publications\":{\"1529074608345\":{\"title\":\"Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.\",\"author\":\"Prolla TA\",\"pubdate\":\"1998 Mar\",\"source\":\"Nat Genet\",\"uid\":\"9500552\"}},\"notes\":{\"note\":\"\"}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"CONFLICTING EVIDENCE REPORTED\",\"CalculatedClassificationDate\":\"05/22/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"REFUTED\",\"FinalClassificationDate\":\"05/22/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1495436400,
    "dateISO8601": "2017-05-22T00:00:00",
    "dateFormated": "May 22, 2017"
  },
  "9854": {
    "title": "APC: Familial Adenomatous Polyposis",
    "label": "Familial Adenomatous Polyposis",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "583": {
        "ontology": "HGNC",
        "curie": "HGNC:583",
        "uri": "HGNC583"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016613"
      },
      "OMIM175100": {
        "ontology": "OMIM",
        "curie": "OMIM:175100",
        "uri": "OMIM175100",
        "iri": "http://purl.obolibrary.org/obo/OMIM_175100"
      },
      "ORPHA247806": {
        "ontology": "ORPHA",
        "curie": "ORPHA:247806",
        "uri": "ORPHA247806",
        "iri": "http://www.orpha.net/ORDO/Orphanet_247806"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"APC\",\"Hgnc\":\"583\",\"OrphaNet\":\"247806\",\"Disease\":\"Familial Adenomatous  Polyposis\",\"Omim\":\"175100\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"10.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli.\",\"author\":\"Gayther SA\",\"pubdate\":\"1994 Jan\",\"source\":\"Hum Mol Genet\",\"uid\":\"8162051\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli.\",\"author\":\"Gayther SA\",\"pubdate\":\"1994 Jan\",\"source\":\"Hum Mol Genet\",\"uid\":\"8162051\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"The APC gene product in normal and tumor cells.\",\"author\":\"Smith KJ\",\"pubdate\":\"1993 Apr 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"8385345\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients.\",\"author\":\"Inomata M\",\"pubdate\":\"1996 May 1\",\"source\":\"Cancer Res\",\"uid\":\"8616874\"},{\"title\":\"The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase.\",\"author\":\"Baeg GH\",\"pubdate\":\"1995 Nov 15\",\"source\":\"EMBO J\",\"uid\":\"8521819\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.\",\"author\":\"Fodde R\",\"pubdate\":\"1994 Sep 13\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"8090754\"},{\"title\":\"Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.\",\"author\":\"Oshima M\",\"pubdate\":\"1995 May 9\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"7753829\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09/11/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"09/11/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1505113200,
    "dateISO8601": "2017-09-11T00:00:00",
    "dateFormated": "Sep 11, 2017"
  },
  "9855": {
    "title": "MUTYH: MUTYH associated Polyposis",
    "label": "MUTYH associated Polyposis",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "7527": {
        "ontology": "HGNC",
        "curie": "HGNC:7527",
        "uri": "HGNC7527"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0012041"
      },
      "OMIM608456": {
        "ontology": "OMIM",
        "curie": "OMIM:608456",
        "uri": "OMIM608456",
        "iri": "http://purl.obolibrary.org/obo/OMIM_608456"
      },
      "ORPHA247798": {
        "ontology": "ORPHA",
        "curie": "ORPHA:247798",
        "uri": "ORPHA247798",
        "iri": "http://www.orpha.net/ORDO/Orphanet_247798"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MUTYH\",\"Hgnc\":\"7527\",\"OrphaNet\":\"247798\",\"Disease\":\"MUTYH associated Polyposis\",\"Omim\":\"608456\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"8.0\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations.\",\"author\":\"Jones S\",\"pubdate\":\"2002 Nov 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"12393807\"},{\"title\":\"Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.\",\"author\":\"Al-Tassan N\",\"pubdate\":\"2002 Feb\",\"source\":\"Nat Genet\",\"uid\":\"11818965\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"4.0\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.\",\"author\":\"Al-Tassan N\",\"pubdate\":\"2002 Feb\",\"source\":\"Nat Genet\",\"uid\":\"11818965\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study.\",\"author\":\"Cleary SP\",\"pubdate\":\"2009 Apr\",\"source\":\"Gastroenterology\",\"uid\":\"19245865\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6.\",\"author\":\"Gu Y\",\"pubdate\":\"2002 Mar 29\",\"source\":\"J Biol Chem\",\"uid\":\"11801590\"},{\"title\":\"Repair of 8-oxoG:A mismatches by the MUTYH glycosylase: Mechanism, metals and medicine.\",\"author\":\"Banda DM\",\"pubdate\":\"2017 Jun\",\"source\":\"Free Radic Biol Med\",\"uid\":\"28087410\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Impaired suppressive activities of human MUTYH variant proteins against oxidative mutagenesis.\",\"author\":\"Shinmura K\",\"pubdate\":\"2012 Dec 21\",\"source\":\"World J Gastroenterol\",\"uid\":\"23322991\"},{\"title\":\"Loss of MUTYH function in human cells leads to accumulation of oxidative damage and genetic instability.\",\"author\":\"Ruggieri V\",\"pubdate\":\"2013 Sep 19\",\"source\":\"Oncogene\",\"uid\":\"23108399\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"5.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis.\",\"author\":\"Sakamoto K\",\"pubdate\":\"2007 Jul 15\",\"source\":\"Cancer Res\",\"uid\":\"17638869\"},{\"title\":\"Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.\",\"author\":\"Sieber OM\",\"pubdate\":\"2004 Dec 15\",\"source\":\"Cancer Res\",\"uid\":\"15604247\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"06/12/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"06/12/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1497250800,
    "dateISO8601": "2017-06-12T00:00:00",
    "dateFormated": "Jun 12, 2017"
  },
  "9856": {
    "title": "SMAD4: Juvenile Polyposis Syndrome",
    "label": "Juvenile Polyposis Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "6770": {
        "ontology": "HGNC",
        "curie": "HGNC:6770",
        "uri": "HGNC6770"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0008276"
      },
      "OMIM174900": {
        "ontology": "OMIM",
        "curie": "OMIM:174900",
        "uri": "OMIM174900",
        "iri": "http://purl.obolibrary.org/obo/OMIM_174900"
      },
      "ORPHA329971": {
        "ontology": "ORPHA",
        "curie": "ORPHA:329971",
        "uri": "ORPHA329971",
        "iri": "http://www.orpha.net/ORDO/Orphanet_329971"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SMAD4\",\"Hgnc\":\"6770\",\"OrphaNet\":\"329971\",\"Disease\":\"Juvenile Polyposis Syndrome\",\"Omim\":\"174900\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations.\",\"author\":\"Howe JR\",\"pubdate\":\"2004 Jul\",\"source\":\"J Med Genet\",\"uid\":\"15235019\"}],\"notes\":{\"note\":\"\"}}},\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"},\"VariantIsDeNovo\":{\"value\":\"7.5\",\"tally\":\"7.5\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the SMAD4/DPC4 gene in juvenile polyposis.\",\"author\":\"Howe JR\",\"pubdate\":\"1998 May 15\",\"source\":\"Science\",\"uid\":\"9582123\"},{\"title\":\"A gene for familial juvenile polyposis maps to chromosome 18q21.1.\",\"author\":\"Howe JR\",\"pubdate\":\"1998 May\",\"source\":\"Am J Hum Genet\",\"uid\":\"9545410\"},{\"title\":\"The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations.\",\"author\":\"Howe JR\",\"pubdate\":\"2004 Jul\",\"source\":\"J Med Genet\",\"uid\":\"15235019\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the SMAD4/DPC4 gene in juvenile polyposis.\",\"author\":\"Howe JR\",\"pubdate\":\"1998 May 15\",\"source\":\"Science\",\"uid\":\"9582123\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Smad4 acts as tumor suppressor by antagonizing lymphangiogenesis in colorectal cancer.\",\"author\":\"Liu Y\",\"pubdate\":\"2015 Apr\",\"source\":\"Pathol Res Pract\",\"uid\":\"25680269\"},{\"title\":\"Smad-dependent and Smad-independent pathways in TGF-beta family signalling.\",\"author\":\"Derynck R\",\"pubdate\":\"2003 Oct 9\",\"source\":\"Nature\",\"uid\":\"14534577\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells.\",\"author\":\"Zhou S\",\"pubdate\":\"1998 Mar 3\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"9482899\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.\",\"author\":\"Takaku K\",\"pubdate\":\"1998 Mar 6\",\"source\":\"Cell\",\"uid\":\"9506519\"},{\"title\":\"Smad4 acts as tumor suppressor by antagonizing lymphangiogenesis in colorectal cancer.\",\"author\":\"Liu Y\",\"pubdate\":\"2015 Apr\",\"source\":\"Pathol Res Pract\",\"uid\":\"25680269\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"06/26/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"06/26/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1498460400,
    "dateISO8601": "2017-06-26T00:00:00",
    "dateFormated": "Jun 26, 2017"
  },
  "9857": {
    "title": "RNF43: Sessile Serrated Polyposis Cancer Syndrome",
    "label": "Sessile Serrated Polyposis Cancer Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "18505": {
        "ontology": "HGNC",
        "curie": "HGNC:18505",
        "uri": "HGNC18505"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0014919"
      },
      "OMIM617108": {
        "ontology": "OMIM",
        "curie": "OMIM:617108",
        "uri": "OMIM617108",
        "iri": "http://purl.obolibrary.org/obo/OMIM_617108"
      },
      "ORPHA157798": {
        "ontology": "ORPHA",
        "curie": "ORPHA:157798",
        "uri": "ORPHA157798",
        "iri": "http://www.orpha.net/ORDO/Orphanet_157798"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RNF43\",\"Hgnc\":\"18505\",\"OrphaNet\":\"157798\",\"Disease\":\"Sessile Serrated Polyposis Cancer Syndrome\",\"Omim\":\"617108\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"3.7\",\"tally\":\"3.7\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas.\",\"author\":\"Gala MK\",\"pubdate\":\"2014 Feb\",\"source\":\"Gastroenterology\",\"uid\":\"24512911\"},{\"title\":\"A deleterious RNF43 germline mutation in a severely affected serrated polyposis kindred.\",\"author\":\"Taupin D\",\"pubdate\":\"2015\",\"source\":\"Hum Genome Var\",\"uid\":\"27081527\"},{\"title\":\"RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.\",\"author\":\"Yan HHN\",\"pubdate\":\"2017 Sep\",\"source\":\"Gut\",\"uid\":\"27329244\"},{\"title\":\"Lack of evidence for germline <i>RNF43</i> mutations in patients with serrated polyposis syndrome from a large multinational study.\",\"author\":\"Buchanan DD\",\"pubdate\":\"2017 Jun\",\"source\":\"Gut\",\"uid\":\"27582512\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"A cancer-associated RING finger protein, RNF43, is a ubiquitin ligase that interacts with a nuclear protein, HAP95.\",\"author\":\"Sugiura T\",\"pubdate\":\"2008 Apr 15\",\"source\":\"Exp Cell Res\",\"uid\":\"18313049\"},{\"title\":\"Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.\",\"author\":\"Koo BK\",\"pubdate\":\"2012 Aug 30\",\"source\":\"Nature\",\"uid\":\"22895187\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.\",\"author\":\"Koo BK\",\"pubdate\":\"2012 Aug 30\",\"source\":\"Nature\",\"uid\":\"22895187\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.\",\"author\":\"Koo BK\",\"pubdate\":\"2012 Aug 30\",\"source\":\"Nature\",\"uid\":\"22895187\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2.5\",\"GeneticEvidenceTotal\":\"3.7\",\"GeneticEvidencePointsTotal\":\"3.7\",\"ExperimentalEvidencePointsTotal\":\"2.5\",\"EvidencePointsTotal\":\"6.2\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"10/23/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"10/23/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1508742000,
    "dateISO8601": "2017-10-23T00:00:00",
    "dateFormated": "Oct 23, 2017"
  },
  "9859": {
    "title": "ENG: Colorectal cancer/Polyposis Susceptibility",
    "label": "Colorectal cancer/Polyposis Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "3349": {
        "ontology": "HGNC",
        "curie": "HGNC:3349",
        "uri": "HGNC3349"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0008276"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA329971": {
        "ontology": "ORPHA",
        "curie": "ORPHA:329971",
        "uri": "ORPHA329971",
        "iri": "http://www.orpha.net/ORDO/Orphanet_329971"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"ENG\",\"Hgnc\":\"3349\",\"OrphaNet\":\"329971\",\"Disease\":\"Colorectal cancer/Polyposis Susceptbility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0.2\",\"pmid\":{\"publications\":[{\"title\":\"Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps.\",\"author\":\"Ngeow J\",\"pubdate\":\"2013 Jun\",\"source\":\"Gastroenterology\",\"uid\":\"23399955\"},{\"title\":\"Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis.\",\"author\":\"Sweet K\",\"pubdate\":\"2005 Nov 16\",\"source\":\"JAMA\",\"uid\":\"16287957\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/\\u03b2-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.\",\"author\":\"Mitselou A\",\"pubdate\":\"2016 May\",\"source\":\"Anticancer Res\",\"uid\":\"27127133\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"0.2\",\"GeneticEvidencePointsTotal\":\"0.2\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"1.2\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"12/11/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/11/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1512979200,
    "dateISO8601": "2017-12-11T00:00:00",
    "dateFormated": "Dec 11, 2017"
  },
  "9860": {
    "title": "MLH3: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "7128": {
        "ontology": "HGNC",
        "curie": "HGNC:7128",
        "uri": "HGNC7128"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM614385": {
        "ontology": "OMIM",
        "curie": "OMIM:614385",
        "uri": "OMIM614385",
        "iri": "http://purl.obolibrary.org/obo/OMIM_614385"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MLH3\",\"Hgnc\":\"7128\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"614385\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"2.0\",\"tally\":\"2\"},\"VariantIsDeNovo\":{\"value\":\"3.0\",\"tally\":\"3\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Evidence that hMLH3 functions primarily in meiosis and in hMSH2-hMSH3 mismatch repair.\",\"author\":\"Charbonneau N\",\"pubdate\":\"2009 Jul\",\"source\":\"Cancer Biol Ther\",\"uid\":\"19483466\"},{\"title\":\"Conditional nuclear localization of hMLH3 suggests a minor activity in mismatch repair and supports its role as a low-risk gene in HNPCC.\",\"author\":\"Korhonen MK\",\"pubdate\":\"2007 Feb\",\"source\":\"Oncol Rep\",\"uid\":\"17203173\"},{\"title\":\"Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair.\",\"author\":\"Cannavo E\",\"pubdate\":\"2005 Dec 1\",\"source\":\"Cancer Res\",\"uid\":\"16322221\"},{\"title\":\"Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair.\",\"author\":\"Cannavo E\",\"pubdate\":\"2005 Dec 1\",\"source\":\"Cancer Res\",\"uid\":\"16322221\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome.\",\"author\":\"Ou J\",\"pubdate\":\"2009 Apr\",\"source\":\"Genes Chromosomes Cancer\",\"uid\":\"19156873\"},{\"title\":\"The first functional study of MLH3 mutations found in cancer patients.\",\"author\":\"Korhonen MK\",\"pubdate\":\"2008 Sep\",\"source\":\"Genes Chromosomes Cancer\",\"uid\":\"18521850\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.\",\"author\":\"Chen PC\",\"pubdate\":\"2005 Oct 1\",\"source\":\"Cancer Res\",\"uid\":\"16204034\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5\",\"GeneticEvidenceTotal\":\"5\",\"GeneticEvidencePointsTotal\":\"5\",\"ExperimentalEvidencePointsTotal\":\"5\",\"EvidencePointsTotal\":\"10\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"02/14/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"02/14/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1487059200,
    "dateISO8601": "2017-02-14T00:00:00",
    "dateFormated": "Feb 14, 2017"
  },
  "9861": {
    "title": "ATM: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "795": {
        "ontology": "HGNC",
        "curie": "HGNC:795",
        "uri": "HGNC795"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"ATM\",\"Hgnc\":\"795\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.\",\"author\":\"Pearlman R\",\"pubdate\":\"2017 Apr 1\",\"source\":\"JAMA Oncol\",\"uid\":\"27978560\"},{\"title\":\"Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.\",\"author\":\"Yurgelun MB\",\"pubdate\":\"2017 Apr 1\",\"source\":\"J Clin Oncol\",\"uid\":\"28135145\"},{\"title\":\"Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas.\",\"author\":\"Gala MK\",\"pubdate\":\"2014 Feb\",\"source\":\"Gastroenterology\",\"uid\":\"24512911\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Downregulated Ku70 and ATM associated to poor prognosis in colorectal cancer among Chinese patients.\",\"author\":\"Lu Y\",\"pubdate\":\"2014\",\"source\":\"Onco Targets Ther\",\"uid\":\"25368522\"},{\"title\":\"Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN.\",\"author\":\"Beggs AD\",\"pubdate\":\"2012 Nov\",\"source\":\"Oncotarget\",\"uid\":\"23154512\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"The depletion of ATM inhibits colon cancer proliferation and migration via B56\\u03b32-mediated Chk1/p53/CD44 cascades.\",\"author\":\"Liu R\",\"pubdate\":\"2017 Apr 1\",\"source\":\"Cancer Lett\",\"uid\":\"28093285\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"5\",\"GeneticEvidencePointsTotal\":\"5\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"7\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"08/28/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"08/28/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1503903600,
    "dateISO8601": "2017-08-28T00:00:00",
    "dateFormated": "Aug 28, 2017"
  },
  "9862": {
    "title": "CHEK2: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "16627": {
        "ontology": "HGNC",
        "curie": "HGNC:16627",
        "uri": "HGNC16627"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM604373": {
        "ontology": "OMIM",
        "curie": "OMIM:604373",
        "uri": "OMIM604373",
        "iri": "http://purl.obolibrary.org/obo/OMIM_604373"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CHEK2\",\"Hgnc\":\"16627\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"604373\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.5\",\"tally\":\"0.25\",\"pmid\":{\"publications\":[{\"title\":\"Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.\",\"author\":\"Yurgelun MB\",\"pubdate\":\"2017 Apr 1\",\"source\":\"J Clin Oncol\",\"uid\":\"28135145\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Homozygous inactivation of <i>CHEK2</i> is linked to a familial case of multiple primary lung cancer with accompanying cancers in other organs.\",\"author\":\"Kukita Y\",\"pubdate\":\"2016 Nov\",\"source\":\"Cold Spring Harb Mol Case Stud\",\"uid\":\"27900359\"}],\"notes\":{\"note\":\"\"}}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"2.5\",\"tally\":\"2.5\",\"pmid\":{\"publications\":[{\"title\":\"Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility.\",\"author\":\"Xiang HP\",\"pubdate\":\"2011 Nov\",\"source\":\"Eur J Cancer\",\"uid\":\"21807500\"},{\"title\":\"CHEK2 mutations and HNPCC-related colorectal cancer.\",\"author\":\"Suchy J\",\"pubdate\":\"2010 Jun 15\",\"source\":\"Int J Cancer\",\"uid\":\"19876921\"},{\"title\":\"The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.\",\"author\":\"Meijers-Heijboer H\",\"pubdate\":\"2003 May\",\"source\":\"Am J Hum Genet\",\"uid\":\"12690581\"},{\"title\":\"The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.\",\"author\":\"Kleibl Z\",\"pubdate\":\"2009 Mar\",\"source\":\"Eur J Cancer\",\"uid\":\"18996005\"},{\"title\":\"CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer.\",\"author\":\"Wasielewski M\",\"pubdate\":\"2008 Aug 1\",\"source\":\"Clin Cancer Res\",\"uid\":\"18676774\"}],\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.\",\"author\":\"van Puijenbroek M\",\"pubdate\":\"2005 Jun\",\"source\":\"J Pathol\",\"uid\":\"15818573\"},{\"title\":\"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.\",\"author\":\"Bartkova J\",\"pubdate\":\"2005 Apr 14\",\"source\":\"Nature\",\"uid\":\"15829956\"},{\"title\":\"DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response.\",\"author\":\"Freiberg RA\",\"pubdate\":\"2006 Mar\",\"source\":\"Mol Cell Biol\",\"uid\":\"16478982\"},{\"title\":\"Alterations of Chk1 and Chk2 expression in colon cancer.\",\"author\":\"Stawinska M\",\"pubdate\":\"2008 Dec\",\"source\":\"Int J Colorectal Dis\",\"uid\":\"18679694\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells.\",\"author\":\"Ertych N\",\"pubdate\":\"2014 Aug\",\"source\":\"Nat Cell Biol\",\"uid\":\"24976383\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2.5\",\"GeneticEvidenceTotal\":\"3.25\",\"GeneticEvidencePointsTotal\":\"3.25\",\"ExperimentalEvidencePointsTotal\":\"2.5\",\"EvidencePointsTotal\":\"5.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"03/13/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"03/13/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1489388400,
    "dateISO8601": "2017-03-13T00:00:00",
    "dateFormated": "Mar 13, 2017"
  },
  "9863": {
    "title": "FAN1: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "29170": {
        "ontology": "HGNC",
        "curie": "HGNC:29170",
        "uri": "HGNC29170"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"FAN1\",\"Hgnc\":\"29170\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.\",\"author\":\"Segu\\u00ed N\",\"pubdate\":\"2015 Sep\",\"source\":\"Gastroenterology\",\"uid\":\"26052075\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.25\",\"pmid\":{\"publications\":[{\"title\":\"Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents.\",\"author\":\"Kratz K\",\"pubdate\":\"2010 Jul 9\",\"source\":\"Cell\",\"uid\":\"20603016\"},{\"title\":\"A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair.\",\"author\":\"Smogorzewska A\",\"pubdate\":\"2010 Jul 9\",\"source\":\"Mol Cell\",\"uid\":\"20603073\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.\",\"author\":\"Segu\\u00ed N\",\"pubdate\":\"2015 Sep\",\"source\":\"Gastroenterology\",\"uid\":\"26052075\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Ubiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability.\",\"author\":\"Lachaud C\",\"pubdate\":\"2016 Feb 19\",\"source\":\"Science\",\"uid\":\"26797144\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2.25\",\"GeneticEvidenceTotal\":\"1.5\",\"GeneticEvidencePointsTotal\":\"1.5\",\"ExperimentalEvidencePointsTotal\":\"2.25\",\"EvidencePointsTotal\":\"3.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"10/23/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"10/23/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1508742000,
    "dateISO8601": "2017-10-23T00:00:00",
    "dateFormated": "Oct 23, 2017"
  },
  "9864": {
    "title": "SEMA4A: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "10729": {
        "ontology": "HGNC",
        "curie": "HGNC:10729",
        "uri": "HGNC10729"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SEMA4A\",\"Hgnc\":\"10729\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.6\",\"tally\":\"0.6\",\"pmid\":{\"publications\":[{\"title\":\"Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.\",\"author\":\"Schulz E\",\"pubdate\":\"2014 Oct 13\",\"source\":\"Nat Commun\",\"uid\":\"25307848\"}],\"notes\":{\"note\":\"\"}}}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.\",\"author\":\"Schulz E\",\"pubdate\":\"2014 Oct 13\",\"source\":\"Nat Commun\",\"uid\":\"25307848\"}],\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis.\",\"author\":\"Adam R\",\"pubdate\":\"2016 Aug 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"27476653\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.\",\"author\":\"Schulz E\",\"pubdate\":\"2014 Oct 13\",\"source\":\"Nat Commun\",\"uid\":\"25307848\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"2.6\",\"GeneticEvidencePointsTotal\":\"2.6\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"3.6\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"11/13/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/13/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1510560000,
    "dateISO8601": "2017-11-13T00:00:00",
    "dateFormated": "Nov 13, 2017"
  },
  "9865": {
    "title": "XRCC4: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "12831": {
        "ontology": "HGNC",
        "curie": "HGNC:12831",
        "uri": "HGNC12831"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"XRCC4\",\"Hgnc\":\"12831\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.\",\"author\":\"Esteban-Jurado C\",\"pubdate\":\"2015 Feb\",\"source\":\"Genet Med\",\"uid\":\"25058500\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"1.5\",\"GeneticEvidencePointsTotal\":\"1.5\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"1.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"05/08/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"05/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1494226800,
    "dateISO8601": "2017-05-08T00:00:00",
    "dateFormated": "May 08, 2017"
  },
  "9866": {
    "title": "SMARCA4: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "11100": {
        "ontology": "HGNC",
        "curie": "HGNC:11100",
        "uri": "HGNC11100"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"SMARCA4\",\"Hgnc\":\"11100\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.1\",\"tally\":\"0.1\",\"pmid\":{\"publications\":[{\"title\":\"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.\",\"author\":\"Esteban-Jurado C\",\"pubdate\":\"2015 Feb\",\"source\":\"Genet Med\",\"uid\":\"25058500\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A.\",\"author\":\"Lin S\",\"pubdate\":\"2016 Dec 27\",\"source\":\"Oncotarget\",\"uid\":\"27852072\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0.5\",\"GeneticEvidenceTotal\":\"0.1\",\"GeneticEvidencePointsTotal\":\"0.1\",\"ExperimentalEvidencePointsTotal\":\"0.5\",\"EvidencePointsTotal\":\"0.6\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"05/08/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"05/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1494226800,
    "dateISO8601": "2017-05-08T00:00:00",
    "dateFormated": "May 08, 2017"
  },
  "9867": {
    "title": "NFKBIZ: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "29805": {
        "ontology": "HGNC",
        "curie": "HGNC:29805",
        "uri": "HGNC29805"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"NFKBIZ\",\"Hgnc\":\"29805\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"0.1\",\"tally\":\"0.1\",\"pmid\":{\"publications\":[{\"title\":\"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.\",\"author\":\"Esteban-Jurado C\",\"pubdate\":\"2015 Feb\",\"source\":\"Genet Med\",\"uid\":\"25058500\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0.1\",\"GeneticEvidencePointsTotal\":\"0.1\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0.1\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07/10/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"07/10/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1499670000,
    "dateISO8601": "2017-07-10T00:00:00",
    "dateFormated": "Jul 10, 2017"
  },
  "9868": {
    "title": "CTNNA1: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "2509": {
        "ontology": "HGNC",
        "curie": "HGNC:2509",
        "uri": "HGNC2509"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"CTNNA1\",\"Hgnc\":\"2509\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"04/24/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"04/24/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1493017200,
    "dateISO8601": "2017-04-24T00:00:00",
    "dateFormated": "Apr 24, 2017"
  },
  "9896": {
    "title": "MSH3: Polyposis susceptibility",
    "label": "Polyposis susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "7326": {
        "ontology": "HGNC",
        "curie": "HGNC:7326",
        "uri": "HGNC7326"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018812"
      },
      "OMIM617100": {
        "ontology": "OMIM",
        "curie": "OMIM:617100",
        "uri": "OMIM617100",
        "iri": "http://purl.obolibrary.org/obo/OMIM_617100"
      },
      "ORPHA480536": {
        "ontology": "ORPHA",
        "curie": "ORPHA:480536",
        "uri": "ORPHA480536",
        "iri": "http://www.orpha.net/ORDO/Orphanet_480536"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MSH3\",\"Hgnc\":\"7326\",\"OrphaNet\":\"480536\",\"Disease\":\"Polyposis susceptibility\",\"Omim\":\"617100\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"TwoNon-LOFVariantsInTrans\":{\"value\":\"\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis.\",\"author\":\"Adam R\",\"pubdate\":\"2016 Aug 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"27476653\"}],\"notes\":{\"note\":\"\"}}},\"TwoNariantsInTransAndAtLeastOneIsLOFOrDeNovo\":{\"value\":\"4.0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis.\",\"author\":\"Adam R\",\"pubdate\":\"2016 Aug 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"27476653\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression.\",\"author\":\"Edelmann W\",\"pubdate\":\"2000 Feb 15\",\"source\":\"Cancer Res\",\"uid\":\"10706084\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression.\",\"author\":\"Edelmann W\",\"pubdate\":\"2000 Feb 15\",\"source\":\"Cancer Res\",\"uid\":\"10706084\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3.5\",\"GeneticEvidenceTotal\":\"4\",\"GeneticEvidencePointsTotal\":\"4\",\"ExperimentalEvidencePointsTotal\":\"3.5\",\"EvidencePointsTotal\":\"7.5\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"12/13/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"12/13/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1481616000,
    "dateISO8601": "2016-12-13T00:00:00",
    "dateFormated": "Dec 13, 2016"
  },
  "9897": {
    "title": "MSH3: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "7326": {
        "ontology": "HGNC",
        "curie": "HGNC:7326",
        "uri": "HGNC7326"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MSH3\",\"Hgnc\":\"7326\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"0.0\",\"tally\":\"0.1\",\"pmid\":{\"publications\":[{\"title\":\"Association of low-risk MSH3 and MSH2 variant alleles with Lynch syndrome: probability of synergistic effects.\",\"author\":\"Duraturo F\",\"pubdate\":\"2011 Oct 1\",\"source\":\"Int J Cancer\",\"uid\":\"21128252\"}],\"notes\":{\"note\":\"\"}}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6.\",\"author\":\"Acharya S\",\"pubdate\":\"1996 Nov 26\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"8942985\"},{\"title\":\"Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis.\",\"author\":\"Adam R\",\"pubdate\":\"2016 Aug 4\",\"source\":\"Am J Hum Genet\",\"uid\":\"27476653\"},{\"title\":\"Tissue-specific mismatch repair protein expression: MSH3 is higher than MSH6 in multiple mouse tissues.\",\"author\":\"Tom\\u00e9 S\",\"pubdate\":\"2013 Jan 1\",\"source\":\"DNA Repair (Amst)\",\"uid\":\"23228367\"},{\"title\":\"hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA.\",\"author\":\"Palombo F\",\"pubdate\":\"1996 Sep 1\",\"source\":\"Curr Biol\",\"uid\":\"8805365\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression.\",\"author\":\"Edelmann W\",\"pubdate\":\"2000 Feb 15\",\"source\":\"Cancer Res\",\"uid\":\"10706084\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression.\",\"author\":\"Edelmann W\",\"pubdate\":\"2000 Feb 15\",\"source\":\"Cancer Res\",\"uid\":\"10706084\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"0.1\",\"GeneticEvidencePointsTotal\":\"0.1\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"3.1\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"11/13/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/13/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1510560000,
    "dateISO8601": "2017-11-13T00:00:00",
    "dateFormated": "Nov 13, 2017"
  },
  "9900": {
    "title": "MRE11: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "7230": {
        "ontology": "HGNC",
        "curie": "HGNC:7230",
        "uri": "HGNC7230"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MRE11\",\"Hgnc\":\"7230\",\"OrphaNet\":\"227535\",\"Disease\":\"Familial breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"The 3\",\"author\":\"Paull TT\",\"pubdate\":\"1998 Jun\",\"source\":\"Mol Cell\",\"uid\":\"9651580\"},{\"title\":\"Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.\",\"author\":\"Zhong Q\",\"pubdate\":\"1999 Jul 30\",\"source\":\"Science\",\"uid\":\"10426999\"},{\"title\":\"Altered expression of DNA double-strand break detection and repair proteins in breast carcinomas.\",\"author\":\"Ang\\u00e8le S\",\"pubdate\":\"2003 Oct\",\"source\":\"Histopathology\",\"uid\":\"14511253\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer.\",\"author\":\"Brandt S\",\"pubdate\":\"2017 Jan 10\",\"source\":\"BMC Cancer\",\"uid\":\"28073364\"},{\"title\":\"Checkpoint failure and chromosomal instability without lymphomagenesis in Mre11(ATLD1/ATLD1) mice.\",\"author\":\"Theunissen JW\",\"pubdate\":\"2003 Dec\",\"source\":\"Mol Cell\",\"uid\":\"14690604\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3.5\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"3.5\",\"EvidencePointsTotal\":\"3.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"10/25/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"10/25/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1508914800,
    "dateISO8601": "2017-10-25T00:00:00",
    "dateFormated": "Oct 25, 2017"
  },
  "9901": {
    "title": "MRE11: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "7230": {
        "ontology": "HGNC",
        "curie": "HGNC:7230",
        "uri": "HGNC7230"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MRE11\",\"Hgnc\":\"7230\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"The 3\",\"author\":\"Paull TT\",\"pubdate\":\"1998 Jun\",\"source\":\"Mol Cell\",\"uid\":\"9651580\"},{\"title\":\"Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.\",\"author\":\"Zhong Q\",\"pubdate\":\"1999 Jul 30\",\"source\":\"Science\",\"uid\":\"10426999\"},{\"title\":\"Altered expression of DNA double-strand break detection and repair proteins in breast carcinomas.\",\"author\":\"Ang\\u00e8le S\",\"pubdate\":\"2003 Oct\",\"source\":\"Histopathology\",\"uid\":\"14511253\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer.\",\"author\":\"Brandt S\",\"pubdate\":\"2017 Jan 10\",\"source\":\"BMC Cancer\",\"uid\":\"28073364\"},{\"title\":\"Checkpoint failure and chromosomal instability without lymphomagenesis in Mre11(ATLD1/ATLD1) mice.\",\"author\":\"Theunissen JW\",\"pubdate\":\"2003 Dec\",\"source\":\"Mol Cell\",\"uid\":\"14690604\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3.5\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"3.5\",\"EvidencePointsTotal\":\"3.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"10/25/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"10/25/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1508914800,
    "dateISO8601": "2017-10-25T00:00:00",
    "dateFormated": "Oct 25, 2017"
  },
  "9902": {
    "title": "MUTYH (AD): Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "7527": {
        "ontology": "HGNC",
        "curie": "HGNC:7527",
        "uri": "HGNC7527"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MUTYH\",\"Hgnc\":\"7527\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"05/24/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"05/24/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1495695600,
    "dateISO8601": "2017-05-25T00:00:00",
    "dateFormated": "May 25, 2017"
  },
  "9903": {
    "title": "MUTYH (AD): Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "7527": {
        "ontology": "HGNC",
        "curie": "HGNC:7527",
        "uri": "HGNC7527"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MUTYH\",\"Hgnc\":\"7527\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.\",\"author\":\"Win AK\",\"pubdate\":\"2016 Oct 1\",\"source\":\"Int J Cancer\",\"uid\":\"27194394\"},{\"title\":\"Expanded extracolonic tumor spectrum in MUTYH-associated polyposis.\",\"author\":\"Vogt S\",\"pubdate\":\"2009 Dec\",\"source\":\"Gastroenterology\",\"uid\":\"19732775\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Evidence for simultaneous protein interactions between human Rad51 paralogs.\",\"author\":\"Schild D\",\"pubdate\":\"2000 Jun 2\",\"source\":\"J Biol Chem\",\"uid\":\"10749867\"},{\"title\":\"Proteomics. Tissue-based map of the human proteome.\",\"author\":\"Uhl\\u00e9n M\",\"pubdate\":\"2015 Jan 23\",\"source\":\"Science\",\"uid\":\"25613900\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"3\",\"GeneticEvidencePointsTotal\":\"3\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"4\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"11/29/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/29/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1511942400,
    "dateISO8601": "2017-11-29T00:00:00",
    "dateFormated": "Nov 29, 2017"
  },
  "9904": {
    "title": "MUTYH (AR): Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "7527": {
        "ontology": "HGNC",
        "curie": "HGNC:7527",
        "uri": "HGNC7527"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MUTYH\",\"Hgnc\":\"7527\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"05/24/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"05/24/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1495609200,
    "dateISO8601": "2017-05-24T00:00:00",
    "dateFormated": "May 24, 2017"
  },
  "9905": {
    "title": "MUTYH (AR): Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "7527": {
        "ontology": "HGNC",
        "curie": "HGNC:7527",
        "uri": "HGNC7527"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MUTYH\",\"Hgnc\":\"7527\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.\",\"author\":\"Win AK\",\"pubdate\":\"2016 Oct 1\",\"source\":\"Int J Cancer\",\"uid\":\"27194394\"},{\"title\":\"Expanded extracolonic tumor spectrum in MUTYH-associated polyposis.\",\"author\":\"Vogt S\",\"pubdate\":\"2009 Dec\",\"source\":\"Gastroenterology\",\"uid\":\"19732775\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Evidence for simultaneous protein interactions between human Rad51 paralogs.\",\"author\":\"Schild D\",\"pubdate\":\"2000 Jun 2\",\"source\":\"J Biol Chem\",\"uid\":\"10749867\"},{\"title\":\"Proteomics. Tissue-based map of the human proteome.\",\"author\":\"Uhl\\u00e9n M\",\"pubdate\":\"2015 Jan 23\",\"source\":\"Science\",\"uid\":\"25613900\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"3\",\"GeneticEvidencePointsTotal\":\"3\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"4\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"11/29/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/29/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1511942400,
    "dateISO8601": "2017-11-29T00:00:00",
    "dateFormated": "Nov 29, 2017"
  },
  "9906": {
    "title": "NBN: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "7652": {
        "ontology": "HGNC",
        "curie": "HGNC:7652",
        "uri": "HGNC7652"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"NBN\",\"Hgnc\":\"7652\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk.\",\"author\":\"Zhang G\",\"pubdate\":\"2013 Oct\",\"source\":\"Tumour Biol\",\"uid\":\"23765759\"}],\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Proteomics. Tissue-based map of the human proteome.\",\"author\":\"Uhl\\u00e9n M\",\"pubdate\":\"2015 Jan 23\",\"source\":\"Science\",\"uid\":\"25613900\"},{\"title\":\"ATM-dependent phosphorylation of nibrin in response to radiation exposure.\",\"author\":\"Gatei M\",\"pubdate\":\"2000 May\",\"source\":\"Nat Genet\",\"uid\":\"10802669\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair.\",\"author\":\"Kang J\",\"pubdate\":\"2002 Mar 15\",\"source\":\"EMBO J\",\"uid\":\"11889050\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"1\",\"GeneticEvidencePointsTotal\":\"1\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"2.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"09/27/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"09/27/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1506495600,
    "dateISO8601": "2017-09-27T00:00:00",
    "dateFormated": "Sep 27, 2017"
  },
  "9908": {
    "title": "ATM: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "795": {
        "ontology": "HGNC",
        "curie": "HGNC:795",
        "uri": "HGNC795"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM114480": {
        "ontology": "OMIM",
        "curie": "OMIM:114480",
        "uri": "OMIM114480",
        "iri": "http://purl.obolibrary.org/obo/OMIM_114480"
      },
      "ORPHA227353": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227353",
        "uri": "ORPHA227353",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227353"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"ATM\",\"Hgnc\":\"795\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"114480\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"1.5\",\"tally\":\"1.5\"}}}},\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\"},\"AggregateVariantAnalysis\":{\"value\":\"10.0\",\"tally\":\"10\"}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.\",\"author\":\"Cortez D\",\"pubdate\":\"1999 Nov 5\",\"source\":\"Science\",\"uid\":\"10550055\"},{\"title\":\"Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas.\",\"author\":\"Ang\\u00e8le S\",\"pubdate\":\"2000 Sep\",\"source\":\"Clin Cancer Res\",\"uid\":\"10999741\"},{\"title\":\"Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient.\",\"author\":\"Varghese S\",\"pubdate\":\"1999\",\"source\":\"Radiat Oncol Investig\",\"uid\":\"10492163\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.\",\"author\":\"Spring K\",\"pubdate\":\"2002 Sep\",\"source\":\"Nat Genet\",\"uid\":\"12195425\"},{\"title\":\"Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.\",\"author\":\"Scott SP\",\"pubdate\":\"2002 Jan 22\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"11805335\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.\",\"author\":\"Spring K\",\"pubdate\":\"2002 Sep\",\"source\":\"Nat Genet\",\"uid\":\"12195425\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"07/12/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"07/12/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1499842800,
    "dateISO8601": "2017-07-12T00:00:00",
    "dateFormated": "Jul 12, 2017"
  },
  "9909": {
    "title": "BARD1: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "952": {
        "ontology": "HGNC",
        "curie": "HGNC:952",
        "uri": "HGNC952"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"BARD1\",\"Hgnc\":\"952\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Inherited Mutations in Women With Ovarian Carcinoma.\",\"author\":\"Norquist BM\",\"pubdate\":\"2016 Apr\",\"source\":\"JAMA Oncol\",\"uid\":\"26720728\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.\",\"author\":\"Hashizume R\",\"pubdate\":\"2001 May 4\",\"source\":\"J Biol Chem\",\"uid\":\"11278247\"},{\"title\":\"Identification of a RING protein that can interact in vivo with the BRCA1 gene product.\",\"author\":\"Wu LC\",\"pubdate\":\"1996 Dec\",\"source\":\"Nat Genet\",\"uid\":\"8944023\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1\",\"GeneticEvidenceTotal\":\"1\",\"GeneticEvidencePointsTotal\":\"1\",\"ExperimentalEvidencePointsTotal\":\"1\",\"EvidencePointsTotal\":\"2\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"08/09/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"08/09/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1502262000,
    "dateISO8601": "2017-08-09T00:00:00",
    "dateFormated": "Aug 09, 2017"
  },
  "9910": {
    "title": "BRIP1: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "20473": {
        "ontology": "HGNC",
        "curie": "HGNC:20473",
        "uri": "HGNC20473"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM114480": {
        "ontology": "OMIM",
        "curie": "OMIM:114480",
        "uri": "OMIM114480",
        "iri": "http://purl.obolibrary.org/obo/OMIM_114480"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3973": {
        "label": "Contradictory (refuted)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"BRIP1\",\"Hgnc\":\"20473\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"114480\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.\",\"author\":\"Cantor SB\",\"pubdate\":\"2001 Apr 6\",\"source\":\"Cell\",\"uid\":\"11301010\"},{\"title\":\"The BRCT domain is a phospho-protein binding domain.\",\"author\":\"Yu X\",\"pubdate\":\"2003 Oct 24\",\"source\":\"Science\",\"uid\":\"14576433\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations.\",\"author\":\"Cantor S\",\"pubdate\":\"2004 Feb 24\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"14983014\"},{\"title\":\"BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.\",\"author\":\"Cantor SB\",\"pubdate\":\"2001 Apr 6\",\"source\":\"Cell\",\"uid\":\"11301010\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair.\",\"author\":\"Bridge WL\",\"pubdate\":\"2005 Sep\",\"source\":\"Nat Genet\",\"uid\":\"16116421\"},{\"title\":\"BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.\",\"author\":\"Litman R\",\"pubdate\":\"2005 Sep\",\"source\":\"Cancer Cell\",\"uid\":\"16153896\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"ValidContradictoryEvidence\":{\"YesNo\":\"YES\",\"pmid\":{\"publications\":{\"1525888062516\":{\"title\":\"Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies.\",\"author\":\"Aloraifi F\",\"pubdate\":\"2015 Sep\",\"source\":\"Cancer Genet\",\"uid\":\"26250988\"}},\"notes\":{\"note\":\"\"}}},\"summary\":{\"ExperimentalEvidenceTotal\":\"3\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"3\",\"EvidencePointsTotal\":\"3\",\"CalculatedClassification\":\"CONFLICTING EVIDENCE REPORTED\",\"CalculatedClassificationDate\":\"05/10/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"REFUTED\",\"FinalClassificationDate\":\"05/10/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1494399600,
    "dateISO8601": "2017-05-10T00:00:00",
    "dateFormated": "May 10, 2017"
  },
  "9911": {
    "title": "BRIP1: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "20473": {
        "ontology": "HGNC",
        "curie": "HGNC:20473",
        "uri": "HGNC20473"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"BRIP1\",\"Hgnc\":\"20473\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer \",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in BRIP1 confer high risk of ovarian cancer.\",\"author\":\"Rafnar T\",\"pubdate\":\"2011 Oct 2\",\"source\":\"Nat Genet\",\"uid\":\"21964575\"}],\"notes\":{\"note\":\"\"}}},\"AggregateVariantAnalysis\":{\"value\":\"10.5\",\"tally\":\"10.5\",\"pmid\":{\"publications\":[{\"title\":\"Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.\",\"author\":\"Ramus SJ\",\"pubdate\":\"2015 Nov\",\"source\":\"J Natl Cancer Inst\",\"uid\":\"26315354\"},{\"title\":\"Inherited Mutations in Women With Ovarian Carcinoma.\",\"author\":\"Norquist BM\",\"pubdate\":\"2016 Apr\",\"source\":\"JAMA Oncol\",\"uid\":\"26720728\"},{\"title\":\"Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.\",\"author\":\"Lilyquist J\",\"pubdate\":\"2017 Nov\",\"source\":\"Gynecol Oncol\",\"uid\":\"28888541\"},{\"title\":\"BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.\",\"author\":\"Weber-Lassalle N\",\"pubdate\":\"2018 Jan 24\",\"source\":\"Breast Cancer Res\",\"uid\":\"29368626\"}]}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in BRIP1 confer high risk of ovarian cancer.\",\"author\":\"Rafnar T\",\"pubdate\":\"2011 Oct 2\",\"source\":\"Nat Genet\",\"uid\":\"21964575\"},{\"title\":\"The BRCT domain is a phospho-protein binding domain.\",\"author\":\"Yu X\",\"pubdate\":\"2003 Oct 24\",\"source\":\"Science\",\"uid\":\"14576433\"},{\"title\":\"The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly.\",\"author\":\"Joukov V\",\"pubdate\":\"2006 Nov 3\",\"source\":\"Cell\",\"uid\":\"17081976\"},{\"title\":\"BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.\",\"author\":\"Cantor SB\",\"pubdate\":\"2001 Apr 6\",\"source\":\"Cell\",\"uid\":\"11301010\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Fanconi anemia group J helicase and MRE11 nuclease interact to facilitate the DNA damage response.\",\"author\":\"Suhasini AN\",\"pubdate\":\"2013 Jun\",\"source\":\"Mol Cell Biol\",\"uid\":\"23530059\"},{\"title\":\"The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells.\",\"author\":\"Peng M\",\"pubdate\":\"2007 Jul 11\",\"source\":\"EMBO J\",\"uid\":\"17581638\"},{\"title\":\"FANCJ suppresses microsatellite instability and lymphomagenesis independent of the Fanconi anemia pathway.\",\"author\":\"Matsuzaki K\",\"pubdate\":\"2015 Dec 15\",\"source\":\"Genes Dev\",\"uid\":\"26637282\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Fanconi anemia group J mutation abolishes its DNA repair function by uncoupling DNA translocation from helicase activity or disruption of protein-DNA complexes.\",\"author\":\"Wu Y\",\"pubdate\":\"2010 Nov 11\",\"source\":\"Blood\",\"uid\":\"20639400\"},{\"title\":\"The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair.\",\"author\":\"Bridge WL\",\"pubdate\":\"2005 Sep\",\"source\":\"Nat Genet\",\"uid\":\"16116421\"},{\"title\":\"Insight into the roles of helicase motif Ia by characterizing Fanconi anemia group J protein (FANCJ) patient mutations.\",\"author\":\"Guo M\",\"pubdate\":\"2014 Apr 11\",\"source\":\"J Biol Chem\",\"uid\":\"24573678\"},{\"title\":\"FANCJ suppresses microsatellite instability and lymphomagenesis independent of the Fanconi anemia pathway.\",\"author\":\"Matsuzaki K\",\"pubdate\":\"2015 Dec 15\",\"source\":\"Genes Dev\",\"uid\":\"26637282\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10/12/2016\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"10/12/2016\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1476255600,
    "dateISO8601": "2016-10-12T00:00:00",
    "dateFormated": "Oct 12, 2016"
  },
  "9940": {
    "title": "PALB2: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "26144": {
        "ontology": "HGNC",
        "curie": "HGNC:26144",
        "uri": "HGNC26144"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PALB2\",\"Hgnc\":\"26144\",\"OrphaNet\":\"ORPHA213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Inherited Mutations in Women With Ovarian Carcinoma.\",\"author\":\"Norquist BM\",\"pubdate\":\"2016 Apr\",\"source\":\"JAMA Oncol\",\"uid\":\"26720728\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.\",\"author\":\"Xia B\",\"pubdate\":\"2006 Jun 23\",\"source\":\"Mol Cell\",\"uid\":\"16793542\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"A recurrent mutation in PALB2 in Finnish cancer families.\",\"author\":\"Erkko H\",\"pubdate\":\"2007 Mar 15\",\"source\":\"Nature\",\"uid\":\"17287723\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2\",\"GeneticEvidenceTotal\":\"6\",\"GeneticEvidencePointsTotal\":\"6\",\"ExperimentalEvidencePointsTotal\":\"2\",\"EvidencePointsTotal\":\"8\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"11/08/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"11/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1510128000,
    "dateISO8601": "2017-11-08T00:00:00",
    "dateFormated": "Nov 08, 2017"
  },
  "9957": {
    "title": "RAD51D: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "9823": {
        "ontology": "HGNC",
        "curie": "HGNC:9823",
        "uri": "HGNC9823"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"RAD51D\",\"Hgnc\":\"9823\",\"OrphaNet\":\"ORPHA213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"12.0\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.\",\"author\":\"Lilyquist J\",\"pubdate\":\"2017 Nov\",\"source\":\"Gynecol Oncol\",\"uid\":\"28888541\"},{\"title\":\"Inherited Mutations in Women With Ovarian Carcinoma.\",\"author\":\"Norquist BM\",\"pubdate\":\"2016 Apr\",\"source\":\"JAMA Oncol\",\"uid\":\"26720728\"},{\"title\":\"Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.\",\"author\":\"Song H\",\"pubdate\":\"2015 Sep 10\",\"source\":\"J Clin Oncol\",\"uid\":\"26261251\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Evidence for simultaneous protein interactions between human Rad51 paralogs.\",\"author\":\"Schild D\",\"pubdate\":\"2000 Jun 2\",\"source\":\"J Biol Chem\",\"uid\":\"10749867\"},{\"title\":\"RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors.\",\"author\":\"Martin RW\",\"pubdate\":\"2007 Oct 15\",\"source\":\"Cancer Res\",\"uid\":\"17942895\"},{\"title\":\"Identification and purification of two distinct complexes containing the five RAD51 paralogs.\",\"author\":\"Masson JY\",\"pubdate\":\"2001 Dec 15\",\"source\":\"Genes Dev\",\"uid\":\"11751635\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations in RAD51D confer susceptibility to ovarian cancer.\",\"author\":\"Loveday C\",\"pubdate\":\"2011 Aug 7\",\"source\":\"Nat Genet\",\"uid\":\"21822267\"},{\"title\":\"Extensive chromosomal instability in Rad51d-deficient mouse cells.\",\"author\":\"Smiraldo PG\",\"pubdate\":\"2005 Mar 15\",\"source\":\"Cancer Res\",\"uid\":\"15781618\"},{\"title\":\"The homologous recombination protein RAD51D protects the genome from large deletions.\",\"author\":\"Reh WA\",\"pubdate\":\"2017 Feb 28\",\"source\":\"Nucleic Acids Res\",\"uid\":\"27924006\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Functionally Null <i>RAD51D</i> Missense Mutation Associates Strongly with Ovarian Carcinoma.\",\"author\":\"Rivera B\",\"pubdate\":\"2017 Aug 15\",\"source\":\"Cancer Res\",\"uid\":\"28646019\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"5.5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"5.5\",\"EvidencePointsTotal\":\"17.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10/11/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"10/11/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1507705200,
    "dateISO8601": "2017-10-11T00:00:00",
    "dateFormated": "Oct 11, 2017"
  },
  "9972": {
    "title": "BRCA1: Familial breast-ovarian cancer susceptibility",
    "label": "Familial breast-ovarian cancer susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "1100": {
        "ontology": "HGNC",
        "curie": "HGNC:1100",
        "uri": "HGNC1100"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011450"
      },
      "OMIM604370": {
        "ontology": "OMIM",
        "curie": "OMIM:604370",
        "uri": "OMIM604370",
        "iri": "http://purl.obolibrary.org/obo/OMIM_604370"
      },
      "ORPHA145": {
        "ontology": "ORPHA",
        "curie": "ORPHA:145",
        "uri": "ORPHA145",
        "iri": "http://www.orpha.net/ORDO/Orphanet_145"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"BRCA1\",\"Hgnc\":\"1100\",\"OrphaNet\":\"145\",\"Disease\":\"Familial breast-ovarian cancer susceptibility\",\"Omim\":\"604370\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"14.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.\",\"author\":\"Miki Y\",\"pubdate\":\"1994 Oct 7\",\"source\":\"Science\",\"uid\":\"7545954\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"12.0\",\"tally\":\"12\",\"pmid\":{\"publications\":[{\"title\":\"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.\",\"author\":\"Miki Y\",\"pubdate\":\"1994 Oct 7\",\"source\":\"Science\",\"uid\":\"7545954\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression.\",\"author\":\"Thompson ME\",\"pubdate\":\"1995 Apr\",\"source\":\"Nat Genet\",\"uid\":\"7795653\"},{\"title\":\"Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.\",\"author\":\"Xu X\",\"pubdate\":\"1999 Mar\",\"source\":\"Mol Cell\",\"uid\":\"10198641\"},{\"title\":\"Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2.\",\"author\":\"Foray N\",\"pubdate\":\"1999 Dec 2\",\"source\":\"Oncogene\",\"uid\":\"10602489\"},{\"title\":\"Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.\",\"author\":\"Chen J\",\"pubdate\":\"1998 Sep\",\"source\":\"Mol Cell\",\"uid\":\"9774970\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"4.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression.\",\"author\":\"Thompson ME\",\"pubdate\":\"1995 Apr\",\"source\":\"Nat Genet\",\"uid\":\"7795653\"},{\"title\":\"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.\",\"author\":\"Farmer H\",\"pubdate\":\"2005 Apr 14\",\"source\":\"Nature\",\"uid\":\"15829967\"},{\"title\":\"High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium.\",\"author\":\"Cornelis RS\",\"pubdate\":\"1995 Jul\",\"source\":\"Genes Chromosomes Cancer\",\"uid\":\"7669740\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Brca1 controls homology-directed DNA repair.\",\"author\":\"Moynahan ME\",\"pubdate\":\"1999 Oct\",\"source\":\"Mol Cell\",\"uid\":\"10549283\"},{\"title\":\"Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.\",\"author\":\"Moynahan ME\",\"pubdate\":\"2001 Jun 15\",\"source\":\"Cancer Res\",\"uid\":\"11406561\"},{\"title\":\"Growth retardation and tumour inhibition by BRCA1.\",\"author\":\"Holt JT\",\"pubdate\":\"1996 Mar\",\"source\":\"Nat Genet\",\"uid\":\"8589721\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"09/13/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"09/13/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1505286000,
    "dateISO8601": "2017-09-13T00:00:00",
    "dateFormated": "Sep 13, 2017"
  },
  "9990": {
    "title": "PTEN: PTEN Hamartoma Tumor Syndrome",
    "label": "PTEN Hamartoma Tumor Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10012",
      "name": "PTEN"
    },
    "genes": {
      "9588": {
        "ontology": "HGNC",
        "curie": "HGNC:9588",
        "uri": "HGNC9588"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0017623"
      },
      "OMIM601728": {
        "ontology": "OMIM",
        "curie": "OMIM:601728",
        "uri": "OMIM601728",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601728"
      },
      "ORPHA306498": {
        "ontology": "ORPHA",
        "curie": "ORPHA:306498",
        "uri": "ORPHA306498",
        "iri": "http://www.orpha.net/ORDO/Orphanet_306498"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PTEN\",\"Hgnc\":\"9588\",\"OrphaNet\":\"306498\",\"Disease\":\"PTEN Hamartoma Tumor Syndrome\",\"Omim\":\"601728\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithNon-LOF\":{\"value\":\"3.0\",\"tally\":\"3.1\",\"pmid\":{\"publications\":[{\"title\":\"Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps.\",\"author\":\"Ngeow J\",\"pubdate\":\"2013 Jun\",\"source\":\"Gastroenterology\",\"uid\":\"23399955\"}],\"notes\":{\"note\":\"\"}}},\"VariantIsDeNovo\":{\"value\":\"11.0\",\"tally\":\"10\",\"pmid\":{\"publications\":[{\"title\":\"Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers.\",\"author\":\"Heald B\",\"pubdate\":\"2010 Dec\",\"source\":\"Gastroenterology\",\"uid\":\"20600018\"}],\"notes\":{\"note\":\"\"}}}}}},\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Lifetime cancer risks in individuals with germline PTEN mutations.\",\"author\":\"Tan MH\",\"pubdate\":\"2012 Jan 15\",\"source\":\"Clin Cancer Res\",\"uid\":\"22252256\"},{\"title\":\"High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.\",\"author\":\"Bubien V\",\"pubdate\":\"2013 Apr\",\"source\":\"J Med Genet\",\"uid\":\"23335809\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"PTEN mutations are common in sporadic microsatellite stable colorectal cancer.\",\"author\":\"Nassif NT\",\"pubdate\":\"2004 Jan 15\",\"source\":\"Oncogene\",\"uid\":\"14724591\"},{\"title\":\"LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.\",\"author\":\"Mehenni H\",\"pubdate\":\"2005 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"15987703\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Ubiquitination regulates PTEN nuclear import and tumor suppression.\",\"author\":\"Trotman LC\",\"pubdate\":\"2007 Jan 12\",\"source\":\"Cell\",\"uid\":\"17218261\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"5.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Pten is essential for embryonic development and tumour suppression.\",\"author\":\"Di Cristofano A\",\"pubdate\":\"1998 Aug\",\"source\":\"Nat Genet\",\"uid\":\"9697695\"},{\"title\":\"Ubiquitination regulates PTEN nuclear import and tumor suppression.\",\"author\":\"Trotman LC\",\"pubdate\":\"2007 Jan 12\",\"source\":\"Cell\",\"uid\":\"17218261\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10/09/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"10/09/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1507532400,
    "dateISO8601": "2017-10-09T00:00:00",
    "dateFormated": "Oct 09, 2017"
  },
  "9991": {
    "title": "TP53: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "11998": {
        "ontology": "HGNC",
        "curie": "HGNC:11998",
        "uri": "HGNC11998"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"TP53\",\"Hgnc\":\"11998\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Inherited Mutations in Women With Ovarian Carcinoma.\",\"author\":\"Norquist BM\",\"pubdate\":\"2016 Apr\",\"source\":\"JAMA Oncol\",\"uid\":\"26720728\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.5\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.\",\"author\":\"Rivlin N\",\"pubdate\":\"2011 Apr\",\"source\":\"Genes Cancer\",\"uid\":\"21779514\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.\",\"author\":\"Monti P\",\"pubdate\":\"2011 Mar\",\"source\":\"Mol Cancer Res\",\"uid\":\"21343334\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas.\",\"author\":\"Soragni A\",\"pubdate\":\"2016 Jan 11\",\"source\":\"Cancer Cell\",\"uid\":\"26748848\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"3.5\",\"GeneticEvidenceTotal\":\"2\",\"GeneticEvidencePointsTotal\":\"2\",\"ExperimentalEvidencePointsTotal\":\"3.5\",\"EvidencePointsTotal\":\"5.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01/10/2018\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"01/10/2018\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1515571200,
    "dateISO8601": "2018-01-10T00:00:00",
    "dateFormated": "Jan 10, 2018"
  },
  "9992": {
    "title": "STK11: Peutz-Jeghers syndrome",
    "label": "Peutz-Jeghers syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "11389": {
        "ontology": "HGNC",
        "curie": "HGNC:11389",
        "uri": "HGNC11389"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0008280"
      },
      "OMIM175200": {
        "ontology": "OMIM",
        "curie": "OMIM:175200",
        "uri": "OMIM175200",
        "iri": "http://purl.obolibrary.org/obo/OMIM_175200"
      },
      "ORPHA2869": {
        "ontology": "ORPHA",
        "curie": "ORPHA:2869",
        "uri": "ORPHA2869",
        "iri": "http://www.orpha.net/ORDO/Orphanet_2869"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"STK11\",\"Hgnc\":\"11389\",\"OrphaNet\":\"2869\",\"Disease\":\"Peutz-Jeghers syndrome\",\"Omim\":\"175200\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"7.0\",\"tally\":\"7\",\"pmid\":{\"publications\":[{\"title\":\"Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase.\",\"author\":\"Jenne DE\",\"pubdate\":\"1998 Jan\",\"source\":\"Nat Genet\",\"uid\":\"9425897\"},{\"title\":\"Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome.\",\"author\":\"Lim W\",\"pubdate\":\"2003 Jul 21\",\"source\":\"Br J Cancer\",\"uid\":\"12865922\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"6.0\",\"tally\":\"6\",\"pmid\":{\"publications\":[{\"title\":\"Fine mapping of a genetic locus for Peutz-Jeghers syndrome on chromosome 19p.\",\"author\":\"Amos CI\",\"pubdate\":\"1997 Sep 1\",\"source\":\"Cancer Res\",\"uid\":\"9288765\"}],\"notes\":{\"note\":\"\"}}}}},\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"4.5\",\"tally\":\"4.5\",\"pmid\":{\"publications\":[{\"title\":\"Frequency and spectrum of cancers in the Peutz-Jeghers syndrome.\",\"author\":\"Hearle N\",\"pubdate\":\"2006 May 15\",\"source\":\"Clin Cancer Res\",\"uid\":\"16707622\"},{\"title\":\"Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study.\",\"author\":\"Resta N\",\"pubdate\":\"2013 Jul\",\"source\":\"Dig Liver Dis\",\"uid\":\"23415580\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.\",\"author\":\"Mehenni H\",\"pubdate\":\"2005 Aug 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"15987703\"},{\"title\":\"Loss of LKB1 expression reduces the latency of ErbB2-mediated mammary gland tumorigenesis, promoting changes in metabolic pathways.\",\"author\":\"Andrade-Vieira R\",\"pubdate\":\"2013\",\"source\":\"PLoS One\",\"uid\":\"23451056\"},{\"title\":\"LKB1 is a DNA damage response protein that regulates cellular sensitivity to PARP inhibitors.\",\"author\":\"Wang YS\",\"pubdate\":\"2016 Nov 8\",\"source\":\"Oncotarget\",\"uid\":\"27705915\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"The LKB1 tumor suppressor negatively regulates mTOR signaling.\",\"author\":\"Shaw RJ\",\"pubdate\":\"2004 Jul\",\"source\":\"Cancer Cell\",\"uid\":\"15261145\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formation.\",\"author\":\"McCarthy A\",\"pubdate\":\"2009 Nov\",\"source\":\"J Pathol\",\"uid\":\"19681070\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"02/22/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"02/22/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1487750400,
    "dateISO8601": "2017-02-22T00:00:00",
    "dateFormated": "Feb 22, 2017"
  },
  "10029": {
    "title": "BMPR1A: Juvenile Polyposis Syndrome",
    "label": "Juvenile Polyposis Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "1076": {
        "ontology": "HGNC",
        "curie": "HGNC:1076",
        "uri": "HGNC1076"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0008276"
      },
      "OMIM174900": {
        "ontology": "OMIM",
        "curie": "OMIM:174900",
        "uri": "OMIM174900",
        "iri": "http://purl.obolibrary.org/obo/OMIM_174900"
      },
      "ORPHA329971": {
        "ontology": "ORPHA",
        "curie": "ORPHA:329971",
        "uri": "ORPHA329971",
        "iri": "http://www.orpha.net/ORDO/Orphanet_329971"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"BMPR1A\",\"Hgnc\":\"1076\",\"OrphaNet\":\"329971\",\"Disease\":\"Juvenile Polyposis Syndrome\",\"Omim\":\"174900\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"9.0\",\"tally\":\"9\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes.\",\"author\":\"Zhou XP\",\"pubdate\":\"2001 Oct\",\"source\":\"Am J Hum Genet\",\"uid\":\"11536076\"}],\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"value\":\"6.5\",\"tally\":\"6.5\",\"pmid\":{\"publications\":[{\"title\":\"Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.\",\"author\":\"Howe JR\",\"pubdate\":\"2001 Jun\",\"source\":\"Nat Genet\",\"uid\":\"11381269\"}],\"notes\":{\"note\":\"\"}}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.0\",\"tally\":\"1\"},\"FunctionalAlteration\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Cyclooxygenase-2 expression in polyps from a patient with juvenile polyposis syndrome with mutant BMPR1A.\",\"author\":\"Kurland JE\",\"pubdate\":\"2007 Mar\",\"source\":\"J Pediatr Gastroenterol Nutr\",\"uid\":\"17325551\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling.\",\"author\":\"He XC\",\"pubdate\":\"2004 Oct\",\"source\":\"Nat Genet\",\"uid\":\"15378062\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4.5\",\"GeneticEvidenceTotal\":\"12\",\"GeneticEvidencePointsTotal\":\"12\",\"ExperimentalEvidencePointsTotal\":\"4.5\",\"EvidencePointsTotal\":\"16.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"06/12/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"06/12/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1497250800,
    "dateISO8601": "2017-06-12T00:00:00",
    "dateFormated": "Jun 12, 2017"
  },
  "10043": {
    "title": "ANKRD1: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:15819": {
        "ontology": "HGNC",
        "curie": "HGNC:15819",
        "uri": "HGNC15819"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM609599": {
        "ontology": "OMIM",
        "curie": "OMIM:609599",
        "uri": "OMIM609599",
        "iri": "http://purl.obolibrary.org/obo/OMIM_609599"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1529264287\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"ANKRD1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:15819\",\"uri\":\"HGNC15819\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:0005045\",\"uri\":\"ORPHA0005045\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:609599\",\"uri\":\"OMIM609599\"}},\"title\":\"ANKRD1 Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"1.10\",\"Tally\":\"1.1\",\"evidence\":{\"publications\":{\"1527872649215\":{\"title\":\"Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy.\",\"author\":\"Arimura T\",\"pubdate\":\"2009 Jul 21\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"19608031\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1.1\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527872724286\":{\"title\":\"Proteomics. Tissue-based map of the human proteome.\",\"author\":\"Uhl\\u00e9n M\",\"pubdate\":\"2015 Jan 23\",\"source\":\"Science\",\"uid\":\"25613900\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527872691785\":{\"title\":\"Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.\",\"author\":\"Crocini C\",\"pubdate\":\"2013 May\",\"source\":\"Basic Res Cardiol\",\"uid\":\"23572067\"}},\"notes\":{\"note\":\"\"}}}},\"ModelsRescue\":{\"Tally\":\"1\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1.1\",\"ExperimentalEvidenceTotal\":\"2\",\"EvidencePointsTotal\":\"3.1\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"09/18/2017\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"09/19/2017\",\"FinalClassificationNotes\":\"This classification was approved by the Hypertrophic Cardiomyopathy Gene Curation Expert Panel.\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1505718000,
    "dateISO8601": "2017-09-18T00:00:00",
    "dateFormated": "Sep 18, 2017"
  },
  "10044": {
    "title": "CACNB2: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:1402": {
        "ontology": "HGNC",
        "curie": "HGNC:1402",
        "uri": "HGNC1402"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM600003": {
        "ontology": "OMIM",
        "curie": "OMIM:600003",
        "uri": "OMIM600003",
        "iri": "http://purl.obolibrary.org/obo/OMIM_600003"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1529264465\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"CACNB2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:1402\",\"uri\":\"HGNC1402\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"MONDO\":{\"curie\":\"MONDO:0000591\",\"uri\":\"MONDO0000591\"},\"OMIM\":{\"curie\":\"OMIM:600003\",\"uri\":\"OMIM600003\"}},\"title\":\"CACNB2 Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.00\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.00\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"\",\"ExperimentalEvidenceTotal\":\"\",\"EvidencePointsTotal\":\"\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"NO REPORTED EVIDENCE\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"06/06/2017\",\"FinalClassificationNotes\":\"This classification was approved by the ClinGen Hypertrophic Cardiomyopathy Expert Panel.\"},\"ReplicationOverTime\":\"NO\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1496732400,
    "dateISO8601": "2017-06-06T00:00:00",
    "dateFormated": "Jun 06, 2017"
  },
  "10047": {
    "title": "ACTA1: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:129": {
        "ontology": "HGNC",
        "curie": "HGNC:129",
        "uri": "HGNC129"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527791889\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"ACTA1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:129\",\"uri\":\"HGNC129\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"}},\"title\":\"ACTA1 Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"0.00\",\"Tally\":\"\",\"evidence\":{\"publications\":{\"1527791287454\":{\"title\":\"Nemaline myopathy and non-fatal hypertrophic cardiomyopathy caused by a novel ACTA1 E239K mutation.\",\"author\":\"Kim SY\",\"pubdate\":\"2011 Aug 15\",\"source\":\"J Neurol Sci\",\"uid\":\"21570694\"},\"1527791299873\":{\"title\":\"Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation.\",\"author\":\"D\",\"pubdate\":\"2006 Oct\",\"source\":\"Neuromuscul Disord\",\"uid\":\"16945537\"}},\"notes\":{\"note\":\"Both patients had nemaline myopathy in addition to HCM.\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.00\",\"Tally\":\"\",\"evidence\":{\"publications\":{\"1527791359465\":{\"title\":\"Missense mutations of ACTA1 cause dominant congenital myopathy with cores.\",\"author\":\"Kaindl AM\",\"pubdate\":\"2004 Nov\",\"source\":\"J Med Genet\",\"uid\":\"15520409\"}},\"notes\":{\"note\":\"Patient had central core disease in addition to HCM.\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"\",\"ExperimentalEvidenceTotal\":\"\",\"EvidencePointsTotal\":\"\",\"CalculatedClassification\":\"\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"NO REPORTED EVIDENCE\",\"CuratorClassificationDate\":\"10/11/2016\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"11/01/2016\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1478041200,
    "dateISO8601": "2016-11-01T16:00:00",
    "dateFormated": "Nov 01, 2016"
  },
  "10048": {
    "title": "MYPN: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:23246": {
        "ontology": "HGNC",
        "curie": "HGNC:23246",
        "uri": "HGNC23246"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM615248": {
        "ontology": "OMIM",
        "curie": "OMIM:615248",
        "uri": "OMIM615248",
        "iri": "http://purl.obolibrary.org/obo/OMIM_615248"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1529513343\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"MYPN\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:23246\",\"uri\":\"HGNC23246\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:615248\",\"uri\":\"OMIM615248\"}},\"title\":\"MYPN Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.90\",\"Tally\":\"0.9\",\"evidence\":{\"publications\":{\"1527792684463\":{\"title\":\"Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations.\",\"author\":\"Purevjav E\",\"pubdate\":\"2012 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"22286171\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.9\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527792746151\":{\"title\":\"Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations.\",\"author\":\"Purevjav E\",\"pubdate\":\"2012 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"22286171\"},\"1527792789051\":{\"title\":\"Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies.\",\"author\":\"Bang ML\",\"pubdate\":\"2001 Apr 16\",\"source\":\"J Cell Biol\",\"uid\":\"11309420\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527792801451\":{\"title\":\"Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies.\",\"author\":\"Bang ML\",\"pubdate\":\"2001 Apr 16\",\"source\":\"J Cell Biol\",\"uid\":\"11309420\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"1.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"1\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527792766194\":{\"title\":\"Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations.\",\"author\":\"Purevjav E\",\"pubdate\":\"2012 May 1\",\"source\":\"Hum Mol Genet\",\"uid\":\"22286171\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.9\",\"ExperimentalEvidenceTotal\":\"2.5\",\"EvidencePointsTotal\":\"3.4\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"06/05/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/01/2016\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1496646000,
    "dateISO8601": "2017-06-05T00:00:00",
    "dateFormated": "Jun 05, 2017"
  },
  "10049": {
    "title": "KCNA2: Infantile Epilepsy Syndrome",
    "label": "Infantile Epilepsy Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10005",
      "name": "Epilepsy"
    },
    "genes": {
      "6220": {
        "ontology": "HGNC",
        "curie": "HGNC:6220",
        "uri": "HGNC6220"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018614"
      },
      "OMIM176262": {
        "ontology": "OMIM",
        "curie": "OMIM:176262",
        "uri": "OMIM176262",
        "iri": "http://purl.obolibrary.org/obo/OMIM_176262"
      },
      "ORPHA442835": {
        "ontology": "ORPHA",
        "curie": "ORPHA:442835",
        "uri": "ORPHA442835",
        "iri": "http://www.orpha.net/ORDO/Orphanet_442835"
      }
    },
    "scores": {
      "3978": {
        "label": "Strong"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527793006\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"KCNA2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6220\",\"uri\":\"HGNC6220\"},\"condition\":{\"name\":\"Infantile Epilepsy Syndrome \",\"OrphaNet\":{\"curie\":\"ORPHA:442835\",\"uri\":\"ORPHA442835\"},\"MONDO\":{\"curie\":\"MONDO:0020071\",\"uri\":\"MONDO0020071\"},\"OMIM\":{\"curie\":\"OMIM:176262\",\"uri\":\"OMIM176262\"}},\"title\":\"KCNA2 Infantile Epilepsy Syndrome \",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"12.00\",\"Tally\":\"12\",\"evidence\":{\"publications\":{\"1516639254170\":{\"title\":\"Ataxia and myoclonic epilepsy due to a heterozygous new mutation in KCNA2: proposal for a new channelopathy.\",\"author\":\"Pena SD\",\"pubdate\":\"2015 Feb\",\"source\":\"Clin Genet\",\"uid\":\"25477152\"},\"1516639267134\":{\"title\":\"De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.\",\"author\":\"Syrbe S\",\"pubdate\":\"2015 Apr\",\"source\":\"Nat Genet\",\"uid\":\"25751627\"},\"1516639369551\":{\"title\":\"Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion.\",\"author\":\"Allen NM\",\"pubdate\":\"2016 Jan\",\"source\":\"Epilepsia\",\"uid\":\"26648591\"},\"1516639376694\":{\"title\":\"Severe early-onset epileptic encephalopathy due to mutations in the KCNA2 gene: Expansion of the genotypic and phenotypic spectrum.\",\"author\":\"Hundallah K\",\"pubdate\":\"2016 Jul\",\"source\":\"Eur J Paediatr Neurol\",\"uid\":\"27117551\"},\"1516639390197\":{\"title\":\"Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.\",\"author\":\"Corbett MA\",\"pubdate\":\"2016 Nov 8\",\"source\":\"Neurology\",\"uid\":\"27733563\"},\"1516639417886\":{\"title\":\"Rett-like phenotypes: expanding the genetic heterogeneity to the KCNA2 gene and first familial case of CDKL5-related disease.\",\"author\":\"Allou L\",\"pubdate\":\"2017 Mar\",\"source\":\"Clin Genet\",\"uid\":\"27062609\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.00\",\"Tally\":\"0\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"0.00\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"0.00\",\"Tally\":\"\",\"1\":{\"evidence\":{\"publications\":{\"1516639402137\":{\"title\":\"Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.\",\"author\":\"Corbett MA\",\"pubdate\":\"2016 Nov 8\",\"source\":\"Neurology\",\"uid\":\"27733563\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"0.00\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1516639876492\":{\"title\":\"Kv1.2-containing K+ channels regulate subthreshold excitability of striatal medium spiny neurons.\",\"author\":\"Shen W\",\"pubdate\":\"2004 Mar\",\"source\":\"J Neurophysiol\",\"uid\":\"13679409\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"0.00\"},\"Expression\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1516639484647\":{\"title\":\"Cell-type-dependent molecular composition of the axon initial segment.\",\"author\":\"Lorincz A\",\"pubdate\":\"2008 Dec 31\",\"source\":\"J Neurosci\",\"uid\":\"19118165\"},\"1516639499986\":{\"title\":\"Association and colocalization of the Kvbeta1 and Kvbeta2 beta-subunits with Kv1 alpha-subunits in mammalian brain K+ channel complexes.\",\"author\":\"Rhodes KJ\",\"pubdate\":\"1997 Nov 1\",\"source\":\"J Neurosci\",\"uid\":\"9334400\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.00\",\"evidence\":{\"publications\":{\"1516639742853\":{\"title\":\"Association and colocalization of the Kvbeta1 and Kvbeta2 beta-subunits with Kv1 alpha-subunits in mammalian brain K+ channel complexes.\",\"author\":\"Rhodes KJ\",\"pubdate\":\"1997 Nov 1\",\"source\":\"J Neurosci\",\"uid\":\"9334400\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1516639352991\":{\"title\":\"De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.\",\"author\":\"Syrbe S\",\"pubdate\":\"2015 Apr\",\"source\":\"Nat Genet\",\"uid\":\"25751627\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"1.00\"},\"CellCultureModel\":{\"Value\":\"0.00\"}},\"ModelsRescue\":{\"Tally\":\"1\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1516639352991\":{\"title\":\"De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.\",\"author\":\"Syrbe S\",\"pubdate\":\"2015 Apr\",\"source\":\"Nat Genet\",\"uid\":\"25751627\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"0.00\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.00\",\"evidence\":{\"publications\":{\"1516640064138\":{\"title\":\"A new Kv1.2 channelopathy underlying cerebellar ataxia.\",\"author\":\"Xie G\",\"pubdate\":\"2010 Oct 15\",\"source\":\"J Biol Chem\",\"uid\":\"20696761\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"0.00\"},\"RescueInPatientCell\":{\"Value\":\"0.00\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"4\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"4\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"08/15/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"STRONG\",\"FinalClassificationDate\":\"10/20/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"NO\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1508482800,
    "dateISO8601": "2017-10-20T00:00:00",
    "dateFormated": "Oct 20, 2017"
  },
  "10051": {
    "title": "PRKAG2: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:9386": {
        "ontology": "HGNC",
        "curie": "HGNC:9386",
        "uri": "HGNC9386"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM600858": {
        "ontology": "OMIM",
        "curie": "OMIM:600858",
        "uri": "OMIM600858",
        "iri": "http://purl.obolibrary.org/obo/OMIM_600858"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1529513109\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"PRKAG2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:9386\",\"uri\":\"HGNC9386\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0010946\",\"uri\":\"MONDO0010946\"},\"OMIM\":{\"curie\":\"OMIM:600858\",\"uri\":\"OMIM600858\"}},\"title\":\"PRKAG2 Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"2.00\",\"Tally\":\"2\",\"evidence\":{\"publications\":{\"1527795758293\":{\"title\":\"Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure.\",\"author\":\"Liu Y\",\"pubdate\":\"2013\",\"source\":\"PLoS One\",\"uid\":\"23741347\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"5.70\",\"Tally\":\"5.7\",\"evidence\":{\"publications\":{\"1527795639006\":{\"title\":\"Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.\",\"author\":\"Blair E\",\"pubdate\":\"2001 May 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"11371514\"},\"1527795658057\":{\"title\":\"Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.\",\"author\":\"Arad M\",\"pubdate\":\"2002 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"11827995\"},\"1527795684885\":{\"title\":\"Severe hypertrophic cardiomyopathy in an infant with a novel PRKAG2 gene mutation: potential differences between infantile and adult onset presentation.\",\"author\":\"Kelly BP\",\"pubdate\":\"2009 Nov\",\"source\":\"Pediatr Cardiol\",\"uid\":\"19787389\"},\"1527795702157\":{\"title\":\"A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis.\",\"author\":\"Lafor\\u00eat P\",\"pubdate\":\"2006 Mar\",\"source\":\"Neuromuscul Disord\",\"uid\":\"16487706\"},\"1527795729453\":{\"title\":\"Shared genetic causes of cardiac hypertrophy in children and adults.\",\"author\":\"Morita H\",\"pubdate\":\"2008 May 1\",\"source\":\"N Engl J Med\",\"uid\":\"18403758\"},\"1527795745797\":{\"title\":\"Glycogen storage diseases presenting as hypertrophic cardiomyopathy.\",\"author\":\"Arad M\",\"pubdate\":\"2005 Jan 27\",\"source\":\"N Engl J Med\",\"uid\":\"15673802\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"3\":{\"evidence\":{\"publications\":{\"1527795849718\":{\"title\":\"Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3.\",\"author\":\"MacRae CA\",\"pubdate\":\"1995 Sep\",\"source\":\"J Clin Invest\",\"uid\":\"7657794\"},\"1527795875246\":{\"title\":\"Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.\",\"author\":\"Arad M\",\"pubdate\":\"2002 Feb\",\"source\":\"J Clin Invest\",\"uid\":\"11827995\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"2\",\"AggregateVariantAnalysis\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1527795920173\":{\"title\":\"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.\",\"author\":\"Walsh R\",\"pubdate\":\"2017 Feb\",\"source\":\"Genet Med\",\"uid\":\"27532257\"}},\"notes\":{\"note\":\"\"}}}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"1.50\",\"evidence\":{\"publications\":{\"1527795938929\":{\"title\":\"Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis.\",\"author\":\"Hinson JT\",\"pubdate\":\"2016 Dec 20\",\"source\":\"Cell Rep\",\"uid\":\"28009297\"},\"1527795997318\":{\"title\":\"Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation.\",\"author\":\"Banerjee SK\",\"pubdate\":\"2010 Feb\",\"source\":\"Biochim Biophys Acta\",\"uid\":\"20005292\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527795964111\":{\"title\":\"Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5\",\"author\":\"Lang T\",\"pubdate\":\"2000 Dec 1\",\"source\":\"Genomics\",\"uid\":\"11112354\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527795949834\":{\"title\":\"Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis.\",\"author\":\"Hinson JT\",\"pubdate\":\"2016 Dec 20\",\"source\":\"Cell Rep\",\"uid\":\"28009297\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"3.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"3\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527795976774\":{\"title\":\"Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.\",\"author\":\"Arad M\",\"pubdate\":\"2003 Jun 10\",\"source\":\"Circulation\",\"uid\":\"12782567\"},\"1527796014582\":{\"title\":\"Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.\",\"author\":\"Sidhu JS\",\"pubdate\":\"2005 Jan 4\",\"source\":\"Circulation\",\"uid\":\"15611370\"},\"1527796051215\":{\"title\":\"Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome.\",\"author\":\"Davies JK\",\"pubdate\":\"2006 May\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"16339829\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"6\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"6\",\"EvidencePointsTotal\":\"18\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"01/30/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"04/04/2017\",\"FinalClassificationNotes\":\"Approved by the Hypertrophic Cardiomyopathy Gene Curation Working Group\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1485763200,
    "dateISO8601": "2017-01-30T00:00:00",
    "dateFormated": "Jan 30, 2017"
  },
  "10057": {
    "title": "FLNC:Myofibrillar myopathy",
    "label": "Myofibrillar myopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:3756": {
        "ontology": "HGNC",
        "curie": "HGNC:3756",
        "uri": "HGNC3756"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0012289"
      },
      "OMIM609524": {
        "ontology": "OMIM",
        "curie": "OMIM:609524",
        "uri": "OMIM609524",
        "iri": "http://purl.obolibrary.org/obo/OMIM_609524"
      },
      "ORPHA171445": {
        "ontology": "ORPHA",
        "curie": "ORPHA:171445",
        "uri": "ORPHA171445",
        "iri": "http://www.orpha.net/ORDO/Orphanet_171445"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527815410\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"FLNC\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:3756\",\"uri\":\"HGNC3756\"},\"condition\":{\"name\":\"Myofibrillar myopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:171445\",\"uri\":\"ORPHA171445\"},\"MONDO\":{\"curie\":\"MONDO:0018943\",\"uri\":\"MONDO0018943\"},\"OMIM\":{\"curie\":\"OMIM:609524\",\"uri\":\"OMIM609524\"}},\"title\":\"FLNC Myofibrillar myopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"6.00\",\"Tally\":\"6\",\"evidence\":{\"publications\":{\"1527815744481\":{\"title\":\"A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy.\",\"author\":\"Vorgerd M\",\"pubdate\":\"2005 Aug\",\"source\":\"Am J Hum Genet\",\"uid\":\"15929027\"},\"1527815770418\":{\"title\":\"Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients.\",\"author\":\"Kley RA\",\"pubdate\":\"2007 Dec\",\"source\":\"Brain\",\"uid\":\"18055494\"},\"1527815810579\":{\"title\":\"In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy.\",\"author\":\"Shatunov A\",\"pubdate\":\"2009 May\",\"source\":\"Eur J Hum Genet\",\"uid\":\"19050726\"},\"1527815840335\":{\"title\":\"Pathophysiology of protein aggregation and extended phenotyping in filaminopathy.\",\"author\":\"Kley RA\",\"pubdate\":\"2012 Sep\",\"source\":\"Brain\",\"uid\":\"22961544\"},\"1527815862809\":{\"title\":\"A novel heterozygous deletion-insertion mutation (2695-2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family.\",\"author\":\"Luan X\",\"pubdate\":\"2010 Jun\",\"source\":\"Neuromuscul Disord\",\"uid\":\"20417099\"},\"1527815898131\":{\"title\":\"Cardiac arrhythmia and late-onset muscle weakness caused by a myofibrillar myopathy with unusual histopathological features due to a novel missense mutation in FLNC.\",\"author\":\"Avila-Smirnow D\",\"pubdate\":\"2016 Oct\",\"source\":\"Rev Neurol (Paris)\",\"uid\":\"27633507\"}},\"notes\":{\"note\":\"PMIDs 15929027 and 18055494 are about the same family and were scored together. Also PMIDs 19050726 and 22961544 had a report of the same proband/family and scored together.\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.50\",\"Tally\":\"1.5\",\"1\":{\"evidence\":{\"publications\":{\"1527815987219\":{\"title\":\"A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy.\",\"author\":\"Vorgerd M\",\"pubdate\":\"2005 Aug\",\"source\":\"Am J Hum Genet\",\"uid\":\"15929027\"},\"1527816002193\":{\"title\":\"Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients.\",\"author\":\"Kley RA\",\"pubdate\":\"2007 Dec\",\"source\":\"Brain\",\"uid\":\"18055494\"}},\"notes\":{\"note\":\"LOD= 4.879 Haplotype and candidate\"}}},\"2\":{\"evidence\":{\"publications\":{\"1527816049660\":{\"title\":\"Cardiac arrhythmia and late-onset muscle weakness caused by a myofibrillar myopathy with unusual histopathological features due to a novel missense mutation in FLNC.\",\"author\":\"Avila-Smirnow D\",\"pubdate\":\"2016 Oct\",\"source\":\"Rev Neurol (Paris)\",\"uid\":\"27633507\"}},\"notes\":{\"note\":\"eLOD= 2.4, candidate\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"7.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527816281820\":{\"title\":\"Filamin C-related myopathies: pathology and mechanisms.\",\"author\":\"F\\u00fcrst DO\",\"pubdate\":\"2013 Jan\",\"source\":\"Acta Neuropathol\",\"uid\":\"23109048\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527816248779\":{\"title\":\"Filamin C-related myopathies: pathology and mechanisms.\",\"author\":\"F\\u00fcrst DO\",\"pubdate\":\"2013 Jan\",\"source\":\"Acta Neuropathol\",\"uid\":\"23109048\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527816146399\":{\"title\":\"Molecular cloning of human ABPL, an actin-binding protein homologue.\",\"author\":\"Xie Z\",\"pubdate\":\"1998 Oct 29\",\"source\":\"Biochem Biophys Res Commun\",\"uid\":\"9791010\"},\"1527816173102\":{\"title\":\"Characterization of muscle filamin isoforms suggests a possible role of gamma-filamin/ABP-L in sarcomeric Z-disc formation.\",\"author\":\"van der Ven PF\",\"pubdate\":\"2000 Feb\",\"source\":\"Cell Motil Cytoskeleton\",\"uid\":\"10658210\"}},\"notes\":{\"note\":\"PMID 10658210 not scored due to unspecificity of the antibody used.\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527816202736\":{\"title\":\"Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure.\",\"author\":\"Dalkilic I\",\"pubdate\":\"2006 Sep\",\"source\":\"Mol Cell Biol\",\"uid\":\"16914736\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"5.50\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527816213578\":{\"title\":\"Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure.\",\"author\":\"Dalkilic I\",\"pubdate\":\"2006 Sep\",\"source\":\"Mol Cell Biol\",\"uid\":\"16914736\"},\"1527816229979\":{\"title\":\"Prioritizing causal disease genes using unbiased genomic features.\",\"author\":\"Deo RC\",\"pubdate\":\"2014 Dec 3\",\"source\":\"Genome Biol\",\"uid\":\"25633252\"},\"1527816266853\":{\"title\":\"Myofibrillar instability exacerbated by acute exercise in filaminopathy.\",\"author\":\"Chevessier F\",\"pubdate\":\"2015 Dec 20\",\"source\":\"Hum Mol Genet\",\"uid\":\"26472074\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"6\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"7.5\",\"ExperimentalEvidenceTotal\":\"6\",\"EvidencePointsTotal\":\"13.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"10/02/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"12/12/2017\",\"FinalClassificationNotes\":\"Approved by the ClinGen Hypertrophic cardiomyopathy Gene Curation Expert Panel\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1513123200,
    "dateISO8601": "2017-12-12T16:00:00",
    "dateFormated": "Dec 12, 2017"
  },
  "10058": {
    "title": "FXN: Friedreich ataxia",
    "label": "Friedreich ataxia",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:3951": {
        "ontology": "HGNC",
        "curie": "HGNC:3951",
        "uri": "HGNC3951"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0009245"
      },
      "OMIM229300": {
        "ontology": "OMIM",
        "curie": "OMIM:229300",
        "uri": "OMIM229300",
        "iri": "http://purl.obolibrary.org/obo/OMIM_229300"
      },
      "ORPHA95": {
        "ontology": "ORPHA",
        "curie": "ORPHA:95",
        "uri": "ORPHA95",
        "iri": "http://www.orpha.net/ORDO/Orphanet_95"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527816865\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"FXN\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:3951\",\"uri\":\"HGNC3951\"},\"condition\":{\"name\":\"Friedreich ataxia\",\"OrphaNet\":{\"curie\":\"ORPHA:95\",\"uri\":\"ORPHA95\"},\"MONDO\":{\"curie\":\"MONDO:0009245\",\"uri\":\"MONDO0009245\"},\"OMIM\":{\"curie\":\"OMIM:229300\",\"uri\":\"OMIM229300\"}},\"title\":\"FXN Friedreich ataxia\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"10.00\",\"evidence\":{\"publications\":{\"1527817165126\":{\"title\":\"Friedreich\",\"author\":\"Campuzano V\",\"pubdate\":\"1996 Mar 8\",\"source\":\"Science\",\"uid\":\"8596916\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"10\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\",\"1\":{\"evidence\":{\"publications\":{\"1527817405349\":{\"title\":\"Friedreich\",\"author\":\"Campuzano V\",\"pubdate\":\"1996 Mar 8\",\"source\":\"Science\",\"uid\":\"8596916\"}},\"notes\":{\"note\":\"eLOD= 1.32\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"10\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527817547611\":{\"title\":\"Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae.\",\"author\":\"Cavadini P\",\"pubdate\":\"2000 Oct 12\",\"source\":\"Hum Mol Genet\",\"uid\":\"11030757\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527817433285\":{\"title\":\"Friedreich\",\"author\":\"Campuzano V\",\"pubdate\":\"1996 Mar 8\",\"source\":\"Science\",\"uid\":\"8596916\"},\"1527817449391\":{\"title\":\"The Friedreich\",\"author\":\"Carvajal JJ\",\"pubdate\":\"1996 Oct\",\"source\":\"Nat Genet\",\"uid\":\"8841185\"},\"1527817465991\":{\"title\":\"Frataxin gene of Friedreich\",\"author\":\"Priller J\",\"pubdate\":\"1997 Aug\",\"source\":\"Ann Neurol\",\"uid\":\"9266741\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527817532021\":{\"title\":\"Silencing of frataxin gene expression triggers p53-dependent apoptosis in human neuron-like cells.\",\"author\":\"Palomo GM\",\"pubdate\":\"2011 Jul 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"21531789\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"4.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527817497586\":{\"title\":\"Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits.\",\"author\":\"Puccio H\",\"pubdate\":\"2001 Feb\",\"source\":\"Nat Genet\",\"uid\":\"11175786\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1527817516841\":{\"title\":\"Rescue of the Friedreich\",\"author\":\"Pook MA\",\"pubdate\":\"2001 Oct\",\"source\":\"Neurogenetics\",\"uid\":\"11714098\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"6\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"10\",\"ExperimentalEvidenceTotal\":\"6\",\"EvidencePointsTotal\":\"16\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08/22/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"10/11/2017\",\"FinalClassificationNotes\":\"Curated by the ClinGen Hypertrophic cardiomyopathy Gene Curation Expert Panel and approved by ClinGen expert Jonathan S. Berg.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1513972800,
    "dateISO8601": "2017-12-22T12:00:00",
    "dateFormated": "Dec 22, 2017"
  },
  "10059": {
    "title": "KCNQ1:Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:6294": {
        "ontology": "HGNC",
        "curie": "HGNC:6294",
        "uri": "HGNC6294"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527817831\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"KCNQ1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6294\",\"uri\":\"HGNC6294\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"}},\"title\":\"KCNQ1 Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"0\",\"evidence\":{\"publications\":{\"1527818027723\":{\"title\":\"DNA sequence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies.\",\"author\":\"D\",\"pubdate\":\"2014 Jan\",\"source\":\"J Mol Diagn\",\"uid\":\"24183960\"}},\"notes\":{\"note\":\"Proband also had variants in MYBPC3 and TNNT2.\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidenceTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"12/22/2016\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"01/04/2017\",\"FinalClassificationNotes\":\"Approved by the ClinGen Hypertrophic cardiomyopathy Gene Curation Expert Panel\"},\"ReplicationOverTime\":\"NO\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1485903600,
    "dateISO8601": "2017-01-31T15:00:00",
    "dateFormated": "Jan 31, 2017"
  },
  "10060": {
    "title": "LAMP2:Danon disease",
    "label": "Danon disease",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:6501": {
        "ontology": "HGNC",
        "curie": "HGNC:6501",
        "uri": "HGNC6501"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0010281"
      },
      "OMIM300257": {
        "ontology": "OMIM",
        "curie": "OMIM:300257",
        "uri": "OMIM300257",
        "iri": "http://purl.obolibrary.org/obo/OMIM_300257"
      },
      "ORPHA34587": {
        "ontology": "ORPHA",
        "curie": "ORPHA:34587",
        "uri": "ORPHA34587",
        "iri": "http://www.orpha.net/ORDO/Orphanet_34587"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527818470\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"LAMP2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6501\",\"uri\":\"HGNC6501\"},\"condition\":{\"name\":\"Danon disease\",\"OrphaNet\":{\"curie\":\"ORPHA:34587\",\"uri\":\"ORPHA34587\"},\"MONDO\":{\"curie\":\"MONDO:0010281\",\"uri\":\"MONDO0010281\"},\"OMIM\":{\"curie\":\"OMIM:300257\",\"uri\":\"OMIM300257\"}},\"title\":\"LAMP2 Danon disease\",\"scoreJson\":{\"ModeOfInheritance\":\"X-linked inheritance (HP:0001417)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"14.00\",\"Tally\":\"12\",\"evidence\":{\"publications\":{\"1527818713406\":{\"title\":\"Danon\",\"author\":\"Charron P\",\"pubdate\":\"2004 Aug\",\"source\":\"Heart\",\"uid\":\"15253947\"},\"1527818772438\":{\"title\":\"Glycogen storage diseases presenting as hypertrophic cardiomyopathy.\",\"author\":\"Arad M\",\"pubdate\":\"2005 Jan 27\",\"source\":\"N Engl J Med\",\"uid\":\"15673802\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"4.50\",\"Tally\":\"4.5\",\"evidence\":{\"publications\":{\"1527818722657\":{\"title\":\"Danon\",\"author\":\"Charron P\",\"pubdate\":\"2004 Aug\",\"source\":\"Heart\",\"uid\":\"15253947\"},\"1527818807001\":{\"title\":\"Genetic basis of end-stage hypertrophic cardiomyopathy.\",\"author\":\"Garcia-Pavia P\",\"pubdate\":\"2011 Nov\",\"source\":\"Eur J Heart Fail\",\"uid\":\"21896538\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.50\",\"Tally\":\"1.5\",\"evidence\":{\"publications\":{\"1527818748780\":{\"title\":\"Glycogen storage diseases presenting as hypertrophic cardiomyopathy.\",\"author\":\"Arad M\",\"pubdate\":\"2005 Jan 27\",\"source\":\"N Engl J Med\",\"uid\":\"15673802\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"2\",\"AggregateVariantAnalysis\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1527818894256\":{\"title\":\"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.\",\"author\":\"Walsh R\",\"pubdate\":\"2017 Feb\",\"source\":\"Genet Med\",\"uid\":\"27532257\"}},\"notes\":{\"note\":\"\"}}}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527818933453\":{\"title\":\"An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner.\",\"author\":\"Konecki DS\",\"pubdate\":\"1995 Oct 13\",\"source\":\"Biochem Biophys Res Commun\",\"uid\":\"7488019\"},\"1527819038166\":{\"title\":\"Expression patterns of murine lysosome-associated membrane protein 2 (Lamp-2) transcripts during morphogenesis.\",\"author\":\"Lichter-Konecki U\",\"pubdate\":\"1999 Jul\",\"source\":\"Differentiation\",\"uid\":\"10448712\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0\",\"NonPatientCells\":{\"Value\":\"0.00\",\"evidence\":{\"publications\":{\"1527819009237\":{\"title\":\"LAMP-2 deficient mice show depressed cardiac contractile function without significant changes in calcium handling.\",\"author\":\"Stypmann J\",\"pubdate\":\"2006 Jul\",\"source\":\"Basic Res Cardiol\",\"uid\":\"16604439\"}},\"notes\":{\"note\":\"Genes altered not involved in heart, and mechanism unclear.\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"4.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527818967133\":{\"title\":\"Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice.\",\"author\":\"Tanaka Y\",\"pubdate\":\"2000 Aug 24\",\"source\":\"Nature\",\"uid\":\"10972293\"},\"1527818975449\":{\"title\":\"LAMP-2 deficient mice show depressed cardiac contractile function without significant changes in calcium handling.\",\"author\":\"Stypmann J\",\"pubdate\":\"2006 Jul\",\"source\":\"Basic Res Cardiol\",\"uid\":\"16604439\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"5\",\"EvidencePointsTotal\":\"17\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"01/24/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"10/11/2017\",\"FinalClassificationNotes\":\"Curated as part of the ClinGen Hypertrophic cardiomyopathy Gene Curation Expert Panel and approved by ClinGen expert Jonathan S. Berg.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1507752000,
    "dateISO8601": "2017-10-11T13:00:00",
    "dateFormated": "Oct 11, 2017"
  },
  "10061": {
    "title": "MYBPC3:Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:7551": {
        "ontology": "HGNC",
        "curie": "HGNC:7551",
        "uri": "HGNC7551"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0007268"
      },
      "OMIM115197": {
        "ontology": "OMIM",
        "curie": "OMIM:115197",
        "uri": "OMIM115197",
        "iri": "http://purl.obolibrary.org/obo/OMIM_115197"
      },
      "ORPHA": {
        "ontology": "ORPHA",
        "curie": "ORPHA:",
        "uri": "ORPHA",
        "iri": "http://www.orpha.net/ORDO/Orphanet_"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527819372\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"MYBPC3\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:7551\",\"uri\":\"HGNC7551\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:115197\",\"uri\":\"OMIM115197\"}},\"title\":\"MYBPC3 Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"6.50\",\"Tally\":\"6.5\",\"evidence\":{\"publications\":{\"1527819606023\":{\"title\":\"Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy.\",\"author\":\"Olivotto I\",\"pubdate\":\"2008 Jun\",\"source\":\"Mayo Clin Proc\",\"uid\":\"18533079\"},\"1527819643988\":{\"title\":\"Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.\",\"author\":\"Niimura H\",\"pubdate\":\"1998 Apr 30\",\"source\":\"N Engl J Med\",\"uid\":\"9562578\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1527819620860\":{\"title\":\"Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy.\",\"author\":\"Watkins H\",\"pubdate\":\"1995 Dec\",\"source\":\"Nat Genet\",\"uid\":\"7493025\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.50\",\"Tally\":\"1.5\",\"1\":{\"evidence\":{\"publications\":{\"1527819684930\":{\"title\":\"Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy.\",\"author\":\"Watkins H\",\"pubdate\":\"1995 Dec\",\"source\":\"Nat Genet\",\"uid\":\"7493025\"}},\"notes\":{\"note\":\"eLOD= 1.8, candidate\"}}},\"2\":{\"evidence\":{\"publications\":{\"1527819736414\":{\"title\":\"Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.\",\"author\":\"Niimura H\",\"pubdate\":\"1998 Apr 30\",\"source\":\"N Engl J Med\",\"uid\":\"9562578\"}},\"notes\":{\"note\":\"Published LOD= 7.12, candidate\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"2\",\"AggregateVariantAnalysis\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1527819774678\":{\"title\":\"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.\",\"author\":\"Walsh R\",\"pubdate\":\"2017 Feb\",\"source\":\"Genet Med\",\"uid\":\"27532257\"}},\"notes\":{\"note\":\"\"}}}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"10.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527819837898\":{\"title\":\"Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology.\",\"author\":\"Carrier L\",\"pubdate\":\"2015 Dec 1\",\"source\":\"Gene\",\"uid\":\"26358504\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527819807921\":{\"title\":\"Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology.\",\"author\":\"Carrier L\",\"pubdate\":\"2015 Dec 1\",\"source\":\"Gene\",\"uid\":\"26358504\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527819856823\":{\"title\":\"Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development.\",\"author\":\"Fougerousse F\",\"pubdate\":\"1998 Jan 9-23\",\"source\":\"Circ Res\",\"uid\":\"9440712\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"4.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527819973528\":{\"title\":\"Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy.\",\"author\":\"Barefield D\",\"pubdate\":\"2014 Mar\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"24464755\"},\"1527820029106\":{\"title\":\"Comparison of two murine models of familial hypertrophic cardiomyopathy.\",\"author\":\"McConnell BK\",\"pubdate\":\"2001 Mar 2\",\"source\":\"Circ Res\",\"uid\":\"11230104\"},\"1527820072413\":{\"title\":\"Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice.\",\"author\":\"Carrier L\",\"pubdate\":\"2004 Aug 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"15249187\"},\"1527820111832\":{\"title\":\"Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice.\",\"author\":\"Harris SP\",\"pubdate\":\"2002 Mar 22\",\"source\":\"Circ Res\",\"uid\":\"11909824\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"6\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"10.5\",\"ExperimentalEvidenceTotal\":\"6\",\"EvidencePointsTotal\":\"16.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"12/18/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"09/05/2017\",\"FinalClassificationNotes\":\"Approved by the ClinGen Hypertrophic cardiomyopathy Gene Curation Expert Panel.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1504641600,
    "dateISO8601": "2017-09-05T13:00:00",
    "dateFormated": "Sep 05, 2017"
  },
  "10062": {
    "title": "SLC25A4: Mitochondrial syndrome",
    "label": "Mitochondrial syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:10990": {
        "ontology": "HGNC",
        "curie": "HGNC:10990",
        "uri": "HGNC10990"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0014175"
      },
      "OMIM615418": {
        "ontology": "OMIM",
        "curie": "OMIM:615418",
        "uri": "OMIM615418",
        "iri": "http://purl.obolibrary.org/obo/OMIM_615418"
      },
      "ORPHA": {
        "ontology": "ORPHA",
        "curie": "ORPHA:",
        "uri": "ORPHA",
        "iri": "http://www.orpha.net/ORDO/Orphanet_"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527821018\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SLC25A4\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:10990\",\"uri\":\"HGNC10990\"},\"condition\":{\"name\":\"Mitochondrial syndrome\",\"MONDO\":{\"curie\":\"MONDO:0014175\",\"uri\":\"MONDO0014175\"},\"OMIM\":{\"curie\":\"OMIM:615418\",\"uri\":\"OMIM615418\"}},\"title\":\"SLC25A4 Mitochondrial syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal recessive inheritance (HP:0000007)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"6.00\",\"evidence\":{\"publications\":{\"1527821212074\":{\"title\":\"Complete loss of expression of the ANT1 gene causing cardiomyopathy and myopathy.\",\"author\":\"Echaniz-Laguna A\",\"pubdate\":\"2012 Feb\",\"source\":\"J Med Genet\",\"uid\":\"22187496\"},\"1527821250002\":{\"title\":\"Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup.\",\"author\":\"Strauss KA\",\"pubdate\":\"2013 Feb 26\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"23401503\"},\"1527821268732\":{\"title\":\"Two Novel Mutations in the SLC25A4 Gene in a Patient with Mitochondrial Myopathy.\",\"author\":\"K\\u00f6rver-Keularts IM\",\"pubdate\":\"2015\",\"source\":\"JIMD Rep\",\"uid\":\"25732997\"},\"1527821309713\":{\"title\":\"Deficiency of the adenine nucleotide translocator in muscle of a patient with myopathy and lactic acidosis: a new mitochondrial defect.\",\"author\":\"Bakker HD\",\"pubdate\":\"1993 Apr\",\"source\":\"Pediatr Res\",\"uid\":\"8479824\"}},\"notes\":{\"note\":\"PMIDS 25732997 and  8479824 report the same proband and were evaluated together.\"}}},\"Tally\":\"7.5\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"1.50\",\"evidence\":{\"publications\":{\"1527821232283\":{\"title\":\"Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy.\",\"author\":\"Palmieri L\",\"pubdate\":\"2005 Oct 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"16155110\"}},\"notes\":{\"note\":\"\"}}}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\",\"1\":{\"evidence\":{\"publications\":{\"1527821356565\":{\"title\":\"Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup.\",\"author\":\"Strauss KA\",\"pubdate\":\"2013 Feb 26\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"23401503\"}},\"notes\":{\"note\":\"10 affected over 13 generations but significant consanguineity impedes eLOD calculations. \"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"7.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1527821411385\":{\"title\":\"A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator.\",\"author\":\"Graham BH\",\"pubdate\":\"1997 Jul\",\"source\":\"Nat Genet\",\"uid\":\"9207786\"},\"1527821422467\":{\"title\":\"A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed.\",\"author\":\"Li K\",\"pubdate\":\"1989 Aug 25\",\"source\":\"J Biol Chem\",\"uid\":\"2547778\"},\"1527821432514\":{\"title\":\"Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes.\",\"author\":\"Levy SE\",\"pubdate\":\"2000 Aug 22\",\"source\":\"Gene\",\"uid\":\"10974536\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"4.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"4\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527821460177\":{\"title\":\"A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator.\",\"author\":\"Graham BH\",\"pubdate\":\"1997 Jul\",\"source\":\"Nat Genet\",\"uid\":\"9207786\"},\"1527821482098\":{\"title\":\"Adenine nucleotide translocase 1 deficiency results in dilated cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and activation of apoptosis.\",\"author\":\"Narula N\",\"pubdate\":\"2011 Jan\",\"source\":\"JACC Cardiovasc Imaging\",\"uid\":\"21232697\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1527821504827\":{\"title\":\"Adeno-associated virus-mediated gene transfer of the heart/muscle adenine nucleotide translocator (ANT) in mouse.\",\"author\":\"Flierl A\",\"pubdate\":\"2005 Apr\",\"source\":\"Gene Ther\",\"uid\":\"15647764\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"6\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"7.5\",\"ExperimentalEvidenceTotal\":\"6\",\"EvidencePointsTotal\":\"13.5\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"07/27/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"08/30/2017\",\"FinalClassificationNotes\":\"Curated as part of the ClinGen Hypertrophic cardiomyopathy Gene Curation Expert Panel and Approved by ClinGen Inborn Errors of Metabolism expert Heather Beaudet.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1504051200,
    "dateISO8601": "2017-08-30T00:00:00",
    "dateFormated": "Aug 30, 2017"
  },
  "10063": {
    "title": "TTR: Hereditary ATTR amyloidosis",
    "label": "Hereditary ATTR amyloidosis",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:12405": {
        "ontology": "HGNC",
        "curie": "HGNC:12405",
        "uri": "HGNC12405"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0017132"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA271861": {
        "ontology": "ORPHA",
        "curie": "ORPHA:271861",
        "uri": "ORPHA271861",
        "iri": "http://www.orpha.net/ORDO/Orphanet_271861"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1527822673\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TTR\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:12405\",\"uri\":\"HGNC12405\"},\"condition\":{\"name\":\"Hereditary TTR amyloidosis\",\"OrphaNet\":{\"curie\":\"ORPHA:271861\",\"uri\":\"ORPHA271861\"},\"MONDO\":{\"curie\":\"MONDO:0017132\",\"uri\":\"MONDO0017132\"}},\"title\":\"TTR Hereditary TTR amyloidosis\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"10.50\",\"Tally\":\"7\",\"evidence\":{\"publications\":{\"1527822129791\":{\"title\":\"Amyloid heart disease mimicking hypertrophic cardiomyopathy.\",\"author\":\"M\\u00f6rner S\",\"pubdate\":\"2005 Sep\",\"source\":\"J Intern Med\",\"uid\":\"16115295\"},\"1527822158634\":{\"title\":\"Cardiomyopathy in Swedish patients with the Gly53Glu and His88Arg transthyretin variants.\",\"author\":\"Holmgren G\",\"pubdate\":\"2005 Sep\",\"source\":\"Amyloid\",\"uid\":\"16194874\"},\"1527822181291\":{\"title\":\"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness.\",\"author\":\"Damy T\",\"pubdate\":\"2016 Jun 14\",\"source\":\"Eur Heart J\",\"uid\":\"26537620\"},\"1527822359136\":{\"title\":\"A Danish kindred with familial amyloid cardiomyopathy revisited: identification of a mutant transthyretin-methionine111 variant in serum from patients and carriers.\",\"author\":\"Ranl\\u00f8v I\",\"pubdate\":\"1992 Jul\",\"source\":\"Am J Med\",\"uid\":\"1626570\"},\"1527822376994\":{\"title\":\"A new transthyretin mutation associated with amyloid cardiomyopathy.\",\"author\":\"Saraiva MJ\",\"pubdate\":\"1992 May\",\"source\":\"Am J Hum Genet\",\"uid\":\"1570831\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"1\":{\"evidence\":{\"publications\":{\"1527822361752\":{\"title\":\"A Danish kindred with familial amyloid cardiomyopathy revisited: identification of a mutant transthyretin-methionine111 variant in serum from patients and carriers.\",\"author\":\"Ranl\\u00f8v I\",\"pubdate\":\"1992 Jul\",\"source\":\"Am J Med\",\"uid\":\"1626570\"}},\"notes\":{\"note\":\"eLOD= 3.3, candidate\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"8\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1527822566821\":{\"title\":\"Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.\",\"author\":\"Ng B\",\"pubdate\":\"2005 Jun 27\",\"source\":\"Arch Intern Med\",\"uid\":\"15983293\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"1.5\",\"NonPatientCells\":{\"Value\":\"1.50\",\"evidence\":{\"publications\":{\"1527822516032\":{\"title\":\"Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes.\",\"author\":\"Sartiani L\",\"pubdate\":\"2016 Nov 1\",\"source\":\"Biophys J\",\"uid\":\"27806283\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"3.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"3\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1527822489192\":{\"title\":\"Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy.\",\"author\":\"Kohno K\",\"pubdate\":\"1997 Apr\",\"source\":\"Am J Pathol\",\"uid\":\"9095004\"},\"1527822501242\":{\"title\":\"Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis.\",\"author\":\"Teng MH\",\"pubdate\":\"2001 Mar\",\"source\":\"Lab Invest\",\"uid\":\"11310831\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"8\",\"ExperimentalEvidenceTotal\":\"5\",\"EvidencePointsTotal\":\"13\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"12/11/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"09/29/2017\",\"FinalClassificationNotes\":\"Curated by the ClinGen Hypertrophic cardiomyopathy Gene Curation Expert Panel and approved by ClinGen expert Jonathan S. Berg.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1513026000,
    "dateISO8601": "2017-12-11T13:00:00",
    "dateFormated": "Dec 11, 2017"
  },
  "10065": {
    "title": "DSP: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:3052": {
        "ontology": "HGNC",
        "curie": "HGNC:3052",
        "uri": "HGNC3052"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM125647": {
        "ontology": "OMIM",
        "curie": "OMIM:125647",
        "uri": "OMIM125647",
        "iri": "http://purl.obolibrary.org/obo/OMIM_125647"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1529265114\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"DSP\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:3052\",\"uri\":\"HGNC3052\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:125647\",\"uri\":\"OMIM125647\"}},\"title\":\"DSP Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"\",\"Tally\":\"\"}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"\",\"ExperimentalEvidenceTotal\":\"\",\"EvidencePointsTotal\":\"\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"NO REPORTED EVIDENCE\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"05/23/2017\",\"FinalClassificationNotes\":\"This classification was approved by the Hypertrophic Cardiomyopathy Gene Curation Expert Panel.\"},\"ReplicationOverTime\":\"NO\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1495522800,
    "dateISO8601": "2017-05-23T00:00:00",
    "dateFormated": "May 23, 2017"
  },
  "10072": {
    "title": "MUTYH: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "7527": {
        "ontology": "HGNC",
        "curie": "HGNC:7527",
        "uri": "HGNC7527"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0012041"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA247798": {
        "ontology": "ORPHA",
        "curie": "ORPHA:247798",
        "uri": "ORPHA247798",
        "iri": "http://www.orpha.net/ORDO/Orphanet_247798"
      }
    },
    "scores": {
      "3976": {
        "label": "Moderate"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MUTYH\",\"Hgnc\":\"7527\",\"OrphaNet\":\"247798\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"SingleVariantAnalysis\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants.\",\"author\":\"Theodoratou E\",\"pubdate\":\"2010 Dec 7\",\"source\":\"Br J Cancer\",\"uid\":\"21063410\"}],\"notes\":{\"note\":\"\"}}},\"AggregateVariantAnalysis\":{\"value\":\"5.0\",\"tally\":\"5\",\"pmid\":{\"publications\":[{\"title\":\"Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer.\",\"author\":\"Win AK\",\"pubdate\":\"2014 May\",\"source\":\"Gastroenterology\",\"uid\":\"24444654\"}]}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6.\",\"author\":\"Gu Y\",\"pubdate\":\"2002 Mar 29\",\"source\":\"J Biol Chem\",\"uid\":\"11801590\"},{\"title\":\"Repair of 8-oxoG:A mismatches by the MUTYH glycosylase: Mechanism, metals and medicine.\",\"author\":\"Banda DM\",\"pubdate\":\"2017 Jun\",\"source\":\"Free Radic Biol Med\",\"uid\":\"28087410\"},{\"title\":\"MUTYH prevents OGG1 or APEX1 from inappropriately processing its substrate or reaction product with its C-terminal domain.\",\"author\":\"Tominaga Y\",\"pubdate\":\"2004\",\"source\":\"Nucleic Acids Res\",\"uid\":\"15199168\"},{\"title\":\"MUTYH-associated polyposis (MAP), the syndrome implicating base excision repair in inherited predisposition to colorectal tumors.\",\"author\":\"Venesio T\",\"pubdate\":\"2012\",\"source\":\"Front Oncol\",\"uid\":\"22876359\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Genetic instability in lymphoblastoid cell lines expressing biallelic and monoallelic variants in the human MUTYH gene.\",\"author\":\"Grasso F\",\"pubdate\":\"2014 Jul 15\",\"source\":\"Hum Mol Genet\",\"uid\":\"24569162\"},{\"title\":\"Impaired suppressive activities of human MUTYH variant proteins against oxidative mutagenesis.\",\"author\":\"Shinmura K\",\"pubdate\":\"2012 Dec 21\",\"source\":\"World J Gastroenterol\",\"uid\":\"23322991\"},{\"title\":\"Mutator phenotype of MUTYH-null mouse embryonic stem cells.\",\"author\":\"Hirano S\",\"pubdate\":\"2003 Oct 3\",\"source\":\"J Biol Chem\",\"uid\":\"12917422\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.\",\"author\":\"Sieber OM\",\"pubdate\":\"2004 Dec 15\",\"source\":\"Cancer Res\",\"uid\":\"15604247\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"4.5\",\"GeneticEvidenceTotal\":\"7\",\"GeneticEvidencePointsTotal\":\"7\",\"ExperimentalEvidencePointsTotal\":\"4.5\",\"EvidencePointsTotal\":\"11.5\",\"CalculatedClassification\":\"STRONG\",\"CalculatedClassificationDate\":\"10/09/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"MODERATE\",\"FinalClassificationDate\":\"10/09/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1507532400,
    "dateISO8601": "2017-10-09T00:00:00",
    "dateFormated": "Oct 09, 2017"
  },
  "10073": {
    "title": "PALB2: Colorectal cancer Susceptibility",
    "label": "Colorectal cancer Susceptibility",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10043",
      "name": "Colon Cancer"
    },
    "genes": {
      "26144": {
        "ontology": "HGNC",
        "curie": "HGNC:26144",
        "uri": "HGNC26144"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0018630"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA443909": {
        "ontology": "ORPHA",
        "curie": "ORPHA:443909",
        "uri": "ORPHA443909",
        "iri": "http://www.orpha.net/ORDO/Orphanet_443909"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PALB2\",\"Hgnc\":\"26144\",\"OrphaNet\":\"443909\",\"Disease\":\"Colorectal cancer Susceptibility\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"VariantIsDeNovo\":{\"value\":\"2.0\",\"tally\":\"2.2\",\"pmid\":{\"publications\":[{\"title\":\"Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.\",\"author\":\"Yurgelun MB\",\"pubdate\":\"2015 Sep\",\"source\":\"Gastroenterology\",\"uid\":\"25980754\"},{\"title\":\"Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.\",\"author\":\"Pearlman R\",\"pubdate\":\"2017 Apr 1\",\"source\":\"JAMA Oncol\",\"uid\":\"27978560\"},{\"title\":\"Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.\",\"author\":\"Chubb D\",\"pubdate\":\"2016 Jun 22\",\"source\":\"Nat Commun\",\"uid\":\"27329137\"},{\"title\":\"Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.\",\"author\":\"Susswein LR\",\"pubdate\":\"2016 Aug\",\"source\":\"Genet Med\",\"uid\":\"26681312\"}],\"notes\":{\"note\":\"\"}}}}}},\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Inherited DNA-Repair Defects in Colorectal Cancer.\",\"author\":\"AlDubayan SH\",\"pubdate\":\"2018 Mar 1\",\"source\":\"Am J Hum Genet\",\"uid\":\"29478780\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"A pathology atlas of the human cancer transcriptome.\",\"author\":\"Uhlen M\",\"pubdate\":\"2017 Aug 18\",\"source\":\"Science\",\"uid\":\"28818916\"},{\"title\":\"The Genotype-Tissue Expression (GTEx) project.\",\"author\":\"GTEx Consortium.\",\"pubdate\":\"2013 Jun\",\"source\":\"Nat Genet\",\"uid\":\"23715323\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0.5\",\"GeneticEvidenceTotal\":\"5.2\",\"GeneticEvidencePointsTotal\":\"5.2\",\"ExperimentalEvidencePointsTotal\":\"0.5\",\"EvidencePointsTotal\":\"5.7\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"03/12/2018\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"03/12/2018\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1520838000,
    "dateISO8601": "2018-03-12T00:00:00",
    "dateFormated": "Mar 12, 2018"
  },
  "10074": {
    "title": "MYH6: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:7576": {
        "ontology": "HGNC",
        "curie": "HGNC:7576",
        "uri": "HGNC7576"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM160710": {
        "ontology": "OMIM",
        "curie": "OMIM:160710",
        "uri": "OMIM160710",
        "iri": "http://purl.obolibrary.org/obo/OMIM_160710"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1529266175\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"MYH6\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:7576\",\"uri\":\"HGNC7576\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:160710\",\"uri\":\"OMIM160710\"}},\"title\":\"MYH6 Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.30\",\"Tally\":\"0.3\",\"evidence\":{\"publications\":{\"1528168789335\":{\"title\":\"Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly.\",\"author\":\"Niimura H\",\"pubdate\":\"2002 Jan 29\",\"source\":\"Circulation\",\"uid\":\"11815426\"},\"1528168821363\":{\"title\":\"A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort.\",\"author\":\"Rubattu S\",\"pubdate\":\"2016 Jul 30\",\"source\":\"Int J Mol Sci\",\"uid\":\"27483260\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.3\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1528227634966\":{\"title\":\"Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.\",\"author\":\"Weiss A\",\"pubdate\":\"1999 Jul 2\",\"source\":\"J Mol Biol\",\"uid\":\"10388558\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1528168897885\":{\"title\":\"Myosin types in the human heart. An immunofluorescence study of normal and hypertrophied atrial and ventricular myocardium.\",\"author\":\"Gorza L\",\"pubdate\":\"1984 Jun\",\"source\":\"Circ Res\",\"uid\":\"6234108\"},\"1528168918808\":{\"title\":\"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.\",\"author\":\"Fagerberg L\",\"pubdate\":\"2014 Feb\",\"source\":\"Mol Cell Proteomics\",\"uid\":\"24309898\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.3\",\"ExperimentalEvidenceTotal\":\"1\",\"EvidencePointsTotal\":\"1.3\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"This classification was approved by the Hypertrophic Cardiomyopathy Gene Curation Expert Panel.\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1509519600,
    "dateISO8601": "2017-11-01T00:00:00",
    "dateFormated": "Nov 01, 2017"
  },
  "10075": {
    "title": "MYH7: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:7577": {
        "ontology": "HGNC",
        "curie": "HGNC:7577",
        "uri": "HGNC7577"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM192600": {
        "ontology": "OMIM",
        "curie": "OMIM:192600",
        "uri": "OMIM192600",
        "iri": "http://purl.obolibrary.org/obo/OMIM_192600"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1529265273\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"MYH7\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:7577\",\"uri\":\"HGNC7577\"},\"condition\":{\"name\":\"Hypertrophic Cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:192600\",\"uri\":\"OMIM192600\"}},\"title\":\"MYH7 Hypertrophic Cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"3.50\",\"Tally\":\"3.5\",\"evidence\":{\"publications\":{\"1528163236424\":{\"title\":\"Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations.\",\"author\":\"Watkins H\",\"pubdate\":\"1992 Nov\",\"source\":\"J Clin Invest\",\"uid\":\"1430197\"},\"1528163257914\":{\"title\":\"A novel de novo mutation of \\u03b2-cardiac myosin heavy chain gene found in a twelve-year-old boy with hypertrophic cardiomyopathy.\",\"author\":\"Okada S\",\"pubdate\":\"2014 Aug\",\"source\":\"J Genet\",\"uid\":\"25189259\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.00\",\"Tally\":\"0\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"3.50\",\"Tally\":\"3.5\",\"evidence\":{\"publications\":{\"0\":{\"title\":\"A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.\",\"author\":\"Geisterfer-Lowrance AA\",\"pubdate\":\"1990 Sep 7\",\"source\":\"Cell\",\"uid\":\"1975517\"},\"1\":{\"title\":\"A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene.\",\"author\":\"Tanigawa G\",\"pubdate\":\"1990 Sep 7\",\"source\":\"Cell\",\"uid\":\"2144212\"},\"2\":{\"title\":\"Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes.\",\"author\":\"Rosenzweig A\",\"pubdate\":\"1991 Dec 19\",\"source\":\"N Engl J Med\",\"uid\":\"1944483\"},\"3\":{\"title\":\"Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.\",\"author\":\"Watkins H\",\"pubdate\":\"1992 Apr 23\",\"source\":\"N Engl J Med\",\"uid\":\"1552912\"},\"1528163099927\":{\"title\":\"Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.\",\"author\":\"Perrot A\",\"pubdate\":\"2005 Jun\",\"source\":\"J Mol Med (Berl)\",\"uid\":\"15856146\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1528163523767\":{\"title\":\"Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.\",\"author\":\"Watkins H\",\"pubdate\":\"1992 Apr 23\",\"source\":\"N Engl J Med\",\"uid\":\"1552912\"},\"1528163542866\":{\"title\":\"Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes.\",\"author\":\"Rosenzweig A\",\"pubdate\":\"1991 Dec 19\",\"source\":\"N Engl J Med\",\"uid\":\"1944483\"},\"1528163562252\":{\"title\":\"A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene.\",\"author\":\"Tanigawa G\",\"pubdate\":\"1990 Sep 7\",\"source\":\"Cell\",\"uid\":\"2144212\"},\"1528163579038\":{\"title\":\"A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.\",\"author\":\"Geisterfer-Lowrance AA\",\"pubdate\":\"1990 Sep 7\",\"source\":\"Cell\",\"uid\":\"1975517\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"2\",\"AggregateVariantAnalysis\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":[{\"title\":\"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.\",\"author\":\"Walsh R\",\"pubdate\":\"2017 Feb\",\"source\":\"Genet Med\",\"uid\":\"27532257\"}],\"notes\":{\"note\":\"\"}}}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1528163753698\":{\"title\":\"Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human \\u03b2-cardiac myosin motor function.\",\"author\":\"Sommese RF\",\"pubdate\":\"2013 Jul 30\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"23798412\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1528163654969\":{\"title\":\"Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy.\",\"author\":\"Perryman MB\",\"pubdate\":\"1992 Jul\",\"source\":\"J Clin Invest\",\"uid\":\"1634614\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"2.00\",\"evidence\":{\"publications\":{\"1528163690644\":{\"title\":\"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells.\",\"author\":\"Lan F\",\"pubdate\":\"2013 Jan 3\",\"source\":\"Cell Stem Cell\",\"uid\":\"23290139\"},\"1528163722715\":{\"title\":\"Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.\",\"author\":\"Han L\",\"pubdate\":\"2014 Nov 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"25209314\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"2\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1528163781536\":{\"title\":\"A mouse model of familial hypertrophic cardiomyopathy.\",\"author\":\"Geisterfer-Lowrance AA\",\"pubdate\":\"1996 May 3\",\"source\":\"Science\",\"uid\":\"8614836\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"5\",\"EvidencePointsTotal\":\"17\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"DEFINITIVE\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"11/01/2016\",\"FinalClassificationNotes\":\"This classification was approved by the Hypertrophic Cardiomyopathy Gene Curation Expert Panel.\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1512201600,
    "dateISO8601": "2017-12-02T00:00:00",
    "dateFormated": "Dec 02, 2017"
  },
  "10076": {
    "title": "RYR2: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:10484": {
        "ontology": "HGNC",
        "curie": "HGNC:10484",
        "uri": "HGNC10484"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1529265655\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"RYR2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:10484\",\"uri\":\"HGNC10484\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:180902\",\"uri\":\"OMIM180902\"}},\"title\":\"RYR2 Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.90\",\"Tally\":\"0.9\",\"evidence\":{\"publications\":{\"1528166289149\":{\"title\":\"Investigation of Pathogenic Genes in Chinese sporadic Hypertrophic Cardiomyopathy Patients by Whole Exome Sequencing.\",\"author\":\"Xu J\",\"pubdate\":\"2015 Nov 17\",\"source\":\"Sci Rep\",\"uid\":\"26573135\"}},\"notes\":{\"note\":\"Fujino et al, 2006, Circulation 114:II_165, 2006\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.9\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1528166427205\":{\"title\":\"Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.\",\"author\":\"Martin C\",\"pubdate\":\"1998 Jul\",\"source\":\"Neuroscience\",\"uid\":\"9607712\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.9\",\"ExperimentalEvidenceTotal\":\"0.5\",\"EvidencePointsTotal\":\"1.4\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"02/07/2017\",\"FinalClassificationNotes\":\"This classification was approved by the Hypertrophic Cardiomyopathy Gene Curation Expert Panel.\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1522652400,
    "dateISO8601": "2018-04-02T00:00:00",
    "dateFormated": "Apr 02, 2018"
  },
  "10077": {
    "title": "TTN: Hypertrophic cardiomyopathy",
    "label": "Hypertrophic cardiomyopathy",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10008",
      "name": "Hypertrophic Cardiomyopathy"
    },
    "genes": {
      "HGNC:12403": {
        "ontology": "HGNC",
        "curie": "HGNC:12403",
        "uri": "HGNC12403"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0005045"
      },
      "OMIM191039": {
        "ontology": "OMIM",
        "curie": "OMIM:191039",
        "uri": "OMIM191039",
        "iri": "http://purl.obolibrary.org/obo/OMIM_191039"
      },
      "ORPHA217569": {
        "ontology": "ORPHA",
        "curie": "ORPHA:217569",
        "uri": "ORPHA217569",
        "iri": "http://www.orpha.net/ORDO/Orphanet_217569"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1528164512\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TTN\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:12403\",\"uri\":\"HGNC12403\"},\"condition\":{\"name\":\"Hypertrophic cardiomyopathy\",\"OrphaNet\":{\"curie\":\"ORPHA:217569\",\"uri\":\"ORPHA217569\"},\"MONDO\":{\"curie\":\"MONDO:0005045\",\"uri\":\"MONDO0005045\"},\"OMIM\":{\"curie\":\"OMIM:191039\",\"uri\":\"OMIM191039\"}},\"title\":\"TTN Hypertrophic cardiomyopathy\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1528164577413\":{\"title\":\"Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction.\",\"author\":\"Hastings R\",\"pubdate\":\"2016 Oct\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"27625337\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"1\":{\"evidence\":{\"publications\":{\"1528164585508\":{\"title\":\"Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction.\",\"author\":\"Hastings R\",\"pubdate\":\"2016 Oct\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"27625337\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1528164913267\":{\"title\":\"Molecular mechanisms of sarcomere dysfunction in dilated and hypertrophic cardiomyopathy.\",\"author\":\"Frazier AH\",\"pubdate\":\"2011 Jan 1\",\"source\":\"Prog Pediatr Cardiol\",\"uid\":\"21297871\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1528164673542\":{\"title\":\"A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy.\",\"author\":\"Freiburg A\",\"pubdate\":\"1996 Jan 15\",\"source\":\"Eur J Biochem\",\"uid\":\"8631348\"},\"1528164783814\":{\"title\":\"Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy.\",\"author\":\"Hayashi T\",\"pubdate\":\"2004 Dec 7\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"15582318\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"1.50\",\"evidence\":{\"publications\":{\"1528165070518\":{\"title\":\"Proteomics. Tissue-based map of the human proteome.\",\"author\":\"Uhl\\u00e9n M\",\"pubdate\":\"2015 Jan 23\",\"source\":\"Science\",\"uid\":\"25613900\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"1.5\",\"NonPatientCells\":{\"Value\":\"1.50\",\"evidence\":{\"publications\":{\"1528164718688\":{\"title\":\"Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene.\",\"author\":\"Satoh M\",\"pubdate\":\"1999 Aug 27\",\"source\":\"Biochem Biophys Res Commun\",\"uid\":\"10462489\"},\"1528165106221\":{\"title\":\"Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy.\",\"author\":\"Arimura T\",\"pubdate\":\"2009 Jul 21\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"19608031\"},\"1528165135110\":{\"title\":\"Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction.\",\"author\":\"Hastings R\",\"pubdate\":\"2016 Oct\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"27625337\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"1.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"1\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1528164850781\":{\"title\":\"Cardiac hypertrophy and reduced contractility in hearts deficient in the titin kinase region.\",\"author\":\"Peng J\",\"pubdate\":\"2007 Feb 13\",\"source\":\"Circulation\",\"uid\":\"17261657\"},\"1528164876039\":{\"title\":\"Truncation of titin\",\"author\":\"Granzier HL\",\"pubdate\":\"2009 Sep 11\",\"source\":\"Circ Res\",\"uid\":\"19679835\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"4.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1.5\",\"ExperimentalEvidenceTotal\":\"4.5\",\"EvidencePointsTotal\":\"6\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"\",\"CuratorClassification\":\"LIMITED\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"12/14/2017\",\"FinalClassificationNotes\":\"This classification was approved by the Hypertrophic Cardiomyopathy Gene Curation Expert Panel.\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1513238400,
    "dateISO8601": "2017-12-14T00:00:00",
    "dateFormated": "Dec 14, 2017"
  },
  "10080": {
    "title": "ATM: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "795": {
        "ontology": "HGNC",
        "curie": "HGNC:795",
        "uri": "HGNC795"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3974": {
        "label": "Limited"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"ATM\",\"Hgnc\":\"795\",\"OrphaNet\":\"213517\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.\",\"author\":\"Couch FJ\",\"pubdate\":\"2017 Sep 1\",\"source\":\"JAMA Oncol\",\"uid\":\"28418444\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.\",\"author\":\"Cortez D\",\"pubdate\":\"1999 Nov 5\",\"source\":\"Science\",\"uid\":\"10550055\"},{\"title\":\"Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I.\",\"author\":\"Barlow C\",\"pubdate\":\"1998 Oct\",\"source\":\"Development\",\"uid\":\"9735362\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient.\",\"author\":\"Varghese S\",\"pubdate\":\"1999\",\"source\":\"Radiat Oncol Investig\",\"uid\":\"10492163\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"2.5\",\"GeneticEvidenceTotal\":\"4\",\"GeneticEvidencePointsTotal\":\"4\",\"ExperimentalEvidencePointsTotal\":\"2.5\",\"EvidencePointsTotal\":\"6.5\",\"CalculatedClassification\":\"MODERATE\",\"CalculatedClassificationDate\":\"07/12/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"LIMITED\",\"FinalClassificationDate\":\"07/12/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1499842800,
    "dateISO8601": "2017-07-12T00:00:00",
    "dateFormated": "Jul 12, 2017"
  },
  "10081": {
    "title": "BARD1: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "952": {
        "ontology": "HGNC",
        "curie": "HGNC:952",
        "uri": "HGNC952"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM114480": {
        "ontology": "OMIM",
        "curie": "OMIM:114480",
        "uri": "OMIM114480",
        "iri": "http://purl.obolibrary.org/obo/OMIM_114480"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"BARD1\",\"Hgnc\":\"952\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"114480\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"11.0\",\"tally\":\"11\",\"pmid\":{\"publications\":[{\"title\":\"Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.\",\"author\":\"Couch FJ\",\"pubdate\":\"2017 Sep 1\",\"source\":\"JAMA Oncol\",\"uid\":\"28418444\"},{\"title\":\"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.\",\"author\":\"Slavin TP\",\"pubdate\":\"2017\",\"source\":\"NPJ Breast Cancer\",\"uid\":\"28649662\"},{\"title\":\"Inherited Mutations in Women With Ovarian Carcinoma.\",\"author\":\"Norquist BM\",\"pubdate\":\"2016 Apr\",\"source\":\"JAMA Oncol\",\"uid\":\"26720728\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"2.0\",\"tally\":\"2\",\"pmid\":{\"publications\":[{\"title\":\"Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand Breaks.\",\"author\":\"Lee C\",\"pubdate\":\"2015 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"26350354\"},{\"title\":\"Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis.\",\"author\":\"Irminger-Finger I\",\"pubdate\":\"2001 Dec\",\"source\":\"Mol Cell\",\"uid\":\"11779501\"},{\"title\":\"The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.\",\"author\":\"Hashizume R\",\"pubdate\":\"2001 May 4\",\"source\":\"J Biol Chem\",\"uid\":\"11278247\"},{\"title\":\"BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export.\",\"author\":\"Fabbro M\",\"pubdate\":\"2002 Jun 14\",\"source\":\"J Biol Chem\",\"uid\":\"11925436\"},{\"title\":\"The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly.\",\"author\":\"Joukov V\",\"pubdate\":\"2006 Nov 3\",\"source\":\"Cell\",\"uid\":\"17081976\"},{\"title\":\"BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer.\",\"author\":\"Sabatier R\",\"pubdate\":\"2010 Dec\",\"source\":\"Genes Chromosomes Cancer\",\"uid\":\"20842729\"}],\"notes\":{\"note\":\"\"}}},\"ModelsRescue\":{\"value\":\"4.0\",\"tally\":\"4\",\"pmid\":{\"publications\":[{\"title\":\"The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression.\",\"author\":\"Shakya R\",\"pubdate\":\"2008 May 13\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"18443292\"},{\"title\":\"Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.\",\"author\":\"McCarthy EE\",\"pubdate\":\"2003 Jul\",\"source\":\"Mol Cell Biol\",\"uid\":\"12832489\"},{\"title\":\"Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand Breaks.\",\"author\":\"Lee C\",\"pubdate\":\"2015 Dec\",\"source\":\"Hum Mutat\",\"uid\":\"26350354\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"6\",\"GeneticEvidenceTotal\":\"11\",\"GeneticEvidencePointsTotal\":\"11\",\"ExperimentalEvidencePointsTotal\":\"6\",\"EvidencePointsTotal\":\"17\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"08/09/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"08/09/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1502262000,
    "dateISO8601": "2017-08-09T00:00:00",
    "dateFormated": "Aug 09, 2017"
  },
  "10082": {
    "title": "NF1: Familial ovarian cancer",
    "label": "Familial ovarian cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "7765": {
        "ontology": "HGNC",
        "curie": "HGNC:7765",
        "uri": "HGNC7765"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016248"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA213517": {
        "ontology": "ORPHA",
        "curie": "ORPHA:213517",
        "uri": "ORPHA213517",
        "iri": "http://www.orpha.net/ORDO/Orphanet_213517"
      }
    },
    "scores": {
      "3975": {
        "label": "No Reported Evidence"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"NF1\",\"Hgnc\":\"7765\",\"OrphaNet\":\"363700\",\"Disease\":\"Familial ovarian cancer\",\"Omim\":\"162200\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantDisease\":{\"ProbandWithLOF\":{\"value\":\"0.0\",\"tally\":\"0\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.0\",\"tally\":\"0\"}},\"ReplicationOverTime\":{\"YesNo\":\"NO\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"0\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"0\",\"EvidencePointsTotal\":\"0\",\"CalculatedClassification\":\"NO REPORTED EVIDENCE\",\"CalculatedClassificationDate\":\"02/22/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"NO REPORTED EVIDENCE\",\"FinalClassificationDate\":\"02/22/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1487750400,
    "dateISO8601": "2017-02-22T00:00:00",
    "dateFormated": "Feb 22, 2017"
  },
  "10084": {
    "title": "MSH2: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "7325": {
        "ontology": "HGNC",
        "curie": "HGNC:7325",
        "uri": "HGNC7325"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"MSH2\",\"Hgnc\":\"7325\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"1.5\",\"tally\":\"1.5\",\"pmid\":{\"publications\":[{\"title\":\"MSH2 rs2303425 Polymorphism is Associated with Early-Onset Breast Cancer in Taiwan.\",\"author\":\"Hsieh YC\",\"pubdate\":\"2017 Feb\",\"source\":\"Ann Surg Oncol\",\"uid\":\"26975740\"},{\"title\":\"The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor alpha.\",\"author\":\"Wada-Hiraike O\",\"pubdate\":\"2005 Jun 20\",\"source\":\"Br J Cancer\",\"uid\":\"15886699\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"0\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"1.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"10/11/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"10/11/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1507705200,
    "dateISO8601": "2017-10-11T00:00:00",
    "dateFormated": "Oct 11, 2017"
  },
  "10085": {
    "title": "PMS2: Hereditary breast cancer",
    "label": "Hereditary breast cancer",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10042",
      "name": "Breast/Ovarian Cancer"
    },
    "genes": {
      "9122": {
        "ontology": "HGNC",
        "curie": "HGNC:9122",
        "uri": "HGNC9122"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0016419"
      },
      "OMIM": {
        "ontology": "OMIM",
        "curie": "OMIM:",
        "uri": "OMIM",
        "iri": "http://purl.obolibrary.org/obo/OMIM_"
      },
      "ORPHA227535": {
        "ontology": "ORPHA",
        "curie": "ORPHA:227535",
        "uri": "ORPHA227535",
        "iri": "http://www.orpha.net/ORDO/Orphanet_227535"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "{\"data\":{\"Gene\":\"PMS2\",\"Hgnc\":\"9122\",\"OrphaNet\":\"227535\",\"Disease\":\"Hereditary breast cancer\",\"Omim\":\"N/A\",\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\"},\"GeneticEvidence\":{\"Case-ControlData\":{\"AggregateVariantAnalysis\":{\"value\":\"3.0\",\"tally\":\"3\",\"pmid\":{\"publications\":[{\"title\":\"Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.\",\"author\":\"ten Broeke SW\",\"pubdate\":\"2015 Feb 1\",\"source\":\"J Clin Oncol\",\"uid\":\"25512458\"},{\"title\":\"MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer.\",\"author\":\"Roberts ME\",\"pubdate\":\"2018 Jan 18\",\"source\":\"Genet Med\",\"uid\":\"29345684\"}]}},\"SingleVariantAnalysis\":{\"pmid\":{\"notes\":{\"note\":\"\"}}}}},\"ExperimentalEvidence\":{\"Function\":{\"value\":\"0.5\",\"tally\":\"0.5\",\"pmid\":{\"publications\":[{\"title\":\"Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.\",\"author\":\"Cannavo E\",\"pubdate\":\"2007 Feb 2\",\"source\":\"J Biol Chem\",\"uid\":\"17148452\"}],\"notes\":{\"note\":\"\"}}},\"FunctionalAlteration\":{\"value\":\"1.0\",\"tally\":\"1\",\"pmid\":{\"publications\":[{\"title\":\"Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis.\",\"author\":\"Baker SM\",\"pubdate\":\"1995 Jul 28\",\"source\":\"Cell\",\"uid\":\"7628019\"}],\"notes\":{\"note\":\"\"}}}},\"ReplicationOverTime\":{\"YesNo\":\"YES\"},\"summary\":{\"ExperimentalEvidenceTotal\":\"1.5\",\"GeneticEvidenceTotal\":\"3\",\"GeneticEvidencePointsTotal\":\"3\",\"ExperimentalEvidencePointsTotal\":\"1.5\",\"EvidencePointsTotal\":\"4.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"11/08/2017\",\"CalculatedClassificationNotes\":null,\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/08/2017\",\"FinalClassificationNotes\":\"\"}}",
    "scoreJsonSerializedSop5": "",
    "file": null,
    "date": 1510128000,
    "dateISO8601": "2017-11-08T00:00:00",
    "dateFormated": "Nov 08, 2017"
  },
  "10145": {
    "title": "ANK2: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:493": {
        "ontology": "HGNC",
        "curie": "HGNC:493",
        "uri": "HGNC493"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015263"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530654010\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"ANK2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:493\",\"uri\":\"HGNC493\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"ANK2 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"2.90\",\"Tally\":\"2.9\",\"evidence\":{\"publications\":{\"1530654162094\":{\"title\":\"Defining the cellular phenotype of \\\"ankyrin-B syndrome\\\" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes.\",\"author\":\"Mohler PJ\",\"pubdate\":\"2007 Jan 30\",\"source\":\"Circulation\",\"uid\":\"17242276\"},\"1530654192405\":{\"title\":\"Genetic Analysis of Arrhythmogenic Diseases in the Era of NGS: The Complexity of Clinical Decision-Making in Brugada Syndrome.\",\"author\":\"Allegue C\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"26230511\"},\"1530654596573\":{\"title\":\"Phenotypic Variability of ANK2 Mutations in Patients With Inherited Primary Arrhythmia Syndromes.\",\"author\":\"Ichikawa M\",\"pubdate\":\"2016 Nov 25\",\"source\":\"Circ J\",\"uid\":\"27784853\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"2.9\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530654299754\":{\"title\":\"Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.\",\"author\":\"Mohler PJ\",\"pubdate\":\"2004 Dec 14\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"15579534\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530654285946\":{\"title\":\"Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.\",\"author\":\"Mohler PJ\",\"pubdate\":\"2004 Dec 14\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"15579534\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"1\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530654324582\":{\"title\":\"Defining the cellular phenotype of \\\"ankyrin-B syndrome\\\" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes.\",\"author\":\"Mohler PJ\",\"pubdate\":\"2007 Jan 30\",\"source\":\"Circulation\",\"uid\":\"17242276\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"2.9\",\"ExperimentalEvidenceTotal\":\"2\",\"EvidencePointsTotal\":\"4.9\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"04/25/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10146": {
    "title": "CACNA1C: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:1390": {
        "ontology": "HGNC",
        "curie": "HGNC:1390",
        "uri": "HGNC1390"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015263"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530654831\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"CACNA1C\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:1390\",\"uri\":\"HGNC1390\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"CACNA1C Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"3.75\",\"Tally\":\"3.75\",\"evidence\":{\"publications\":{\"1530654930886\":{\"title\":\"Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death.\",\"author\":\"Antzelevitch C\",\"pubdate\":\"2007 Jan 30\",\"source\":\"Circulation\",\"uid\":\"17224476\"},\"1530654956647\":{\"title\":\"Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.\",\"author\":\"Burashnikov E\",\"pubdate\":\"2010 Dec\",\"source\":\"Heart Rhythm\",\"uid\":\"20817017\"},\"1530655017459\":{\"title\":\"L-type calcium channel mutations in Japanese patients with inherited arrhythmias.\",\"author\":\"Fukuyama M\",\"pubdate\":\"2013\",\"source\":\"Circ J\",\"uid\":\"23575362\"},\"1530655058273\":{\"title\":\"Nonsense-mediated mRNA decay due to a CACNA1C splicing mutation in a patient with Brugada syndrome.\",\"author\":\"Fukuyama M\",\"pubdate\":\"2014 Apr\",\"source\":\"Heart Rhythm\",\"uid\":\"24321233\"},\"1530655306104\":{\"title\":\"Brugada syndrome and calcium channel mutation in a patient with congenital deaf mutism.\",\"author\":\"Canpolat U\",\"pubdate\":\"2017 Jan - Feb\",\"source\":\"Indian Pacing Electrophysiol J\",\"uid\":\"28401855\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"3.75\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530655100560\":{\"title\":\"Cloning, chromosomal localization, and functional expression of the alpha 1 subunit of the L-type voltage-dependent calcium channel from normal human heart.\",\"author\":\"Schultz D\",\"pubdate\":\"1993 Jul 1\",\"source\":\"Proc Natl Acad Sci U S A\",\"uid\":\"8392192\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.3\",\"NonPatientCells\":{\"Value\":\"0.30\",\"evidence\":{\"publications\":{\"1530655087570\":{\"title\":\"Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.\",\"author\":\"Burashnikov E\",\"pubdate\":\"2010 Dec\",\"source\":\"Heart Rhythm\",\"uid\":\"20817017\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"0.8\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"3.75\",\"ExperimentalEvidenceTotal\":\"0.8\",\"EvidencePointsTotal\":\"4.55\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"04/27/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10147": {
    "title": "CACNA2D1: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:1399": {
        "ontology": "HGNC",
        "curie": "HGNC:1399",
        "uri": "HGNC1399"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011001"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530655650\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"CACNA2D1\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:1399\",\"uri\":\"HGNC1399\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"CACNA2D1 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1530655752065\":{\"title\":\"Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.\",\"author\":\"Burashnikov E\",\"pubdate\":\"2010 Dec\",\"source\":\"Heart Rhythm\",\"uid\":\"20817017\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"1.5\",\"ProteinInteraction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530655810080\":{\"title\":\"Targeted disruption of the voltage-dependent calcium channel alpha2/delta-1-subunit.\",\"author\":\"Fuller-Bicer GA\",\"pubdate\":\"2009 Jul\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"19429829\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530655788078\":{\"title\":\"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.\",\"author\":\"Fagerberg L\",\"pubdate\":\"2014 Feb\",\"source\":\"Mol Cell Proteomics\",\"uid\":\"24309898\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530655933186\":{\"title\":\"Functional characterization of CaV\\u03b12\\u03b4 mutations associated with sudden cardiac death.\",\"author\":\"Bourdin B\",\"pubdate\":\"2015 Jan 30\",\"source\":\"J Biol Chem\",\"uid\":\"25527503\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1\",\"ExperimentalEvidenceTotal\":\"2\",\"EvidencePointsTotal\":\"3\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"10/05/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10148": {
    "title": "CACNB2: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:1402": {
        "ontology": "HGNC",
        "curie": "HGNC:1402",
        "uri": "HGNC1402"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011001"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530656209\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"CACNB2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:1402\",\"uri\":\"HGNC1402\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"CACNB2 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"3.40\",\"Tally\":\"3.4\",\"evidence\":{\"publications\":{\"1530656287417\":{\"title\":\"Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death.\",\"author\":\"Antzelevitch C\",\"pubdate\":\"2007 Jan 30\",\"source\":\"Circulation\",\"uid\":\"17224476\"},\"1530656305219\":{\"title\":\"Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome.\",\"author\":\"Cordeiro JM\",\"pubdate\":\"2009 May\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"19358333\"},\"1530656325758\":{\"title\":\"Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.\",\"author\":\"Burashnikov E\",\"pubdate\":\"2010 Dec\",\"source\":\"Heart Rhythm\",\"uid\":\"20817017\"},\"1530656347975\":{\"title\":\"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.\",\"author\":\"Crotti L\",\"pubdate\":\"2012 Oct 9\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"22840528\"},\"1530656561813\":{\"title\":\"Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay.\",\"author\":\"Kanter RJ\",\"pubdate\":\"2012 Jan 3\",\"source\":\"Circulation\",\"uid\":\"22090166\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"3.4\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530656373986\":{\"title\":\"Cloning of the beta(2a) subunit of the voltage-dependent calcium channel from human heart: cooperative effect of alpha(2)/delta and beta(2a) on the membrane expression of the alpha(1C) subunit.\",\"author\":\"Yamaguchi H\",\"pubdate\":\"2000 Jan 7\",\"source\":\"Biochem Biophys Res Commun\",\"uid\":\"10623591\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"3.4\",\"ExperimentalEvidenceTotal\":\"0.5\",\"EvidencePointsTotal\":\"3.9\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"08/08/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10149": {
    "title": "GPD1L: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:28956": {
        "ontology": "HGNC",
        "curie": "HGNC:28956",
        "uri": "HGNC28956"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011001"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530656792\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"GPD1L\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:28956\",\"uri\":\"HGNC28956\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"GPD1L Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.60\",\"Tally\":\"0.6\",\"evidence\":{\"publications\":{\"1530656885014\":{\"title\":\"Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.\",\"author\":\"London B\",\"pubdate\":\"2007 Nov 13\",\"source\":\"Circulation\",\"uid\":\"17967977\"},\"1530656906475\":{\"title\":\"Mutation analysis of the glycerol-3 phosphate dehydrogenase-1 like (GPD1L) gene in Japanese patients with Brugada syndrome.\",\"author\":\"Makiyama T\",\"pubdate\":\"2008 Oct\",\"source\":\"Circ J\",\"uid\":\"18762705\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"6.00\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1530657310489\":{\"title\":\"Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.\",\"author\":\"London B\",\"pubdate\":\"2007 Nov 13\",\"source\":\"Circulation\",\"uid\":\"17967977\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"3.6\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530656965640\":{\"title\":\"GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A.\",\"author\":\"Valdivia CR\",\"pubdate\":\"2009 Oct\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"19666841\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1.75\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530656998666\":{\"title\":\"GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A.\",\"author\":\"Valdivia CR\",\"pubdate\":\"2009 Oct\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"19666841\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.75\",\"evidence\":{\"publications\":{\"1530656934008\":{\"title\":\"Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.\",\"author\":\"London B\",\"pubdate\":\"2007 Nov 13\",\"source\":\"Circulation\",\"uid\":\"17967977\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530656949651\":{\"title\":\"Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.\",\"author\":\"London B\",\"pubdate\":\"2007 Nov 13\",\"source\":\"Circulation\",\"uid\":\"17967977\"},\"1530657009707\":{\"title\":\"GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A.\",\"author\":\"Valdivia CR\",\"pubdate\":\"2009 Oct\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"19666841\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2.75\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"3.6\",\"ExperimentalEvidenceTotal\":\"2.75\",\"EvidencePointsTotal\":\"6.35\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"05/09/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10150": {
    "title": "HCN4: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:16882": {
        "ontology": "HGNC",
        "curie": "HGNC:16882",
        "uri": "HGNC16882"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011001"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530657570\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"HCN4\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:16882\",\"uri\":\"HGNC16882\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"HCN4 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.90\",\"Tally\":\"1.9\",\"evidence\":{\"publications\":{\"1530657656772\":{\"title\":\"Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.\",\"author\":\"Ueda K\",\"pubdate\":\"2004 Jun 25\",\"source\":\"J Biol Chem\",\"uid\":\"15123648\"},\"1530657674185\":{\"title\":\"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.\",\"author\":\"Crotti L\",\"pubdate\":\"2012 Oct 9\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"22840528\"},\"1530657684290\":{\"title\":\"Mutation in S6 domain of HCN4 channel in patient with suspected Brugada syndrome modifies channel function.\",\"author\":\"Biel S\",\"pubdate\":\"2016 Oct\",\"source\":\"Pflugers Arch\",\"uid\":\"27553229\"},\"1530657714168\":{\"title\":\"Role of HCN4 channel in preventing ventricular arrhythmia.\",\"author\":\"Ueda K\",\"pubdate\":\"2009 Feb\",\"source\":\"J Hum Genet\",\"uid\":\"19165230\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1.9\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530657738038\":{\"title\":\"Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.\",\"author\":\"Ueda K\",\"pubdate\":\"2004 Jun 25\",\"source\":\"J Biol Chem\",\"uid\":\"15123648\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530657746847\":{\"title\":\"Mutation in S6 domain of HCN4 channel in patient with suspected Brugada syndrome modifies channel function.\",\"author\":\"Biel S\",\"pubdate\":\"2016 Oct\",\"source\":\"Pflugers Arch\",\"uid\":\"27553229\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1.9\",\"ExperimentalEvidenceTotal\":\"1\",\"EvidencePointsTotal\":\"2.9\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"06/25/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10151": {
    "title": "KCND3: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:6239": {
        "ontology": "HGNC",
        "curie": "HGNC:6239",
        "uri": "HGNC6239"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011001"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530657975\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"KCND3\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6239\",\"uri\":\"HGNC6239\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"KCND3 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.70\",\"Tally\":\"0.7\",\"evidence\":{\"publications\":{\"1530658398631\":{\"title\":\"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.\",\"author\":\"Giudicessi JR\",\"pubdate\":\"2011 Jul\",\"source\":\"Heart Rhythm\",\"uid\":\"21349352\"},\"1530658413421\":{\"title\":\"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.\",\"author\":\"Crotti L\",\"pubdate\":\"2012 Oct 9\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"22840528\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530658128483\":{\"title\":\"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.\",\"author\":\"Crotti L\",\"pubdate\":\"2012 Oct 9\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"22840528\"},\"1530658138648\":{\"title\":\"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.\",\"author\":\"Giudicessi JR\",\"pubdate\":\"2011 Jul\",\"source\":\"Heart Rhythm\",\"uid\":\"21349352\"},\"1530658147508\":{\"title\":\"Sodium current and potassium transient outward current genes in Brugada syndrome: screening and bioinformatics.\",\"author\":\"Holst AG\",\"pubdate\":\"2012 Mar-Apr\",\"source\":\"Can J Cardiol\",\"uid\":\"22284586\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.5\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1.2\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530658198636\":{\"title\":\"Two novel Brugada syndrome-associated mutations increase KV4.3 membrane expression and function.\",\"author\":\"You T\",\"pubdate\":\"2015 Jul\",\"source\":\"Int J Mol Med\",\"uid\":\"26016905\"},\"1530658211753\":{\"title\":\"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.\",\"author\":\"Giudicessi JR\",\"pubdate\":\"2011 Jul\",\"source\":\"Heart Rhythm\",\"uid\":\"21349352\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"2\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530658269016\":{\"title\":\"Two novel Brugada syndrome-associated mutations increase KV4.3 membrane expression and function.\",\"author\":\"You T\",\"pubdate\":\"2015 Jul\",\"source\":\"Int J Mol Med\",\"uid\":\"26016905\"},\"1530658457080\":{\"title\":\"Cloning and expression of the human kv4.3 potassium channel.\",\"author\":\"Dilks D\",\"pubdate\":\"1999 Apr\",\"source\":\"J Neurophysiol\",\"uid\":\"10200233\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1.2\",\"ExperimentalEvidenceTotal\":\"2\",\"EvidencePointsTotal\":\"3.2\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07/12/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10152": {
    "title": "KCNE3: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:6243": {
        "ontology": "HGNC",
        "curie": "HGNC:6243",
        "uri": "HGNC6243"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015263"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530658625\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"KCNE3\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6243\",\"uri\":\"HGNC6243\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"KCNE3 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1530658699947\":{\"title\":\"Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.\",\"author\":\"Delp\\u00f3n E\",\"pubdate\":\"2008 Aug\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"19122847\"},\"1530658713928\":{\"title\":\"KCNE3 T4A as the genetic basis of Brugada-pattern electrocardiogram.\",\"author\":\"Nakajima T\",\"pubdate\":\"2012\",\"source\":\"Circ J\",\"uid\":\"22987075\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"1\":{\"evidence\":{\"publications\":{\"1530658783059\":{\"title\":\"Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.\",\"author\":\"Delp\\u00f3n E\",\"pubdate\":\"2008 Aug\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"19122847\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"2\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530658868097\":{\"title\":\"Expression of multiple KCNE genes in human heart may enable variable modulation of I(Ks).\",\"author\":\"Lundquist AL\",\"pubdate\":\"2005 Feb\",\"source\":\"J Mol Cell Cardiol\",\"uid\":\"15698834\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530658739721\":{\"title\":\"Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.\",\"author\":\"Delp\\u00f3n E\",\"pubdate\":\"2008 Aug\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"19122847\"},\"1530658748862\":{\"title\":\"KCNE3 T4A as the genetic basis of Brugada-pattern electrocardiogram.\",\"author\":\"Nakajima T\",\"pubdate\":\"2012\",\"source\":\"Circ J\",\"uid\":\"22987075\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"2\",\"ExperimentalEvidenceTotal\":\"1\",\"EvidencePointsTotal\":\"3\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"06/30/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10153": {
    "title": "KCNE5: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:6241": {
        "ontology": "HGNC",
        "curie": "HGNC:6241",
        "uri": "HGNC6241"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015263"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530659024\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"KCNE5\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6241\",\"uri\":\"HGNC6241\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"KCNE5 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.40\",\"Tally\":\"0.4\",\"evidence\":{\"publications\":{\"1530659138901\":{\"title\":\"KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation.\",\"author\":\"Ohno S\",\"pubdate\":\"2011 Jun\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"21493962\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.4\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530659173839\":{\"title\":\"KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis.\",\"author\":\"Abbott GW\",\"pubdate\":\"2016 Nov 30\",\"source\":\"Gene\",\"uid\":\"27484720\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1.25\",\"ProteinInteraction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530659276757\":{\"title\":\"KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis.\",\"author\":\"Abbott GW\",\"pubdate\":\"2016 Nov 30\",\"source\":\"Gene\",\"uid\":\"27484720\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530659282381\":{\"title\":\"KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis.\",\"author\":\"Abbott GW\",\"pubdate\":\"2016 Nov 30\",\"source\":\"Gene\",\"uid\":\"27484720\"},\"1530659349056\":{\"title\":\"KCNE1-like gene is deleted in AMME contiguous gene syndrome: identification and characterization of the human and mouse homologs.\",\"author\":\"Piccini M\",\"pubdate\":\"1999 Sep 15\",\"source\":\"Genomics\",\"uid\":\"10493825\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.25\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.4\",\"ExperimentalEvidenceTotal\":\"1.25\",\"EvidencePointsTotal\":\"1.65\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01/07/17\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10154": {
    "title": "KCNH2: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:6251": {
        "ontology": "HGNC",
        "curie": "HGNC:6251",
        "uri": "HGNC6251"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015263"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530659595\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"KCNH2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6251\",\"uri\":\"HGNC6251\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"KCNH2 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"2.50\",\"Tally\":\"2.5\",\"evidence\":{\"publications\":{\"1530659642228\":{\"title\":\"Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome.\",\"author\":\"Verkerk AO\",\"pubdate\":\"2005 Dec 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"16043162\"},\"1530659660217\":{\"title\":\"A novel KCNH2 mutation as a modifier for short QT interval.\",\"author\":\"Itoh H\",\"pubdate\":\"2009 Sep 11\",\"source\":\"Int J Cardiol\",\"uid\":\"18692916\"},\"1530659674613\":{\"title\":\"Gain-of-function KCNH2 mutations in patients with Brugada syndrome.\",\"author\":\"Wang QI\",\"pubdate\":\"2014 May\",\"source\":\"J Cardiovasc Electrophysiol\",\"uid\":\"24400717\"},\"1530659763574\":{\"title\":\"Complex genetic background in a large family with Brugada syndrome.\",\"author\":\"Saber S\",\"pubdate\":\"2015 Jan 1\",\"source\":\"Physiol Rep\",\"uid\":\"25626866\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"2.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530659715075\":{\"title\":\"Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome.\",\"author\":\"Verkerk AO\",\"pubdate\":\"2005 Dec 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"16043162\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.25\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"0.5\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530660086014\":{\"title\":\"Selective knockout of mouse ERG1 B potassium channel eliminates I(Kr) in adult ventricular myocytes and elicits episodes of abrupt sinus bradycardia.\",\"author\":\"Lees-Miller JP\",\"pubdate\":\"2003 Mar\",\"source\":\"Mol Cell Biol\",\"uid\":\"12612061\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530660190132\":{\"title\":\"Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-\\u00e1-go-go-related gene potassium channels.\",\"author\":\"Gianulis EC\",\"pubdate\":\"2011 Jun 24\",\"source\":\"J Biol Chem\",\"uid\":\"21536673\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"2.5\",\"ExperimentalEvidenceTotal\":\"1\",\"EvidencePointsTotal\":\"3.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01/13/17\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511312400,
    "dateISO8601": "2017-11-21T17:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10155": {
    "title": "KCNJ8: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:6269": {
        "ontology": "HGNC",
        "curie": "HGNC:6269",
        "uri": "HGNC6269"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011001"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530660569\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"KCNJ8\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:6269\",\"uri\":\"HGNC6269\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"KCNJ8 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.25\",\"Tally\":\"0.25\",\"evidence\":{\"publications\":{\"1530660630050\":{\"title\":\"Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes.\",\"author\":\"Medeiros-Domingo A\",\"pubdate\":\"2010 Oct\",\"source\":\"Heart Rhythm\",\"uid\":\"20558321\"},\"1530660641169\":{\"title\":\"Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8.\",\"author\":\"Barajas-Mart\\u00ednez H\",\"pubdate\":\"2012 Apr\",\"source\":\"Heart Rhythm\",\"uid\":\"22056721\"},\"1530660666040\":{\"title\":\"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.\",\"author\":\"Crotti L\",\"pubdate\":\"2012 Oct 9\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"22840528\"},\"1530660854993\":{\"title\":\"Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel.\",\"author\":\"Ha\\u00efssaguerre M\",\"pubdate\":\"2009 Jan\",\"source\":\"J Cardiovasc Electrophysiol\",\"uid\":\"19120683\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.25\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530660716256\":{\"title\":\"Role of ATP-sensitive K+ channels in cardiac arrhythmias.\",\"author\":\"Nakaya H\",\"pubdate\":\"2014 May\",\"source\":\"J Cardiovasc Pharmacol Ther\",\"uid\":\"24367007\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530660805195\":{\"title\":\"Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1.\",\"author\":\"Miki T\",\"pubdate\":\"2002 May\",\"source\":\"Nat Med\",\"uid\":\"11984590\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.25\",\"ExperimentalEvidenceTotal\":\"0.5\",\"EvidencePointsTotal\":\"0.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01/19/17\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10156": {
    "title": "PKP2: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:9024": {
        "ontology": "HGNC",
        "curie": "HGNC:9024",
        "uri": "HGNC9024"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011001"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530661053\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"PKP2\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:9024\",\"uri\":\"HGNC9024\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"PKP2 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1530661176682\":{\"title\":\"Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.\",\"author\":\"Cerrone M\",\"pubdate\":\"2014 Mar 11\",\"source\":\"Circulation\",\"uid\":\"24352520\"},\"1530661284364\":{\"title\":\"Epicardial Ventricular Tachycardia Ablation in a Patient With Brugada ECG Pattern and Mutation of PKP2 and DSP Genes.\",\"author\":\"Forkmann M\",\"pubdate\":\"2015 Apr\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"25900994\"},\"1530661304856\":{\"title\":\"High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.\",\"author\":\"Hasdemir C\",\"pubdate\":\"2015 Jul\",\"source\":\"Heart Rhythm\",\"uid\":\"25998140\"},\"1530661568840\":{\"title\":\"Arrhythmogenic cardiomyopathy and provocable Brugada ECG in a patient caused by missense mutation in plakophilin-2.\",\"author\":\"Peters S\",\"pubdate\":\"2014 May 1\",\"source\":\"Int J Cardiol\",\"uid\":\"24681023\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530661475493\":{\"title\":\"Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes.\",\"author\":\"Sato PY\",\"pubdate\":\"2009 Sep 11\",\"source\":\"Circ Res\",\"uid\":\"19661460\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530661505736\":{\"title\":\"Plakophilins 2a and 2b: constitutive proteins of dual location in the karyoplasm and the desmosomal plaque.\",\"author\":\"Mertens C\",\"pubdate\":\"1996 Nov\",\"source\":\"J Cell Biol\",\"uid\":\"8922383\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530661691541\":{\"title\":\"Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.\",\"author\":\"Cerrone M\",\"pubdate\":\"2014 Mar 11\",\"source\":\"Circulation\",\"uid\":\"24352520\"},\"1530661705685\":{\"title\":\"Desmosomes and the sodium channel complex: implications for arrhythmogenic cardiomyopathy and Brugada syndrome.\",\"author\":\"Cerrone M\",\"pubdate\":\"2014 Jul\",\"source\":\"Trends Cardiovasc Med\",\"uid\":\"24656989\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.75\",\"NonPatientCells\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530661750267\":{\"title\":\"Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes.\",\"author\":\"Sato PY\",\"pubdate\":\"2009 Sep 11\",\"source\":\"Circ Res\",\"uid\":\"19661460\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\",\"evidence\":{\"publications\":{\"1530661444005\":{\"title\":\"Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency.\",\"author\":\"Cerrone M\",\"pubdate\":\"2012 Sep 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"22764151\"}},\"notes\":{\"note\":\"\"}}},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.25\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.5\",\"ExperimentalEvidenceTotal\":\"1.25\",\"EvidencePointsTotal\":\"1.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01/27/17\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10157": {
    "title": "RANGRF: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:17679": {
        "ontology": "HGNC",
        "curie": "HGNC:17679",
        "uri": "HGNC17679"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015263"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530662466\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"RANGRF\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:17679\",\"uri\":\"HGNC17679\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"RANGRF Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1530662000378\":{\"title\":\"MOG1: a new susceptibility gene for Brugada syndrome.\",\"author\":\"Kattygnarath D\",\"pubdate\":\"2011 Jun\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"21447824\"},\"1530662019058\":{\"title\":\"Brugada syndrome and p.E61X_RANGRF.\",\"author\":\"Campuzano O\",\"pubdate\":\"2014\",\"source\":\"Cardiol J\",\"uid\":\"24142675\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530662409648\":{\"title\":\"Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5.\",\"author\":\"Wu L\",\"pubdate\":\"2008 Mar 14\",\"source\":\"J Biol Chem\",\"uid\":\"18184654\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1.25\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530662131555\":{\"title\":\"MOG1: a new susceptibility gene for Brugada syndrome.\",\"author\":\"Kattygnarath D\",\"pubdate\":\"2011 Jun\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"21447824\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530662090646\":{\"title\":\"A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmias.\",\"author\":\"Olesen MS\",\"pubdate\":\"2011 Jul-Aug\",\"source\":\"Can J Cardiol\",\"uid\":\"21621375\"},\"1530662423156\":{\"title\":\"Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5.\",\"author\":\"Wu L\",\"pubdate\":\"2008 Mar 14\",\"source\":\"J Biol Chem\",\"uid\":\"18184654\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\",\"evidence\":{\"publications\":{\"1530662337026\":{\"title\":\"MOG1 rescues defective trafficking of Na(v)1.5 mutations in Brugada syndrome and sick sinus syndrome.\",\"author\":\"Chakrabarti S\",\"pubdate\":\"2013 Apr\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"23420830\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530662097285\":{\"title\":\"A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmias.\",\"author\":\"Olesen MS\",\"pubdate\":\"2011 Jul-Aug\",\"source\":\"Can J Cardiol\",\"uid\":\"21621375\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.50\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"0.5\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530662110517\":{\"title\":\"Cardiac sodium channel regulator MOG1 regulates cardiac morphogenesis and rhythm.\",\"author\":\"Zhou J\",\"pubdate\":\"2016 Feb 23\",\"source\":\"Sci Rep\",\"uid\":\"26903377\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"2.25\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.5\",\"ExperimentalEvidenceTotal\":\"2.25\",\"EvidencePointsTotal\":\"2.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"01/12/17\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10158": {
    "title": "SCN1B: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:10586": {
        "ontology": "HGNC",
        "curie": "HGNC:10586",
        "uri": "HGNC10586"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011001"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530662583\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SCN1B\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:10586\",\"uri\":\"HGNC10586\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"SCN1B Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1530662970733\":{\"title\":\"SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients.\",\"author\":\"Ricci MT\",\"pubdate\":\"2014 Sep 25\",\"source\":\"Sci Rep\",\"uid\":\"25253298\"},\"1530662988808\":{\"title\":\"A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.\",\"author\":\"Hu D\",\"pubdate\":\"2012 May\",\"source\":\"Heart Rhythm\",\"uid\":\"22155597\"},\"1530663058995\":{\"title\":\"Contribution of Cardiac Sodium Channel \\u03b2-Subunit Variants to Brugada Syndrome.\",\"author\":\"Peeters U\",\"pubdate\":\"2015\",\"source\":\"Circ J\",\"uid\":\"26179811\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1530662959056\":{\"title\":\"Sodium channel \\u03b21 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans.\",\"author\":\"Watanabe H\",\"pubdate\":\"2008 Jun\",\"source\":\"J Clin Invest\",\"uid\":\"18464934\"},\"1530663283863\":{\"title\":\"SCN1Bb R214Q found in 3 patients: 1 with Brugada syndrome and 2 with lone atrial fibrillation.\",\"author\":\"Olesen MS\",\"pubdate\":\"2012 May\",\"source\":\"Heart Rhythm\",\"uid\":\"22155598\"},\"1530663367313\":{\"title\":\"Cardiac conduction defects and Brugada syndrome: A family with overlap syndrome carrying a nonsense SCN5A mutation.\",\"author\":\"Aoki H\",\"pubdate\":\"2017 Feb\",\"source\":\"J Arrhythm\",\"uid\":\"28217227\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"0.00\"},\"Tally\":\"0\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530662872871\":{\"title\":\"Contribution of Cardiac Sodium Channel \\u03b2-Subunit Variants to Brugada Syndrome.\",\"author\":\"Peeters U\",\"pubdate\":\"2015\",\"source\":\"Circ J\",\"uid\":\"26179811\"},\"1530662892331\":{\"title\":\"Sodium channel \\u03b21 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans.\",\"author\":\"Watanabe H\",\"pubdate\":\"2008 Jun\",\"source\":\"J Clin Invest\",\"uid\":\"18464934\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.75\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530662882702\":{\"title\":\"SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients.\",\"author\":\"Ricci MT\",\"pubdate\":\"2014 Sep 25\",\"source\":\"Sci Rep\",\"uid\":\"25253298\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.50\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"0.5\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530662900260\":{\"title\":\"Sodium channel \\u03b21 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans.\",\"author\":\"Watanabe H\",\"pubdate\":\"2008 Jun\",\"source\":\"J Clin Invest\",\"uid\":\"18464934\"},\"1530663329022\":{\"title\":\"Scn1b deletion leads to increased tetrodotoxin-sensitive sodium current, altered intracellular calcium homeostasis and arrhythmias in murine hearts.\",\"author\":\"Lin X\",\"pubdate\":\"2015 Mar 15\",\"source\":\"J Physiol\",\"uid\":\"25772295\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.25\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1\",\"ExperimentalEvidenceTotal\":\"1.25\",\"EvidencePointsTotal\":\"2.25\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"12/22/2016\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10159": {
    "title": "SCN2B: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:10589": {
        "ontology": "HGNC",
        "curie": "HGNC:10589",
        "uri": "HGNC10589"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011001"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530663649\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SCN2B\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:10589\",\"uri\":\"HGNC10589\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"SCN2B Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"1.00\",\"Tally\":\"1\",\"evidence\":{\"publications\":{\"1530663719285\":{\"title\":\"A missense mutation in the sodium channel \\u03b22 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.\",\"author\":\"Riur\\u00f3 H\",\"pubdate\":\"2013 Jul\",\"source\":\"Hum Mutat\",\"uid\":\"23559163\"},\"1530663731135\":{\"title\":\"Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort.\",\"author\":\"Selga E\",\"pubdate\":\"2015\",\"source\":\"PLoS One\",\"uid\":\"26173111\"},\"1530663748696\":{\"title\":\"Contribution of Cardiac Sodium Channel \\u03b2-Subunit Variants to Brugada Syndrome.\",\"author\":\"Peeters U\",\"pubdate\":\"2015\",\"source\":\"Circ J\",\"uid\":\"26179811\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.25\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530663987924\":{\"title\":\"Mutations in sodium channel \\u03b21- and \\u03b22-subunits associated with atrial fibrillation.\",\"author\":\"Watanabe H\",\"pubdate\":\"2009 Jun\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"19808477\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"1\",\"NonPatientCells\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530663766775\":{\"title\":\"A missense mutation in the sodium channel \\u03b22 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.\",\"author\":\"Riur\\u00f3 H\",\"pubdate\":\"2013 Jul\",\"source\":\"Hum Mutat\",\"uid\":\"23559163\"},\"1530663794332\":{\"title\":\"Scn2b Deletion in Mice Results in Ventricular and Atrial Arrhythmias.\",\"author\":\"Bao Y\",\"pubdate\":\"2016 Dec\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"27932425\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530663780246\":{\"title\":\"Scn2b Deletion in Mice Results in Ventricular and Atrial Arrhythmias.\",\"author\":\"Bao Y\",\"pubdate\":\"2016 Dec\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"27932425\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.25\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"1\",\"ExperimentalEvidenceTotal\":\"1.25\",\"EvidencePointsTotal\":\"2.25\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07/05/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10160": {
    "title": "SCN3B: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:20665": {
        "ontology": "HGNC",
        "curie": "HGNC:20665",
        "uri": "HGNC20665"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011001"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530664150\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SCN3B\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:20665\",\"uri\":\"HGNC20665\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"SCN3B Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.50\",\"Tally\":\"0.5\",\"evidence\":{\"publications\":{\"1530664228465\":{\"title\":\"A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype.\",\"author\":\"Hu D\",\"pubdate\":\"2009 Jun\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"20031595\"},\"1530664245152\":{\"title\":\"Novel SCN3B mutation associated with brugada syndrome affects intracellular trafficking and function of Nav1.5.\",\"author\":\"Ishikawa T\",\"pubdate\":\"2013\",\"source\":\"Circ J\",\"uid\":\"23257389\"},\"1530664282182\":{\"title\":\"Contribution of Cardiac Sodium Channel \\u03b2-Subunit Variants to Brugada Syndrome.\",\"author\":\"Peeters U\",\"pubdate\":\"2015\",\"source\":\"Circ J\",\"uid\":\"26179811\"},\"1530664293434\":{\"title\":\"Is sudden unexplained nocturnal death syndrome in Southern China a cardiac sodium channel dysfunction disorder?\",\"author\":\"Liu C\",\"pubdate\":\"2014 Mar\",\"source\":\"Forensic Sci Int\",\"uid\":\"24529773\"},\"1530664317455\":{\"title\":\"Sudden infant death syndrome-associated mutations in the sodium channel beta subunits.\",\"author\":\"Tan BH\",\"pubdate\":\"2010 Jun\",\"source\":\"Heart Rhythm\",\"uid\":\"20226894\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530664395978\":{\"title\":\"The sodium channel beta-subunit SCN3b modulates the kinetics of SCN5a and is expressed heterogeneously in sheep heart.\",\"author\":\"Fahmi AI\",\"pubdate\":\"2001 Dec 15\",\"source\":\"J Physiol\",\"uid\":\"11744748\"},\"1530664411241\":{\"title\":\"Modulation of Na(v)1.5 by beta1-- and beta3-subunit co-expression in mammalian cells.\",\"author\":\"Ko SH\",\"pubdate\":\"2005 Jan\",\"source\":\"Pflugers Arch\",\"uid\":\"15455233\"},\"1530664469708\":{\"title\":\"Distinct subcellular localization of different sodium channel alpha and beta subunits in single ventricular myocytes from mouse heart.\",\"author\":\"Maier SK\",\"pubdate\":\"2004 Mar 23\",\"source\":\"Circulation\",\"uid\":\"15007009\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"1\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530664427479\":{\"title\":\"A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype.\",\"author\":\"Hu D\",\"pubdate\":\"2009 Jun\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"20031595\"},\"1530664439305\":{\"title\":\"Mutations in sodium channel \\u03b2-subunit SCN3B are associated with early-onset lone atrial fibrillation.\",\"author\":\"Olesen MS\",\"pubdate\":\"2011 Mar 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"21051419\"},\"1530664455290\":{\"title\":\"Scn3b knockout mice exhibit abnormal ventricular electrophysiological properties.\",\"author\":\"Hakim P\",\"pubdate\":\"2008 Oct-Nov\",\"source\":\"Prog Biophys Mol Biol\",\"uid\":\"19351516\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\",\"evidence\":{\"publications\":{\"1530664344778\":{\"title\":\"A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype.\",\"author\":\"Hu D\",\"pubdate\":\"2009 Jun\",\"source\":\"Circ Cardiovasc Genet\",\"uid\":\"20031595\"},\"1530664357861\":{\"title\":\"Novel SCN3B mutation associated with brugada syndrome affects intracellular trafficking and function of Nav1.5.\",\"author\":\"Ishikawa T\",\"pubdate\":\"2013\",\"source\":\"Circ J\",\"uid\":\"23257389\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"2.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"2\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530664481815\":{\"title\":\"Scn3b knockout mice exhibit abnormal ventricular electrophysiological properties.\",\"author\":\"Hakim P\",\"pubdate\":\"2008 Oct-Nov\",\"source\":\"Prog Biophys Mol Biol\",\"uid\":\"19351516\"},\"1530664621382\":{\"title\":\"Embryonic type Na<sup>+</sup> channel \\u03b2-subunit, SCN3B masks the disease phenotype of Brugada syndrome.\",\"author\":\"Okata S\",\"pubdate\":\"2016 Sep 28\",\"source\":\"Sci Rep\",\"uid\":\"27677334\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"3\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.5\",\"ExperimentalEvidenceTotal\":\"3\",\"EvidencePointsTotal\":\"3.5\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"12/01/2016\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10161": {
    "title": "SCN10A: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:10582": {
        "ontology": "HGNC",
        "curie": "HGNC:10582",
        "uri": "HGNC10582"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0011001"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530665561\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SCN10A\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:10582\",\"uri\":\"HGNC10582\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"SCN10A Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"evidence\":{\"publications\":{\"1530664887753\":{\"title\":\"Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome.\",\"author\":\"Hu D\",\"pubdate\":\"2014 Jul 8\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"24998131\"},\"1530664996201\":{\"title\":\"Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study.\",\"author\":\"Behr ER\",\"pubdate\":\"2015 Jun 1\",\"source\":\"Cardiovasc Res\",\"uid\":\"25691538\"},\"1530665029664\":{\"title\":\"Novel SCN10A variants associated with Brugada syndrome.\",\"author\":\"Fukuyama M\",\"pubdate\":\"2016 Jun\",\"source\":\"Europace\",\"uid\":\"25842276\"},\"1530665055635\":{\"title\":\"Association of common and rare variants of SCN10A gene with sudden unexplained nocturnal death syndrome in Chinese Han population.\",\"author\":\"Zhang L\",\"pubdate\":\"2017 Jan\",\"source\":\"Int J Legal Med\",\"uid\":\"27272739\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"3\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"0.75\",\"ProteinInteraction\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530665078853\":{\"title\":\"Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome.\",\"author\":\"Hu D\",\"pubdate\":\"2014 Jul 8\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"24998131\"},\"1530665503248\":{\"title\":\"A common genetic variant within SCN10A modulates cardiac SCN5A expression.\",\"author\":\"van den Boogaard M\",\"pubdate\":\"2014 Apr\",\"source\":\"J Clin Invest\",\"uid\":\"24642470\"}},\"notes\":{\"note\":\"\"}}},\"Expression\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530665312248\":{\"title\":\"A tetrodotoxin-resistant voltage-gated sodium channel from human dorsal root ganglia, hPN3/SCN10A.\",\"author\":\"Rabert DK\",\"pubdate\":\"1998 Nov\",\"source\":\"Pain\",\"uid\":\"9839820\"},\"1530665439204\":{\"title\":\"Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic.\",\"author\":\"Yang T\",\"pubdate\":\"2012 Jul 20\",\"source\":\"Circ Res\",\"uid\":\"22723299\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"0.5\",\"NonPatientCells\":{\"Value\":\"0.50\",\"evidence\":{\"publications\":{\"1530665091101\":{\"title\":\"Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic.\",\"author\":\"Yang T\",\"pubdate\":\"2012 Jul 20\",\"source\":\"Circ Res\",\"uid\":\"22723299\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530665391732\":{\"title\":\"Contrasting Nav1.8 Activity in Scn10a-/- Ventricular Myocytes and the Intact Heart.\",\"author\":\"Stroud DM\",\"pubdate\":\"2016 Nov 2\",\"source\":\"J Am Heart Assoc\",\"uid\":\"27806966\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.25\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"3\",\"ExperimentalEvidenceTotal\":\"1.25\",\"EvidencePointsTotal\":\"4.25\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07/18/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10163": {
    "title": "SLMAP: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:16643": {
        "ontology": "HGNC",
        "curie": "HGNC:16643",
        "uri": "HGNC16643"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015263"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530665794\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SLMAP\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:16643\",\"uri\":\"HGNC16643\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"SLMAP Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"0.25\",\"Tally\":\"0.25\",\"evidence\":{\"publications\":{\"1530665990552\":{\"title\":\"A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5.\",\"author\":\"Ishikawa T\",\"pubdate\":\"2012 Dec\",\"source\":\"Circ Arrhythm Electrophysiol\",\"uid\":\"23064965\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"0.25\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530666152564\":{\"title\":\"Molecular properties of cardiac tail-anchored membrane protein SLMAP are consistent with structural role in arrangement of excitation-contraction coupling apparatus.\",\"author\":\"Guzzo RM\",\"pubdate\":\"2005 Apr\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"15591093\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"0.5\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"0.25\",\"evidence\":{\"publications\":{\"1530666112007\":{\"title\":\"Molecular cloning, expression, and chromosomal assignment of sarcolemmal-associated proteins. A family of acidic amphipathic alpha-helical proteins associated with the membrane.\",\"author\":\"Wigle JT\",\"pubdate\":\"1997 Dec 19\",\"source\":\"J Biol Chem\",\"uid\":\"9405447\"}},\"notes\":{\"note\":\"\"}}}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"1.00\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"1\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530666192249\":{\"title\":\"Tail-anchored membrane protein SLMAP is a novel regulator of cardiac function at the sarcoplasmic reticulum.\",\"author\":\"Nader M\",\"pubdate\":\"2012 Mar 1\",\"source\":\"Am J Physiol Heart Circ Physiol\",\"uid\":\"22180652\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"0.25\",\"ExperimentalEvidenceTotal\":\"1.5\",\"EvidencePointsTotal\":\"1.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07/11/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10164": {
    "title": "TRPM4: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:17993": {
        "ontology": "HGNC",
        "curie": "HGNC:17993",
        "uri": "HGNC17993"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015263"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3980": {
        "label": "Contradictory (disputed)"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530666718\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"TRPM4\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:17993\",\"uri\":\"HGNC17993\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"TRPM4 Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"2.25\",\"Tally\":\"2.25\",\"evidence\":{\"publications\":{\"1530666462400\":{\"title\":\"Brugada ECG pattern: a physiopathological prospective study based on clinical, electrophysiological, angiographic, and genetic findings.\",\"author\":\"Duthoit G\",\"pubdate\":\"2012\",\"source\":\"Front Physiol\",\"uid\":\"23293604\"},\"1530666491255\":{\"title\":\"Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel.\",\"author\":\"Liu H\",\"pubdate\":\"2013\",\"source\":\"PLoS One\",\"uid\":\"23382873\"},\"1530666520819\":{\"title\":\"Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome.\",\"author\":\"Gualandi F\",\"pubdate\":\"2017\",\"source\":\"Cardiology\",\"uid\":\"28494446\"},\"1530666668437\":{\"title\":\"Mutational spectrum in the Ca(2+)—activated cation channel gene TRPM4 in patients with cardiac conductance disturbances.\",\"author\":\"Stallmeyer B\",\"pubdate\":\"2012 Jan\",\"source\":\"Hum Mutat\",\"uid\":\"21887725\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"\",\"Tally\":\"\"}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"\",\"AggregateVariantAnalysis\":{\"Value\":\"\"}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"2.25\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\"},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\"}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"0.50\"},\"CellCultureModel\":{\"Value\":\"\"}},\"ModelsRescue\":{\"Tally\":\"0.5\",\"NonHumanModelOrganism\":{\"evidence\":{\"publications\":{\"1530666559902\":{\"title\":\"Increased \\u03b2-adrenergic inotropy in ventricular myocardium from Trpm4-/- mice.\",\"author\":\"Mathar I\",\"pubdate\":\"2014 Jan 17\",\"source\":\"Circ Res\",\"uid\":\"24226423\"},\"1530666578764\":{\"title\":\"TRPM4 channels in the cardiovascular system.\",\"author\":\"Kruse M\",\"pubdate\":\"2014 Apr\",\"source\":\"Curr Opin Pharmacol\",\"uid\":\"24721656\"},\"1530666703731\":{\"title\":\"Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations.\",\"author\":\"Demion M\",\"pubdate\":\"2014\",\"source\":\"PLoS One\",\"uid\":\"25531103\"}},\"notes\":{\"note\":\"\"}}}},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"0.5\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"2.25\",\"ExperimentalEvidenceTotal\":\"0.5\",\"EvidencePointsTotal\":\"2.75\",\"CalculatedClassification\":\"LIMITED\",\"CalculatedClassificationDate\":\"07/09/2017\",\"CuratorModifyCalculation\":\"YES\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DISPUTED\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  },
  "10165": {
    "title": "SCN5A: Brugada Syndrome",
    "label": "Brugada Syndrome",
    "type": "clinicalValidity",
    "affiliation": {
      "id": "10045",
      "name": "Brugada Syndrome"
    },
    "genes": {
      "HGNC:10593": {
        "ontology": "HGNC",
        "curie": "HGNC:10593",
        "uri": "HGNC10593"
      }
    },
    "conditions": {
      "MONDO": {
        "ontology": "MONDO",
        "iri": "http://purl.obolibrary.org/obo/MONDO_0015263"
      },
      "OMIM601144": {
        "ontology": "OMIM",
        "curie": "OMIM:601144",
        "uri": "OMIM601144",
        "iri": "http://purl.obolibrary.org/obo/OMIM_601144"
      },
      "ORPHA130": {
        "ontology": "ORPHA",
        "curie": "ORPHA:130",
        "uri": "ORPHA130",
        "iri": "http://www.orpha.net/ORDO/Orphanet_130"
      }
    },
    "scores": {
      "3979": {
        "label": "Definitive"
      }
    },
    "scoreJsonSerialized": "",
    "scoreJsonSerializedSop5": "{\"iri\":\"http://www.clinicalgenome.org/gci-lite/1530666845\",\"jsonMessageVersion\":\"GCILite.5\",\"statusPublishFlag\":\"Publish\",\"SopVersion\":\"5.0\",\"type\":\"clinicalValidity\",\"genes\":{\"symbol\":\"SCN5A\",\"ontology\":\"HGNC\",\"curie\":\"HGNC:10593\",\"uri\":\"HGNC10593\"},\"condition\":{\"name\":\"Brugada Syndrome\",\"OrphaNet\":{\"curie\":\"ORPHA:130\",\"uri\":\"ORPHA130\"},\"MONDO\":{\"curie\":\"MONDO:0011001\",\"uri\":\"MONDO0011001\"},\"OMIM\":{\"curie\":\"OMIM:601144\",\"uri\":\"OMIM601144\"}},\"title\":\"SCN5A Brugada Syndrome\",\"scoreJson\":{\"ModeOfInheritance\":\"Autosomal dominant inheritance (HP:0000006)\",\"GeneticEvidence\":{\"CaseLevelData\":{\"VariantEvidence\":{\"AutosomalDominantOrXlinkedDisorder\":{\"VariantIsDeNovo\":{\"Value\":\"\",\"Tally\":\"\"},\"ProbandWithPredictedOrProvenNullVariant\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"evidence\":{\"publications\":{\"1530667111613\":{\"title\":\"Novel mutations in domain I of SCN5A cause Brugada syndrome.\",\"author\":\"Vatta M\",\"pubdate\":\"2002 Apr\",\"source\":\"Mol Genet Metab\",\"uid\":\"12051963\"},\"1530667147506\":{\"title\":\"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.\",\"author\":\"Chen Q\",\"pubdate\":\"1998 Mar 19\",\"source\":\"Nature\",\"uid\":\"9521325\"}},\"notes\":{\"note\":\"\"}}},\"ProbandWithOtherVariantTypeWithSomeEvidenceOfGeneImpact\":{\"Value\":\"2.50\",\"Tally\":\"2.5\",\"evidence\":{\"publications\":{\"1530666938420\":{\"title\":\"Novel mutations in domain I of SCN5A cause Brugada syndrome.\",\"author\":\"Vatta M\",\"pubdate\":\"2002 Apr\",\"source\":\"Mol Genet Metab\",\"uid\":\"12051963\"},\"1530666957480\":{\"title\":\"Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes.\",\"author\":\"Desch\\u00eanes I\",\"pubdate\":\"2000 Apr\",\"source\":\"Cardiovasc Res\",\"uid\":\"10727653\"},\"1530666980611\":{\"title\":\"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.\",\"author\":\"Chen Q\",\"pubdate\":\"1998 Mar 19\",\"source\":\"Nature\",\"uid\":\"9521325\"},\"1530667408586\":{\"title\":\"A single Na(+) channel mutation causing both long-QT and Brugada syndromes.\",\"author\":\"Bezzina C\",\"pubdate\":\"1999 Dec 3-17\",\"source\":\"Circ Res\",\"uid\":\"10590249\"}},\"notes\":{\"note\":\"\"}}}},\"AutosomalRecessiveDisease\":{\"TwoVariantsInTransAndAtLeastOneDeNovoOrAPredictedProvenNullVariant\":{\"Value\":\"\"},\"Tally\":\"\",\"TwoVariantsNotPredictedProvenNullWithSomeEvidenceOfGeneImpactInTrans\":{\"Value\":\"\"}}},\"SegregationEvidence\":{\"EvidenceOfSegregationInOneOrMoreFamilies\":{\"Value\":\"3.00\",\"Tally\":\"3\",\"1\":{\"evidence\":{\"publications\":{\"1530667198963\":{\"title\":\"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.\",\"author\":\"Chen Q\",\"pubdate\":\"1998 Mar 19\",\"source\":\"Nature\",\"uid\":\"9521325\"}},\"notes\":{\"note\":\"\"}}}}}},\"CaseControlData\":{\"SingleVariantAnalysis\":{\"Value\":\"\"},\"Tally\":\"5.5\",\"AggregateVariantAnalysis\":{\"Value\":\"5.50\",\"evidence\":{\"publications\":{\"1530667017568\":{\"title\":\"An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.\",\"author\":\"Kapplinger JD\",\"pubdate\":\"2010 Jan\",\"source\":\"Heart Rhythm\",\"uid\":\"20129283\"},\"1530667038737\":{\"title\":\"Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease.\",\"author\":\"Schulze-Bahr E\",\"pubdate\":\"2003 Jun\",\"source\":\"Hum Mutat\",\"uid\":\"14961552\"}},\"notes\":{\"note\":\"\"}}}},\"TotalGeneticEvidencePoints\":{\"Tally\":\"12\",\"notes\":\"\"}},\"ExperimentalEvidence\":{\"Function\":{\"BiochemicalFunction\":{\"Value\":\"\"},\"Tally\":\"\",\"ProteinInteraction\":{\"Value\":\"\"},\"Expression\":{\"Value\":\"\"}},\"FunctionalAlteration\":{\"PatientCells\":{\"Value\":\"\",\"evidence\":{\"publications\":{\"1530667071394\":{\"title\":\"Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.\",\"author\":\"Liang P\",\"pubdate\":\"2016 Nov 8\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"27810048\"}},\"notes\":{\"note\":\"\"}}},\"Tally\":\"\",\"NonPatientCells\":{\"Value\":\"\",\"evidence\":{\"publications\":{\"1530667349033\":{\"title\":\"Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.\",\"author\":\"Rook MB\",\"pubdate\":\"1999 Dec\",\"source\":\"Cardiovasc Res\",\"uid\":\"10690282\"}},\"notes\":{\"note\":\"\"}}}},\"Models\":{\"NonHumanModelOrganism\":{\"Value\":\"\"},\"CellCultureModel\":{\"Value\":\"1.00\",\"evidence\":{\"publications\":{\"1530667251596\":{\"title\":\"Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.\",\"author\":\"Liang P\",\"pubdate\":\"2016 Nov 8\",\"source\":\"J Am Coll Cardiol\",\"uid\":\"27810048\"}},\"notes\":{\"note\":\"\"}}}},\"ModelsRescue\":{\"Tally\":\"1\"},\"Rescue\":{\"RescueInHuman\":{\"Value\":\"\"},\"RescueInNonHumanModelOrganism\":{\"Value\":\"\"},\"RescueInCellCultureModel\":{\"Value\":\"\"},\"RescueInPatientCell\":{\"Value\":\"\"}},\"TotalExperimentalEvidencePoints\":{\"Tally\":\"1\",\"notes\":\"\"}},\"summary\":{\"GeneticEvidenceTotal\":\"12\",\"ExperimentalEvidenceTotal\":\"1\",\"EvidencePointsTotal\":\"13\",\"CalculatedClassification\":\"DEFINITIVE\",\"CalculatedClassificationDate\":\"07/13/2017\",\"CuratorClassification\":\"\",\"CuratorClassificationDate\":\"\",\"CuratorClassificationNotes\":\"\",\"FinalClassification\":\"DEFINITIVE\",\"FinalClassificationDate\":\"11/21/2017\",\"FinalClassificationNotes\":\"\"},\"ReplicationOverTime\":\"YES\",\"ValidContradictoryEvidence\":{\"value\":\"\"}}}",
    "file": null,
    "date": 1511251200,
    "dateISO8601": "2017-11-21T00:00:00",
    "dateFormated": "Nov 21, 2017"
  }
}
